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ABSTRACT 
 
Introduction and aims: Following the 2008 financial crisis, performance 
monitoring and evaluation in the form of Health System Performance Assessment 
(HSPA) received heightened attention and is now used by policy makers and health 
service leaders for decision taking.  However, despite its increased importance and 
relevance, there is, as yet, no common internationally recognised standardised 
methodology for its development and implementation.  Moreover, whilst there is 
ample evidence linking HSPA with service improvement, the literature on the impact 
of HSPA upon health policy-making is limited.  The research questions aim at 
addressing these two research gaps, looking into the most appropriate method for 
developing a health system performance assessment framework for Malta and 
examining the role, if any, that national health system performance assessment 
frameworks play in the development of national health policy.  These two facets of 
HSPA are the focus of this research, where a methodology for implementing HSPA in 
a small state (Malta) is developed and the relationship between HSPA and policy 
development at national and European level is thoroughly investigated. 
 
Methods: The study consisted of three phases.  A comprehensive document 
analysis was first carried out.  This was followed by the development and 
implementation of a HSPA framework and performance assessment report for Malta.  
The final phase consisted of a three-year ethnographic study across Europe’s capitals, 
resulting in the collection and analysis of data on the relationship between HSPA and 
health policy development in the European region.   
 
Results: HSPA methodology must combine scientific robustness with policy 
constraints to take into account the political exigencies of the health system it is 
purported to assess.  This is deemed both important and appropriate for HSPA, 
especially for small states like Malta.  The research also reveals the unique role HSPA 
plays in policy development, as one of the many variables that influences health 
policy.  However, the study also goes on to highlight the mismatch between the 
evidence generated by HSPA and a more evidence-based approach to policy making. 
 
Conclusions: The study concludes by proposing a new model for policy making, 
incorporating HSPA as a central tenet of this process.  Several options are then 
suggested to better align the disparate agendas of policy makers and researchers, such 
as matching the research and policy priorities closely at the start of the research and 
policy process. 
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CHAPTER 1 
BACKGROUND AND CONTEXT 
 
 
 
“Not everything that can be counted counts, and not everything 
that counts can be counted.” 
Albert Einstein 
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CHAPTER 1 
BACKGROUND AND CONTEXT 
 
 
 
1.1 Introduction 
The 2008 financial crisis changed the world as we knew it.  Health care was not spared.  
Consequently, the performance of health systems was put under the scrutiny of 
governments and international agencies, where health systems have since been 
constrained to function within a more restrictive environment, make do with less 
resources whilst dealing with increased expectations and greater efficiencies. 
 
Tools were subsequently developed to measure how health systems perform and 
function, where the collection, analysis and elucidation of performance data has had a 
major impact upon improving health systems and enhancing health care performance 
(Smith, et al., (2009a).  Moreover, over the last decade, the development of health 
system performance assessment (HSPA) frameworks has significantly contributed 
towards the advancement of performance assessment and improvement at system and 
national level.   
 
Although several countries and geo-political blocks have developed their own health 
system performance models, the methodology employed to develop these HSPA 
frameworks has not been well researched, with little standardisation between different 
models.  Also, whilst health system improvement is considered a priority, the effect 
of performance assessment upon steering the course of health systems through policy 
development is less clear.  There is little evidence to suggest that HSPAs have a direct, 
or indeed, subsidiary impact or influence upon the development and shaping of 
policies in the health sector.   
 
Research into the methodology utilised for the development of HSPA models and the 
results that are derived from this process as well as the relationship between HSPA 
and policy making are the rationale for this research. 
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1.2 Background and rational for study 
This section provides the context and rationale for this study, touching upon the 
current debate on HSPA development and its impact upon policy making.  It also 
introduces Malta as the focus for this research. 
 
1.2.1  Methodological development of HSPA frameworks 
In an attempt to continually improve health systems and the various facets within a 
health system, measurement of its performance became a crucial and determining 
component for the governance of health care services (World Health Organisation, 
2000).  The art and science of performance measurement and hence management, 
developed significantly over the last few decades and many modern health systems 
have now introduced robust and rigorous methods and tools for collecting and 
analysing the required data to be able to measure performance of the system as a 
whole, as well as its component parts (Gerring, et al., 2013).  Health system 
performance assessment is one such tool, used to assess the performance of a health 
system at national or system level, as opposed to the performance tools at 
organisational or institutional level.  The World Health Report produced by the World 
Health Organisation in 2000 heralded, for the first time, the concept of assessing and 
comparing the performance of its member states (World Health Organisation, 2010); 
(Murray & Evans, 2003).  The Tallinn Ministerial conference in 2008 and the resulting 
Tallinn Charter (World Health Organisation, Regional Office for Europe, 2008) 
launched HSPA at a European level and marked the start of performance assessment 
in Europe.   
Nevertheless, despite the promulgation of HSPA frameworks since the Tallinn 
Charter, the methodological development of these frameworks has not been well 
documented or researched (Braithwaite, et al., 2017).  Whilst each country that 
developed HSPA provided a descriptive account of the methodology used, the critical 
thinking and evolutionary or developmental process leading to their HSPA 
frameworks is rarely elaborated upon, assuming perhaps that each country has its own 
‘way’ of doing things (Carinci, et al., 2015).  Moreover, a standardised approach to 
HSPA development has, to date, not been advocated (Expert Panel On Effective Ways 
Of Investing In Health, 2014).  This is, in a way, similar to the natural history of Health 
Technology Assessments (HTA), which started off as disparate attempts at assessing 
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new technology, only to develop into a new scientific and standardised approach 
adopted across the EU (Garrido, et al., 2008).  Whether HSPA will follow the same 
fate is yet to be seen but a greater understanding and further research into the 
methodologies used for HSPA development are certainly required (Perić, Hofmarcher-
Holzhacker & Simon (2017).  One of the main facets of this research is to critically 
appraise the methodological development of HSPA models and in so doing, apply this 
knowledge to the production of Malta’s first HSPA. 
 
1.2.2  Malta 
Like some other European countries, Malta had yet to develop its first national Health 
System Performance Assessment (HSPA) framework.  Following the launch of its 
National Health System Strategy (NHSS), the need for a national HSPA framework 
became apparent and the author was commissioned, together with other experts to 
develop and test such a framework.  This was the first time Malta had the opportunity 
to assess its health system using a scientific approach and this study will outline the 
steps taken to develop this assessment.  Malta always had (and still has) a problem 
with measurement, where senior health service managers did not know precisely how 
the health services they manage are performing, especially at system or national level.  
As a senior member of Malta’s public health service, the author always struggled to 
gain insight into Malta’s health system performance, dealing with significant 
resistance and reticence to measure its performance.  This research offered a unique 
possibility to break the mould. 
 
Moreover, it is known that the capacity and propensity for developing HSPA 
frameworks is much more limited and challenging for small countries and hence small 
health systems such as Malta (Azzopardi Muscat & Camilleri, 2018); (Azzopardi 
Muscat, et al., 2016).  For this reason, Malta was chosen as a model for HSPA 
development in a small state since the methods employed for a small state may be 
different to other larger, perhaps more developed and mature health systems  (Grech 
& Lai, 2014).  Furthermore, Malta is also ideally placed for this research since, 
although small, it encapsulates all the aspects of a complete health system which can 
be more easily assessed and influenced by the findings of this study.  Part of this thesis 
outlines the methodological process undertaken by the researcher in achieving this 
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objective, as well as the results that followed, including the theoretical underpinnings 
that guided this process.   
 
1.2.3  HSPA and its impact on policy 
The latter part of the study follows from the previous sections in that it enquires into 
the usefulness of HSPA once these are developed and implemented, in terms of its 
influence on changing policy and instigating reform.  Every health system undergoes 
its unique evolutionary process.  Health systems take decades (if not centuries) in the 
making and are influenced by numerous externally driven and internally motivated 
factors (Figueras, et al., 2004).  Cultural, politic-socio-economic and structural factors 
determine the physiognomy of a health system over time and in turn, these factors 
have a direct and indirect impact upon policy development and change within a health 
system.  Health policy is shaped by both internal and external variables which in turn 
have a significant impact upon how a health system is moulded.  It is determined 
through the influence of health professionals, the role of unions and other professional 
groupings, patient advocacy groups, health related industries especially those related 
to pharmaceuticals and food, as well as the political agenda.  These factors shape 
health policy at the local, national and international level and furthermore determine 
the speed and extent of change and reform.  Some health systems are more susceptible 
to policy changes whilst others are slow to react to the needs of the population.  Many 
models of policy development have been promulgated (Warner & Bjarkman, 2011), 
(Walt, et al., 2008), and these shall be discussed as a preamble to this part of this 
research.  Many of these models have been extracted from other policy sectors and 
adapted to health systems and health care, without necessarily being empirically tested 
(Béland & Howlett, 2016).   
 
The literature provides ample empirical evidence on the link between performance 
assessment and measurement and improvement of health systems and health care 
(Loeb, 2004); (Smith, 2005); (Smith, et al., 2009a).  The advent of performance 
measures and the development of performance indicators in health care has been one 
of the singular most important tools for improving the performance of health care in 
many areas of clinical practise (Fitzpatrick, 2009).  Various countries have integrated 
performance measurement into service frameworks, with clear targets and 
deliverables.  This was the case, for instance, in England, where in 2001 the 
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Department of Health for England announced the National Service Framework (NSF) 
programme, which was a programme meant to transform the way services are 
delivered for patients by the National Health.  Moreover, there is evidence to show 
that, depending upon their agendas and priorities, health care organisations can 
influence the performance of the health system as a whole (Hauck, et al., 2003).  This, 
in itself, is not a negative aspect, unless there is lack of alignment between the 
objectives of the health system with that of its constituent parts. 
 
However, there seems to be little experience and hence evidence in the literature on 
how performance assessment frameworks impact health policy.  Smith and Busse 
(2009) examine how health policies and target setting may, and indeed do, influence 
the manner in which performance measurement is viewed and structured.  This is 
evidently obvious since in order to create and maintain a robust health system 
performance assessment framework, financial, human and technological resources 
need to be dedicated for this venture and hence governments and health care 
organisations need to commit such resources to continually measure their 
performance.  Conversely, the contrary is not evident, in that performance assessment 
can and should influence policy development.  Veillard et al. (2010) opine that whilst 
international comparisons of health systems are useful for governments to adjust their 
health policies, performance data still needs to be integrated into the policy-making 
process.  He cites a few non-European examples as exceptions, one of which is from 
the Ontario Ministry of Health and Long-Term Care in Canada where there is evidence 
to show that they make systematic use of performance information and its flow 
through the decision-making process. 
 
Performance assessment should be intricately linked to providing the evidence to 
generate change and reform.  Mannion and Goddard (2001) found that, although 
Scotland had a very well developed performance monitoring system in place, there is 
little to show for how this impacted upon changes in the health system.  Similarly, for 
the Dutch, successive publications of their biennial Dutch Health Care Performance 
Report have had minimal impact upon policy formulation and priority setting at 
national level (Westert, et al., 2010). 
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At the turn of the millennium, the World Health Organisation has already realised that 
the link between policy development and performance assessment frameworks was 
weak and consequently launched the Enhancing Health Systems Performance 
Initiative (EHSPI) as a means to improve and manage performance supported with 
relevant policies (World Health Organisation, 2001).  The aim was for the EHSPI to 
feed into the national policy debate, thereby linking evidence to priority objectives and 
subsequent actions. WHO hoped that, at a global level, EHSPI would enhance the 
movement towards more robust evidence-base policy making.   
 
The latter part of the study explores the underlying drivers of health policy and 
whether policy development is predominantly evidence-based or whether other more 
utilitarian factors have a greater influence upon policy formulation.  For the purposes 
of this thesis, the evidence base is postulated to be derived from health system 
performance data, including indicators embedded within purposefully created HSPA 
frameworks. 
 
1.2.4  Phases of study 
This study therefore focuses upon the development of a national health system 
performance assessment (HSPA) framework for Malta and considers the impact such 
frameworks have upon policy development.  The study consists of three phases: 
 
Phase I  Document Analysis 
Phase II Development of Malta’s HSPA 
Phase III Relationship between performance assessment and policy making 
 
These will be explained further in Chapter 3. 
 
1.3 Historical and policy context of Malta 
Malta has a very long and distinguished history of health care delivery, spanning 
several centuries.  The arrival in Malta of the Hospitallers Order of the Knights of St 
John placed Malta on the international medical map.  This order was renowned for its 
highest standards of care and innovative medical practices during this period (Savona-
Ventura, 1997), (Savona-Ventura, 2004).  The establishment of the Sacra Infermeria 
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in 1574 attracted many noble families from Europe for care and rehabilitation.  In 
1676, one of the oldest medical schools in the world was established by the Knights, 
heralding a new era of medical education, training, and best practices.  Malta’s health 
care system continued to strengthen during the English occupation between 1798 and 
1964, especially in the post-World War II era of medical and technological advances.   
 
In its post-independence years (post-1964), Malta experienced a few turbulent but 
significant events during a prolonged 10-year doctors’ strike which transformed the 
Maltese health care landscape completely (Azzopardi Muscat & Dixon (1999).  
Paradoxically, several new developments and primary and secondary care services 
arose from the turmoil of that period, which, coupled with the economic growth in the 
late eighties and early nineties, saw a considerable expansion of services and a revival 
of medical training and education (Pincock, (2005).  Accession to the European Union 
(EU) in 2004 provided further impetus for medical developments, especially in public 
health and pharmaceuticals, cumulating in the opening of Malta’s new main acute 
hospital in 2007, which, due to its contextual significance for Malta, impacted 
significantly upon the health system and its performance in the subsequent years 
(Azzopardi Muscat, et al., 2016). 
 
The Maltese Health System is unique in that it is a small but overly complete health 
care system.  Although small in size relative to other health systems, it serves the needs 
of an entire nation and its population.  It encompasses most, if not all, components of 
a modern health system, from primary, secondary and tertiary care, to public health 
services and health promotion/education, to community services and rehabilitation and 
mental health services (Azzopardi Muscat & Dixon, 1999).  Being an island state, 
although easily affected by outside influences in today’s modern age of 
communication and social media, external influences on the island in the past were 
less apparent and so improvements or the lack thereof of health care services and 
health outcomes in Malta in the past were mainly attributable to internal factors.  This 
unique ‘laboratory’ setting presents an ideal opportunity to study certain 
characteristics of a health system and how this system performed over time and in 
comparison, with other health systems.  On the other hand, since the different elements 
of the Maltese health system are similar to any other health system abroad, the findings 
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from this research may be applicable, to a certain extent, to other health systems, 
generating new knowledge and insight into how a health system work and performs.   
 
1.4 Research questions 
The research questions to be addressed in this study are based upon the two facets 
discussed earlier, namely the developmental process of HSPA and the relationship 
between HSPA and policy making.  The principal research questions are outlined 
below and presented in more detail in Chapter 3. 
 
1. Which is the most appropriate method for developing a health system 
performance assessment model for Malta? 
This explores the methods that can be employed for its development and 
implementation, elucidation of which set of national performance indicators 
would be the most appropriate for Malta’s first HSPA framework and an 
assessment on Malta’s health system. 
 
2. What role, if any, do national health system performance assessment 
frameworks play in the development of national health policy?   
This question examines the impact such frameworks have on policy 
development at a national level and how HSPA can be better utilised for policy 
making and service improvement. 
 
1.5 Aims and objectives 
The aim and objectives comprise two main elements, the first dealing with the 
development of a HSPA Framework for Malta and the second to study the relationship 
between HSPA and policy making. 
 
The overall aim of the study is to develop a national health system performance 
assessment framework for Malta and to examine the impact such frameworks have 
upon policy development. 
 
The objectives are derived from this aim and mirror the 3 phases of the study. 
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Phase I - Document Analysis 
The purpose of the document analysis is two-fold; first to understand the 
methodologies employed for the development of health system performance 
assessment models and secondly to elicit documentary and historical evidence on the 
impact of performance assessment on policy development. 
 
Phase II - Malta Health System Performance Assessment Framework 
The objectives of this phase centre on the development of Malta’s first ever HSPA, 
including the elucidation of a set of key national performance indicators for the 
Maltese health system and the presentation of the results of Malta’s first performance 
assessment of its health system. 
 
Phase III - Policy Development in relation to performance frameworks 
This third phase investigates the relationship between the introduction and 
implementation of national health system performance assessment frameworks and 
national policy making and reform.  It continues to evaluate whether evidence, in the 
form of HSPA, has a bearing upon the development and adoption of policies. 
 
These objectives are further outlined in Chapter 3. 
 
1.6 Contribution to research and policy development 
Each of the above-mentioned objectives aim to cover a gap in the current academic 
research, as well as address specific policy imperatives.  The development of a national 
performance assessment framework for Malta not only laid the groundwork for future 
performance measurement in Malta but also contributed to the body of European and 
international knowledge on the appropriate methodological process used for this type 
of endeavour.  Such a methodology could be compared and used to inform the 
development of other performance frameworks, especially for small states, and is also 
particularly apt at this juncture due to the increasing interest within EU circles to create 
a Europe-wide, standardised performance assessment framework and also to assist 
small countries in developing their own HSPA.  Moreover, the results emanating from 
measuring the indicators within the framework are comparable and useful for 
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benchmarking with other countries, opening the path for Malta to partake in numerous 
international comparative studies in the future. 
 
Although significant research has been carried out on the link between performance 
measurement and service improvement, the same could not be said of the link with 
policy development.  This study provides a unique insight into the relationship 
between national performance frameworks and the development of policy and 
implementation of reforms at national level.  This association is important to 
consolidate and expand the use of performance assessment frameworks whilst 
ensuring that policy making is grounded increasingly more in evidence rather than in 
other extraneous factors. 
 
1.7 Scope and structure of the thesis 
This thesis focuses upon the methodology for the development and implementation of 
national HSPA frameworks and the impact such frameworks have upon policy 
development. 
 
The next chapter, Chapter 2 provides a conceptual and analytical framework for the 
thesis, together with a literature review while Chapter 3 outlines the overall aims, 
research questions and methodologies employed for the study. 
 
The first phase of this research, outlined in Chapter 4, consists of a document analysis 
to explore the various methodologies and experiences in developing HSPA models 
internationally.  This review also began to investigate the relationship between 
performance assessment and policy development.   
 
The second phase of the thesis (Chapter 5) outlines the development of a national 
HSPA framework for Malta.  This is the first time that a formal model for performance 
measurement was produced at a national level in Malta.  The research delineates the 
methodological process undertaken to develop this framework whilst comparing with 
similar developments abroad.  It then creates a set of system wide performance 
indicators for Malta and outlines the results generated by this process. 
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There is strong evidence to suggest that the collection, analysis and elucidation of 
health performance data has a major impact upon improving health systems and health 
care performance (Smith, et al., 2009a).  However, the link or relationship between 
HSPA Frameworks and policy development and formulation, as well as policy change 
is less clear.  There is little evidence to suggest that HSPA frameworks have a direct, 
or indeed, subsidiary impact or influence upon the development and shaping of 
policies in the health sector.   
 
The third phase of this study, outlined in Chapter 6, examines this hypothesis by 
building on the findings of the document analysis in continuing to explore the 
relationship, if any, between HSPA frameworks and health policy development in the 
European region and examines whether such frameworks have an impact or influence 
upon policy development and change in several European countries.   
 
Due to the qualitative nature of Chapters 4 and 6, the results and discussion are 
presented together.  However, the author also discusses the results of all three stages 
of the research in a holistic and integrative manner in Chapter 7, whilst the 
conclusions determined by this study, as well as various recommendations are 
presented in Chapter 8. 
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CHAPTER 2 
LITERATURE REVIEW:  
A CONCEPTUAL AND ANALYTICAL FRAMEWORK 
 
 
 
“Without data, you’re just another person with an opinion.” 
W. Edwards Deming 
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CHAPTER 2 
LITERATURE REVIEW:  
A CONCEPTUAL AND ANALYTICAL FRAMEWORK 
 
 
 
2.1 Introduction 
This chapter outlines the historical and policy development of performance 
frameworks internationally and maps out their progress in different countries.  It 
considers current health performance frameworks, their origin and the process utilised 
to develop such frameworks.  The author will assess their applicability or otherwise 
for Malta as a model for the development of a similar national framework for this 
country.  The second part of the chapter draws upon the process of policy development 
in relation to HSPA and reflects on how it informs policy making and reform. 
 
2.2 Health systems 
There is no doubt that, throughout the centuries, health systems have contributed 
enormously towards improving the health of populations, where health systems have 
been attributed to increasing life expectancy and quality of life, mostly due to 
technological advances in medicine and better health care practices (Nolte & McKee, 
2004).  However, it was not until the seminal, if not controversial, work of the World 
Health Organisation (WHO) at the turn of the millennium that a comprehensive 
definition of a health system was proposed in its far-reaching World Health Report.  
This report defined the health system as ‘… all the activities whose primary purpose 
is to promote, restore or maintain health’.  Operationally, this definition is further 
dissected into comprising ‘the resources, actors and institutions related to the 
financing, regulation and provision of health actions,’ where health actions are ‘all 
activities whose primary purpose is to promote, restore or maintain health’ (World 
Health Organisation, 2000, p. 5). 
 
Most health systems share a common genesis in that they serve to generate health 
within and improve the health of a population by ensuring equitable access, 
guaranteeing an adequate standard of care and supporting an efficient and sustainable 
delivery of health care (McPake & Mills, 2000).  WHO summarises these attributes in 
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a succinct manner by stating that health systems should always strive towards three 
fundamental goals – ‘improving health, enhancing responsiveness to the expectations 
of the population, and assuring fairness of financial contribution’ (Murray & Frenk, 
2001).  In summary, health systems are in the business of continually improving the 
health outcomes of the population it serves and all health system performance 
measures ultimately measure this final objective or goal.   
 
Due to its inclusive nature, the boundaries of a health system are difficult to define.  A 
health system certainly incorporates all ‘health care’ activities but also includes 
‘public health’ activities, as well as formal and informal personal care and voluntary 
care (Canadian Institute for Health Information, 2013).  However, since health is 
determined by many interdependent factors, of which health care is only one, a multi-
dimensional approach to health is necessary to understand the complexity of health 
systems (Arah, et al., 2006).  This concept was first introduced by Lalonde in his 
‘White Paper’ in Canada in 1974 (Lalonde, 1974), which gave way to many other 
publications on the subject (Evans & Stoddart, 1990), leading eventually to the ever 
expanding research on social determinants of health (Marmot & Wilkinson, 2005). 
 
2.2.1  Measuring the performance of health systems 
Measurement of performance of health systems has been around for several years 
(McIntyre, et al., 2001).  Initially the performance of health care services and systems 
was measured through ad hoc, individual and non-related measures and indicators.  
These pertained, in the main, to general population health, responsiveness of the 
system to the health care needs of the population, throughput (production) indicators 
and financial parameters.  Other important performance domains were introduced 
during the eighties and nineties, mostly relating to quality of care, health equity, 
transparency and accountability, governance and cost-effectiveness or value for 
money.  Quality-adjusted or healthy life measures were later introduced as the focus 
shifted towards a healthier life rather than a longer life (Kelley & Hurst, 2006). 
 
The breakthrough in health system performance assessment was spurred by the 
publication of WHO’s World Health report (World Health Organisation, 2010) in 
2000, wherein WHO advocated the use of health system performance assessment and 
measurement as a key feature in the governance of health systems.  For the first time, 
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the performance of different health systems was measured and compared in a 
landmark health system performance assessment (Murray & Evans, 2003).  WHO 
defined health system performance assessment as ‘a country-specific process of 
monitoring, evaluating, communicating and reviewing the achievement of high-level 
health system goals based on health system strategies’ (World Health Organization, 
2012, p. ii).   
 
At a European level, the Tallinn Ministerial conference in 2008 and the resulting 
Tallinn Charter (World Health Organisation, Regional Office for Europe, 2008) 
committed EU countries, for the first time, albeit rather late in the day, to produce 
measurable results and to promote transparency and accountability for their health 
systems.  This marked the start of measuring health system performance in Europe, 
after which several countries took up the challenge (Van Den Berg, et al., 2014).   
 
2.2.2  Health system performance assessment frameworks 
Up until the 1990s, although the use of performance indicators was widespread, these 
indicators were not captured within a conceptual model or framework.  One of the first 
attempts to develop a performance framework at local level was that by van der Bij 
and Vissers in the Netherlands in 1999 (van der Bij & Vissers, 1999).  The seminal 
work of the WHO, the Organisation for Economic Co-operation and Development 
(OECD) and the Commonwealth Fund in the United States (Murray & Frenk, 2000), 
(Arah, et al., 2006), (Commonwealth Fund, Commission on a High Performance 
Health System, USA, 2006) laid the basis for further frameworks to be developed 
throughout the world (Department of Health, UK, 1999a), (Canadian Institute for 
Health Information, 2000), (Queensland Health, National Health Performance 
Committee, 2001), (Institute of Medicine, 2001a), (Institute of Medicine, 2001b), 
(Institute of Medicine, 2006).   
 
No explicit or direct definition of a performance assessment framework is evident 
from the literature.  The WHO, through its World Health Report in 2000, describes 
HSPA as a process carried out at country level which allows the health system to be 
assessed holistically; a ‘health check’, if you wish, of the entire health system (World 
Health Organisation, 2000).  The literature offers several references on what a HSPA 
framework is, how it works and its purpose, but no clear single definition is advocated.  
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The closest to a definition that the literature provides is that promulgated by the 
Department of Health in England, as that of a framework which ‘provides a structure 
and benchmarks for organisations to use to assess its performance.  It covers fair 
access to services, effective delivery of healthcare, efficiency and the patient and carer 
experience’ (Department of Health, UK, 2001, p. 6).  The World Bank states that a 
health system framework is a generic conceptual tool used to describe a health system, 
termed as follows: ‘It defines, describes and explains the health system, its objectives, 
structural and organizational elements, function and processes’ (Shakarishvili, et al., 
2009, p. 4).  A HSPA framework is a conceptual model that incorporates the most 
relevant dimensions that best describe the goals of the health system it promulgates.  
It depicts the inter-relationships that exist between the different dimensions of a health 
system and the goals of the health system (Kelley & Hurst, 2006) and therefore a 
HSPA framework permeates from the strategic objectives of the health system it is 
supposed to measure.   
 
These frameworks encompass a similar array of indicators organised into different 
health domains or dimensions, pertaining to effectiveness, quality and safety, 
responsiveness, access, equity, efficiency, financial mechanisms, determinants of 
health and more (Canadian Institute for Health Information, 2013).  A performance 
assessment framework typically groups these domains under health inputs, health 
outputs, health outcomes and health impact, outlining the journey of a health system 
in providing and improving health.   
 
Within each domain, performance indicators that are relevant to the health system are 
extracted and so a HSPA framework gives structure and formality to the measurement 
of the performance of the various components of a health system.  A HSPA framework 
also delineates the method of indicator selection, the data sources that are used for the 
indicators chosen, its analysis and how results are communicated to stakeholders 
(World Health Organisation, 2010).   
 
There is no universal template or methodology of developing a HSPA framework.  
Although WHO believes that each country should devise its own methodological 
process which is suitable for its circumstances and context, there are a few key 
principles which should be respected.   
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These are: 
 
• HSPA, as the name implies, should focus upon health systems as a 
whole and not on the components parts of a health system. 
• Outcome measures are better placed to mirror performance.  
• HSPA should form part of a regular process to measure performance 
and devise policy as implied within the policy cycle of a HSPA. 
• Although each country or health system should develop its own HSPA, 
its structure and content should be comparable with that of other 
countries and health systems. 
 
2.2.3  Indicators, the crux of performance assessment 
It is important to understand the key role of indicators in measuring performance.  The 
Joint Commission on Accreditation on Healthcare Organisations defined a 
performance indicator (PI) as a ‘measurement tool used to monitor and evaluate the 
quality of important governance, management, clinical and support functions’ (Joint 
Commission on Accreditation of Healthcare Organisations, 1990, p. 7).  The Health 
Information and Quality Authority of Ireland sees key performance indicators as 
measures of performance that are used by organisations to measure how well they are 
performing against targets or expectations. KPIs measure performance by showing 
trends to demonstrate that improvements are being made over time (Irish Health 
Information and Quality Authority, 2013).  Performance indicators can be regarded as 
tools in the hands of policy makers, scientists and health care providers to assess where 
they are, how they are performing at that point in time or over a period of time (looking 
at trends) and the direction they are taking.  Most of the work around indicators 
initially revolved around safety and quality of health care provision.  Eventually this 
was expanded to include every facet and aspect of health care, public health and the 
wider health outcomes.  However, Perera, Dowell and Crampton (2012, p. 49) warn 
that indicators are not always ‘axiomatically good’ since their application in the field 
depends upon the contextual background in which they are developed.  Developing 
indicators out of context is flawed if not dangerous since they may provide for 
incorrect and misleading data and information.  Perera, Dowell and Crampton. (2012) 
continue to explain that credibility of a performance system would suffer if indicators 
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are not developed and chosen appropriately for a defined purpose and if the data is 
misinterpreted.  This is especially relevant when PIs are utilised to measure 
performance by comparing results against standards or with other similar 
organisations. 
 
2.3 Search Method: Analysis of current HSPA frameworks 
The purpose of this first part of the chapter is to provide an analytical overview of the 
more salient studies and research that has been carried out in the area of performance 
assessment frameworks at health system level, starting with some broad definitions 
and followed by a historical overview in order to contextualise and understand the 
development of HSPA Frameworks.  This is followed by describing and comparing 
the different methodologies used in the drawing up of HSPA Frameworks.  Lastly, an 
analytical review was used to inform the methodological process towards the 
development of Malta’s first performance assessment framework, linking this to the 
research objectives and questions for the first phase of this dissertation. 
 
2.3.1  Sources of information used in this study 
The key words used as search terms for this part of the literature review were ‘health 
system’ (incorporating ‘health care’ where appropriate), ‘performance assessment 
and/or measurement,’ ‘framework’ and ‘performance indicators.’  A normal literature 
search method was employed since the aim was not to produce a systematic review 
using a strict methodology, such as Prisma.  
 
The electronic databases of Medline, Embase and Web of Science were first used to 
derive a representation of the width and breadth required for this research.  Medline 
was used to derive the main medical sources of information whilst Embase widened 
the search to include other aspects of human medicine and related biomedical research.  
Web of Science was sought to include articles extraneous to the typical medical fields 
and, in fact, the number of hits derived from the Web of Science exceeded the other 
two databases by far.  The year 2000 was chosen as the cut-off point since this seemed 
to be the period where performance assessment frameworks started to gain importance 
and relevance in the academic literature, with the exception of seminal articles.  Only 
English language peer-reviewed articles were sought, except in a few exceptions.  
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Depending upon the database used, single term searches produced hits in their 
hundreds or thousands in certain cases.  For this reason, combinations of two or, in 
some cases, three and even four keywords were necessary to narrow down the number 
of hits to more manageable and relevant numbers.  These searches produced numerous 
hits but many were of dubious relevance to the topics under review, especially in 
relation to the development and use of performance assessment/measurement 
frameworks and health system performance.  Many hits produced articles on either 
specific clinical areas (and were not relevant to system wide performance assessment), 
on hospital based performance studies or on performance measurement initiatives 
linked to service improvement but not linked to a specific performance assessment 
framework. 
 
Tables 2.1 – 2.4 provide a summary of the search results. The figures in brackets are 
the number of articles that were deemed relevant for this research and were 
downloaded and reviewed in detail.  The figures in the tables still include duplicates 
and the exercise of removing duplicates was undertaken after the more relevant articles 
were downloaded and reviewed.  In fact, the author noted that a saturation for new 
articles was reached after reviewing all three databases. 
 
Table 2.1: References from two-word combinations (just Medline) 
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Framework 
12 (1) 1 (1) N/A N/A 2 (2) N/A 
Health 
System 
1 (1) 39821 24 (7) 39 (10) 58 (8) 952 
Performance 
Assessment 
N/A 24 (7) 1181 N/A 24 (5) 82 (9) 
Performance 
Measurement 
N/A 39 (10) N/A 847 40 (8) 84 (20) 
Performance 
Indicators 
2 (2) 58 (8) 24 (5) 40 (8) 1434 106 (25) 
Framework N/A 952 82 (9) 84(20) 106 (25) 105018 
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Table 2.2: References from two-word combinations (just Embase) 
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Framework 
18 (6) 2 (2) N/A N/A 2 (2) N/A 
Health 
System 
2(2) 63267 45 (11) 123 (14) 85 (16) N/A 
Performance 
Assessment 
N/A 45 (11) 1820 N/A 41 (11) 126 (17) 
Performance 
Measurement 
N/A 123 (14) N/A 4019 147 (34) 282 (31) 
Performance 
Indicators 
2 (2) 85 (16) 41 (11) 147 (34) 2200 171 (34) 
Framework N/A N/A 126 (17) 282 (31) 171 (34) 147181 
 
Table 2.3: References from two-word combinations (just Web of Science) 
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Assessment 
Framework 
5099 331 N/A N/A 52 (8) N/A 
Health 
System 
331 146722 2580 1945 1385 N/A 
Performance 
Assessment 
N/A 2580 83964 N/A 4868 5099 
Performance 
Measurement 
N/A 1945 N/A 154,263 4061 5536 
Performance 
Indicators 
52 (8) 1385 4868 4061 33512 2384 
Framework N/A N/A 5099 5536 2384 604521 
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Since in some instances, too many hits were registered with two-word combinations, 
three keyword combinations were also examined.  The results are presented below. 
 
Table 2.4: References derived from three and four word combinations  
  (Medline, Embase and Web of Science) 
 
 Medline Embase 
Web of 
Science 
Perf. Ass.+Framework+Health 
System 
1 (1) 7 (4) 215 (17) 
Perf.Meas.+Framework+Health 
System 
13 (2) 25 (16) 188 (23) 
Perf.Meas.+Framework+Health 
(Care) 
69 (16) 169 (38) / 
Perf. Ass.+Framework+Health 
(Care) 
26 (8) 48 (13) / 
Perf.Ass+Framework+Perf. Ind. 11 (5) 11 (5) 77 (7) 
Perf.Ind.+Framework+Health 
System 
13 (11) 13 (11) 203 
PAF+Perf.Ind.+Perf.Meas.+ 
Health System 
0 0 19 (4) 
 
In addition to the above, snowballing techniques were also used where the author 
extracted several references from suitable articles.  Much documentation was also 
found in the grey literature since this subject was not always subject to empirical 
research and many governments and organisations carried out studies and published 
reports which were not submitted to peer-reviewed journals for publication. 
 
2.4 Historic development of performance assessment frameworks 
Indicators have been used extensively for many decades, starting from the quality 
movement in the 70s and 80s to the emphasis on efficiency and financial sustainability 
in the crisis years of the 1980s and 1990s (van der Bij & Vissers, 1999).  However, 
despite the promulgation of various types and forms of performance indicators, up to 
the late 1990s, these were not yet mapped within a formal, structured conceptual 
framework.    
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2.4.1  Early national frameworks 
In Europe, Scotland was amongst the first to develop and publicise the use of clinical 
indicators.  In 1992, the Clinical Outcomes Working Group was set up with a mandate 
to create outcome clinical indicators for Scotland.  The first set of clinical indicators 
was first produced in 1993 and since then, an indicators report was published on an 
annual basis (NHS Quality Improvement Scotland, 2005).  However, up to that point, 
the focus was channelled into the development of the indicators themselves with little 
interest in mapping these indicators into a framework that could be used for the overall 
improvement in performance (Kendrick, et al., 1999). 
 
In 1997, the Department of Health in England published a white paper ‘The new NHS: 
Modern, Dependable’ (Department of Health, UK, 1997), launching the 
Government’s new vision for the NHS at the time.  This document outlined, for the 
first time, a new national Performance Assessment Framework as the main instrument 
for securing management control in the NHS.  This was deemed necessary due to the 
changes envisaged in the white paper, in order to equip Health Authorities, Primary 
Care Groups and NHS Trusts to discharge their new roles and responsibilities.  This 
led to a realisation that if the population’s health needs could be charted through an 
umbrella performance framework, this would be equally applicable to a Health 
Authority, a Primary Care Group, or an NHS Trust.  Indeed, this is the first time that 
clear incentives and sanctions were introduced at a national or system level to improve 
the performance of these organisations. 
 
The new millennium lent itself to a plethora of new performance concepts, such as 
that promulgated by the UK Treasury in its document – ‘Choosing the Right Fabric; 
A Framework for Performance Information’ (HM Treasury, 2000).  Using the health 
sector as a guide, the proponents of this document outlined the basic criteria for 
determining the appropriate framework for performance management and monitoring.  
Whilst the emphasis at the time was still one of compliance to targets and external 
monitoring, the methodology chosen for establishing the correct criteria for 
performance measures was robust and served the test of time, as we shall see when 
discussing the criteria for choosing performance indicators.  This document wittingly 
chose to use the acronym of FABRIC to describe the properties of a performance 
information system.  These were – Focused, Appropriate, Balanced, Robust, 
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Integrated and Cost Effective, whilst the criteria for establishing performance 
measures were defined as requiring to be relevant, to avoid perverse incentives, 
attributable, well-defined, timely and reliable – all criteria used today in developing 
performance indicators within a HSPA framework. 
 
Canada was also amongst the first to develop their own HSPA framework, where the 
Canadian Institute for Health Information (CIHI) was tasked with creating a 
framework for the Canadian provinces in 2000.  They produced a report known as the 
Canadian Health Information Roadmap Initiative Indicators Framework (Canadian 
Institute for Health Information, 2000), with the aim of assessing, for the first time, 
the health of the Canadian population and to gauge how their health care system 
performs.  This was a population-based approach assessing the health status of the 
population and was one of the first frameworks to explicitly map performance 
indicators with specific domains such as acceptability, efficiency and effectiveness. 
 
In the United States, work on a national health improvement framework started in 
2001 by the Institute of Medicine (IOM) (Institute of Medicine, 2001a), where they 
proposed six performance domains, namely safety, effectiveness, patient-
centeredness, timeliness, efficiency and equity.  The IOM argued that improvements 
in these six key areas would lead to better patient outcomes.  The IOM was also 
responsible in drawing up the National Health Care Quality Report (Institute of 
Medicine, 2001b) and in later building upon its initial work in 2001 by suggesting a 
new methodology to measure and improve health systems improvement (Institute of 
Medicine, 2006).  Paradoxically however, to date, after 14 years of developing robust 
performance assessments frameworks and a myriad of performance indicators that are 
utilised across the country, there is, as yet, no nationally agreed framework to which 
all states and authorities subscribe to.  This is perhaps reflective of the federal and 
decentralised political model of the country, as well the dominance of the private 
sector in health care provision and funding.  This situation also begs the question – is 
a HSPA framework really required at national level?   
 
The US model is proving to be an exception with time since most Western and modern 
health systems have now developed their own national HSPA frameworks.  This 
anachronistic situation was still present in 2006 when the Commonwealth Fund 
  
25 
created a ‘Commission on the High Performance Health System (Commonwealth 
Fund, Commission on a High Performance Health System, USA, 2006) to spearhead 
the development of a ‘framework for a high performance system’.  This, after the 
increasing realisation that, despite spending more on health care than any other 
country, the USA still lagged in key performance areas and more worryingly, did not 
experience the improvements in performance that other modern societies were 
experiencing during that decade.  
 
The Australian performance system (Queensland Health, National Health 
Performance Committee, 2001) was based on the health determinants model, utilising 
three tiers – health status and outcomes, determinants of health and health system 
performance.  The last tier possesses the usual set of dimensions such as effectiveness, 
efficiency, responsiveness and accessibility, amongst others.  As for the Canadian 
model, the Australian HSPA framework was developed with the aim of answering the 
same basic questions on health status of the population and the health system 
performance (Duckett & Ward, 2008). 
 
In 2003, Arah et al. (2003) from the Netherlands produced a succinct yet profound 
analysis on the various performance frameworks developed up to 2003, namely those 
mentioned above.  This seminal work was pioneering since it later paved the way for 
their ground-breaking work of OECD in developing its now widely used HSPA 
framework, as well as define the main precepts and criteria for developing the 
conceptual models behind many frameworks that exist today.  This work was later 
complemented by their efforts in developing a HSPA framework for the Netherlands 
in 2004 (Ten Asbroek, et al., 2004). 
 
Table 2.5 summarises the main features of the early national frameworks of the USA, 
UK, Canada and Australia prior to 2003. 
  
  
26 
Table 2.5: Early national frameworks of the USA, UK, Canada and Australia 
 
 USA UK Canada Australia 
Institutional 
input 
Institute of 
Medicine 
Department of 
Health 
Canadian 
Institute for 
Health 
Information 
National Health 
Performance 
Committee 
Rationale 
behind 
development 
of PAF 
Service 
improvement; 
provide 
consumer 
information in 
competing 
market; 
regulation. 
Securing 
management 
control in the 
NHS; regulation 
and monitoring 
in new 
decentralised 
model; 
accountability 
and financial 
incentives. 
Quality driven 
and 
establishment of 
benchmarks / 
standards across 
provinces. 
Performance 
reporting; 
measurement of 
health status and 
health system 
performance. 
Type of 
framework 
Weak national 
framework; 
dependent upon 
purchaser and 
provider needs; 
emphasises 
population 
health and 
patient oriented 
performance 
reporting. 
Coherent 
national 
framework; 
increasing 
number of 
indicators and 
targets; domain 
local use of PIs 
being 
entrenched. 
Integrated 
national 
framework 
applied across 
provinces; based 
on both 
population 
health and 
health system 
performance 
measures. 
Evaluation of 
inputs, outputs, 
and outcomes 
measures linked 
to health system 
performance, 
health 
determinants and 
health. 
Accountability 
focus 
Performance 
measures and 
indicators made 
available to 
providers, 
funders and 
consumers; 
market driven 
performance 
measures. 
Quality and 
clinical 
governance; 
performance 
reporting for 
funding and to 
reach clinical & 
operational 
targets; 
production of 
‘league’ tables. 
Comparability / 
dissemination of 
information; 
timely decision 
making. 
Professional 
focus; 
implementation 
and setting of 
standards and 
benchmarking 
practices); 
financial 
monitoring. 
Source: Adapted by author from Arah et al. (2003) 
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2.4.2 International frameworks 
Whilst, at the turn of the millennium, the UK, USA, Australia and Canada led the way 
for the development of country specific frameworks, it was the work of OECD and 
WHO that really placed HSPA frameworks on the international map.  This work was 
then followed, many years later, by the European Commission (CION).  This section 
outlines the development of these international frameworks.  The catalyst for these 
new developments was the increasing concern on the sustainability of health care, as 
well as the drive to improve quality of care and health outcomes.  Jee and Or (1999) 
were commissioned by OECD to draw up a paper which served as the basis for 
OECD’s work in this area for the years to follow.  This was the first time that health 
outcomes, using the Donabedian model (Donabedian, 1980a), were linked to health 
policy development. 
 
2.4.2.1 World Health Organisation 
In 2000, WHO launched its first World Health Report (World Health Organisation, 
2000), which had a major impact on performance assessment for two main reasons.  
To begin with, it was the first time that an international health organisation developed 
and measured performance indicators within a performance framework and secondly 
it was the first attempt at classifying the performance of WHO member states using a 
performance metric (Murray & Frenk, 2000).  Whilst the former development was 
welcomed and hailed as a breakthrough, the latter was mired in controversy and lacked 
consensus, since it was argued that producing a performance league of countries was 
neither scientifically sound, nor did it reflect reality on the ground (Navarro, 2000).   
 
In this report, WHO (World Health Organisation, 2000, p. xii) defined the boundaries 
of health systems and created a conceptual framework ‘to help Member States measure 
their own performance, understand the factors that contribute to it, improve it, and 
respond better to the needs and expectations of the people they serve and represent’ 
and thus allow individual member states to mould their own national HSPA 
framework from this WHO conceptual model.  The WHO framework was built on the 
premise of a health system whose primary objective is the improvement of health.  It 
therefore put forward, for the first time, the belief that the health system of a country 
or region should be planned for the attainment of better health, through a number of 
  
28 
dimensions.  In this innovative report, WHO subscribed to determining the health 
status of a population through population based, efficiency and effectiveness 
measures.  Contrary to the OECD work carried out a few years later, it did not focus 
upon quality indicators per se but supplants quality with overall indicators of 
effectiveness and performance.  However, it created a new measure of overall 
population health, something of a ‘sum of all measures of burden of disease,’ or more 
precisely the numbers of disability-adjusted life years (DALYs) lost.  This summative 
type indicator paved the way for many other similar indicators that now attempt to 
measure population health or lack of health thereof. 
 
2.4.2.2 OECD 
In 2006, OECD commissioned a number of expert groups to draw up various 
performance assessment frameworks.  The work by Arah and his colleagues in the 
Netherlands (Arah, et al., 2006) led the process which took some years to complete.  
The impetus for this work arose from the increasing burden placed upon health 
systems to deliver with fewer resources, in a climate of increasing expectations, ageing 
populations and advances in medical technologies.  This prompted many OECD 
member states to develop performance measurement and management frameworks 
that capture equity, quality and efficiency goals within their health systems (Hurst, 
2000), (Hurst & Jee-Hughes, 2001), (Hurst, 2002).   
 
OECD’s Health Care Quality Indicator (HCQI) Project was an international effort 
utilising the expertise of OECD member states to develop a common set of indicators, 
primarily linked to quality of health care.  The OECD health system performance 
framework contained three main goals, namely health improvement and outcomes, 
responsiveness and access and financial contribution and health expenditure.  
Following this project, 5 separate panels were set up to develop indicators for specific 
disease groups or areas, namely Cardiac Indicators (Ulla, et al., 2006), (17 indicators); 
Diabetes (Nicollucci, et al., 2006), (12 indicators); Primary Care (Marshall, et al., 
2006), (27 indicators); Mental Health (Hermann, et al., 2006), (12 indicators); and 
Patient Safety (Mcloughlin, et al., 2006), (21 indicators). 
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2.4.2.3 European core health indicators 
The European Core Health Indicators (ECHI) project was devised by the Network of 
Competent Authorities on Health Information in 2004 (Network of Competent 
Authorities on Health Information, 2004).  This was preceded by work on the 
development of a list of around 400 indicators as part the ECHI-1 and ECHI-2 projects 
under the Health Monitoring Programme, a sub-set of the Public Health Programme 
(1996-2003).  One of the objectives of the Public Health Programme was to develop 
comparable information on the health of the population, health behaviours and 
lifestyles, disease incidence, and on health systems, including data on access to care, 
quality of care, human resources, and on financial viability of health care systems.   
 
DG SANCO (now Sante) continued to refine the data collection and analysis 
methodology and almost 10 years later, commissioned a study to evaluate the use and 
impact of the ECHI project by the Member States (DG SANCO, EU Commission, 
2013).  The outcome was the development of the European Core Health Indicators, 
with 88 indicators covering 17 policy areas.  The indicators fall under one of five 
categories – demography and socio-economic measures, health status, indicators on 
health determinants of health, health services and health promotion.  The resultant set 
of 88 core indicators is now used as a framework for EU member states to align their 
data collection and analytical methodologies with this core list (European 
Commission, 2013). 
 
The three frameworks outlined above now overlap considerably in terms of policy 
areas and indicators used.  There is, thankfully one may add, a growing momentum of 
sharing data sets and other information between WHO, OECD and the EU, moving 
towards greater convergence possibly creating an agreed list of core and 
supplementary indicators for all member states.  This will certainly go a long way in 
reducing duplication of effort and data as well as streamline methodologies.  This has 
resulted in the publication of OECD’s ‘Health at a Glance’ as a collaborative effort 
between OECD, WHO and EU.1 
  
                                                 
1   http://www.oecd.org/health/health-systems/health-at-a-glance-19991312.htm.  
  Accessed 26/01/18. 
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2.5 Methods in developing HSPA frameworks 
This section outlines the principal methodologies used to develop the various 
frameworks that have been elucidated upon in the previous sections.  Although there 
is a common ultimate purpose for the development and application of HSPA 
frameworks, there is a multiplicity of methods in how each framework was developed.  
The comprehension of the methods employed was deemed important for the author to 
then determine and inform on the best, or rather most appropriate, method to be used 
for the development of Malta’s first performance assessment framework.  Each model 
was formulated according to the contextual needs of its health system, even though 
there was always a common thread between most frameworks.  Although not explicitly 
or deliberately demonstrated, the literature consistently shows three principle iterative 
steps in formulating a HSPA framework, with one iteration building on the previous.   
 
These could be viewed as: 
 
1. Determination of the model to be used. 
2. Definition of the domains or dimensions that would constitute the 
framework. 
3. Identification and generation of the performance indicators that would 
populate the framework. 
 
2.5.1  Developing a model 
Most processes start off with an in-depth review of existing literature and a policy 
analysis to identify the main policy and strategy documents and priorities that the 
framework would cover.  This approach is common to almost all frameworks 
developed at national level.  The Dutch HSPA framework (Ten Asbroek, et al., 2004, 
p. i67) first considered the development of the conceptual model and then selected the 
different indicator areas.  The Dutch modelling emphasised that the framework must 
be ‘coherently balanced, covering various performance dimensions such as 
effectiveness, efficiency, quality, and equity.’  Also, the framework must be inclusive 
of all areas of the health system, including health care and public health domains.  
Finally, a good framework needs to ensure that it is measuring the impact of the health 
system upon the health of the population.  This latter point is disputable however, since 
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other proponents argue that a health system encompasses areas that are beyond the 
direct reach or influence of health care organisations (Kelley, Arispe & Holmes, 2006).  
This argument is important when we come to discuss attributability as a general 
limitation of HSPA frameworks. 
 
2.5.2  Testing the model 
Once a draft model is developed, this is invariably tested.  El Turabi et al (2011) used 
a hybrid methodology of combining the Logic Model with the Balanced Scorecard to 
draw up their initial model.  This was then validated using interviews and focus 
groups, followed by piloting of the framework to test for acceptability, suitability and 
feasibility.  The wider applicability of the framework could then be gauged by 
implementing the framework system-wide.  El Turabi et al. (2011) also utilised an 
approach that is commonly used in developing HSPA frameworks, that of discussion 
based consensus decision taking, used primarily amongst experts with high technical 
knowledge of the subject and then tested through surveys or focus groups/modified 
Delphi Technique to obtain a wider understanding and ‘buy-in’ from relevant 
stakeholders.   
 
Mainz (2003) used a similar approach in developing a ‘state of the art’ methodology.  
His paper outlined two main stages – the planning phase, which included the 
identification of the clinical areas to be assessed and the ‘measurement team or 
experts’, and the ‘development phase,’ where the policy and documentation analysis 
is carried out, followed by the identification of indicators.  Pilot testing then followed 
as a final step.   
 
Together with colleagues, Mainz used this same methodology to develop the HSPA 
framework for the Danish health system.  In their paper, Mainz et al. (2004) outlined 
their work on the National Indicator Project in Denmark, which initially covered 
specific target diseases, such as stroke, lung cancer and schizophrenia.  The steps 
undertaken for this project were similar to other iterations in that they first identified 
the problem and set the priority areas, then developed the indicator base, collected and 
analysed the data and provided interpretive guidance to the policy makers and 
managers.  This data was also audited and disseminated to the public. 
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2.5.3  Scientific basis of methodology 
Whilst the methods used by various experts share a common thread, arguments have 
been raised from early on that some methods are unsatisfactory and not robust enough 
to pass the test of scientific rigour.  This is mainly attributed to two overriding factors.  
The first is due to the nature of the framework itself, in an attempt to ‘trap’ all the key 
attributes that a health system should have, including quality of care, health 
inequalities, sustainability, efficiency measures and political acceptance.  Whilst these 
attributes are undoubtedly important and relevant, they are not enough to ensure a 
comprehensive overview of the true objectives of a health system.  Another common 
pitfall is for experts to start the process by simply choosing those indicators that are 
either already available or easily attainable, with the obvious conundrum of excluding 
other more relevant dimensions of the health system.  Murray and Frenk (2000) gave 
an early warning shot across our bows in the primordial days of the early 2000s, where 
they argued that each process to develop a HSPA framework should commence with 
asking the most basic of questions: What are health systems for? The answer to this 
question will present the authors with the key goals and strategic objectives of the 
health system they wish to evaluate and this then paves the way to develop a robust 
and scientifically sound health system performance assessment framework. 
 
Nonetheless, there is consensus that there are a number of key principles which should 
be respected, irrespective of which method is embarked upon.  These are: 
 
• HSPA, as the name implies, should focus upon health systems as a 
whole and not on the components parts of a health system. 
• Whilst outcome measures are better positioned to mirror performance, 
structure and process indicators are also valuable. 
• HSPA should form part of a regular process to measure performance 
and devise policy as implied within the policy cycle of a HSPA. 
• Although each country or health system should develop its own HSPA, 
its structure and content should be comparable with that of other 
countries and health systems. 
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2.6 Theoretical archetypal models for HSPA 
A performance assessment framework could be seen as a conceptual model that 
incorporates the most relevant domains that best describe the goals of the health 
system it promulgates.  It depicts the inter-relationships that exist between the different 
domains of a health system and the goals of the health system (Kelley & Hurst, 2006) 
and therefore, such a framework evolves from the strategic objectives of the health 
system.  A performance assessment framework therefore provides structure and 
formality to the measurement of the performance of the various components of a health 
system.  This section shall outline the main models used, citing specific case studies 
as examples. The next section will then describe the contents of a HSPA framework. 
 
2.6.1  Donabedian Model 
The Donabedian Model (Donabedian, 2005) for assessing performance is the most 
predominant model that has been used to underpin the development of many HSPA 
frameworks.  This model, first developed in the sixties by Avedis Donabedian, 
assesses quality through three broad areas; structure or inputs, process and outcomes.   
 
‘Structure’ refers to all the various inputs and resources that are utilised to provide a 
health care service, such as infrastructure, equipment, human capital, training, 
financial resources and IT systems.  The way the structural factors come together and 
interact delineate the process of care.  This includes care pathways, the interaction 
between patients, care providers and funders, clinical protocols and guidelines.  Many 
models then identify and measure outcomes in the form of health status of the 
population, patient satisfaction, financial and social protection systems, quality of life 
measures, hospital indices and many others.  The HSPA frameworks of Portugal, 
Estonia, Hungary and eventually Malta followed this conceptual model. 
 
Figure 2.1 features Portugal’s HSPA which is based on the Donaedian framework. 
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Figure 2.1: Portugal’s HSPA based on the Donabedian framework 
Source: World Health Organisation, Regional Office for Europe (2010a) 
 
2.6.2 Balanced score card and outcomes framework 
The first UK HSPA framework was developed within the context of a new Public 
Service Agreement between the UK Treasury and the Department of Health (2001).  
The agreement focused upon performance monitoring, creating the right performance 
data infrastructure to collect the performance measures and to have a robust regulatory 
framework in a decentralised system.  Due to its emphasis upon performance 
monitoring and reporting, this framework was based upon the balanced scorecard 
approach (Kaplan & Norton, 1992).  This model coalesces all the indicators in a 
unified cohesive manner and creates a system of measurement, assessment and reward 
(or retribution).  The original framework looked at the service user, internal 
management processes, continuous improvement, and financial outcomes (Audit 
Commission, UK, 2000).   
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With a change of government in 2010, a White Paper (Liberating the NHS) was 
released which outlined the Coalition Government’s intention to move the NHS away 
from focusing on process targets to measuring health outcomes.  In December 2010, 
the first NHS Outcomes Framework was published and has been updated yearly.  Five 
domains, derived from Lord Darzi’s three-part definition were developed within the 
Framework.   
 
2.6.3  The Logic Model 
The Canadian model was initially developed for the Treasury Board of Canada using 
a results-based Logic-Model (Treasury Board of Canada, 2001), (Watson, 2009a).  A 
Logic Model pursues a Donabedian approach in that it depicts the flow of resources 
and processes required to produce the outcomes in line with the organisation’s policies 
and objectives.  In other words, as for the Donabedian way, this model attempts to 
visually depict and outline the link between inputs, activities, outputs and outcomes.  
It is useful in certain circumstances since it offers a structured approach towards the 
development of an information system where this is absent.  It has, therefore, been 
used in settings where data is absent or rudimentary and was adopted for the 
development of a framework and indicators in the primary care setting, both in Canada 
(Watson, 2009b) and in China (Wong, et al., 2010).   
 
In 2013, this model was updated by the CIHI (2013) with the intention to provide a 
pan-Canadian perspective on health system performance.  This framework includes 
four interrelated quadrants namely; health system outcomes, social determinants of 
health, health system outputs and health system inputs and characteristics, again based 
upon the Donabedian model as proposed in his 1980 paper (Donabedian, 1980a).   
 
As for all frameworks, these quadrants or dimensions relate to each other within an 
external demographic, political, economic and cultural context.  Interestingly, this is 
one of the few models which explicitly recognises the social determinants of health as 
a determining factor within a performance framework. 
 
This framework is presented in Figure 2.2. 
 
  
 
  
 Figure 2.2: CIHI’s new Health System Performance Measurement Framework 
 Source:  Canadian Institute for Health Information (2013) 
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2.6.4  The OECD Quality Model 
The OECD project (Arah, et al., 2006) on developing quality indicators focused upon 
a conceptual framework to emphasise primarily the quality dimension of the project, 
whilst also keeping in mind a broader perspective on health and its other determinants, 
in line with the priorities and objectives of OECD member states.  It was built upon 
elements of the frameworks produced by the Institute of Medicine of the US, the CIHI 
framework, as well as adaptations from the Australian and WHO frameworks.   
 
As with the CIHI framework, the OECD HSPA Framework contains four dimensions 
related to health, namely; non-health care determinants of health, health system 
performance and health system design and context.  Again, this model follows the 
input/structure/process/outcomes model used in the other frameworks mentioned 
earlier.  Quality occupies a central tenet of the model and is represented by the sub-
dimensions of effectiveness, safety and responsiveness and patient centeredness.   
 
This model shows that quality is portrayed by many definitions, but this model places 
an emphasis on these three qualities of quality.  Non-health care determinants of health 
also play an important role in the model in recognition of factors outside the direct 
influence of health that affect health and the performance of the health care system.   
 
This model was adopted by many of OECD’s member states for the development of 
their own quality indicators.  Also, OECD produced numerous other reports and 
publications using this model as a premise.   
 
This model is depicted in Figure 2.3. 
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Figure 2.3: Conceptual framework for Organisation for Economic Cooperation and 
Development Health Care Quality Indicator (HCQI) Project.   
Source:  Carinci, et al., (2015) 
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2.6.5  WHO’s goal driven model 
The model proposed by WHO takes a different path from many of the models 
described so far.  The main tenet pertaining to the WHO model is that it is goal driven 
(Murray & Frenk, 2000).  It examines the key strategic objectives of a health system, 
defines its boundaries and formulates the model around processes designed to achieve 
these objectives.  One can argue that this approach is different from the others since 
WHO was amongst the first to draw up a HSPA framework.  However, the author 
believes that there is more purpose than chance in the reason for using this type of 
model.  WHO needs to cater for over 190 member-states, with significant variations 
in wealth, health status and degree of health care development and provision.  
Therefore, the previous models may not be applicable to all settings and indeed may 
be more appropriate to higher GDP countries.  The approach towards a ‘goal 
performance’ model is attuned to the needs of those member states which are still 
developing their health infrastructure and systems and hence, would find the WHO 
model (Figure 2.4) easier to apply in their local setting. 
 
 
 
Figure 2.4: WHO’s HSPA Framework 
Source: World Health Organization (2007) 
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2.7 Content of frameworks 
Each framework inevitably comprises the various dimensions or domains.  The way 
they are depicted visually is important as it portrays the importance and relevance of 
the dimensions and their relationship to the objectives of the health system the model 
represents. 
 
2.7.1  Outline of dimensions and their significance 
The identification of the dimensions or domains within a framework is the second or 
intermediary step to finalising the HSPA framework.  After determination of the goals, 
objectives and priorities of the health system and following the elucidation of the 
underlying conceptual model that would underpin the framework, the next step is to 
identify and elaborate on the various domains or dimensions that constitute the main 
body of the framework.   
 
These dimensions are derived from the original strategic objectives of the health 
system in that they represent what the health system ‘stands for.’  Whilst in themselves 
they do not provide any purposeful information, their purpose is to encapsulate the 
various indicators that measure health system performance and hence, provide 
structure and form to the framework.  They also ensure as comprehensive an approach 
as possible to include all those indicators that are of relevance for that particular health 
system.   
 
2.7.2  Input or structures domains 
These domains usually pertain to aspects of the health system that deal with human, 
capital and financial resources.  Hence, any measures linked to human capital, 
infrastructure, equipment and beds, financial resources and the proper allocation of 
these resources are linked to these domains.  Health system design, policies, 
organisational arrangements, stewardship (including leadership) and ICT systems are 
also regarded as domains pertaining to the inputs side of the equation.   
 
2.7.3  Process domains 
Process domains are regarded as the ‘operationalisation’ of the inputs and touch upon 
important issues such as equity and coverage, access (of care and finance), efficiency, 
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quality of care, responsiveness and choice, including patient centeredness, supply 
chain factors, innovation and patient safety.  These domains are sometimes grouped 
under intermediate outcomes or goals. 
 
2.7.4  Outcome domains 
These domains deal with measuring the health outcomes of the health system and 
therefore include health status measures (usually at population level), patient or 
consumer satisfaction indices, financial and social risk protection, value for money 
and sustainability, as well as overall health system responsiveness. 
 
2.7.5  Domains as reflections of the health systems they measure 
As can be seen from the previous sections, the domains provide a reflection of what 
the health system stands for, or reflect the overriding priorities and strategic objectives 
of the health system.  Whilst most of these domains are common to all HSPA 
frameworks, variations do occur since each health system has its unique characteristics 
and goals.  Hence, a framework for a developing country may place more emphasis 
upon infrastructure, equity and access and capacity, whilst that of a mature health 
system would focus primarily upon sustainability, efficiency and quality of care.  The 
figure in Appendix 1 is taken from work undertaken by Arah et al. (2006) and shows 
the various dimensions or domains within the different HSPA Frameworks.   
 
As part of the exercise to develop a HSPA framework for Malta, the author identified 
the framework presented in Figure 2.5 as a template on which to build upon.  This was 
taken from the recent work carried out by Estonian colleagues (Sotsiaal Ministerium, 
2009) in the development of Estonia’s HSPA framework and will be mentioned again 
in the methodology part of this chapter.  
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Figure 2.5: Conceptual model of Estonia’s HSPA Framework 
Source: World Health Organisation, Regional Office for Europe (2010b) 
 
2.7.6  Indicators 
The generation, collection and analysis of indicators represents the last step in the 
methodology used to develop HSPA frameworks and constitutes the ‘core business,’ 
so to say, of all frameworks.  The literature describes a myriad of methods in the 
identification, definition, classification, validation, collection and analysis of 
indicators.  The purpose of this section is not to repeat what is already available in the 
literature but to inform the process that could be used in the formulation and validation 
of indicators relevant to the Malta model. 
 
Klazinga (2001) contended that information captured by an indicator is primarily used 
in processes of monitoring (control) and evaluation (planning and improvement / 
change) and explained that the process for development of indicators should always 
start with the question: ‘Who wants this indicator to do what, in relation to whom?’  
This is required to ensure methodological rigour. 
 
Indicators have been developed and mapped into frameworks through a variety of 
methods.  The most commonly used method is that of identifying suitable indicators 
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from the international literature and then mapping these indicators onto the domains 
referred to above.  Unfortunately, this method is principally flawed, since the 
identified indicators may not be appropriate or relevant to the priorities and goals of 
the health system they are meant to assess.  Ideally, indicators are generated de novo, 
seeking to identify those indicators or measures that would provide a direct or indirect 
(proxy) measure of the domains within the framework, assuming of course that these 
domains have already been purposefully chosen to reflect the objectives and priorities 
of the health system.   
 
In the early development days of HSPA frameworks, Rubin, Pronovost and Diette 
(2001) outlined in detail the methodology for the development and testing of 
indicators.  They contended that measures need to be meaningful, scientifically sound, 
generalisable and interpretable and went on to describe a 7-step process to develop a 
robust measure, including testing for validity and reliability.  A scoring method, based 
on the RAND Appropriateness Method, was then devised to rate/score draft indicators, 
using 5 to 7 independent raters (to ensure inter-rater reliability).  The next stage 
involved drawing up of the specifications for each indicator and then carrying out 
preliminary testing for reliability and validity, usually through piloting.  The above 
described methodology outlines the most common process used to create indicators 
by most studies in the decade that followed.   
 
Kristensen, Mainz and Bartels (2009) used a three-phase approach towards developing 
safety of care indicators for the ‘Safety Improvement for Patients in Europe’ project.  
These phases were classified as the Planning Phase (choice of area of study, selection 
of priorities and establishment of expert team), the Development Phase (review of 
existing evidence and rating and mapping of indicators) and the last, the Testing Phase 
(validation of indicators).  In this last phase, indicators were scored for relevance and 
appropriateness (Score 1-9), validity and reliability (Score 1-9) and feasibility (Score 
1-9).  This scoring methodology can be found in many other studies and is also 
primarily based upon the RAND Appropriateness methodology (Fitch, et al., 2001). 
 
Perera, Dowell and Crampton (2012) provides an elaboration of previous methods to 
identify indicators using what they term as the Systematic Indicator Development 
Method (SID), based on the premise that indicators need to be appropriately chosen 
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for the purpose they have been created and the information generated from the results 
needs to be correctly interpreted.  They contend that indicators are not always 
‘axiomatically good’ since indicators developed for one purpose may not be 
appropriate for a different application.  Sound judgments and interpretations are 
required to assure that indicators are not technically flawed, unreliable or worse, create 
controversy and perverse interpretations.  As with other authors, the initial work was 
based on a literature review and interviews with policy makers, planners, providers 
and clinicians.  Similar to other techniques employed by other authors, they produced 
a 6-step iterative process as follows: 
 
Stage 1 Prioritisation and Selection; 
Stage 2 Delineation of Intent (definition of purpose); 
Stage 3 Determination of Implementation Requirements; 
Stage 4 Development of Measure Specifications; 
Stage 5 Assessment of fitness for purpose; 
Stage 6 Development of Targets (benchmarks).  
 
2.7.6.1 Testing indicators for appropriateness: Validity vs feasibility 
All the studies reviewed give away a certain tension between choosing indicators that 
are scientifically robust and sound and those that are feasible and acceptable to 
measure.  Whilst the testing of reliability and validity is considered an essential step 
in all of the studies, there is an equally weighted acknowledgment that an indicator 
also needs to be relatively easy to measure, available and acceptable to the policy 
makers as well as to the wider audience and not just to the scientific community.  This 
dilemma was amply considered in the OECD quality indicators project when devising 
their core set of indicators (Jee & Or, 1999).  Arah et al.  (2003, p. 392) consider: 
 
… that there is a trade-off between scientific objectivity and feasibility that 
appears to be at work in how these effectiveness indicators are 
conceptualized and operationalized, just as these countries and agencies 
strive to appease both purists and pragmatist.   
 
However having said this, in a study on comparing validity / reliability with feasibility, 
Pena et al (2010) used two rounds of the modified Delphi process to test validity versus 
feasibility of a set of proposed indicators using the RAND / UCLA appropriateness 
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method (Fitch, et al., 2001).  They found a surprisingly high level of association 
between validity and feasibility which jars with the opinion that these two attributes 
run counter to each other when formulating and testing indicators.  Hence, it would 
seem that a balance could indeed be reached in order to appease both the scientific 
mandarins, as well as the policy makers. 
 
2.8 Lessons learnt 
After several years of developing HSPA frameworks, the scientific community and 
health system stewards have learnt several valuable lessons that are applicable to all 
settings and frameworks (Kelley, Arispe & Holmes, 2006).  Firstly, the creation of a 
conceptual model within which the HSPA framework would fit is still considered an 
essential passage to help guide the eventual formulation and selection of indicators, 
although it is tempting to forego this initial step.   
 
The conceptual framework provides the health system with the required boundaries 
and inherent structure to develop the measures and indicators.  Methods then adapt to 
add and subtract indicators while maintaining a stable set of indicators to track over 
time.  Changing indicators over time was also found to be required in response to the 
ever-changing health system landscape, especially to remain responsive to changes in 
the evidence base for quality measurement. 
 
One must also fully comprehend the limitations of HSPA frameworks, especially in 
view of attributability or causality, as well as limitations in comparability.  Mitigating 
measures are taken in the form of adjustment for case mix (Mainz, et al., 2004).  To 
secure the comparability of the collected data at various levels, predictive factors are 
identified and used as explanation variables to adjust for case mix.   
 
This is important as it then becomes possible to evaluate whether a favourable or 
unfavourable outcome is due to the health care system or due to conditions over which 
the health care system has no influence, e.g. conditions related to the patient or the 
disease.  Such case mix adjustment models have allowed us to overcome the issues of 
causality and comparability across health systems. 
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2.9  Relationship between performance assessment frameworks and  
policy development 
In his foreword for the volume ‘Performance Measurement for Health System 
Improvement’ (Smith, et al., 2009a, p. ix), the Deputy Regional Director of WHO 
states that ‘the provision of relevant, accurate and timely performance information is 
essential for assuring and improving the performance of health system.’  This 
statement shows that whilst performance improvement is very much on the agenda of 
senior health policy makers, the impact of performance assessment on health policy 
development seems to play second fiddle.   
 
This observation epitomises the focus of the second part of the thesis which aims to 
explore the impact health system performance assessment frameworks have upon the 
development of policy and the shaping of reforms within the health system.  This is 
also known as the policy cycle, wherein the performance assessment framework 
‘informs’ policy and assists policy makers in setting priorities and in taking key 
system-wide decisions.  These policy developments in turn shape the content and 
structure of performance frameworks and determine which performance indicators are 
included/excluded in line with changing priorities and policies.  Hence, a continuous 
cycle is created which links performance assessment frameworks with policy 
development.  
 
Forty-five years ago, Campbell (1969) described reform as a social experiment that 
requires careful evaluation using scientifically robust and quasi-experimental methods 
to ensure a link between the evidence and policy development.  He likened policy 
reform to the development of new pharmaceuticals and technology, where if not 
properly introduced, can damage people’s (and in the case of system reform, 
population’s) health.  However, this piece of advice seems to have fallen on deaf ears 
since, 40 years later, reforms and policy development are still poorly regulated and 
certainly do not undergo systematic evaluation using quasi-experimental or 
Randomised Controlled Trial methodology as advocated by Campbell (Expert Group 
on Health System Performance Assessment - Primary care focus group, 2017).   
 
This part of the literature review explores the relationship, if any, between Health 
System Performance Assessment Frameworks and policy development and reform.  
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We already know and have shown that the policy agenda informs and indeed guides 
the development of HSPA Frameworks and anchors the use of such frameworks within 
a contextual delineation.  However, there is little evidence to show that the contrary is 
also applicable, where HSPA Frameworks have had a direct and enduring impact or 
influence upon policy development and reform decision taking. 
 
2.10 Search method 
The key words used as search terms for this part of the literature review were ‘policy 
cycle,’ ‘health policy’ and ‘(health) policy development,’ in addition to the previously 
used terms of ‘performance measurement,’ ‘performance assessment’ and 
‘performance assessment framework.’  As in the previous search strategy, a normal 
literature search method was employed since the aim was not to produce a systematic 
review using a strict methodology such as Prisma.  
 
The electronic databases of Medline, Embase and Web of Science were also used for 
this part of the literature review, using the year 2000 as a cut-off date and only English 
language peer reviewed articles were sought, again with a few exceptions.  Depending 
upon the database used, single term searches produced hits in their hundreds or 
thousands in certain cases.  For this reason, combinations of two or, in some cases, 
three keywords were necessary to narrow down the number of hits. 
 
Tables 2.6 – 2.9 provide a summary of the search results. The figures in brackets are 
the number of articles that were deemed relevant for this research and were 
downloaded and reviewed in detail.  Duplicates are included in the figures. 
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2.10.1 Medline 
The search through the Medline database produced the following results: 
 
Table 2.6: References derived from two-word combinations (just Medline) 
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Policy Cycle 20 (6) N/A N/A N/A 1 (1) 1 (1) 0 
Health 
Policy 
N/A 73177 N/A N/A 26 (4) 63 (13) 1 (1) 
Policy 
Development 
N/A N/A 2189 N/A 4 (1) 2 (1) 1 (0) 
Health 
Policy 
Development 
N/A N/A N/A 
184 
(16) 
0 0 0 
Performance 
Assessment 
1 (1) 26 (4) 4 (1) 0 1181 N/A N/A 
Performance 
Measurement 
1 (1) 63 (13) 2 (1) 0 N/A 849 N/A 
Performance 
Assessment 
Framework 
0 1 (1) 1 (0) 0 N/A N/A 18 (7) 
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2.10.2 Embase 
The search through the Embase database produced the following results: 
 
Table 2.7: References derived from two-word combinations (just Embase) 
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Policy Cycle 32 (6) N/A N/A N/A 1 (1) 1 (1) 0 
Health 
Policy 
N/A 47239 N/A N/A 31 (5) 
183 
(14) 
1 (1) 
Policy 
Development 
N/A N/A 2839 N/A 5 (1) 5 (2) 1 (0) 
Health 
Policy 
Development 
N/A N/A N/A 232 (9) 0 1 (1) 0 
Performance 
Assessment 
1 (1) 31 95) 5 (1) 0 1820 N/A N/A 
Performance 
Measurement 
1 (1) 
183 
(14) 
5 (2) 1 (1) N/A 4019 N/A 
Performance 
Assessment 
Framework 
0 1 (1) 1 (0) 0 N/A N/A 18 
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2.10.3 Web of Science 
The search through the Web of Science database produced the results as shown in 
Table 2.8 and 2.9: 
 
Table 2.8: References from two-word combinations (just Web of Science) 
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Policy Cycle 9919 N/A N/A N/A 245 (2) 45 (3) 53 (2) 
Health 
Policy 
N/A 62967 N/A N/A 555 
285 
(29) 
110 
(14) 
Policy 
Development 
N/A N/A 68266 N/A 773 358 175 (6) 
Health 
Policy 
Development 
N/A N/A N/A 12885 175 (7) 80 (13) 45 (6) 
Performance 
Assessment 
245 (2) 555 773 175 (7) 83964 N/A N/A 
Performance 
Measurement 
45 (3) 
285 
(29) 
358 80 (13) N/A 154263 N/A 
Performance 
Assessment 
Framework 
53 (2) 
110 
(14) 
175 (6) 45 (6) N/A N/A 5099 
 
Table 2.9: References from three-word combinations (just Web of Science) 
 
 Web of Science 
Health Sys+Perf.Ass.Framework+Policy Dev. 64 (7) 
Perf.Meas.+Policy Dev.+Health Policy 161 (8) 
Perf Ass.+Policy Dev.+Health Policy 175 (12) 
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In addition to the above, the use of snowballing was also used and grey literature was 
also extracted given that many policy-related documents are not submitted to peer-
reviewed journals for publication. 
 
2.11 Reform and policy development: An overview 
Health care reform is driven by several salient overarching objectives which every 
health system strives to achieve through the changes it promulgates.  These can be 
summarised as the pursuit of universal access to all its population through various 
mechanisms of health care coverage, improving choice and quality of services, 
ensuring a sustainable health care system through cost-effective and value-for-money 
measures as well as creating a more transparent and accountable health system.   
 
2.11.1 Constituting reforms 
There is no widely accepted definition of what constitutes reform in health care.  
Cassals (1995) defined health care reform as activities concerned with changing health 
policies and the institutions through which these changes are implemented.  Hence, 
reform is both about changing or refining health policies and changing the structures 
responsible for reforms, to be in a better position to deliver these policies. 
 
To achieve these ambitious aims, health reform can also be defined as a process that 
involves sustained and profound institutional and structural change, which is usually, 
but not necessarily, led by governments, but which always seeks to attain a series of 
clear explicit policy objectives.  Saltman and Figueras (1997) outline an analytical 
model to capture the characteristics of what constitutes a real or true health reform: 
 
- Process 
• Structural rather than incremental or evolutionary change; 
• Change in policy objectives, followed by institutional change rather 
than redefinition of objectives alone; 
• Purposive rather than haphazard change; 
• Sustained and long term rather than one-off change; 
• Political top-down process led by national, regional or local 
government. 
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- Content 
• Diversity in the measures adopted; 
• Determination by country-specific characteristics of health systems. 
 
This analytical model leaves very little doubt as to the far-reaching and profound 
changes that are implicit for real reform to occur.  However, not all proponents of 
change would agree that reform needs to be so cataclysmic, as many other different 
models of change have been postulated.  The Burke-Litwin Model of Change (Burke 
& Litwin, 1992) portrays change through a transformational process or through a 
transactional process.  Whilst the former may be considered more revolutionary in 
nature, health care change management processes are more consistent with the latter 
process, since this entails a less dramatic change.  Another major model of change 
developed in recent times is the concept of organisational development (Beckhard & 
Pritchard, 1992), (Koeck, 1998), (Huntington, Gilliam & Rosen (2000).  
Organisational development is focused upon empowering organisations to manage 
their own change.  It views change in three phases, that of unfreezing (removal of 
expectations, dealing with the anxiety of change and conversion of anxiety into 
motivation to change), moving (creating a new role model and new relevant 
formation) and refreezing (consolidation of new structures and networks).  It is a 
model often subscribed to in the UK NHS.  A similar model of change is based upon 
the transformational change process as first described by Lewin (Lewin, 1958), where 
he was concerned with social change and, more particularly, with effective, permanent 
social change, believing that the motivation to change was strongly related to action.   
 
Business process re-engineering is a more established model of change, championed 
by major manufacturing industries in Japan and the US.  Whilst its conceptual 
framework is robust, and it has indeed proven to be a major driver for change, its 
applicability and appropriateness in health is questionable since it presupposes a 
completely clean sheet to start the change, a situation that is rarely encountered in 
health.  Whilst Saltman and Figueras (1997) subscribe to the notion that reform is a 
radical and profound change in the process and content of health systems, experience 
has otherwise shown that reform or policy development and change could also and 
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indeed, is more often, gradual and incremental, less planned in origin and less 
purposeful in scope.   
 
Policy change can be instigated from within or can be brought about due to changes 
in the external environment.  It is usually, but not necessarily, driven by government, 
using a top-down approach.  However, reform is more often about healthcare politics 
and less about reform of health systems (Giaimo & Manow, 1999), (Freedom, 2000). 
 
Finally, health reforms have been described in four phases over the last four decades.  
The 70’s and 80’s saw an emphasis upon cost containment at the macro level.  Micro-
efficiency and responsiveness were the main impetus for reforms in the early 1990’s, 
whilst the turn of the century heralded the era of rationing and priority-setting (Ham, 
1997).  The more recent reforms have placed quality improvements and safety in 
health care as priority areas.  These provided a basis for policy development 
throughout these years and each period reflected the different priorities in policy 
making. 
 
2.11.2 Models of policy development 
As already noted, policy development is a multifaceted iterative process, involving 
many actors and influenced by many factors.  It is an art as well as a scientific means 
to take important decisions and whilst public policy making invariably involves the 
State, governments do not have a monopoly of policy development.  Having said this, 
Anderson (1975, p. 2) views policy making as the role governments play in taking 
decisions and adhering to a course of action in order to address a specific social or 
economic challenge, and in so doing, the State adopts specific strategies to implement 
the policy at hand.  In fact, he defines policy as ‘a purposive course of action followed 
by an actor or series of actors in dealing with a problem or matter of concern.’   
 
Many view policy development as a process rather than as a stand-alone event, since 
policy varies according to the level it is fashioned and is not only considered a starting 
point but also an incremental cycle of decision making and change (Rose, 1976), 
(Jenkins, 1978).  Rose (1969) had already made such an argument when stating that 
policy making is best conveyed by describing it as a process, rather than as a single, 
once-for-all act.  Linking policy making to specific events makes it wholly dependent 
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upon the context in which policy is formulated.  Such contextual factors have a crucial 
influence upon the content of a policy.  The same policy may change with changing 
circumstances, since this is primarily a ‘political’ process.  The context may refer to 
the political system, the socio-economic situation, the values and other cultural factors 
that influence societal changes, local and international-based legislation, structural and 
organisational factors, the geo-political dimension and historical perspective, as well 
as religious and environmental factors.  Policy is also determined by ‘actors,’ acting 
either individually or more often together.  Actors steer, conduct, implement and 
evaluate the policy process.  It is important to appreciate that actors are not value-free 
and always form part of an interest group. 
 
At a local level, the most influential actor is of course the government of the day, in 
addition to the political parties, the legislature, the judiciary, the executive, the public 
service and external expert advisors.  International organisations, such as WHO, 
CION, the World Bank, International Monetary Fund and OECD are increasingly 
becoming influential in shaping national, regional and even international policies.  The 
media is no longer a mere spectator but with today’s technology and social 
networking, the media has evolved into becoming one of the key players in influencing 
the policy agenda.  Finally, the academic community is slowly but surely making 
inroads when it comes to swaying policy decisions which are more knowledge-based 
and grounded in evidence, rather than all the other aforementioned shaping factors.   
 
The above mentioned four areas have been amply elucidated upon by Walt (1994) in 
her seminal work on the political process of policy making.  She argued that policy 
development could be viewed in four different but interlinked dimensions, pertaining 
to policy content, the context within which a policy is created, the policy process and 
finally, the actors involved in the drawing up of the policy. 
 
Another policy change model is that promulgated by Kingdon in his ‘multiple streams’ 
model of change (Kingdon, 1984);  (Rawat & Morris, 2016).  Kingdon developed the 
multiple streams model as an off-shoot of the Garbage Can model of Cohen, March 
and Olsen  (Cohen, et al., 1972).  He postulated that change is instigated by a 
combination of two main factors, those of participants and processes.  Similar to the 
Walt model, participants refer to those actors that influence policy change directly or 
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indirectly.  More importantly the processes or streams refer to the confluence of three 
aspects: those of problems, policies and politics.  Once there is convergence of these 
three streams in a timely manner, then Kingdon postulates that change would occur, 
in what he terms as a ‘policy window’.  This is important to consider in health care as 
serious problems occur frequently but potential solutions and the political will to 
tackle the problem is not always evident.  HSPA interjects in this process but 
highlighted the problems or gaps in the system and offering potential solutions.   
 
2.11.3 Approaches to policy development 
The literature presents a large number of approaches in policy making, including the 
rational approach (Vedung, 2000), the incremental approach (Lindblom, 1959), the 
mixed scanning model (Etzioni, 1967), group theory, elite theory (Prewitt & Stone, 
1973), pluralist theory (Hirst, 1993) and the political system model (Duverger, 1980).   
 
The rational approach presupposes that policy is determined primarily through a 
rigorous scientific approach based on identification of the problem and need, setting 
clear objectives, an optional appraisal (considering alternatives and consequences) and 
making a choice that maximises the attainment of the goals identified beforehand.  On 
the other hand, the incrementalist approach is based upon the premise that new policy 
is formulated on past policies and experiences, through a selection of goals determined 
by past and present policies and closely linked to the means of implementation.  The 
options chosen in this scenario differ only marginally from the status quo and the best 
option is often that which achieves the widest agreement or consensus amongst policy-
makers.  This approach is invariably used in international settings such as the WHO 
or EU.   
 
A combination of some approaches has also been advocated over time.  These pertain 
to the approaches promulgated by Simon (1957) (Bounded Rationality), that of 
Disjointed Incrementalism or ‘muddling through’ as proposed by Lindblom (1959), 
the Mixed Scanning (broad angle then zoom) approach of Etzioni (1967) and the 
Extra-rationality or Normative Model by Dror (1989).   
 
Another important theory is that put forward by Sabatier termed the Advocacy 
Coalition Framework (Sabatier, 2007).  This theory views policy making as a result of 
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a confluence of coalitions which work together and seek a coordinated approach to 
policy solutions.  This enables complex policy problems involving several actors and 
different levels of state and non-state involvement to be resolved, in spite of the 
presence of uncertainty and ambiguity.  This theory is influential in that it provides a 
framework for complex policy solutions, where it is postulated that policy change and 
reforms are instigated by the competitive forces between these coalitions. 
 
2.12 Analysing policy change 
Many models of analysis of reform and change have been put forward.  The more 
traditional models have been utilised many a time to describe and explore the reasons 
and characteristics of organisations before and after change has occurred.  PESTEL 
Analysis (Political, Economic, Social, Technological, Environmental and Legal) 
describes a framework of macro-environmental factors used in analysing 
organisations from a strategic perspective, whilst the McKinsey 7S Model is a model 
postulated by Waterman, Peters and Phillips (1980) drawing upon the internal 
structural and process driven elements of an organisation.  
 
Of perhaps more value to the political process of policy development are the theories 
of new institutionalism which seek to not only provide a descriptive and evaluative 
perspective but more importantly, for the objectives of this research, an explanatory 
viewpoint.  New institutionalism encompasses three main branches; historical 
institutionalism, rational choice institutionalism and sociological institutionalism 
(Hall & Taylor, 1996), (Rittberger, 2003).  Of these, ‘historical institutionalism’ is the 
more relevant since it utilises the ‘path dependency’ paradigm which postulates that 
‘institutions push policy along particular paths, where early choices and events play 
a crucial role in determining the subsequent development of institutions and policies’ 
(Oliver & Mossialas, 2005, p. 11).   
 
In the path-dependent model, actors are constrained by existing institutions and 
structures that channel them along established policy paths.  Therefore, large (non-
incremental) change is unlikely, although systems do occasionally experience 
significant change over a relatively short period of time (Wilsford, 1994).  This theory 
subscribes to the position that reform is slow to progress just like nature, but then it is 
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punctuated by rapid events of change, just like genetic mutations or a natural event 
having global effects.  Despite a general perception to the contrary, the concept of path 
dependency is not about ‘policy inertia’ (Hall, 1993, p. 275–296), but about the impact 
that historical, contextual events have upon policy change.  It draws on the principle 
that institutions have a ‘memory’ which is the cause of friction between proponents of 
change and policy laggards.   
 
2.13 Measuring policy success 
Marmora and Wendt (2012), in a political analysis of health care reforms, advocate 
that research into policy development and system reform is not complete without 
actually measuring the successes or otherwise of policy decisions.  Measurement of 
policy outcomes forms an integral part of any reform process and without performance 
information, there is no strong evidence with which to design health care reform 
(Smith, et al., 2012).  Defining health policy goals, such as improving cost 
effectiveness, augmenting population health and assuring patient safety, as well as 
performance monitoring, are examples of how health policy decision making can be 
better informed (Smith, et al., 2009b). 
 
Marmora and Wendt (2012, p. 11) feel that we need ‘to extend our understanding 
about the outcomes of different national healthcare arrangements and whether policy 
reforms actually deliver results.  To do this, we need to pay more attention to the 
measurement of success.’  In this context, Kutzin (2010) has drawn up a 
methodological approach for comparing health policy results, rather than just 
comparing reform strategies between different countries.  To date, there have been few 
comparative studies that have focused upon the results arising from the 
implementation of health policy, other than using financial reforms and levels of care 
provision.  There is a gap in comparative inter-country studies on targets and 
performance measurement, linked to health policy processes and health system 
outcomes, especially looking at performance measurement through the 
implementation of HSPA Frameworks.   
 
The objective of performance assessment is to provide governments, health authorities 
and populations with appropriate information about the state of their healthcare 
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systems.  Altes et al. (2007), in their work to develop a performance assessment 
framework and indicators for a twinning project between Barcelona and Montreal, 
stated that: 
 
… some of the aims of any relevant performance assessment are to build an 
evidence base on the relationship between a health‐system design and its 
performance, providing policy makers with crucial tools to develop 
effective, efficient and equitable systems, and to help determine priorities 
for healthcare interventions, contributing to their design and management  
(Altes et al., (2007, p. 791). 
 
This is essentially the raison d’être of performance assessment frameworks and in 
recent years, an increasing volume of work and attention has been devoted to the 
measurement of performance within health systems at the country level, with an aim 
to improve them, but not necessarily to change or influence policy. 
 
2.14  Linking performance assessment frameworks to policy  
  development 
The adage goes that performance assessment impacts policy development.  However, 
the extent of this influence is debatable as the evidence base is tenuous and more 
research is needed to explore this relationship.  This section reviews this evidence. 
 
2.14.1 The evidence base 
The literature provides ample empirical evidence on the link between performance 
assessment and measurement and improvement of health systems and health care 
(Loeb, 2004), (Smith, 2005).  The advent of performance measures and the 
development of performance indicators in health care has been one of the singular 
most important tools for improving the performance of health care in many areas of 
clinical practice (Fitzpatrick, 2009).   
  
The tools used for the measurement of clinical care have been extrapolated to the 
population wherein most health systems now have methods of collecting and 
analysing performance data at population level to appraise how well the health system 
is fairing.  Various countries have incorporated performance measurement into service 
frameworks, with clear targets and deliverables.  This was the case, for instance, in 
England, where, as described previously, in 2001 the Department of Health for 
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England launched the National Service Framework (NSF) programme, which was 
meant to transform the way services are delivered for patients by the National Health 
Service (Chapman & Adam, 2001). 
 
On the other hand, performance measurement was not without its challenges and 
drawbacks.  Mannion and Braithwaite (2012) identified four main challenges whilst 
examining the unintended consequences in implementing various performance 
measurement systems.  These pertained to erroneous measurement, creating perverse 
incentives, imposing sanctions incorrectly and the creation of an environment of 
mistrust and suspicion.  Moreover, there is evidence to show that, depending upon 
their agendas and priorities, health care organisations can influence the performance 
of the health system as a whole (Hauck, Rice & Smith (2003).  This, in itself, is not a 
negative aspect, unless there is lack of alignment between the objectives of the health 
system with that of its constituent parts. 
 
Nevertheless, given that the main focus of the second part of the research deals with 
how health system performance assessment frameworks influence policy making, 
there seems to be little experience and hence, evidence in the literature on this 
particular aspect of performance assessment.   
 
Smith and Busse (2009), in their volume on Performance Measurement for Health 
System Improvement, examine how health policies and target setting may, and indeed 
do, influence the manner in which performance measurement is viewed and structured.  
This is evidently obvious since to create and maintain a robust HSPA framework, 
financial, human and technological resources need to be dedicated for this venture and 
hence governments and health care organisations need to commit such resources to 
continually measure their performance.  This is more so when one considers the 
substantial investment required in Information Technology (ICT) systems to routinely 
collect and analyse the volumes of data that are created through the system.  Still, the 
contrary is not evident, in that performance assessment can and should influence 
policy development.   
 
Veillard et al (2010) opine that whilst international comparisons of health systems are 
useful for governments to adjust their health policies, performance data still needs to 
 60 
be integrated into the policy-making process.  They cite a few non-European examples 
of this relationship, one of which is from the Ontario Ministry of Health and Long-
Term Care in Canada where there is evidence to show that the Canadians make 
systematic use of performance information into their decision-making process.   
 
The Ontario authorities identified a core set of health system and local health system 
performance indicators which are then incorporated into accountability agreements 
with the Local Health Integration Networks.  This is illustrated in the conceptual figure 
below (Figure 2.6), which shows how comparative performance data is used at various 
phases of the decision-making cycle within the Ministry.   
 
Step 1 shows the development of the vision and the direction taken for future health 
policy.  Actions and specific strategies are planned along this vision (Step 2), which 
are then linked to budget planning (Step 3).  The actions and their outcomes are then 
monitored and evaluated against strategic targets (Step 4).   
 
The procedures and outcomes are often monitored and evaluated in the context of 
resource allocation to ascertain value for money.  Finally, based on the results of 
evaluation, accountability lines are evoked (Step 5) so that institutions and persons 
responsible for different steps of policy development improve their understanding of 
their role in health systems and can make changes in their behaviour for improved 
performance.  
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Figure 2.6: A strategy-based performance management framework 
  (Ontario Ministry of Health and Long Term Care) 
Source: Veillard, et al. (2010). 
 
Performance assessment should be intricately linked to providing the evidence to 
generate change and reform.  Mannion and Goddard (2001) found that, although 
Scotland had a very well-developed performance monitoring system in place, there is 
little to show for how this impacted upon changes in the health system.   
 
Similarly for the Dutch, successive publications of their biennial Dutch Health Care 
Performance Report (DHCPR) have had minimal impact upon policy formulation and 
priority setting at national level (Westert, et al., 2010), and it is only with their most 
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recent iteration, after several years, that policy was influenced by their HSPA process 
(Van Den Berg, et al., 2014).   
 
At the turn of the millennium, the World Health Organisation has already realised that 
the link between policy development and performance assessment frameworks was 
weak and consequently launched the Enhancing Health Systems Performance 
Initiative (EHSPI) as a means to improve and manage performance supported with 
relevant policies (World Health Organisation, 2001).   
 
The aim was for the EHSPI to feed into the national policy debate, thereby linking 
evidence to priority objectives and subsequent actions. WHO hoped that, at a global 
level, EHSPI would enhance the drive towards more robust evidence-base policy 
making (World Health Organisation, Regional Office for Europe, 2001), however 
although this initiative was launched in 2003, the author could not find any evidence 
of its widespread uptake at national or regional level and so its effectiveness remains 
in doubt. 
 
In July 2012, CION set up an expert panel to provide advice on effective ways of 
investing in health and as part of this work, the panel drafted a working document on 
the criteria and framework to be used in identifying priority areas for the assessment 
of the performance of health systems (Expert Panel On Effective Ways Of Investing 
In Health, 2014).   
 
At around the same time that the Department of Health for England launched its new 
manifesto – ‘A First Class Service: Quality in the New NHS’, (Department of Health, 
UK, 1998), it also announced the National Service Framework (NSF) programme.  
The approach for the development of NSFs at the time was innovative and drew upon 
the best of public health art and science in developing, implementing and evaluating 
practical policies to improve health and health services.  This was further consolidated 
in the subsequent white paper – ‘Saving lives: Our healthier nation’ (Department of 
Health, UK, 1999b), where the UK Government set out its plan to improve health and 
reduce health inequalities.  The ‘A ﬁrst class service: Quality in the new NHS’ 
(Department of Health, UK, 1998) and ‘The National Cancer Plan’ (Department of 
Health, UK, 2000) introduced NSFs as one of a range of measures to raise quality and 
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tackle unacceptable variations in health experience and in health care.  This 
experiment was deemed a partial success in that NSFs did show the impact that a 
public health model can have in policy development, especially after the creation of 
the UK performance assessment framework and indicators which did, to a certain 
extent, inform policy development (Chapman & Adam, 2001).  However, this was 
punctuated by overriding political considerations that very often ignored, or at worse 
dismissed, the evidence to suit the policy agenda of the government of the day.   
 
On the other hand, and on the other side of the Atlantic, the USA has had a long history 
of publicly reporting data on performance and clinical outcomes.  This practice has 
led to the advancement of robust comparative performance information in the form of 
‘report cards,’ ‘provider profiles’ and ‘physician profiling.’  Mannion and Davies 
(2002) carried out a series of structured interviews with leading experts on the US 
health system and concluded that in order to inform policy and take the right decisions, 
indicators need to be robustly developed, involving all stakeholders, in order to 
understand the needs of the end users, i.e. the patient, public and staff delivering the 
service at the cold face.   
 
Mannion and Davies (2002, p. 215) state that ‘any national strategy emphasizing 
comparative data must grapple with how to engage the serious attention of those 
individuals and organizations to whom change is to be delivered.’  This is perhaps one 
of the reasons why performance assessment frameworks have not yet had a profound 
impact upon policy decision taking.  
 
In their recent study on the effects of the UK’s performance assessment framework, 
Mannion and Braithwaite (2012) concluded that although these frameworks are geared 
towards providing policy makers and managers with clear, accurate and timely 
information on the performance of the system or institution, there have also been 
adverse results.  These include poor narrow-minded measurement, perverse incentives 
and misplaced sanctions, breaches of trust and also what Mannion and Braithwaite 
(2012, p. 569) term as the ‘politicisation of performance systems.’  They conclude that 
whilst there is no doubt as to the efficacy of performance measures to improve the 
efficiency and quality of services, their wider applicability in informing policy 
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development and using HSPA as a strategic decision-making tool should be viewed 
with caution.   
 
In a policy piece, Brian Salter (2007) surmises that, in the UK again, there is a lack of 
consensus between the State and the professional on which policies should take 
priority.  This ‘struggle for the control of the agenda setting, formation and 
implementation stages of the policy process’ has resulted in little engagement between 
government and professional bodies, leading to the generation of two separate but 
parallel policy streams.  This was not the experience of Langlois et al. (2016) where, 
through different approaches, policy makers and researchers were brought together in 
Mexico, Nicaragua, South Africa and Cameroon resulting in an increased awareness 
of evidence-based policy making and improved quality programmes. 
 
Mannion, together with Goddard, believed that delineation of priorities and 
performance monitoring has little purpose if relevant actors do not have the power to 
use the results to affect change (Mannion & Goddard, 2001).  In a study on 
performance management in Scotland, which was one the first European countries to 
introduce performance indicators and assessment, the authors found that performance 
monitoring had little impact on health system behaviour because of a lack of 
accountability mechanisms and the associated incentives to prompt appropriate 
responses on the part of practitioners, managers and organisations.  The same can be 
said of national health system performance frameworks, where the biennial Dutch 
Health Care Performance Report (Westert, et al., 2010) has been slow to inform the 
policy debate and national priority setting. 
 
In conclusion, Smith, et al., (2012, p. 39) contend that ‘a primary purpose of 
performance information is therefore to promote transparency throughout the health 
system and to enable stakeholders to hold actors within the health system properly to 
account.’  They propose a model to account for the feedback loop between 
performance assessment and policy change, depicted in Figure 2.7: 
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Figure 2.7: Feedback loop model between performance assessment and policy change 
Source: Smith, et al (2012, p. 38) 
 
Through the model shown in Figure 2.7, performance information on outputs and 
outcomes can be fed back to the policy maker and management, in the first place to 
ensure accountability for delivery of the agreed targets and secondly, for re-setting 
priorities and developing policy further.  This feedback loop is the missing link that 
needs to be closed to fulfil the true purpose of a performance assessment framework.  
 
2.14.2 The policy cycle 
One of the main objectives of a health system is to bring about health improvement to 
its population.  However, the manner in which this is achieved varies tremendously, 
allowing for room for development (Westert, et al., 2010).  Such development should 
be grounded in evidence, certainly from an academic viewpoint.  Dobrow, Goel and 
Upshur (2004) and also Niessen, Grijseels and Rutten, (2000) believe that the best 
available quantitative and qualitative evidence should be used to develop consensus 
on the main health issues, as well as how to achieve these priorities.  This evidence 
feeds into a policy development cycle where a policy is drawn up, implemented and 
the impact of the policy is assessed.  This is known as the policy cycle, consisting of 
several iterative steps, depending upon the level of complexity and detail of the policy 
at hand (Roberts, et al., 2008), (Niessen, et al., 2000), (Collins, 2005).   
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One possible depiction of a policy cycle is that which was promulgated by Roberts et 
al., (2008) and presented in Figure 2.8.  This cycle portrays a policy decision process 
consisting of several steps, including problem definition, diagnosis of underlying 
causes, policy development, political decision, implementation of policy change and 
evaluation of the impact of the policy change.  Evaluation of policy changes post 
implementation requires additional appropriate measurement mechanisms (Morrato, 
Elias and Gericke (2007), measurements that are increasingly being supplied through 
the application of HSPA methods. 
 
 
 
Figure 2.8: The policy cycle (Roberts, et al., 2008) 
 
The literature cites some examples of countries that have adopted the policy cycle as 
part of their HSPA process (Frenk, et al., 2003).  The DHCPR is fulfilling several 
functions in the rational model of policymaking such as agenda-setting (problem 
recognition), policy formulation (proposal of solutions), decision-making (choice of 
solution), policy implementation (putting solution into practice) and policy evaluation 
(monitoring the results). The DHCPR can ‘rationally’ be placed between evaluation 
(accountability) and agenda-setting (for strategic decision-making (Van Den Berg, et 
al., 2014). 
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2.15 Conclusion 
This literature review discussed the development of HSPA as an effective method to 
assess the performance of health systems as a means to improve service provision and 
steer policy.  It anchored the methodology that was to follow and provided a basis for 
the ensuing document analysis which continued to build on the evidence gathered from 
the literature. 
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CHAPTER 3 
RESEARCH FOCUS, AIMS AND METHODS: 
AN OVERVIEW 
 
 
 
“If you can’t measure it, you can’t improve it.” 
Peter Drucker 
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CHAPTER 3 
RESEARCH FOCUS, AIMS AND METHODS: AN OVERVIEW 
 
 
 
3.1 Introduction 
This chapter provides an overview of the methodologies adopted for the various 
phases of this research, details of which are then elaborated upon in each respective 
chapter.  This study focused upon the development of a national health system 
performance assessment (HSPA) framework for Malta and considered the impact such 
frameworks have upon policy development.  There were three phases of the study as 
shown in Box 3.1: 
 
Box 3.1: Phases of research process 
 
 
 
 
 
 
 
3.2 Research questions 
The research questions which have been addressed in this study are presented in Box 
3.2. 
 
  
Phase I  Document Analysis 
Phase II Development of Malta’s HSPA Report 
Phase III Relationship between performance assessment and policy making 
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Box 3.2: Research questions 
 
Topic Main Research Question Subsidiary research questions 
Methodology 
for HSPA 
development 
for Malta 
1. What is the most 
appropriate method for 
developing a health system 
performance assessment 
model for Malta? 
1a. Which methods can be employed 
for its development and 
implementation? 
1b. Which key set of national 
performance indicators might be the 
most appropriate for Malta’s first health 
system performance assessment 
framework? 
1b. What is the overall result of Malta’s 
first performance assessment of its 
health system? 
Policy 
development 
in relation to 
HSPA 
2. What role, if any, do 
national health system 
performance assessment 
frameworks play in the 
development of national 
health policy? 
2a. Does the implementation of such 
frameworks have an impact on, or 
inform, policy development at a 
national level? 
2b. What is the main use of HSPA 
today and how can be it better utilised 
for policy making and service 
improvement? 
 
3.3 Aim and objectives of the research 
The aim and objectives for this study are derived from the research gaps identified in 
the literature review.  They comprise two main elements, the first being the 
development of a HSPA Framework for Malta and the second to study the relationship 
between HSPA and policy making. 
 
3.3.1  Aim of the research 
The aim of the research is outlined in Box 3.3. 
 
Box 3.3: Main aim of research project 
 
  
The overall aim of the study is to develop a national health system performance 
assessment framework for Malta and to examine the impact such frameworks have 
upon policy development. 
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3.3.2  Objectives of the research 
Based on the literature review undertaken, this study will focus upon the research 
objectives outlined in Table 3.1. 
 
Table 3.1: Research objectives 
 
PHASE CHAPTER STAGE RESEARCH OBJECTIVE 
Phase I Chapter 4 
Document 
Analysis 
1. To understand the methodologies 
employed for the development of health 
system performance assessment models. 
 
2. To elicit documentary and historical 
evidence on the impact of performance 
assessment on policy development. 
Phase II Chapter 5 
Malta Health 
System 
Performance 
Assessment 
Framework 
3. To develop a national health system 
performance assessment framework for 
Malta. 
 
4. To develop a set of key national 
performance indicators for the Maltese 
health system. 
 
5. To produce and present the results of 
Malta’s first performance assessment of 
its health system. 
Phase III Chapter 6 
Policy 
Development 
in relation to 
performance 
frameworks 
6. To investigate whether there is a 
relationship between the introduction 
and implementation of national health 
system performance assessment 
frameworks and national policy making 
and reform. 
 
7. To evaluate to what extent evidence has 
a bearing upon the development and 
adoption of policies and to understand 
which factors (other than evidence and 
performance data) impact and inform 
policy and decision making. 
 
The methodology follows, to a large extent, both the research questions and the 
research objectives, as the thesis is designed and structured around meeting these 
objectives and thus answering the research questions.  Hence the study will be carried 
out in three phases and the detailed methodological approach will be explained in each 
respective chapter, an outline of which is presented in Appendices 2a, 2b, and 2c. 
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3.4 Research process 
Figure 3.1 shows the research journey undertaken in the course of this thesis. 
 
 
Figure 3.1: Research phases 
  
PHASE IIIC
Policy Focus Groups
PHASE IIIB
Peer Review Meetings
PHASE IIIA
EU HSPA Expert Group Meetings
PHASE II
Malta HSPA Working Group Meetings
PHASE I
Document Analysis
PREPARATORY PHASE
Literature Review
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The Gantt Chart (Table 3.2) provides a timeline of this study’s stages (2011 - 2018). 
 
Table 3.2: Timeline adopted for this study 
 
 
C
h
a
p
ter 
2011 *2012 2013 2014 2015 2016 2017 2018 
Literature Review# 2         
Phase I - Document 
Analysis 
4         
Phase II - Malta 
HSPA Working 
Group 
5         
Phase III - EU 
HSPA Expert 
Group 
6         
Discussion and 
Conclusion chapters 
7 & 8         
Write up All         
* Author was granted a suspension for one year in 2012 due to personal family health reasons. 
# Literature was updated throughout research project. 
 
3.5 Phase I: Document analysis 
Document analysis is a method by which the researcher analyses, investigates, 
interprets and categorises existing material, i.e. material and data that is already 
available (Bowling, 2014).  Buse, Mays & Walt (2012) add that document analysis 
uncovers evidence that predicts or illustrates policy development and reforms. 
 
Following a review of the literature (October 2011 to mid-2014, with updates through 
to 2017), the author undertook a document analysis (2013 to 2015) which informed 
the research process of the next two phases.  This was performed to gain a deep 
understanding of the various models and methodologies that were applied for the 
development of health system performance assessment models in Europe and 
internationally.  The document analysis was also carried out to gather preliminary 
documentary and historical evidence on the relationship between performance 
assessment and policy making, especially evidence on the bearing that HSPA models 
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may have had upon the elucidation of policy and initiation of reforms in the health 
sector.   
 
Document analysis is a key qualitative method used either in combination with other 
methods as part of a methodological approach, such as in data triangulation, or as a 
stand-alone method.  Documents of all types assist the researcher uncover meaning, 
develop understanding, and discover insights relevant to the research problem.  
‘Document analysis is a systematic procedure for reviewing or evaluating documents, 
both printed and electronic’ (Bowen, 2009, p. 27).  Corbin and Strauss (2008) explain 
that, like other analytical methods, document analysis requires close scrutiny and 
elucidation of the data in order to elicit meaning, gain understanding, and develop 
empirical knowledge.  The focus of the analysis should therefore provide a critical 
examination, rather than a mere description of the documents.  The analytic procedure 
entails yielding data in the form of references, quotations, citations, or entire passages, 
which are then organised into themes, categories and cases through various methods 
of data analysis, such as content analysis (Labuschagne, 2003).   
 
The basis of a document analysis presupposes that the text and images contained 
within the document under examination have been recorded without the researcher’s 
intervention.  Whilst documents are intended to be read as objective statements of fact, 
nonetheless they also contain ‘in between the lines’ messages and nuances that reveal 
the author’s hidden thoughts and intentions when producing the document.   
 
3.6 Phases II and III: Participant Observation 
Following the completion of the documentary analysis, a three-year participant 
observation journey commenced where the author was given the dual opportunity to 
participate in two key fora. 
 
In Phase II, the author was tasked with the coordination of the proceedings of a 
national working group set up with the mandate to develop Malta’s first health system 
performance assessment framework, which led to the production of Malta’s first ever 
performance assessment report (2014-15). 
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Phase III consisted of the author’s active participation on the European Commission 
Expert Group on HSPA (2014-16).  Amongst other functions, this group was tasked 
with examining the link or relationship between HSPA and health policy development 
in the European region.  This phase involved the author’s participation in eight EU 
Expert Group meetings, three peer review meetings and two policy focus groups, all 
part of the HSPA process at EU level. 
 
This participant observation experience allowed the author to undertake further in-
depth research to confirm or refute the findings from the document analysis.  Whilst 
the analysis of documents presented a rich source of information, a deeper 
understanding of the complexity of the development of HSPA frameworks and on the 
interaction between policy making and performance assessment was needed.  
Furthermore, country specific evidence was also required to complete the picture since 
most policy is generated at country or local level.  
 
3.6.1 Type and level of participation:  
 From observatory to participatory to action research 
The researcher’s participation in the Malta HSPA Working Group and in the EU 
HSPA Expert Group and subsequent peer review meetings and focus group meetings 
was possible due to his membership on these groups.  This fits into a participant 
research methodology.  However, the author’s membership and active participation, 
as a research opportunity, does not follow the traditional participant observatory route.  
Gold (1958) suggested four observation traits that are commonly referred to in the 
participant observation process.  These range from ‘complete participation’ (but 
complete concealment) to ‘the participant as an observer,’ to the ‘observer as a 
participant’ and finally, on the other end, as a ‘complete observer.’  This classification 
denotes the traditional viewpoint of participant observatory studies, but it does not 
fully correspond with the researcher’s role on these groups.  The author was a complete 
participant, but his research was also known to the other members of the groups and 
so this does not fit neatly into the role of the ‘complete participant’ since this also 
denotes full concealment of the research process. 
 
DeWalt and DeWalt (2011), Spradley (1980, pp. 58-62) and Adler and Adler (1987) 
provide alternative viewpoints to classifying participant observation, using 
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membership roles as a proxy of interaction between the researcher and the participants.  
Spradley (1980) classifies these roles as ‘non-participation,’ ‘passive participation,’ 
‘moderate participation’ and finally, as ‘complete participation.’  Adler and Adler 
(1987) advocate a similar classification, using the type of membership as their focus, 
going from ‘peripheral membership,’ to ‘active membership,’ and ‘full membership.’  
Many times, the type and level of interaction with or participation in a group is 
dependent upon the objectives of the study, the nature of the group and by the 
participants in the study (DeWalt & DeWalt, 2011), (Gustafson & Hertting, 2017). 
 
Whilst the above categorisations are important from a theoretical point of view, they 
may also be considered somewhat ‘arbitrary’ and, thus, may not always necessarily 
represent the reality that the researcher faces when carrying out participant research 
Potvin, Bisset and Walz (2013, pp. 433-441).  Perhaps these classifications are 
important from an ethical and purist (in terms of methodology) viewpoint since the 
type of interaction between the researcher and the participants poises varying ethical 
and methodological challenges, usually related to the level of concealment of the 
research process from the participants.  However, as Whyte (1979, p. 5666) observes, 
the most important feature of participant research is the collaborative effort, in 
whichever form or shape this takes.  A mature and dependable interface between 
researcher and participants is an essential prerequisite for building solid relationships 
and in so doing, gaining access to the richness and fullness of information that the 
participatory process is meant to provide (Silverman, 2013, p. 214).  This level of trust 
is also essential to complete the transition from participant observation to participant 
action. 
 
3.6.2  The reflexive nature of participant action research 
Participant action research (PAR) combines the research prerogative with that of 
participating in the research setting whilst contemporaneously affecting or influencing 
the course of action on the subject area being studied (Kemmis, 2008, p. 121).  Some 
argue that this is not a distinct research methodology but a ‘research style’ 
encompassing many of the other research practices and provides a ‘pluralistic 
orientation to knowledge making and social change’ (Chambers, 2008, p. 297–318).  
It is, nonetheless an approach that favours the involvement of research partners in the 
‘knowledge-production process’ (Bergold, 2007, pp. 57-66), where the researcher 
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attempts to integrate the three aspects of this approach, that of participation, action and 
research (Chevalier & Buckles, 2013, pp. 9-10). 
 
PAR assumes a collective yet self-reflective approach where both the researcher and 
the participants actively partake in the research process. They collective seek to 
understand the phenomenon under study with the aim of not only advancing 
knowledge on the subject but in the process, also seek to institute changes that are 
beneficial (Cook, 2012).  However, in PAR, there has always been a tension between 
the emphasis placed on the collaborative effort versus the action and change elements 
of PAR (Kemmis & McTaggart, 2005, p. 563).  This pendulum seems to swing back 
and forth over time, depending also upon the research project under consideration.   
 
On the other hand, the reflective element is a constant where Baum, MacDougall and 
Smith (2006, p. 854) states that the ‘the reflective process is directly linked to action, 
influenced by understanding of history, culture, and local context and embedded in 
social relationships.’  Whilst the immersion of culture and history may not seem 
attuned to the subject area of performance assessment, they are, however, important 
aspects of policy making as the document analysis has demonstrated.   
 
During the author’s three-year participatory experience, first as part of Malta’s 
National Expert Working Group and then as a member of the EU HSPA Expert Group, 
he had the chance to interact, discuss, participate and mould decisions and influence 
the direction taken in these groups.  Since this was an iterative and rather lengthy 
process, he had the opportunity to reflect upon the deliberations of each meeting, of 
reviewing the documentation and reports that ensued from this process and of 
providing feedback.  This reflexive process allowed the author to gain a profound 
insight and understanding into the subject matter and also into the thinking of his 
colleagues and their actions in this regard.  A reflexive mindset is deemed important 
to fully grasp the various platitudes and complexities of HSPA and policy making and 
constitutes an essential component of the ethnographic experience (Lichterman, 
2017).   
 
Moreover, the author’s background, perspective and reflections certainly shaped the 
research agenda.  As a public health physician with several years of senior 
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management and policy experience at both national (Maltese) and European level, he 
was well placed to observe and extract the information of a complex nature as that 
generated by the HSPA and policy making process.  He was well attuned to the 
intricacies of local and European politics and his training proved useful in 
understanding and grasping the highly technical nature of performance assessment.  
However, he was also aware that this ‘baggage’ also influenced his thinking, the data 
which he collected and more importantly the interpretation of this data for research 
purposes.   
 
Whilst most of the information was straight forward and not necessarily open to 
interpretation, some more complex issues and delicate subjects required further in-
depth discussion and insight.  For this reason, the author ‘retained’ a set of ‘hidden’ 
but trusted colleagues around him who were knowledgeable in the topics at hand and 
with whom he could confront his ideas and discuss and argue matters that were both 
sensitive and complex.  This ensured as much as an unbiased approach to data 
collection and analysis.  Nonetheless the author was also aware of his vested interest 
in participating in these fora in seeking to complete his thesis as quickly and smoothly 
as possible.   
 
Participant observation implies the production of fieldnotes and the extraction of other 
material from the proceedings of the various meetings and fora that the author 
participated in.  Whilst the author produced his own meeting notes and observational 
material, given that numerous documents and reports were presented in these 
meetings, these were also utilised as a source of data for analysis.  The collation and 
interpretation of these documents required a consistent and standardised approach due 
to the possibility of observer and interpretation bias.  Given the author’s intimate 
immersion into the research milieu, his observations and interpretations may have 
been swayed by the relationships and friendships shaped over the course of the three 
years.  Silverman (2013, p. 299) postulates that methods such as fieldnote conventions 
and inter-coder agreement go some way to reduce such biases and instil a modicum of 
objectivity into the data collection and analytical process.  Whilst the author attempted 
to emulate these conventions, since he was working on his own, inter-coder analysis 
was not possible. 
 
 79 
3.7 Analytical underpinnings 
This section provides an overview of the analytical aspects of the methods outlined 
before.  It includes explaining the benefits of triangulation and mixed methodology as 
well as explains the data analytical process. 
 
3.7.1  Triangulation of methods 
The synergistic combination of different methods provided a robust interpretation in 
response to the research questions.  The combination of methodologies in the study of 
the same phenomenon added strength to the findings and their interpretation (Denzin, 
1970, p. 291).  By drawing upon multiple sources of evidence and methods, this 
approach sought convergence and corroboration using different data sources and 
methods, including those of document analysis, participant (action) research and focus 
groups (Yin, 1994).  Eisner (1991, p. 110) contended that triangulation attempts to 
provide ‘a confluence of evidence that breeds credibility.’  This reduces the possibility 
of an artefactual finding or potential bias as a result of using only one method to study 
the same phenomenon (Pope, et al., 2007, pp. 95-101). 
 
3.7.2  Mixed methods 
Phase II of the study adopted a mixed methods approach.  The choice of method was 
consistent for this type of research project, wherein it consisted of both qualitative and 
quantitative techniques over multiple stages with several inputs and outputs and many 
players participating at various interludes of the research process.  ‘Mixed methods’ 
is not simply the ad hoc combination of qualitative and quantitative methods.  It is the 
planned mixing of methods at a pre-determined stage of the research and hence this 
methodology is incorporated into the research design from the start (Kroll & Neri, 
2009, pp. 31-49).  Therefore, mixed methods research collects both qualitative and 
quantitative data in one study and integrates these data at some stage or at different 
stages of the research process.   
 
A mixed method was deemed appropriate for the extraction and analysis of the data 
and information to develop a meaningful and robust HSPA framework for Malta.  In 
this case, a Mixed Method Multiphase (or Multistage) Design was proposed due to the 
developmental nature of the research, where the results of one stage of the analysis 
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informs the subsequent stage and so on.  The successive data collection over multiple 
phases is carried out sequentially such that the one strand (qualitative or quantitative) 
apprises the next strand of analysis.  Greene (2007, p. 148) describes this as ‘the 
importation of mid-stream results from the analysis of one data type into the analysis 
of a different data type.’ 
 
3.7.3  Applied Inductive Thematic Analysis 
Applied Inductive Thematic Analysis was the main analytical approach employed for 
Phase I and III of the study.  According to Guest, MacQueen and Namey (2012, pp. 
15-16), this process consists of reading through textual and other types of data, 
identifying themes in the data, coding the themes and then interpreting the structure 
and content of the themes.  They describe applied inductive thematic analysis as ‘a 
rigorous, yet inductive, set of procedures designed to identify and examine themes 
from textual data in a way that is transparent and credible.’  Moreover, Elo & Kynga 
(2008, pp. 107-115) explain that the inductive approach is preferred over the deductive 
approach when there is little former knowledge about the phenomenon being studied 
or where the knowledge is fragmented.  Hence the inductive approach was used to 
open up new lines of enquiry and, following the generation of themes and sub-themes, 
a framework was created for data analysis.   
 
For the purpose of triangulating the findings, the use of the same analytical technique 
for the Document Analysis and Participatory Observation phases of the study was 
considered appropriate and more manageable, especially since the latter phase 
(participative research, peer review and focus groups) have built upon (and also 
expanded on) the same themes and sub-themes generated by the earlier document 
analysis.   
 
3.8 Research paradigms 
This section provides a brief explanation of the ontological and epistemological 
orientations of the study.  The ontological aspects refer to the nature of the reality that 
the study is looking into (Hudson & Ozanne, 1988, pp. 508-521).  The qualitative 
nature of the study embraces the ontological dimensions of multiple truths and realities 
where each researcher views his research from his individualistic personal perspective 
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(Lincoln & Guba, 1985).  Sometimes these beliefs or perspectives are shared and 
corroborated by multiple researchers and a deeper understanding of the subject is 
obtained.  The qualitative element of this research is undertaken by a document 
analysis and by participant observation.  For the purpose of this study, document 
analysis is viewed as positivist (Guba, et al., 2018), since an element of objectivity 
and a rational and logical approach is adopted for this type of research.  On the other 
hand, the participant observation part of the study is considered interpretivist in nature, 
since multiple interpretations and multiple realities are reviewed as part of the author’s 
emersion into the context he is studying.  The knowledge acquired in this phase is 
socially constructed rather than objectively determined. 
 
The epistemological nature of a study refers to the relationship between the author as 
researcher and the reality he is studying and how this reality is captured or understood 
(Carson, et al., 2001, pp. 4-15).  In this sense, document analysis could be considered 
inductive in nature, where knowledge already available is extracted.  The participant 
observation and action research parts of the study adhere to a constructivist approach 
according to the definitions provided by Bourgeault et al. (2013, p. 438).  This 
approach places the emphasis on the constructive aspects of knowledge generation, 
where the data obtained through these methods are viewed in a social, political and 
historical context.   
 
Applied inductive thematic analysis comprises a mix of various epistemological 
orientations, from grounded theory, to positivism, interpretivism, and 
phenomenology.  It is considered to be mainly positivist in its approach, but it is also 
aligned to interpretive consideration.  It is positivist in that assertions are required to 
be supported with evidence (textual analysis) but the methods and processes can also 
be used in an interpretive analysis (Guba, Lincoln & Lynham (2018).   
 
Unlike grounded theory which is anchored in theory building, applied thematic 
analysis is not restricted to this objective alone / per se but offers a more practical or 
pragmatic approach, which is conducive to the area under research since it explores 
the management and policy aspects of performance assessment.  Likewise, whilst 
interpretive phenomenology generally focuses on the individualistic, subjective 
human experience, the focus of an inductive analysis can be broader and include 
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social, political, economic and cultural manifestations as well, which, again, is more 
suitable for this study.  On the other hand, although more comfortably applied within 
a positivist framework, many of the principles of applied thematic analysis can also 
be incorporated into an interpretive analytic enterprise.  This ‘mixed bag’ approach 
was thought to align itself well with the complex and multifaceted areas of 
performance measurement and policy development. 
 
3.9 Contribution to research and policy development 
Each of the above-mentioned objectives aimed to cover a gap in the current academic 
research, as well as address specific policy imperatives.  The development of a national 
performance assessment framework for Malta not only laid the groundwork for future 
performance measurement in Malta but also contributed to the body of European and 
international knowledge on the appropriate methodological process used for this type 
of endeavour.   
 
Such a methodology could be compared and used to inform the development of other 
performance frameworks, especially for small states, and is also particularly apt at this 
juncture due to the increasing interest within EU circles to create a Europe-wide, 
standardised performance assessment framework.  Moreover, the results emanating 
from measuring the indicators within the framework are comparable and useful for 
benchmarking with other countries, opening the path for Malta to partake in numerous 
international comparative studies in the future. 
 
Although significant research has been carried out on the link between performance 
measurement and service improvement, the same could not be said of the link with 
policy development.  This study provided a unique insight into the relationship 
between national performance frameworks and the development of policy and 
implementation of reforms at national level.  This association is important to 
consolidate and expand the use of performance assessment frameworks whilst 
ensuring that policy making is grounded increasingly more in evidence rather than in 
other extraneous factors. 
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3.10 Exclusions 
This study focused primarily upon performance information as extracted specifically 
from health system performance assessment frameworks.  Although the initial 
intention was to exclude performance data and information derived from other 
sources, the document analysis and the subsequent participatory research component 
of the study uncovered a raft of other sources of performance information that 
influence policy making and so these were also referenced.  Nonetheless, for the 
purpose of this research, performance information was taken to mean information 
derived exclusively from performance indicators.   
 
The study did not delve into the relationship between performance assessment and 
performance or service improvement.  Enough empirical evidence in the literature 
dealing with this relationship existed and therefore, it was deemed superfluous for the 
author to delve into this relationship as the study would not have contributed any new 
knowledge in this area. 
 
3.11 Conclusion 
This chapter provided an overview of the varied methods employed in this study, 
spanning both qualitative and quantitative designs through the implementation of a 
document analysis and ethnographic experience over 3 years.  The next chapters 
discuss these phases in more detail. 
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CHAPTER 4 
PHASE I - DOCUMENT ANALYSIS 
 
 
 
“Documents create a paper reality we call proof.” 
Mason Cooley 
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CHAPTER 4 
PHASE I – DOCUMENT ANALYSIS 
 
 
 
4.1 Introduction 
Chapter 4 describes the methodology, results and discussion of the document analysis.  
This was carried out as a prelude to the participatory observation part of the author’s 
research.  The raison d’etre for choosing this method was explained in Chapter 3.  
Although document analysis may be used on its own, in this case it was combined 
with the analysis carried out in Phases II and III and contributed towards the 
methodological triangulation of this study.  Thus, the document analysis served as a 
starting point in scoping the available evidence on the development of HSPA models 
and the utility of using performance assessment methods for policy making.   
 
4.2 Objectives of Phase I 
The objectives for this first phase of the study were: 
 
1. To understand the methodologies employed for the development of 
health system performance assessment models. 
 
2. To elicit documentary and historical evidence on the impact of 
performance assessment on policy development. 
 
4.3 Method 
Bowling (2014) cites several sources and types of documents that could be used for a 
document analysis.  These include policy reports, legislative papers and acts of 
parliament, government publications, minutes of meetings etc.  The author used 
Scott’s list of criteria to ensure a quality-controlled process in choosing and 
interpreting the documents sourced (Scott, 2014).  These pertain to authenticity, in 
terms of the validity of the source of the document; credibility as to whether the data 
is typical of its kind; meaning, referring to the clarity and unambiguousness of the 
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information; and representativeness, as to the document’s claim to be able to represent 
the views of other sources. 
 
For the purpose of this exercise, documents were principally sourced from various 
databases through the internet but also from public and academic repositories of 
publications, such as libraries and various archives at the disposal of the author and 
thus, in the public domain.   
 
Since performance assessment as a discipline and the development of HSPAs were 
effectively launched in 2000 after the publication of WHO’s World Health Report 
(World Health Organisation, 2000), this date (i.e. 2000) was the start date used to 
source the documents in question, with the exception of a few seminal documents 
published before 2000.  Most documents were in the English language, except for 
documents in other languages which the author could access and understand.  No 
translation techniques were employed. 
 
4.3.1  Source and types of documents 
Documents originated from several different sources.  These included international 
organisations, national authorities and ministries, research and academic 
organisations, as well as meeting notes from official legislative and policy bodies.   
 
A full compendium of documents accessed and used for this analysis can be found in 
Section B of the Bibliography, a summary of which is given in Table 4.1.  Over 250 
documents were reviewed, from which 159 documents were included in the analysis.  
This initial sifting of documents was based on a rapid review of each document 
covering the subjects dealing with either performance assessment, HSPA, evidence-
based policy making, performance indicators and performance related political and 
legal factors. 
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Table 4.1: Sources of documents 
 
Source 
No. of 
documents 
World Health Organisation 37 
European Commission, including European projects and programmes 11 
European Observatory on Health Systems and Policies 28 
Organisation for Economic Co-operation and Development 16 
National Ministries, Departments, Authorities and Agencies 24 
National Parliaments and other legislative and policy bodies 6 
National HSPA reports and other performance and quality documents 5 
Proceedings and meeting notes from conferences, seminars and other fora 11 
Bridge Project 4 
Miscellaneous 17 
Total 159 
 
The collation and analysis of documents was carried out contemporaneously.  
Sampling and data collection procedures in an applied thematic analysis context is an 
iterative process, and this technique allowed the author to be guided appropriately to 
source the most relevant documents and only when the data analysed from the 
documents generated a clear and consistent picture in relation to the research questions 
was it deemed sufficient to consider the collection and analysis as complete.  This was 
an exercise in diminishing returns, where little new information was generated as more 
data was collected and analysed, similar to ‘data saturation.’ 
 
4.3.2  Examination of documents 
A document analysis worksheet was produced for each document that was reviewed 
and analysed.  The worksheet contained a standard format with information relevant 
to the document under review.  This included the title, author and organisation 
responsible for the publication, its intended audience, any potential biases or conflicts 
of interest of the authors, key words, the reason why the document was written in the 
first place, a summary of the contents of the document and its main conclusions, and 
finally any evidence of the link between performance assessment and policy making.  
As Patton (2015, p. Module 67) contends, it is important to not only analyse the 
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contents of the document but also understand the context and reasons why it was 
written.  This is especially so for documents of a policy or political nature.  Two 
samples, as examples, of the Document Analysis Worksheets can be found in 
Appendix 3a and 3b.  A total of 159 worksheets were consequently produced.  These 
are available for review but have not been appended due to the volume of the material. 
Once the details of each document were inputted into its respective document analysis 
worksheet, it was classified into one of several types of documents (Table 4.2) 
 
Table 4.2: Types of documents 
 
Type of Document Number 
Articles 6 
Books 20 
Country & National Reports 34 
Media & Communications 2 
Meetings and Presentations 18 
Official policy & legal papers 27 
Position and policy papers 18 
Reports 32 
Miscellaneous 2 
Total number of documents 159 
 
Each document was given a unique number identifier and uploaded onto Nvivo® 11 
for coding.  Ideally, document analysis involves initial sifting or skimming (superficial 
examination), close-reading (thorough examination) and interpretation.  However, 
given that documents of various sizes and types were reviewed, this iterative process 
was not always feasible.  Depending upon its size, relevance and source, the author 
employed two different methods for coding the text.   
 
Shorter documents (up to 20-30 pages) and longer documents of significant relevance 
and importance were read and coded in full.  For other longer documents, a text search 
for key words (Box 4.1) was carried out.  The surrounding text of these key words 
(from a paragraph to a few pages) was then reviewed and coded if relevant.  These key 
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search words were similarly used in other studies, especially those carrying out 
systematic reviews (Garrido, et al., 2008, pp. 53-74). 
 
Box 4.1: Key search words for document analysis 
 
Performance 
Performance assessment 
HSPA 
Evidence 
Policy 
Indicator 
Political 
Legal 
 
4.3.3  Modelling of Thematic Analysis 
The author reviewed the selected data and generated codes and categories, uncovering 
themes pertinent to the research questions.  As Charmaz (2006, p. 121) indicates, ‘by 
engaging in theoretical sampling, saturation and sorting, you create robust categories 
and penetrating analyses.’  Codes and themes were generated from the data using 
Nvivo® 11 to support the coding process.  To ensure consistency and strengthen the 
validity of the process, all data was coded directly by the author (Frost, et al., 2010), 
although some authors recommend the use of multiple coders to enhance inter-rater 
reliability of the study.  
 
As codes emerged, these were clustered into natural groupings or categories, leading 
to the generation of categories, main themes and sub-themes.  Points of convergence 
or divergence were recorded as this enriched the data analytical process, whilst 
exceptional occurrences were also documented to reflect the variety and complexity 
of the arguments as they emerged during the analysis.   
 
As the main core themes and sub-themes came into shape, several iterations of a 
conceptual framework were devised and used as a sensitising tool on new themes as 
they emerged.  The development of the coding structure was only completed when 
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‘the point of theoretical saturation was reached’ for each theme and sub-theme 
(Kyratsis, et al., 2014), (Dey, 1993, p. 276), (Graneheim & Lundman, 2004).   
 
The document analysis generating the first iteration of a model comprising 6 
categories, 13 main themes and 45 sub-themes.  This preliminary model is depicted in 
Figure 4.1 and was used to illustrate the results of this chapter, as well as to generate 
the discussion surrounding this first phase of the study.  This model was further 
adapted after the analysis of the participatory research phase was completed, 
generating an additional 3 main themes and 18 sub-themes, where a final model was 
produced.  This is elaborated upon in Chapter 6. 
 
Moreover, apart from the models cited above, Table 4.3 shows all the themes 
generated by the document analysis and the participatory research phase, grouped into 
categories, themes and sub-themes and showing the number of sources and references 
attached to each theme, as derived from the four main sources of the thematic analysis 
namely; documents, EU Expert Group meetings, peer review meetings and policy 
focus groups. 
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Figure 4.1: Preliminary Thematic Analysis Model 
 
Further work
Gaps in research Further research Recommendations
Communication
Communicating the evidence The media and evidence based policy
National and international perspectives
Promoting performance assessment Good practice examples
Improving health care delivery through performance monitoring
Performance assessment as a tool for service improvement
Relationship between performance assessment and policy development
Linking HSPA with policy 
development
Comparative 
policy making
Political process
Development of HSPA Frameworks
Methodology Legal, organisational and technological issues
  
9
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Table 4.3: Distribution of sources and references across the themes, clusters and main topics 
 
Categories Themes Sub-themes 
Document 
Analysis 
Participatory Action Analysis 
Combined 
Methods 
   Documents 
EU HSPA 
Expert 
Group 
Meetings 
Peer Review 
Meetings 
Focus 
Groups 
(including 
QoC sub-
group) 
TOTALS 
  (Sources – SRC; References – REF) SRC REF SRC REF SRC REF SRC REF SRC REF 
Development 
of HSPA 
Frameworks 
Methodology 
Definitions 12 18 1 1   3 6 16 25 
Methods 17 63 14 28 11 18 11 25 53 134 
Process in development of HSPAs 
and actors involved 
17 49 11 18 18 38 7 14 53 119 
HSPA models, indicators and 
dimensions 
43 118 15 22 13 25 9 35 80 200 
Conditions for using performance 
assessment for policy making 
34 80 1 1   1 2 36 83 
Legal, 
organisational 
and 
technological 
issues 
Information technological tools for 
assessing evidence & for 
performance measurement 
75 217 10 13 11 21 9 24 105 275 
Organisational issues 8 19   1 1 1 1 10 21 
Legal basis for performance 
assessment and evidence-based 
policy making 
22 52 9 13 5 7 5 8 41 80 
  Category totals 228 616 61 96 59 110 46 115 394 937 
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Table 4.3: Distribution of sources and references across the themes, clusters and main topics (cont.) 
 
Categories Themes Sub-themes 
Document 
Analysis 
Participatory Action Analysis 
Combined 
Methods 
   Documents 
EU HSPA 
Expert 
Group 
Meetings 
Peer Review 
Meetings 
Focus 
Groups 
(including 
QoC sub-
group) 
TOTALS 
  (Sources – SRC; References – REF) SRC REF SRC REF SRC REF SRC REF SRC REF 
Relationship 
between 
performance 
assessment 
and policy 
development 
Linking 
HSPA with 
policy 
development 
*Translating the evidence into policy           
Evidence in favour or against the link 
between performance assessment and 
policy making 
30 48 6 6   1 3 37 57 
Use of HSPA frameworks to inform 
policy 
25 104 11 14 9 12 5 9 50 139 
Policy cycle, process and tools 58 185 14 20 6 9 6 10 84 224 
Use of measures and targets to reach 
policy objectives 
16 46 6 7 3 4 6 9 31 66 
Non-health sectors - use of evidence, 
performance assessment & policy 
making 
21 49 2 2     23 51 
  Category totals 150 432 39 49 18 25 18 31 225 537 
* Sub-theme included under the umbrella theme - ‘Challenges in using performance data for policy making’ 
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Table 4.3: Distribution of sources and references across the themes, clusters and main topics (cont.) 
 
Categories Themes Sub-themes 
Document 
Analysis 
Participatory Action Analysis 
Combined 
Methods 
   Documents 
EU HSPA 
Expert 
Group 
Meetings 
Peer Review 
Meetings 
Focus 
Groups 
(including 
QoC sub-
group) 
TOTALS 
  (Sources – SRC; References – REF) SRC REF SRC REF SRC REF SRC REF SRC REF 
Relationship 
between 
performance 
assessment 
and policy 
development 
(cont.) 
Comparative 
policy 
making 
International and regional 
cooperation to inform policy 
20 34 3 5 7 8   30 47 
International & regional comparisons 
of performance to inform policy 
29 89 14 22 7 12 15 41 65 164 
*Challenges in comparative  
policy making 
          
*Challenges in using performance 
data for policy making 
85 255 16 17 12 18 17 40 130 330 
The political 
process 
Models of policy making 13 31 2 2 2 2 2 2 19 37 
The political prerogative 42 110 8 15 2 3 3 3 55 131 
Reforms 29 67 6 10 2 2 5 6 42 85 
Factors other than evidence and 
performance assessment that affect 
policy making 
34 129 1 1   2 4 37 134 
Consequences (benefits & dis-
benefits) of using performance 
information & evidence 
14 22 1 1     15 23 
  Category totals 266 737 51 73 32 45 44 96 393 951 
* Sub-theme included under the umbrella theme - ‘Challenges in using performance data for policy making’  
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Table 4.3: Distribution of sources and references across the themes, clusters and main topics (cont.)  
 
Categories Themes Sub-themes 
Document 
Analysis 
Participatory Action Analysis 
Combined 
Methods 
   Documents 
EU HSPA 
Expert 
Group 
Meetings 
Peer Review 
Meetings 
Focus 
Groups 
(including 
QoC sub-
group) 
Totals 
  (Sources – SRC; References – REF) SRC REF SRC REF SRC REF SRC REF SRC REF 
Improving 
health care 
delivery 
through 
performance 
monitoring. 
Performance 
assessment as 
a tool for 
service 
improvement 
Use of HSPA frameworks for  
service improvement. 
15 27 8 11 5 5 3 7 31 50 
Performance monitoring  
and improvement. 
44 85 3 4 1 2 1 1 49 92 
Accountability 17 36 8 11 8 10 1 1 34 58 
Performance 
assessment of 
quality of 
care 
Conceptual framework; quality of 
care indicators; policy focus group  
on quality of care. 
  1 1 3 5 10 46 14 52 
Performance 
assessment of 
integrated 
care 
Types and levels of integration; 
policy focus group on integrated 
care; Measuring the effects (benefits) 
of integrated care; Models of policy 
change incorporating integrated care. 
  8 25 7 28 8 39 23 92 
  Category totals 76 148 28 52 24 50 23 94 151 344 
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Table 4.3: Distribution of sources and references across the themes, clusters and main topics (cont.)  
 
Categories Themes Sub-themes 
Document 
Analysis 
Participatory Action Analysis 
Combined 
Methods 
   Documents 
EU HSPA 
Expert 
Group 
Meetings 
Peer Review 
Meetings 
Focus 
Groups 
(including 
QoC sub-
group) 
Totals 
  (Sources – SRC; References – REF) SRC REF SRC REF SRC REF SRC REF SRC REF 
National and 
international 
perspectives 
Promoting 
Performance 
Assessment 
Promoting performance assessment 
across Europe and internationally 
25 54 11 23 12 20   48 97 
Role of national organisations 56 142 2 4 4 5 2 2 64 153 
Role of international & regional 
organisations & networks 
50 116 11 17 3 4 2 2 66 139 
Good practice 
examples 
Case studies linking evidence with 
policy change 
73 178 1 2 4 6 2 3 80 189 
Examples in the use of HSPA for 
determining the policy agenda 
94 271 3 4 4 5 3 3 104 283 
Country 
experiences 
Austria; Bulgaria; Croatia; Cyprus; 
France; Germany; Greece: Hungary; 
Norway; Slovenia; Sweden 
  39 125 23 57 34 72 96 254 
  Category total: 298 761 67 175 50 97 43 82 458 1115 
Communication 
Communicating 
the evidence 
How to communicate; what and to 
whom to communicate; alignment 
14 60 17 36 5 8 3 12 39 116 
The media and 
evidence-based 
policy 
The role of the media; public 
accountability and transparency 
16 37 3 4 3 3   22 44 
  Category totals 30 97 20 40 8 11 3 12 61 160 
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Table 4.3: Distribution of sources and references across the themes, clusters and main topics (cont.)  
 
Categories Themes Sub-themes 
Document 
Analysis 
Participatory Action Analysis 
Combined 
Methods 
   Documents 
EU HSPA 
Expert 
Group 
Meetings 
Peer Review 
Meetings 
Focus 
Groups 
(including 
QoC sub-
group) 
Totals 
  (Sources – SRC; References – REF) SRC REF SRC REF SRC REF SRC REF SRC REF 
Further 
work 
Gaps in 
evidence 
Gaps in evidence 9 17     1 1 10 18 
Further 
Research 
Further research 14 19       14 19 
Recommendations 
Action by researchers; action by 
policy makers; action directed at both 
researchers and policy makers 
22 55 1 2 2 3 2 2 27 62 
  Category totals 45 91 1 2 2 3 3 3 51 99 
CATEGORY TOTALS:           
Development of HSPA Frameworks 228 616 61 96 59 110 46 115 394 937 
Relationship between performance assessment and policy 
development 
416 1169 90 122 50 70 62 127 618 1488 
Improving health care delivery through performance monitoring 76 148 28 52 24 50 23 94 151 344 
National and international perspectives 298 761 67 175 50 97 43 82 458 1115 
Communication 30 97 20 40 8 11 3 12 61 160 
Further work 45 91 1 2 2 3 3 3 51 99 
Overall Totals 1093 2882 267 487 193 341 180 433 1733 4143 
  General relevant comments 41 80 1 2 1 1   43 83 
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4.4 Phase I: Document analysis – Results and discussion 
As explained above, each document extracted from the document analysis of the thesis 
was recorded on an analysis worksheet and given a unique identifier number from 1 
to 159.  Whilst references from the literature are denoted within the main text, 
references to documents as part of the document analysis (and in Chapter 6, the 
documents used in the participatory observation study) are denoted as footnotes.  
These correspond to the list of data and documents listed in Section B of the 
Bibliography.  Given the qualitative nature of this part of the research, the subsequent 
sections present the results as well as engages in a discussion of these results. 
 
4.5 Development of HSPA frameworks 
The first part of the model deals with the central argument at hand, that of the 
development of HSPA frameworks.  It considers the methodological process of 
developing HSPAs, including the various models at play and the challenges and 
conditions related to their development and implementation.  The legal, organisational 
and technological aspects and difficulties of performance assessment are also 
discussed. 
 
4.5.1  Methodology 
As seen from the literature review, there is, as yet, no standardised approach towards 
developing and implementing HSPAs (Carinci, et al., 2015).  Each country or region 
has developed its HSPA based primarily upon its own contextual needs and objectives.  
However, there is a general consensus that certain parameters and methodological 
imperatives need to be met to generate a robust, methodologically sound and high 
quality HSPA (Prinja, et al., 2017). 
 
4.5.1.1 Definitions 
Given the wide interpretation promulgated by various HSPA models, it is important 
to first review the definitions used in the documents that were analysed to gauge 
whether authors are consistent in their usage of the concept of HSPA and performance 
assessment in general.  WHO is probably the main authority on defining HSPAs.2   
                                                 
2 116 WHO (Europe). Case Studies on HSPA.  2012; pg.1. 
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It uses specific key terms to define a HSPA – country; the process of monitoring, 
evaluating, communicating and reviewing; health system; indicators; goals and 
strategies.  Despite a lack of a standardised approach towards HSPA, these terms are 
invariably included in all HSPAs produced to date and guide the construction and 
implementation of HSPAs across health systems.  WHO also contends that a mature 
HSPA has a number of key attributes.  It should be regular, systematic and transparent, 
and a whole system approach should be adopted.  It should not be linked to any reform 
and health strategy agenda and there should be a constant revision of targets and 
priorities.3  However, this is not consistent with many other WHO supported HSPA 
processes in member states where HSPA was always closely associated with the 
country’s national policy agenda and health strategy (Marra, 2017).  On the other hand, 
WHO4 continues to state that ‘the challenge lies in aligning performance assessment 
and accountability based on strategy, by cascading performance indicators at the 
macro, meso and micro levels while recognizing and adapting to the different levels 
of responsibility.’  This is also the position taken by the EU and OECD. 
 
In linking HSPA with health policy, most HSPA contenders choose not to use WHO’s 
rather narrow definition of health policy, where WHO contends that policy is 
generated through initiation and delivery of health care, but define health policies as 
‘decisions, plans and actions that are undertaken to achieve speciﬁc health goals 
within a society,’ irrespective of where these policies originate from.5 
 
4.5.1.2 Methods 
The document review uncovered an insipidly uniform approach in the development 
and implementation of HSPAs in various countries, with a few exceptions.  This is 
rather surprising and inconsistent with individual countries’ traditional but stoic 
reticence to develop anything close to a common European or WHO-wide or OECD-
wide HSPA framework and methodology.  The document analysis also informed the 
methodological steps adopted for the development of Malta’s HSPA, which is 
congruent with many of the methodologies adopted by other countries.  The analysis 
also confirmed that international experts are invariably brought in and consulted at the 
                                                 
3 123 WHO (Europe).  The European health report 2009.  2009 pg. 142. 
4 123 WHO (Europe).  The European health report 2009.  2009; pg. 146. 
5 11 Mackenbach JP, McKee, M. Successes and Failures of Health Policy in Europe. 2013, pg. 17. 
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initial stage. This was the case for Georgia, Armenia and Belgium, where several 
international and WHO experts were enlisted to assist in developing their respective 
HSPA.6,7,8  International input is also deemed important to provide oversight and 
technical support, especially in ascertaining an acceptable level of scientific rigour.9   
 
Most HSPA frameworks are based upon the strategic objectives of the national health 
system, since the model needs to reflect the country’s needs and objectives.  This was 
the case for the Netherlands where their model was based upon their principles of 
quality of care, accessibility, and affordability.10  The EU Expert Panel on Effective 
Ways of Investing in Health reiterate that a conceptual framework is essential to 
delineate the boundaries of the health system to be assessed, as well as to inform a set 
of dimensions and allow for the selection of appropriate performance indicators to 
proceed.  This Expert Panel also states that ‘a conceptual model would help clarify the 
relationship between health system inputs, processes, outputs and impacts, as well as 
contextual factors influencing policy change mechanisms and the ways in which policy 
changes should be prioritized and evaluated.’11 
 
The phase of extracting and populating each dimension with performance indicators 
then follows.  OECD, WHO and ECHI have all developed a set of criteria for choosing 
indicators and these criteria are increasingly being used by countries for their own 
identification of national indicators.  Many of the indicator sets developed by 
international agencies are repeated iterations on the same theme and proponents in 
performance assessment are gradually working towards congruence and 
standardisation across regional and national HSPAs.  There is, in fact, significant 
overlap in the indicator sets used by the EU (ECHI), OECD (Health at a Glance), 
WHO (Health for All), the Millennium Development Goals, the Parma Declaration on 
Environment and Health and the Comprehensive Global Monitoring Framework and 
Targets for the Prevention and Control of Non-Communicable Diseases.12 
                                                 
6 152 WHO (Europe).  Georgia Health System Performance Assessment, 2009.  2010  pg. 15. 
7 150 WHO (Europe).  Armenia Health System Performance Assessment, 2009.  2009, pg. 25. 
8 116 WHO (Europe).  Case Studies on HSPA.  2012 pg.17. 
9 53 WHO (Europe).  Pathways to Health System Performance Assessment. 2012, pg. 52. 
10 154 van den Berg M et al. The Dutch health care performance report. Health Research Policy &  
 Systems 2014; pg. 3. 
11 124 EXPH (EC). Definition & Endorsement of Criteria to Identify Priority Areas. 2014. pg. 6, 10. 
12 145 WHO (Europe).  Regional consultation on targets and indicators for Health 2020 monitoring.   
2013 pg. 5. 
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The presentation of the results is usually geared to initiate a policy dialogue of sorts 
with policy makers.13  This process, which was outlined in detail in the literature 
review, was followed by several countries, such as the Netherlands, Belgium, Estonia, 
Turkey, Malta and Portugal (Rotar, et al., 2016).  It is increasingly becoming apparent 
that international organisations need to work together and collaborate on HSPA in 
order to standardise the framework, definitions and also data sources.  In its report 
regarding health investments, the EU Working Party on Public Health at Senior Level, 
stated that ‘this coordination will have a positive impact on Member States by reducing 
the burden of data collection and reporting, limiting duplication of efforts and 
producing more consistent results.’14  However, the EU diplomatically and 
understandably leaves each member state to follow its own route although in essence, 
all the routes are exceedingly similar and lead to the same outcome.  In certain 
instances, such as in Portugal, the policy dialogue and policy cycle that invariably 
proceeded from the HSPA process formed an integral part of the methodology.  The 
performance assessment of the Portuguese HSPA was driven by a set of policy 
imperatives on which subsequent policy recommendations were formulated on the 
advice of experts.15 
 
The mode of presentation of results presents certain challenges.  In most HSPAs, 
results are usually presented against a standard or predefined benchmark or are 
inserted into a trend analysis.  However, standardised approaches are required to 
compare like-with-like and statistical methods are key to ensure validity and reliability 
of results.  This is also important to understand variations in performance and to ensure 
that the observed variation is genuine.  To this end, risk adjustment is often used to 
overcome the problem of attributability, to ensure that the outcomes are casually 
linked to the activity or care under measure, in what Donabedian called ‘attributional 
validity’ (Donabedian, 1980 (b), p. 103).  However, this is also not without difficulties.  
Risk adjustment (or adjustment for case-mix), if performed on its own, may also give 
false results, depending upon the technique used for risk adjustment.  This is evident, 
for instance, when producing performance ranking scores for regional health systems 
                                                 
13 116 WHO (Europe).  Case Studies on HSPA.  2012. 
14 4 Working Party on Public Health at Senior Level - Report by sub-group 5: Health  
 investments. 2013. 
15 46 WHO (Europe).  Portugal Health System Performance Assessment. 2010. 
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or hospitals.  This is known as the ‘case-mix fallacy’ (Lilford, et al., 2004, p. 1148).  
On the other hand, the usefulness of comparative rankings is limited unless 
accompanied by a detailed understanding of mutable regional and intra-country 
contextual factors and even so, is primarily used by health authorities to spur a policy 
debate, rather than to take firm policy decisions. 
 
4.5.1.3 Process in the development of HSPAs and the actors involved 
Many factors need to be considered before embarking on the HSPA journey.16 
 
• Optimal frequency for reporting on performance of health system. 
• Ownership of the HSPA process. 
• Relationship between the HSPA process and the policy cycle. 
• Level of application of HSPA (national level, regional or local). 
• Report content: Technical/scientific elements plus/minus policy element. 
• Type of report: Descriptive/analytical component plus recommendations. 
• How to communicate results. 
 
The ‘owner’ of the process is an important consideration.  Most HSPAs are developed 
directly by the ministries responsible for health (Estonia, Turkey, Malta).  Whilst this 
is understandable due to the intimate link between HSPA and national strategy 
making, this presents challenges in dealing with independence and autonomy in the 
research and analytical stages of the process.  Whilst no documents explicitly stated 
that this was a problem, many documents did emphasise the importance of retaining 
methodological integrity and authenticity.  Some countries have circumvented this 
problem by ‘contracting out’ this function to autonomous research organisations, such 
as in Belgium, the Netherlands and Slovenia.  However, political ownership of the 
process is deemed essential for the development and implementation of HSPAs within 
a country.   
 
Some countries, such as Belgium, actively and purposefully involve politicians and 
policy makers through formal fora or conferences, where key policy decisions are 
                                                 
16 116 WHO (Europe).  Case Studies on HSPA.  2012. Pg. 1; 53 – WHO (Europe).  Pathways to  
Health System Performance Assessment. 2012. Pg. 43. 
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taken as part of the HSPA process (Perić, Hofmarcher-Holzhacker & Simon (2017).  
This, in itself, is positive in that it demonstrates a direct link between the development 
of HSPA and policy making and serves as an opportunity to keep ‘all relevant parties 
well informed and able to contribute to the process.’17  In Estonia and Portugal, a 
synergistic approach was maintained between the development and content of their 
national political priorities as espoused in their respective National Health 
Programmes.18   
 
The EU Expert Panel on Effective Ways in Investing in Health (EUEPIH) believes 
that consultation with end users is essential when developing and testing the 
framework, especially in the context of EU member states.19  WHO also believe that 
‘effective communication and wide dissemination are required to create platforms to 
introduce important changes in health system.’20  On the other hand, a right balance 
needs to be reached between scientific rigour and political ownership.  This is usually 
achieved through an iterative and participatory process, such as in the incremental 
process developed by the Belgian Health Care Knowledge Centre (KCE), where each 
stage envisaged the sharing of the findings with policy makers and stakeholders.  This 
process, although with certain methodological limitations, served to inculcate a sense 
of ownership and deliberation which then allowed for the report to be more readily 
accepted and taken up at policy and political level.  
 
4.5.1.4 HSPA models, indicators and dimensions 
This section provides a description on the various HSPA models in place today. Whilst 
it is largely a descriptive account of the models, dimensions and indicator sets, it also 
attempts to bring to light the association between the various model types and the 
policy cycle.  Although most models follow the same conceptual framework, there are 
nonetheless noteworthy variations which differentiate one model from another.  This 
is true in their scope, their approach to performance assessment, ownership and many 
other facets that delineate HSPA models (Perić, Hofmarcher-Holzhacker & Simon 
(2017). 
                                                 
17 116 WHO (Europe). Case Studies on HSPA.  2012; pg.17. 
18 116 WHO (Europe).  Case Studies on HSPA.  2012; pg.33 and pg.50. 
19 124 EXPH (EC). Definition and Endorsement of Criteria to Identify Priority Areas. 2014. Pg. 11. 
20 123 WHO (Europe).  The European health report 2009.  2009. Pg.147. 
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4.5.1.4.1 Models and dimensions 
The NHS suffered through several iterations of performance models, each moulded to 
reflect the political agenda of the government of the day.  Due to its long history of 
performance measurement at institutional level, England does not have one national 
health system performance assessment framework covering the whole health system 
as other more novice countries do.21  The ﬁrst attempt of measuring performance in 
the NHS was in 1983, where target setting was the main objective.  Over 500 process 
and input indicators, mostly clinical in nature, were launched.  Next came the NHS 
Plan in 2000, containing a more limited number of indicators.  This was again 
primarily grounded in the performance of the health authorities and hospitals at the 
time.  A traffic light system ensued to classify, reward or penalise these organisations, 
followed by the star rating system.   
 
Successive legislations tweaked these performance models, from the NHS Operating 
Framework to Vital Signs between 2007 and 2011, again based upon target setting and 
monitoring.  However, Vital Signs was still considered input- and process-oriented.  
The latest iteration comes in the form of the NHS Outcomes Framework (Figure 4.2), 
first published in December 2010.22   
 
This model differs from many others in that it is not health system driven and places 
the emphasis on outcome measures in contrast to other models which usually also 
include input, process and output measures.  The first Outcomes Framework is 
structured around 5 domains, and 60 performance indicators, measuring various facets 
of care.   
 
These dimensions or domains differ from the traditional set of dimensions that 
measure efficiency, financial protection, quality of care, etc.23  A more recent 
outcomes-based model is that promulgated by New Zealand termed the ‘Systems 
Level Measure Framework’ (Chalmers, Ashton & Tenbensel (2017). 
  
                                                 
21 116 WHO (Europe).  Case Studies on HSPA.  2012. 
22 107 Secretary of State for Health (UK).  Secretary of State’s Annual Report. 2012. 
23 133 Anne Gulland.  English Health Secretary Unveils 60 Performance Indicators.  BMJ. 2011. 
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Figure 4.2: England’s Outcomes Framework 
Source: NHS Group, Department of Health (December 2014) 
 
The Estonian model is based upon the Donabedian approach, with 11 dimensions 
organised along Levers (Inputs), Intermediate Goals (Process) and Goals (Outputs).24  
Similarly, the Portuguese HSPA is also derived from the Donabedian model, 
consisting of 12 dimensions.25   
 
As part of Georgia’s reform process, it developed an ambitious HSPA model, 
consistent with the WHO framework of health system goals and objectives.  It consists 
of 9 dimensions portrayed as objectives to improve the health system’s stewardship, 
health information systems, allocative efficiency, financial protection, accessibility, 
health service effectiveness, quality outcomes and population outcomes.26  The 
recently developed Hungarian HSPA model also promulgates a Donabedian approach 
(Giedrojć, 2016).   
 
                                                 
24 151 WHO (Europe).  Estonia Health System Performance Assessment, 2009.  2010. 
25 153 WHO (Europe).  Portugal Health System Performance Assessment. 2010. 
26 152 WHO (Europe).  Georgia Health System Performance Assessment, 2009.  2010. 
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4.5.1.4.2 Indicator sets 
Mackenbach and McKee27 used various ‘policy’ indicators to demonstrate the success 
or otherwise of health policy formulation and implementation in Europe.  They termed 
indicators with the prefix ‘policy’ to demonstrate the ability performance indicators 
have in determining how policies are scrutinised and assessed.  However, they were 
not the first to understand the importance of linking indicators with policy generation.  
Jee and Or28 in 1999 had already drawn up a list of ‘policy indicators’ for use by OECD 
member states.  McKee (pg. 29), this time in conjunction with Rechel, again contended 
on the importance of choosing a ‘set of carefully selected, policy- relevant and valid 
indicators’ to measure health system performance29.  McKee, as part of the EUEPIH, 
distinguished between ‘normal’ health indicators and ‘leading’ indicators, which are 
meant to provide an early warning to policy makers.  
 
Rechel and McKee also contend that selection of indicators should be driven by need 
rather than availability of data. This position contrasts greatly with the 
recommendations put forward by a WHO expert group in 2013 when discussing well-
being indicators.  They commented that ‘indicators should be selected on the basis of 
their availability for most countries, and be collected in international data collection 
effort.’30  One would assume that this easier path was advocated to overcome the 
difficulties and challenges in choosing the correct indicators, which, in part, can, and 
indeed, should be mitigated in the long run by developing robust and appropriate 
health information systems to gather such data on a routine basis, in what Rechel and 
McKee31 term the ‘metainformation on the indicators used in health information 
system.’ 
 
4.5.1.5 Conditions for using performance assessment in policy making 
There are certain conditions that need to be satisfied to ensure the proper development 
and implementation of HSPA frameworks.  Many countries are simply not equipped 
to generate the required evidence through performance assessment and to translate that 
evidence into useful information for policy making.  As Green and Bennett succinctly 
                                                 
27 11 Mackenbach JP, McKee, M. Successes and Failures of Health Policy in Europe. 2013. 
28 71 Jee, M. and Z. Or – OECD.  Health Outcomes in OECD Countries. 1999. 
29 125 Rechel, B., McKee M. (Eds).  Facets of Public Health in Europe.EOHSP. 2014; pg. 29. 
30 144 WHO (Europe).Measurement of and target setting for well-being.2013; pg. 9. 
31 125 Rechel, B., McKee M. (Eds).  Facets of Public Health in Europe.EOHSP. 2014; pg. 29. 
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put it ‘the variations in health and health systems experience suggest that many 
countries simply do not have the necessary policy-making components in place.’32 
 
Swedish public health authorities have identified several conditions that need to be 
met to ensure a robust public health monitoring and performance system.  These 
include more specific and explicit measurable goals, better access to data at regional 
and local, better control of management systems and the need for increased expertise 
and knowledge.33  Moreover, one of the most important tenants of HSPA and 
performance assessment in general is that the results are not used for punishment but 
for learning, change and improvement.  This is one of the most fundamental precepts 
of HSPA and needs to be clearly understood by all involved, most especially policy 
makers and managers.34 
 
Experience from countries that have introduced HSPA frameworks shows that unless 
there is firm government ownership and support for HSPA at the highest level, its 
impact upon service improvement and moreover policy making would be minimal.  
Various case studies have shown that whilst some countries, such as Belgium and the 
Netherlands, have integrated the HSPA process into their policy cycle, others such as 
Portugal and Estonia did not yet manage to garner the required support at central level 
to follow suit.35   
 
The EUEPIH have agreed that establishing HSPA as part of a repetitive policy cycle 
is essential to extract the full benefit of performance assessment tools and in so doing 
nurture a greater sense of accountability and transparency amongst policy makers.36  
This is improved upon if HSPA is relevant to policy makers and is aligned to current 
health priorities.37  As Oliver et al (2015) put it, ‘relevance is achieved by interaction 
between policy makers and researchers during the review process.’38  This however 
                                                 
32 94 Green A., Bennett S. Sound choices-enhancing capacity for evidence-informed health policy.   
 WHO. 2007. Pg. 28. 
33 49 SNIPH. Ten years of Swedish public health policy. 2013. Pg. 22. 
34 67 WHO (Europe). Performance Assessment Tool for Quality Improvement in Hospitals  
 (PATH). 2007. Pg. 12. 
35 116 WHO (Europe).  Case Studies on HSPA.  2012. Pg. 14. 
36 4 Working Party on Public Health at Senior Level - Report by sub-group 5: Health  
 investments. 2013.  Pg. 19. 
37 53 WHO (Europe).  Pathways to Health System Performance Assessment. 2012. Pg. 15. 
38 98 Oliver S. et al.  Systematic reviews-making them policy relevant.  2015. Pg 1. 
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depends on whether the HSPA report is purely technical or whether it also includes a 
policy angle with policy recommendations.  Whilst some proponents argue that the 
HSPA process should be completely independent of the policy making machinations 
to retain full objectivity and transparency, others argue that this distance would work 
against the proper assimilation of the HSPA process into the policy cycle.  WHO 
believes that ‘for the knowledge generated through HSPA to be translated into policy, 
a dialogue between the evaluators and policy-makers is critical, at the outset and at 
key milestones of the process.’39 
 
The expectant expertise and competences are also required to build a correct model 
and to translate the findings into tangible results.  The ‘proper statistical treatment of 
performance indicators is essential if appropriate policy inferences are to be drawn, 
given the large degree of random variation present in most performance indicators.’40   
 
Timeliness is also an important factor to consider since the data produced needs to be 
relevant for the time-period under consideration, especially since data quickly 
becomes outdated.41  This delay is not understood nor appreciated by policy makers 
and the lack of timely produced evidence risks rendering the HSPA process redundant 
if not managed properly.42   
 
4.5.2  Legal, organisational and technological issues 
There are legal, organisational and technological factors that need to be considered in 
the development of HSPAs and their implementation across health systems. 
 
4.5.2.1 ICT tools for assessing evidence and for performance measurement 
Information technology plays an essential role in measuring the data that is 
subsequently used for performance assessment.  This section outlines the importance 
and application of ICT in data performance systems. 
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4.5.2.1.1 The importance of health information systems 
A reliable and robust Health Information System (HIS) is essential to develop an 
effective HSPA and generate the required evidence in the form of performance data.  
A HIS allows for the consistent and comprehensive collection and analysis of data 
using routine monitoring and reporting activities.  Mackenbach and McKee (2013) are 
very clear on the importance of HIS when they state that ‘Health policies also require 
functioning information systems.  These are necessary to identify those at greatest 
need’ and ‘information systems are also essential to monitor the performance of a 
health policy in order to identify when and where to intervene if problems arise.’43   
 
Some may argue that many countries have advanced HIS in place to capture the 
required data.  However, even countries such as the Netherlands have realised, through 
various research initiatives, that ‘their health information systems were, as yet, 
insufficient to enable the type of fine-grain analysis considered necessary.’44   
 
From another perspective, the proper capture and use of information is a ‘resource for 
securing managerial, political and democratic control of the health system, in short, 
improving governance.’45  High quality data capture is essential but this needs a 
significant investment and a deep understanding of the value of health information 
systems.46 
 
There have been considerable attempts by CION, in collaboration with WHO and 
OECD, to devise a broad but unified European health information database for the 
European region47.  To this end, CION has sought to create an EU-wide legal 
framework and to open lines of communication to address information gaps and 
improve the gathering of evidence through a robust HIS, although to date this has 
proven problematic.48. 
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4.5.2.1.2 Link between HSPAs and Health Information Systems 
HSPAs and HISs are mutually synergistic but not mutually exclusive.  They are both 
essential elements to generate, collect and disseminate the required evidence for 
clinical and management decision taking.  However, ‘HSPA has brought to the 
forefront a number of issues regarding fragmentation of databases and has 
highlighted the opportunities that arise when data from difference sources are brought 
together.’49 
 
As a result of technological advances and reduced costs, many countries have now 
‘developed national repositories of health information or national performance 
assessment programmes. Indeed, several systems often coexist in many countries.’50  
This co-existence has some advantages.  The availability and accessibility of public 
domain health performance data adds credence to the performance assessment 
paradigm, which in turn is important to increase acceptability in the sharing of 
sensitive health performance data as required by the HSPA process.51   
 
4.5.2.1.3 Health information databases: Their use and applicability 
There are several national and international databases containing a myriad of health 
performance indicators.  Information databases have become increasingly possible 
with the ‘enormous increase in capacity for measurement and analysis as seen in the 
last decade, driven in no small part by massive changes in information technology and 
associated advances in measurement methodology.’52  These technological advances 
have revolutionised the manner in which performance data is acquired, stored and 
analysed and has led to the advent of ‘big data research.’ 
 
The ECHI database has been instrumental in assessing the progress of European health 
systems and, together with HSPA, is considered by CION as one of the pillars for 
gathering evidence of the effects of structural reforms in the EU.53  Whilst 
international health databases have several advantages, there are significant 
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challenges, related primarily to standardisation of definitions and data comparability 
among countries.  WHO’s work on the classification of diseases has sought to 
overcome these difficulties.  On the health financing side, OECD’s System of Health 
Accounts has been instrumental in generating a standardised approach to measuring 
health financing.54  Although the United States does not have a nation-wide HSPA 
framework, the Commonwealth Fund has developed a National Scorecard on U.S. 
Health System Performance.  This database measures the performance of the US 
health system through 38 indicators across five dimensions.55 
 
4.5.2.2 Organisational issues 
The institutionalisation of HSPA takes on many forms.  The HSPA function within a 
health ministry may form an integral part of the ministry or may be positioned at arms-
length in a semi-independent or independent unit or agency.  The model adopted is 
usually determined by the motive for setting up the HSPA function in the first place.  
Ministries for Health which adopt an iterative policy making process usually embed 
the HSPA function within its core function, allowing synergies to be created between 
researchers and policy makers.  This also creates a strong sense of ownership whilst 
allowing closer alignment between policy makers and researchers.  On the other hand, 
independent agencies are more appropriate if the main purpose of the HSPA to foster 
greater accountability and transparency.56 
 
WHO have been fierce advocates for the integration of HSPA into core government 
business.  It encourages member states to dedicate enough resources and expertise to 
development and sustain HSPA.  It firmly believes that HSPA would inculcate a 
culture of excellence in health system performance.  However, evidence shows that 
few countries have really adopted HSPA as a core function within their arsenal for 
policy making and health system improvement.  Italy may be one of the exceptions, 
where the Ministry of Health created a new department to oversee the performance of 
the Italian health system and coordinate the responses from the regions.57 
 
                                                 
54 6 Smith, PC. et al. Performance Measurement for Health System 2009. Part 5. Pg. 651. 
55 12 McCarthy et al., 2009 as cited in 12 - Papanicolas, I, Smith, PC. Health System Performance  
Comparison. 2013. Pg. 85. 
56 116 WHO (Europe).  Case Studies on HSPA.  2012. Pg. 63. 
57 142 MOH (Italy).  Piano della performance 2015 – 2017.  2015. Pg. 4. 
 112 
Research organisations that wish to have an impact on policy making need to create 
the right organisational model to align their objectives with the needs of policy makers.  
Organisations that are sought after for policy support are usually geared towards 
providing ‘policy friendly’ reports and policy briefs.  There are several organisations 
that have been successful in this game, such as those adopting an organisational model 
that focuses upon knowledge brokering to provide evidence for policy making.58  
‘Knowledge-brokering organizations need to match form to function when designing 
organizational models that will best support well-informed health systems decision-
making.’59  On the other hand, many academic units, especially those within 
universities, are not concerned with producing evidence for policy making but purely 
for advancing scientific knowledge.   
 
Chatham House, in one of their policy papers, produces an insightful overview of the 
barriers and potential solutions to share public health data for policy making.  There 
are technical, motivational, economic, political, legal and ethical barriers which could 
be overcome by a robust legal framework and promoting political advocacy, building 
enough capacity and expertise, and building trust and inculcating a culture of 
transparency and accountability.60 
 
4.5.2.3 Legal basis for performance assessment and evidence-based 
 policy making 
A legal framework provides greater legitimacy for performance measurement and 
assessment.  Some countries have embedded their performance process within a legal 
framework, whilst others have adopted a more voluntary approach. 
 
4.5.2.3.1 Inter-country legal provisions 
CION took a roundabout way to introduce the concept of evidence-based policy 
making into its legal framework, by inserting an article (Article 15) dealing with 
European networks for health technology assessment within the directive on patients’ 
rights in cross-border healthcare (European Commission , 2011).  HTAs have been 
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introduced by most member states and can serve as a basis for additional evidence-
based mechanisms, such as HSPAs.61  Nonetheless, there is also an acknowledgment 
that Europe lacks a legal framework for sharing of data and information for policy 
making, except in dealing with data protection and data security issues.62 
 
4.5.2.3.2 Data sharing 
The EU’s legal framework on patient data and privacy has been criticised due to its 
potential barrier to sharing patient data for research purposes.  Whilst it is not the 
intention of this study to delve into any great detail on this complex issue, its mention 
is important since it may have an impact upon the comparison of performance data 
across health systems since patient and population data characteristics feed into the 
performance indicators that populate the HSPAs.63  Chatham House is not hopeful that 
a global data sharing legal framework is likely any time soon.  The alternative, in its 
view, is to create a ‘global data governance or ethical framework, supplemented by 
local memoranda of understanding that take into account the local context.’64  The 
International Health Regulations (IHR) framework can be considered as an 
arrangement for data sharing, although these are not a mandatory requirement on 
countries, neither do they set minimum data set standards.   
 
4.5.2.3.3 Legislative instruments 
Only a few countries have legislation in place to ensure the production and 
dissemination of evidence and to assure quality of care.  Germany, Hungary, the 
Netherlands, Austria and Sweden have laws dealing with quality assurance 
programmes, sufficiency of standards of care and health system performance.65  
However, legislation linked to HSPA is not a common feature of a country’s legal 
portfolio and, unlike HTAs, has not yet been integrated into any relevant legal 
instruments.  Hungary decried that HSPA should be incorporated into their legal 
framework although it took more than 4 years to translate this law into reality 
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(Babarczy, et al., 2017).  Belgium’s KCE has a legal mandate to generate and provide 
evidence for the Belgian authorities.66   
 
Many laws relating to performance assessment and quality of care were introduced in 
the context of evolving health care reforms, such as in the case of the ‘Agence 
nationale d'appui à la performance des établissements de santé et médico-sociaux’.67   
 
England has a similar requirement where the Health and Social Care Act 2012 now 
requires the Secretary of State for Health to report, on an annual basis, on the 
performance of the health service.  These reports would, for the first time, be open to 
parliamentary scrutiny.68  Finland also has a legal mandate to report to parliament, 
through the work of its National Institute for Health and Welfare.69 
 
4.6  Relationship between performance assessment and policy 
  development 
This set of themes looks at the evidence linking HSPAs with policy making, citing 
various models of policy making and the impact of extraneous factors on policy 
development.   
 
It is important to highlight at this juncture that although there is an abundance of 
literature and documentation on evidence-based policy making, there is little evidence 
to show how HSPAs have, in a real and effectual manner, impacted policy.  This 
problem was already recognised by WHO in 2007, where Green and Bennett (2007) 
claimed that there was, at the time, a growing need to discover what works and what 
doesn’t work in policy terms, based upon the available evidence.70 
 
4.6.1  Linking HSPA with policy development 
This next section discusses the evidence showing a direct or causal link between HSPA 
and policy making. 
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4.6.1.1 Translating the evidence into policy 
Evidence-based policy making is challenging since policy makers and researchers 
occupy very different positions with ‘different values, ideologies, languages, 
backgrounds, institutional settings and reward systems.’71  This is probably the main 
challenge faced by proponents of HSPA, that of bridging the gap between those who 
construct and report on performance assessment and those who assimilate this 
information and take policy decisions.  The marrying of these two paradigms is key to 
the successful incorporation of the HSPA process into the policy cycle.  This 
relationship is further complicated since policy implementation itself is not an exact 
science but a ‘natural experiment’ without control groups and, therefore, cause and 
effect cannot easily be established.72  This was amply expressed by the Alliance for 
Health Policy and Systems Research in Geneva wherein it stated that: 
 
‘policy-makers and managers complain that they frequently encounter 
research that is not relevant to real life problems, full of results expressed 
in esoteric or obscure language, often published in inaccessible journals. 
Conversely, researchers often complain that policy-makers and health 
managers ignore research results which are the fruit of careful work 
supported by substantial investment.’73   
 
This mismatch creates an inherent tension between researchers and policy makers 
which is further compounded by policy makers who may lack the tools and skills to 
interpret scientific evidence but also by the lack of ‘policy or political astute’ 
researchers.  Greater trust and mutual respect is therefore advocated between 
researchers and policy makers through greater engagement in a purposeful dialogue, 
where policy makers participate at inception of the performance assessment process, 
allowing researchers to meet their requirements.   
 
However, even if the above is adhered to, WHO still admits that ‘policy decisions, 
especially on broad, systemic and politically sensitive issues, such as HSPA, cannot 
be based solely on evidence,’ even though it is still imperative that the ‘evidence-
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informed approach implies a transparent and systematic method for generating and 
using research and other evidence as an input into the policy-making process.’74 
 
4.6.1.2 Evidence in favour or against the link between performance  
 assessment and policy making 
The document review noted different policy responses to HSPA.  Whilst the Dutch 
Health Care Performance Report necessitated two to three iterations to have a 
discernible impact upon its national policy agenda,75 the Belgian HSPA process was 
still not ‘fully embedded within the ongoing Belgian political debate and health 
policymaking’76 up to 2014, although its latest iteration claims to have made inroads 
into the policy process.77  On the other hand, Armenia’s HSPA has contributed directly 
to the development of several national policies such as the National Tobacco Control 
Programme and a policy paper on tackling non-communicable diseases.78   
 
The opposite holds true in the case of alcohol policy, where although the burden 
attributable to alcohol is well documented, the policy response is not consistent.79  The 
same can be said for the global rise of non-communicable diseases where, in a 
conference organised by Chatham House and in the presence of the Director General 
of the WHO, it was acknowledged that in spite of the overwhelming evidence on the 
burden of non-communicable diseases, policy makers still do not make a concerted 
effort to deal with this epidemic.80   
 
4.6.1.3 Use of HSPA frameworks to inform policy 
Georgia’s HSPA was instrumental in expounding several policy recommendations 
dealing with improving health system stewardship, improving health information 
systems and the efficient allocation of resources were proposed.81  These 
recommendations follow the same pattern as for Armenia and this is not surprising 
since WHO spearheaded this process in both these countries.  WHO has long 
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advocated for the integration of HSPA into the performance and policy building 
process and has provided several examples of the usefulness and effectiveness of 
HSPAs but its declarations contrasts with that of other authors, who have documented 
several limitations in the use of HSPAs.  Smith et al., in their compendium on health 
system performance, also outlined several case studies of good practice, from the 
United States Veteran Health Administration where ‘performance indicators were 
used to monitor the effects of health system reforms while driving accountability 
agreements at sub-system and individual levels’, to the Ontario Ministry of Health and 
Long-Term Care where they have extensive experience in utilising performance 
information decision making cycle.82 
 
On the other hand, several authors contend that since HSPA is not yet embedded into 
the national legal framework, its influence on policy is understandably limited.  
However, given the importance given to HSPA by the EU, WHO and OECD, some 
contend that it will only be a matter of time before many countries recognise its 
importance and integrate some form of HSPA into their official policy making 
process.83   
 
This is the view of the EUEPIH and the European Commission ‘Report by Sub-Group 
5 on Measuring and Monitoring the Effectiveness of Health Investments,’ which have 
reinforced the concept of evidence-based policymaking throughout their mandate,84 
although they also reported that whilst some countries do use HSPA occasionally for 
policy development, the extent of this across the EU is still not clear.85 
 
4.6.1.4 Policy cycle, process and tools 
The policy cycle contains four stages, namely; planning, implementation, evaluation 
(appraisal) and redesign of the intervention.  Evidence on the outcome of the 
intervention is required at the evaluation stage to appraise the various options under 
scrutiny before deciding which direction to take.  HSPA provides such evidence by 
interjecting at the appraisal stage as an integral part of the policy cycle.   
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4.6.1.4.1 HSPA as part of the policy cycle 
Estonia has aligned its first HSPA report with its national health strategy and both 
tools have been used in setting the policy agenda.  Both these functions have been 
integrated under the same responsibility as they claim that these synergies would 
augment the policy cycle.86  Turkey’s HSPA framework has also featured heavily in 
the national and regional policy making process, where its proponents commented 
about ‘embedding performance assessment in policy and management of the system.’87  
However, there is no evidence or published material to show that these aims, however 
noble, have been reached and how HSPA, after its launch, was actually instrumental 
in steering policy in Turkey.   
Nonetheless, WHO has ascertained that there is an intimate link between performance 
indicators and the establishment of targets as part of a national health plan.  It claims 
that this is the case in 43 out of the 53 Member States of the European Region where 
outcomes form an integral part of their national health strategy.88 
 
4.6.1.4.2 Sources of evidence other than from HSPA frameworks 
 
Research evidence may play different roles at different stages of the policy 
formulation cycle. Since evidence can come from many different sources, in 
many different forms and with varying degrees of quality (and 
transferability), significant capacities are required to draw upon research 
evidence in policy-making.89   
 
HSPA does not have a monopoly on generating the required evidence for policy 
making.  This became quite evident as the document analysis progressed.  There are 
several other tools at the disposal of policy makers to garner the required evidence to 
take important decisions. Health Technology Assessment (HTA) is now an established 
mechanism to provide evidence on the use of technology and drugs.  Most European 
countries today have established a statutory and/or scientific HTA programme and this 
usually forms an integral part of the policy making process,90 where its use has been 
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formalised through the implementation of the EU directive on patients’ rights in cross-
border healthcare, in particular in the application of Article 15 dealing with the 
European network for health technology assessment.91  HTA could serve as a model 
for the future integration of other scientific tools into the policy cycle, such as HSPA 
frameworks, where evidence would be a statutory requirement for decision making in 
health care.  HTAs are also very similar to the HSPA process in that both determine 
or attempt to influence policy prospectively contrary to traditional policy analysis 
which is predominantly retrospective, where the aim is to ‘inform policy processes 
before the formulation of policies or a formal decision.’92 
 
The downside of using complex scientific methods as an adjunct to public decision-
making is that the methods and sometimes, the conclusions are not understood by the 
public and can be sometimes misconstrued and even overtly criticised.  This derision 
does not go down well with politicians who are, perhaps understandably so, reluctant 
to take policy decisions that, whilst well-grounded in evidence, go against the public 
sentiment or perception. 
 
4.6.1.4.3 Influencing policy agenda beyond available evidentiary path 
Mackenbach and McKee (2013) analysed which countries have introduced successful 
policies and why some policies seem to work better than others.  They conclude that 
there are several factors that are key for successful policy making, which include 
recognition of the problem, the availability of scientific evidence and the involvement 
of stakeholders at multiple levels.  Moreover, they contend that health policies are 
particularly dependent on ‘service provision, behaviour change and intersectoral 
policies.’93   
 
Figueras et al., as quoted in Smith et al. (2009), postulates that policy formulation is 
influenced by a variety of circumstances which are ‘path-dependent,’ where policies 
are influenced by historical factors and that each policy has a ‘historical path’ that 
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needs to be taken in consideration.94  This supports the incremental model of policy 
making.95   
 
It goes without saying that politics plays a crucial role in policy making.  In many 
areas, the two are indistinguishable, including the health sector, which is as equally 
influenced by the political agenda as any other sector.  Indeed, it would be foolhardy 
to try to detach the political reality from policy making, even in health.  This unrealistic 
view is sometimes referred to as the ‘technocratic wish’ (Chinitz & Israeli, 1999), 
where scientists believe, perhaps mistakably so, that policy and management decisions 
could and should be based solely on evidence.  Some would argue that ‘politics is not 
only an unavoidable and legitimate part of decision making regarding the allocation 
of health resources, but also that evidence-based medicine itself is a political 
endeavour.’96  Furthermore, most policy decisions within pluralistic democracies are 
taken as part of a wider democratic process, often with public consultation.  This is 
termed as the ‘democratic wish’ (Morone, 1998), with the people or public having a 
greater voice in decisions that affect them.   
 
4.6.1.4.4 The causality dilemma 
One of the well-documented challenges of using performance assessment at system 
level is the issue of causality.  Whilst this was amply covered in the literature review 
(Mainz, 2003); Filippidis, Mian & Millett; (2016), the document analysis also came 
across this important issue.  The main difficulty seems to lie in correlating success or 
failure of high-level strategic goals and reforms with the performance or otherwise of 
specific areas of the health system.  To achieve this, ‘policy-makers need a solid 
performance assessment framework that highlights the expected causal relationships 
between the different performance dimensions.’97  A more technical response to this 
challenge is proposed by Smith et al., (2009), where they recommend that ‘policy-
makers should be careful to control properly for measurement and attribution error 
by using statistical methods to evaluate causal relationships and inform policy.’98 
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4.6.1.4.5 Research organisations as part of the policy cycle 
Many research driven organisations are now attuned to the requirements of policy 
makers.  In fact, in recent years, the need for evidence-based policy making has 
become more commonplace and policy is more frequently being informed by the 
results of their research.  Those organisations that steer their research agenda as close 
as possible to pertinent public issues of relevance have been more successful in 
influencing the policy agenda through their research.   
 
The Norwegian Knowledge Centre for the Health Services (NOKC) is one such 
organisation, where it has ‘been successful in informing policy-making as a result of 
the organization’s proximity to the policy-making process, both by design and through 
the active work of senior management, while retaining its independence from political 
agendas and interest groups.’99  The NOKC has become a comfortable ‘bed fellow’ 
in policy circles, to the point of inviting politicians and other decision-makers to 
submit requests for evidence-based policy topics, and also participating in policy 
dialogues.   
 
4.6.1.5 Use of measures and targets to reach policy objectives 
Using targets for performance monitoring has always been a controversial topic.  On 
the one hand, supporters of this method insist that targets are an essential prerequisite 
for adequate performance assessment.  They claim that it fosters accountability and 
guides policy makers to set the right priorities.  On the other hand, detractors claim 
that target setting is discriminatory, subjective and creates an unequal playing field.  
Whichever point of view is adopted, evidence indicates both advantages and 
drawbacks. 
 
Even after three decades, target setting in England still attracts considerable 
controversy.  It has evolved over time and passed through several iterations, the latest 
one reflecting a more outcome-oriented and quality-oriented approach.  The star rating 
system (2001–2005) was perhaps the most explicit example of target setting where 
NHS hospitals were rated annually, based on a wider range of targets and indicators 
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in a balanced scorecard.  Although not well received, the star rating system did manage 
to register improvements in several clinical areas, such as waiting times at Accident 
and Emergency and for elective surgery.100  The impact on longer term health gains is 
however, not yet verified as the results of target setting have not yet produced the 
anticipated gains in health outcomes.101   
 
4.6.1.6 Non-health sectors:  
 Use of evidence, performance assessment & policy making 
The notion that only health factors affects health is nonsensical.  Throughout time, it 
has been shown that the major public health advances have resulted from 
improvements in other areas, such as housing, clean water sources, employment, etc.  
Hence, the discussion of non-health related factors in influencing health policy is 
always an important consideration that should not be overlooked.  Chatham House 
summarises this succinctly where it states that ‘to combat the rise of these diseases, 
policies in other sectors, like food, agriculture, and trade, must change.’102 
 
Moreover, health was not a leading proponent in the use of performance assessment 
for improvement and policy making.  Health was preceded by other sectors, such as 
education, transport and the environment which have been using international 
performance indicators as an assessment tool for many years, prior to health.  In fact, 
the use of performance assessment methods in these sectors ‘paved the way for their 
acceptance in the health-care field.’103 
 
4.6.1.6.1 Use of health system evidence:  
 For decision taking in other sectors and vice versa 
The interaction between health and other sectors is mutually re-enforcing.  Health 
affects many other sectors, such as social care, employment, education, the economy, 
whilst the same is true for these sectors having an impact upon health.  These sectors 
also utilise performance assessment tools and indicators, some of which overlap and 
cooperate in sharing knowledge on methods of performance assessment, such as the 
‘knowledge acquired about global environmental governance which, according to 
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Sandberg et al. (2015), ‘will help global health researchers to leapfrog analytical 
groundwork on global governance and fast forward their own research.’104  This is 
understandable given that environmental issues, such as climate change and 
environmental pollution have provided for greater public debate for far longer than 
health issues, especially because of the global appeal of environmental issues.  In fact, 
unlike environmental impact assessments or strategic environmental assessments, the 
use of health impact assessment (HIS) as a planning and policy tool is not usually 
mandated by law, nor is there a regulatory regime which regulates its use and 
methodology.105 
 
4.6.1.6.2 Performance assessment in non-health sectors 
Social care and social policy are closely aligned with health and many examples on 
performance assessment and monitoring of care emanate from the social sphere.  There 
is a trust at European level to use evidence-based policy making in social care, as part 
of EU-wide social care reforms with the aim of improving the welfare state.  The 
Europe 2020 Strategy targets key social and welfare areas for action,106 and the 
implementation of these measures are monitored through a series of indicators, 
through scoreboards incorporated into various frameworks such as the Joint 
Assessment Framework (JAF), the Social Protection Performance Monitor (SPPM) 
and the Employment Performance Monitor (EPM).107 
 
In England, like the NHS Outcomes Framework, there is a mirror framework in adult 
social care.  The components of the Adult Social Care Outcomes Framework are 
analogous to its health cousin, looking into quality of life, reducing need for social 
care and protection of the vulnerable elements of the population.108 
 
Performance assessment is also prevalent in other government circles.  In England, 
education has a long tradition of performance assessment, such as in the use of the 
Early Development Instrument which is widely used to assess early childhood 
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development,109 whilst Ofsted produce school ratings based on various quality 
dimensions.110  This has not been immune to controversy either, as for in health, star 
ratings and league tables are subject to criticism and do not necessarily reflect the true 
situation on the ground, especially in complex areas as in health, social policy and 
education (Klassen, et al., 2010). 
 
In sharp contrast with the health care sector, many other sectors possess a composite 
or summary or overarching indicator or set of indicators that provide policy makers 
and the public with key information on the performance of the sector in question and 
on the trends in that sector.  This is true for Gross Domestic Product in economics, 
Carbon Monoxide emissions for environment, unemployment rates for the 
employment sector, qualified school leavers in education and so on.  ‘In the health 
sector, however, no single overarching indicator has been agreed upon.’111 
 
4.6.2  Comparative policy making 
A great amount of work in relation to HSPA has revolved around inter-country, 
regional and international comparative work.  Comparisons of performance 
assessment data have been instrumental in moulding policy at regional, national and 
international level and on this basis national and international comparisons of HSPA 
generated data are considered a cornerstone of policy development.   
 
This benchmarking is only possible through international collaboration and 
cooperation.  This phenomenon was not common until more recently as each country 
or region had different measurement systems and incongruent data collection and 
assessment models.  Moreover, data sharing was not readily accepted as the norm.   
 
Globalisation, the advent of the internet and electronic means of data generation and 
communication, and interdependence between nations changed the information 
paradigm completely where health systems are now expected to share data on the 
performance of their health system.  This necessitates a great deal of cooperation, trust 
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and convergence towards common goals and international agencies have contributed 
significantly towards the realisation of this project.   
 
4.6.2.1 International and regional cooperation to inform policy 
The main premise for cooperation between countries is that there is potential to learn 
from each other, in terms of how their health systems and services work.  Europe is 
probably at the forefront of international comparative research through the 
implementation of multi-lateral Europe-wide studies, usually funded by CION.  This 
natural laboratory with its wide variation in health systems, funding mechanisms and 
quality divergences provides considerable insight into performance related research 
and data analysis.112 
 
4.6.2.1.1 Projects and programmes 
Bilateral, cross national, multi-regional and international cooperation is usually 
hatched through bespoke and purposely devised multi-national projects or 
programmes which are usually funded by international consortia, foundations, 
agencies or bodies.  There are numerous examples to this effect.   
 
An ERA-NET was developed to share examples and information on integrated models 
of care, methods for transferability of data and innovative practices in health system 
performance.113  Another project which utilises big data for comparative performance 
assessment is the European Collaboration for Health Optimization (ECHO), which is 
an international effort to bring health care information from several European 
countries into a single data warehouse, utilising patient data from participating 
institutions. This project has developed innovative approaches in comparative 
methodology.114 
 
4.6.2.1.2 Policy making  
Intercountry sharing of evidence and performance related data has become essential 
to sustain a meaningful cross country and inter-regional policy dialogue which 
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depends upon the accumulation and exchange of evidence.  This approach has been at 
the forefront of WHO’s impetus to generate a Health in All Policies and its drive to 
embed this concept into the political decision-making process at all levels.115   
One way of ensuring the ‘policy space’ for embedding the Health in All Policy 
framework into national and local policy making is through the establishment of 
international agreements and treaties.  The international health regulations, 
international pharmaceutical standards and other legal instruments are testimony to 
this development.116 
 
4.6.2.1.3 Data sharing 
The sharing of data is essential for international cooperation to succeed, especially in 
a field which is heavily dependent upon health information, such as is performance 
assessment.  Data sharing is not a new phenomenon.  This was common practice in 
the corporate sector, where businesses operating in the financial, aviation and ICT 
sectors have long shared data in their daily operations.117  WHO and OECD have long 
advocated for data harmonisation and data sharing.118  Participants in a meeting 
organised by OECD in the early years of 2002 had already envisioned a situation 
where the ‘information process’ is harmonised across an ‘international system’ of 
participating nations.  One such proponent stated: 
  
… but I would also like to emphasise the importance of an international 
system. The OECD and WHO are presently working on comparing different 
aspects of health system performance across countries. It would be really 
helpful if we could have common international standards and common 
indicators, so that we spoke one single language in comparing 
performances across countries. How much easier it would be for all of us to 
look for best practices if comparisons were based on a set of common and 
reliable indicators.119   
 
Indeed, this inter-dependability is a potential drawback or weakness if it limits 
exchange of data and information, but one which can be transformed into a powerful 
tool if these challenges are overcome.  OECD continues to state that ‘national 
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activities (on their own) do not lead to internationally comparable quality indicators, 
except by accident.’120 
 
4.6.2.2 International/regional comparisons of performance to inform policy 
Ever since the publication of the World Health Report in 2000, did governments 
realise the potential power of comparative approaches as a means to improve health 
care and devise policies based on international good practice (Braithwaite, et al., 
2017).  This study has, on several occasions, pressed upon the importance of 
international comparison of health systems performance as ‘one of the most powerful 
drivers of health systems improvement by inﬂuencing policy-makers’121. 
 
Since 2003, the OECD has been at the forefront in generating interest in comparative 
methodologies through their innovative HCQI project, which has developed and tested 
a range of internationally comparable quality indicators covering various health care 
domains.  With time, the application of these findings has consolidated the use of 
comparative studies and has increased the potential for cross-country learning.  
Moreover, comparative evidence is progressively being used as a means to hold 
politicians to account, where ‘international data play a key role in the accountability 
agenda when countries can compare their relative performance to other countries.’122 
 
Veillard et al. (2009) as cited in Papanicolas and Smith (2013)123 identify three main 
functions for international health system performance comparison; that of enforcing 
accountability in politicians and public servants, developing strategies based on 
evidence as generated through the comparative process and supporting countries in 
learning from each other. 
 
4.6.2.2.1 The use of composite indicators 
Comparative methodology assumes that the data definitions, data collection and data 
analysis are standardised and use the same parameters.  This is the main challenge in 
international comparative analysis.124  Composite indicators offer a broader or 
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helicopter view of how a health system is performing, it adapts more readily to policy 
objectives, drawing greater attention to policy makers and allowing for increased 
accountability and transparency.125  It allows for easier cross-regional or cross-country 
comparisons which facilitates the development of league or comparator tables between 
institutions, regions or countries.  On the other hand, composite indicators are known 
to disguise and hence, miss performance failures in specific areas of the health system.  
The methodological robustness is also often under question due to the way the 
composite set is compiled and the application of weights to composite indicators is not 
yet adequately developed.  For these reasons, this methodology is still controversial 
and needs to be carefully considered. 
 
Many HSPAs make use of composite indicators.  Examples of projects using 
composite indicators include the Commonwealth Fund in the United States, ECHI, the 
previously deployed Healthcare Commission star ratings in England and the WHO 
World Health Report produced in 2000,126 although proponents of HSPA frameworks 
have long conflicted between offering single number measures or scores for the whole 
health system as against different sets of metrics outlining the performance of the 
singular parts of the whole health system.  This is the central argument of developing 
composite indicators in contrast with single indicators and is the basis on which global 
ranking of health systems are constructed.127   
 
4.6.2.2.2 Comparative evidence for policy making and reforms 
There is evidence to show that successful reforms and strategic policy making were 
informed by performance assessment data and evidence derived from the process of 
international comparison of health system performance.  For instance: 
 
Mexico and Turkey utilised national and international health data to help 
diagnose the shortcomings in access to health services, in financial 
protection and in health status that were tackled by the introduction of the 
‘Seguro Popular’ and the ‘Health Transformation Programme,’ 
respectively.128   
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There is evidence to show that real ‘efficiency gains in health systems result from 
international benchmarking and comparisons across pair countries – i.e. within 
groups of countries sharing similar institutions.’129 
 
Comparative performance assessment was instrumental for England to overhaul its 
cancer services.  Evidence that emerged from the Eurocare studies in the late 1990s 
showed that the UK was trailing in cancer care and survival rates.  Acknowledging 
this, the government launched a major drive (NHS Plan) to improve cancer care and 
lower mortality rates to comparable acceptable levels.130  Bilateral comparative 
exercises have also been used to inform policy or to compare the outcomes of reforms.  
In fact, major reforms have often been used as a platform to undertake comparative 
research and to link reforms with performance assessment.  One such study was 
followed by the Dutch who carried out extensive reforms contemporaneously with the 
Canadian province of Ontario.  Both regions developed HSPAs to compare the 
outcomes of their respective reforms.131  
 
4.6.2.3 Challenges in comparative policy making 
Although comparative policy making is a powerful and effective tool at the disposal 
of the policy maker, its application is not without challenges, some of which are 
significant.  It is important for all to recognise these difficulties, to either circumvent 
them or factor them in when interpreting the data. 
 
4.6.2.3.1 Methodological pitfalls 
Comparative policy making presents certain methodological challenges.  These 
include the lack of proper definitions, incompleteness and opportunistic selection of 
indicators.  There are also security issues, data confidentiality and technical problems 
which all need to be overcome to allow countries to compare ‘notes.’  Data 
standardisation and standard operating procedures are being formulated and a 
consensus based on international best practices is growing.132  However, even though 
international organisations understand and push for these solutions, they still require 
                                                 
129 79 OECD. Health Care Systems - Efficiency and Policy Settings.  2010Pg. 142. 
130 12 Papanicolas, I, Smith, PC. Health System Performance Comparison. 2013. Pg 3. 
131 6 Smith, PC. et al. Performance Measurement for Health System 2009. Pg. 650. 
132 123 WHO (Europe).  The European health report 2009.  2009. Pg. 146. 
 130 
ownership from their respective member states and ‘broad international cooperation 
is required to tackle current health information challenges efficiently and sustainably. 
Countries should drive the priority-setting for such international research and 
development activities.’133 
 
4.6.2.3.2 Contextual factors 
The contextual elements of health systems and their distinctive environments should 
be taken into consideration before conclusions are reached using the comparative 
approach.  As stated by Papanicolas and Smith (2013, p. 335) ‘comparisons can be 
misleading when not accompanied by an understanding, or explanation, of key 
differences in national settings, leading to the potential for important 
misinterpretation.’  Hence, whilst international comparative performance information 
can serve as inputs for national strategy development, caution needs to be exercised 
due to potential hidden political agendas and a phenomenon known as ‘selective 
perception’ which can distort the available evidence.134   
 
Just as comparative measurement could be a powerful tool in the hands of experienced 
policy makers, it could also be deleterious to unseasoned decision makers.135  Many 
authors draw attention to the danger that comparison can lead to serious policy errors 
if not accompanied by careful consideration of the contextual factors and reforms 
within which the HSPA operates.  This is important to avoid what is termed as ‘policy 
abuses of comparative measures’136.   
 
4.6.3  The political process 
The literature shows that policy formulation is a complex enduring process, involving 
a myriad of factors that are not necessarily evidence-based nor are derivatives of 
performance assessment frameworks.  Indeed, Green and Bennett (2007)137 succinctly 
points out that ‘a tension clearly exists between a naive representation of a simple 
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linear relationship between evidence and policy, and an overly complex depiction with 
a multitude of variables suggesting no real opportunity for a rational process.’   
 
Gollust et al. (2014), as cited in IOM’s opinion piece, found that even when policy 
makers have all the required information at hand, they may still not use this evidence 
to take important decisions.  This is the case in many instances when dealing, for 
instance, with obesity, alcohol, nutrition policies etc.138  Indeed, the evidence 
generated through the performance assessment process is ‘often contested and viewed 
differently by different actors at different stages in policy development.’ 139  The policy 
making function is the crucial end-point of the HSPA process.  This theme covers the 
art of policy making in relation to HSPA. 
 
4.6.3.1 Models of policy making  
Whilst models of policy making have already been elucidated in the literature review 
(Warner & Bjarkman, 2011), this sub-theme provides a particular focus on the link 
between policy development and performance assessment. 
 
Kingdon’s multi-stream or non-linear policy framework is used by many exponents in 
health policy circles showing there needs to be alignment between the ‘problem,’ 
potential policy solutions and the political will or commitment to effect change 
(Cairney & Jones, 2016).  This trio of conditions allows for the creation of a ‘window 
of opportunity’ that helps shape long-term policy-making.140   
 
Mackenbach and McKee (2013) also reiterate that policies are formulated within a 
specific context, where a ‘window of opportunity’ or ‘policy window’ needs to present 
itself, usually in the form of a ‘scandal, a disaster or an individual tragedy that creates 
popular demands for action, causing politicians to search for some way that they can 
be seen to respond.’141   
 
                                                 
138 136 Bayer E & Thompson D. (Rapporteurs).  Communicating to Advance the Public's Health. 
IOM.  2015. Pg. 37. 
139 94 Green A., Bennett S. Sound choices-enhancing capacity for evidence-informed health policy. 
WHO. 2007. Pg. 22. 
140 14 Leppo, K. et al. Health in All Policies. 2013; pg. 16. 
141 11 Mackenbach JP, McKee, M. Successes & Failures of Health Policy in Europe. 2013; pg. 320. 
 132 
There is general agreement that evidence-based medicine follows the rationalist 
approach, using established scientific methodologies to determine the safest and 
greatest value treatment.  On the other hand, evidence-based management, and by 
extrapolation, evidence-based policy utilises more of an ‘incremental approach,’ 
supplementing existing evidence.   
 
The ‘contingency approach’ is also advocated where management and policy solutions 
that work in one situation may not necessarily be effective in another.  This situational 
or contextual dimension to policy formulation creates significant challenges in 
applying evidence from one context to another142. 
 
4.6.3.2 The political prerogative 
Politics is intimately intertwined with performance assessment and accountability and 
it is important to understand and acknowledge this reality. 
 
4.6.3.2.1 Sharing of politically sensitive data 
Sharing politically sensitive data can be problematic.  Performance data, like outbreak 
data, is classified as politically sensitive data and, given that national governments are 
well aware of these potential sensitivities, are usually reluctant to share data with other 
countries and regions.  It is only when the benefits outweigh the risks that governments 
warm up to the idea of sharing data.  Indeed, reluctance to share data in a timely, 
orderly and structured manner has been responsible for the spread of communicable 
diseases and the lack of safeguards to contain infectious diseases, such as the outbreaks 
of SARS in China and the Ebola outbreak in West Africa.143 
 
4.6.3.2.2 Policy instruments 
Whilst this study refers to the process of policy making several times, it would be 
appropriate to understand that there are many forms of policy instruments that can be 
realised.  Political declarations in ministerial and international conferences are 
commonly used.  Collaborative and action programmes provide space for networking 
and sharing best practices.  Directives, legislation, norms and standards are commonly 
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used policy instruments both at national and international level.  International, 
multilateral and bilateral agreements, treaties and covenants are also extensively used.  
Arbitration, litigation and judicial review also determine policy, although not always 
in the direction that is expected.144 
 
Another policy instrument that it commonly used in parliamentary democracies is 
reports to parliamentary select committees and sittings.  This is a common feature of 
the British political landscape.  The Report on Health Inequalities and the response of 
the Secretary of State for Health to the criticisms that arose from this report clearly 
demonstrates how performance assessment and the production of evidence have a 
powerful and profound impact upon the political process.145 
 
4.6.3.2.3 Politics that work 
The public health policy cycle assumes a traditional cyclical process, in which 
evidence and assessment informs policy development.  The policy is then 
implemented and evaluated, after which the policy is adjusted, and the cycle starts 
again (Institute of Medicine, 1988).  However, experience, if not evidence, has shown 
that this portrayal of policy formulation is naïve at best, inadequate at worst.  Whilst 
analysis and the generation of evidence are important factors to consider, they are 
certainly not enough.   
 
Public health promoters who rely on classic knowledge transfer techniques 
and try to convince policymakers to pass legislation often fail because policy 
change is often achieved through coalition- building, mobilizing public 
opinion, lobbying and influencing political values, and not through 
disseminating research findings alone.146   
 
Hence ‘old assumptions that the outputs of research will feed cleanly into policy-
making are now widely accepted as naïve.  It is clear that the links and dynamics 
between research and policy-making are complex and only partially understood.’147 
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Weiss, as cited in WHO (2012)148, discusses the influence that politics plays on 
assessment and evaluation.  ‘Evaluation is a rational enterprise that takes place in a 
political context.’  He concludes that political factors ‘interfere’ in the evaluative 
process in several ways, if interference is the right term to use.  First of all, assessment 
of programmes and policies is a political process in itself and hence cannot be divorced 
from the political reality of the day.  Secondly the results of any evaluation, including 
that of performance assessment resulting from HSPA, are fed into the policy making 
melting pot and compete with other priorities for political attention.   
 
Weiss also believes that the act of assessment is, in itself, a political act, since it makes 
explicit declarations which certainly have political connotations.  This concept is 
further reinforced by Sandberg et al. (2015)149 in stating that the ‘first myth was that 
expert knowledge is always neutral and politics is always conflicted.  The second was 
that failures of governance happen when policy-makers let political interests override 
evidence-based solutions.’ 
 
4.6.3.2.4 Political accountability and power of performance assessment 
The political process is about accountability.  Whilst policy makers are accountable to 
the public, the available information to pass ‘judgement’ on politicians is surprisingly 
limited or not factually grounded.  Academics and researchers refer to this information 
as ‘evidence’ but its comprehension by the public is a measure of its usefulness.  
Evidence on policies that work and those that do not work is usually highly technical 
and difficult to grasp.  However, some authors, whilst acknowledging that politics is 
very complex and difficult to assess, suggest that tools such as: 
 
HTA provides transparency and thereby offers a foundation for ensuring 
accountability for government decisions and performance.  In particular, 
citizens can gain more insight into arguments for and against the decisions 
made and can use this information to evaluate the legitimacy of the 
policymakers.150   
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Whilst this all seems very well, it is indeed hard to appraise how lay people would be 
able to gain insight into the results and the meaning of HTAs.  The same could be said 
of HSPA unless this information is ‘translated’ into a language that could be 
assimilated easily, although ‘with more data in the public domain, ministers (and 
policy makers) become subject to more external challenges.’151 
 
Performance assessment is a powerful tool and it therefore comes as no surprise that 
performance assessment and HSPA could be perceived as either a threat or a benefit, 
depending which point of view is taken.   
 
The political nature of performance measurement is an inevitable 
consequence of its power to challenge vested interests within the health 
system. There is an enormous range of interest groups.  Performance 
information often serves the interests of some of these groups but will also 
challenge others.152 
 
4.6.3.2.5 Political commitment to the HSPA process  
Politicians are not, as yet, fully committed to the HSPA paradigm.  Several case studies 
have noted the lack of political commitment to utilise the results of the HSPA process 
for policy making or decision taking.  The reasons cited are several; from a lack of 
understanding to a lack of prominence of the HSPA process in political circles.   
 
Raising the profile of HSPA among the political class by making it more relevant to 
their needs and aligning the applications of HSPA to their own perspectives is 
required.  Still, many ‘case studies show that initial HSPA objectives (such as 
increased transparency and accountability or creating an evidence base to inform 
policy) tend to be overly ambitious.’153  The EU structures have also shown 
commitment towards performance assessment and HSPA.   
 
The Italian Presidency, in one of its reports, has summarised the conclusions of the 
Council of Health ministers stating that ‘more attention at national level should be 
given to the outcomes that health systems deliver. To achieve this, it will be necessary 
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to develop indicators and promote the use of Health System Performance 
Assessment.’154 
 
4.6.3.3 Reforms 
HSPA has a dual connection with reforms.  On the one hand, HSPA spurs on reforms 
and changes in policies by providing the required evidence and data.  This is its 
primary purpose, where ‘without performance information, there is no evidence with 
which to design health system reforms.’155  On the other hand, HSPA also measures 
the impact of reforms and changes in policies, once instituted.156  This cycle places 
HSPA and, performance assessment in general, at the centre of reform activity.  
However, not all countries use HSPA or performance data as a basis of their reforms.   
 
In fact, evidence suggests that even though there are political and economic 
imperatives to institute far-reaching reforms, still not all countries base these reforms 
on the available evidence base.157  A possible exception is England where the ‘NHS 
Performance Framework was also developed in accordance with the Department’s 
principles for change.’158 
 
HSPA invariably accompanies the development and implementation of national health 
strategies and reform plans, such as in Armenia and Turkey.  In Armenia, reforms of 
their primary care sector and hospital services were one of the priorities of its HSPA,159 
whilst WHO (Europe), the Ministry of Health of Turkey and the World Bank all 
‘consider HSPA to be an effective tool for steering Turkey’s ongoing health reform.’160  
The HSPA process in Estonia and Portugal was also part of the wider strategic 
process.161 
 
Hofmarcher and Smith (2013) believe that ‘if undertaken carefully, health system 
performance comparison offers a powerful resource for suggesting relevant health 
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system reforms.’162  OECD’s exposition on reforms provides several insights into the 
relationship between HSPA and reforms.  HSPA provides the required evidence to 
justify reforms as mandated by the electorate where ‘effective communication, 
underpinned by solid research, can help secure such a mandate.’163   
 
4.6.3.4 Factors other than performance assessment that affect policy making 
There is a myriad of other non-performance related factors that affect policy making, 
as outlined in detail below. 
 
4.6.3.4.1 Mediating factors influencing policy 
There are several extraneous or mediating factors that ‘compete’ (with evidence) for 
the policy maker’s attention.  These mediating factors include organisational factors, 
professional attitudes, personal experiences, inter-personal relationships, local 
political issues, resource availability, and existing national and/or organisational 
policies and priorities.  Some would argue that the available evidence and other non-
evidentiary factors are not mutually exclusive but should complement, if not augment, 
each other and that policy makers need to consider all possible angles and 
permutations before reaching policy conclusions.  This obliges policy makers to have 
a more critical outlook and not accept evidence ‘at face value.’  They need to 
‘continuously interpret and (re)construct the evidence in some way, according to one’s 
own professional identity, organisational role, team members and audience, and 
organisational objective.’164  Kyratsis et al. (2014) continue to state that ‘far from 
being merely technical or ‘scientiﬁc’, we found this process to be highly iterative and 
‘messy.’165 
 
4.6.3.4.2 Influence by stakeholders, including the public 
Civil society plays a persuasive part in the formulation of any policy, but health policy 
is particularly prone to such influence.  The health sector is teeming with numerous 
patient and disease-oriented groups and organisations, which all have a level of 
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influence on the mind sets of policy makers, who have learnt not to ignore their pleas 
and desires (Sabi & Rieker, 2017).  However, rather than viewing these ‘incursions’ 
as a distraction, civil society can also be the source of important pieces of evidence 
that indeed should be taken in consideration as part of the policy making process 
(Bruen & Brugha, 2014).   
 
Civil society acts as mediators in bringing relevant issues to the attention of both 
researchers and policy makers, highlighting ‘issues overlooked by politicians but 
which are a matter of concern to the public.’166  However, competing elements could 
derail the policy process leading to ‘policy paralysis,’ such that ‘public policy is an 
iterative process that is historically layered and path dependent, but always 
characterized by competing interests within and outside government.’167  On the other 
hand, involvement of the public spurs on the debate and forces a hand on policy 
makers to descend from the fence, compelling them to take decisions.  This ‘level of 
involvement, or the degree of influence that the public will have in the policy-making 
process is known as the ladder of citizen participation,’ first coined by Arnstein in 
1969.168  Other ‘influencers’ include government agencies, networks and policy 
bodies, professional groups, elected officials and public servants and insurance and 
other funding bodies.169 
 
4.6.3.4.3 National and international politics 
Local, regional or national policy is increasingly being dictated by external or 
international actors and factors.  These include the Ministry of Finance which 
indirectly steers health policy through decisions on allocation and allotment of 
financial and other resources as well as through fiscal policy.  Member states of the 
European Union, World Health Organisation, OECD and other international 
organisations are obliged, in a wide variety of ways, to align their domestic health 
policies with international law, norms or regulations.  However, reassuringly, most of 
these agencies promote and support the use of evidence-based tools and methods.170   
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External or foreign funding agencies and donors can also influence domestic health 
policy through the regulation and allocation of funding and loans which are usually 
entwined with specific reforms and/or programmes.171  The international economic 
climate also affects national policy making.   
 
The 2008 financial crisis impacted negatively upon investment in health and there is 
growing evidence to show how this crisis changed the health status and health 
outcomes in those countries mostly affected.172 
 
4.6.3.5 Consequences of using performance information and evidence 
As with most other tools, the use of HSPA and other performance assessment tools 
has intended, and sometimes, unintended consequences (benefits & dis-benefits).  This 
‘collateral damage’ may shape the deployment of performance assessment systems 
within the health system (Mannion & Braithwaite, 2012).   
 
HSPA brings ‘warring factions’ together.  In a decentralised health care system, HSPA 
has been known to provide convergence and unison between different sectors, areas 
or regions.  It seems to have the propensity of building ‘a common understanding 
among different institutions of how the system performs and helps build consensus on 
priorities for the future.’173 
 
The availability of evidence through empirical research and political gain are strange 
bed fellows.  On the one hand, evidence can, and indeed should, be used to gain 
political insight to tackle difficult policy issues.  However, it can, but should not be, 
used for political gain, ‘to retrospectively justify or clarify policy decisions that have 
been taken already.’174  This ‘cherry picking’ is commonplace amongst politicians to 
fit their own agendas, although many decision makers still yearn for objective 
evidence-based advice.  Evidence is invariably also used (and abused) in political 
debates, to advance or denigrate an argument or view.  Researchers who have been in 
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the game for long are aware of these tactics and usually steer clear of controversies 
that are not necessarily grounded in evidence.175 
 
Perhaps the most compelling reason to ensure policy is well-grounded in evidence is 
clearly spelled out by the British Secretary of State for Health in his report on 
inequalities wherein he claimed that: 
 
… there is an ethical imperative to develop and use evidence-based policy. 
All the reforms we have discussed are experiments on the public and can be 
as damaging (in terms of unintended effects and opportunity costs) as 
unevaluated new drugs or surgical procedures. Such wanton large scale 
experimentation is unethical, and needs to be superseded by a more 
rigorous culture of piloting, evaluating and using the results to inform 
policy.176 
 
4.6.3.6 Concluding remarks 
Some may wonder why evidence-based solutions to problems are not implemented in 
practice.  From the above-discussed themes, we have seen that policy making is a 
dynamic, fluid process, involving a myriad of actors with different agendas.177  We 
have also deduced that policy is influenced by many factors, not all of which are 
grounded in evidence.  If a wider interpretation of evidence is considered, beyond the 
narrower scientific definition, one can argue that all factors indeed contribute to 
providing the required evidence to take the correct policy decisions.  This paradigm 
shift moves beyond ‘evidence-based public health,’ to ‘evidence- informed public 
health,’ which ‘acknowledges more explicitly the multitude of factors that influence 
public health decisions.’178  This is a fundamental consideration to understand the role 
that HSPAs have in future policy making.  The Alliance for Health Policy and Systems 
Research in Geneva summarises these concluding remarks very succinctly by stating 
that: 
 
… an overview of decision-making processes provides insights into the role 
of information, and in particular, information from health systems research 
in decision making in the health system.  Policy-making is a complex and 
essentially political process that is influenced by several factors.   
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The full complexity of health policymaking is revealed in frameworks that 
combine the various factors, and it is then clear that information generated 
by research is but one among the several competing factors. Recognition 
and understanding of decision-making processes and factors that influence 
the process can increase the potential for inserting research information 
into the process.179 
 
4.7 Improving health care delivery through performance 
 monitoring  
Performance assessment is an integral part of the performance improvement cycle.  
The link between performance monitoring and service improvement is well 
documented and does not require any further elaboration.  However, the document 
analysis revealed numerous instances of how performance assessment and HSPA has 
also been utilised for the improvement of care, including the quality of care and 
advances in integrated care.  This theme covers aspects of performance improvement 
as driven by performance assessment in general and HSPA in particular. 
 
4.7.1  Performance assessment as a tool for service improvement 
The literature review disclosed several examples of the link between performance 
assessment, HSPAs and service improvements.  This relationship is well-documented 
and has been utilised for the benefit of service providers and their patients 
(Bramesfelda, et al., 2016); (Schwartz & Deber, 2016). 
 
4.7.1.1 Use of HSPA frameworks for service improvement 
Given the importance of HSPAs in improving services, this section looks specifically 
at this angle in contrast to their application for policy making.  WHO have recognised 
the importance of using HSPA for health system improvement stating that: 
 
… improving the performance of countries’ health systems is a priority issue 
across the European Region, especially in the current economic climate in 
which obtaining the greatest value from existing resources is paramount. In 
this regard, health system performance assessment is a recognized 
approach among the countries in the WHO European Region.180  
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On the other hand, WHO also acknowledges that whilst many WHO member states 
have introduced facets of HSPA into their governance structures, few, however, have 
integrated HSPA to the extent of producing tangible improvements in performance. 
 
4.7.1.2 Performance monitoring and improvement 
Performance assessment and monitoring in health has come to a head since the 
financial crisis of 2008.  Prior to this, health was not considered worthy of debate and 
analysis in economic and financial circles.  Ever since high and medium income 
countries started to face significant challenges in managing their health care 
expenditure and in meeting ever increasing demands, interest in the performance and 
efficiency of health systems has soared, leading to a concomitant surge in the 
development and deployment of performance tools and mechanisms.181  The EU is 
also pushing for greater efficiency and effectiveness, which requires well-developed 
performance assessment tools to ensure that ‘European health systems meet their 
targets in delivering the expected outputs (effectively and efficiently).’182   
 
4.7.1.2.1 HSPA and performance improvement 
Most of the literature on HSPA relates to its role in monitoring performance for 
improvement purposes.  There is ample evidence that shows how performance 
assessment is the main mechanism for setting targets and improving health services.  
In one of its white papers published in 2011, the English Department of Health was 
convinced of the usefulness of using performance assessment for improvement; ‘there 
is compelling evidence that better information also creates a clear drive for 
improvement in providers.’183   
 
Rechel and McKee (2014)184 considers ‘HSPA (as) a concept that is closely related 
to, and partially overlaps, general public health monitoring.’  According to the 
President of the Royal College of Physicians, the ‘regular measurement and 
publishing of outcomes leads to better patient care.’185 
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4.7.1.2.2 Resources/information needed for performance improvement 
Providing evidence for system improvement is not straight forward.  Although many 
mechanisms are in place throughout various health systems, countries that embark 
upon the HSPA path to generate the required evidence for service improvement or 
policy making find that significant resources and commitment are necessary.  The 
Portuguese national health plan describes this well, explaining that the Office of the 
High Commissioner for Health instituted a series of capacity building steps to create 
and sustain a performance assessment model and inculcate a ‘culture of continuous 
performance improvement.’186 
 
The European Regions Research and Innovation Network (ERRIN) project has clearly 
concluded that to improve a health system, access to information on its performance 
is required.187  However, most of the data required to generate the evidence on 
performance of health systems emanates from personal patient data.  The ‘collection, 
analysis, linkage and reporting of results from personal health data is assets for health 
care quality monitoring and improvement, population health policy, and health system 
performance measurement and evaluation.’  This, of course, presents data protection, 
governance, legal and technical challenges, which if overcome, will generate ‘new 
evidence to improve population health, health care quality and the performance of the 
health system.’188 
 
4.7.1.3 Accountability 
Performance assessment provides a platform for the generation of an accountability 
environment, especially in publicly-funded health care systems.   
 
4.7.1.3.1 Political accountability 
The overriding purpose of England’s Outcomes Framework is one of accountability.  
One could say that the English are somewhat gripped by the need to monitor and hold 
people and organisations to account.  This is clearly stated in the Health Secretary of 
State’s statement when unveiling 60 new NHS performance indicators in 2011.  He 
                                                 
186 44a MOH (Portugal). National Health Plan 2012 – 2016. 2012. Pg. 8. 
187 139 ERRIN 15.  Enhancing Value in European Health Systems: 
 The Role of Outcomes Measurement.  2016. Pg. 4. 
188 82 OECD.  Strengthening Health Information Infrastructure for Health Care Quality Governance. 
2013. Pgs. 26, 149. 
 144 
explicitly declared that these (and other) performance indicators will be used to ‘hold 
the NHS Commissioning Board to account.’189   
 
Similar performance mechanisms have been employed in the Netherlands, where its 
health care performance report, a product of its HSPA, holds politicians to account as 
it regularly reports on progress achieved in the performance of its health system.  This 
is formalised on an annual basis when the Minister responsible for health reports to 
parliament, using the Dutch health care performance report as the basis for the 
discussion.190  The French Ministry of Health also produces an annual performance 
report (Rapports Annuels de Performances) reviewing the results of the previous year 
based on indicators in specific domains.191 
 
4.7.1.3.2 HSPA’s role in garnering accountability 
WHO refers to HSPA as the ‘steward’ of transparent and accountability within a health 
system.  It believes that the advent of HSPA has introduced a new accountability 
paradigm by stating that ‘health system performance assessment corresponds to a 
performance accountability approach grounded in management science, which aims 
at demonstrating and accounting for performance in light of agreed-upon 
performance targets …’192  
 
This was further elaborated at an international conference in Jerusalem which declared 
that: 
 
… professionals and politicians could rely no longer on their ex cathedra 
authority and their professionalism to secure public support.  Their 
performance began to come under scrutiny … and the professionals were 
now obliged to fulﬁl measurable and quantitative deﬁnitions of 
performance.193 
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4.7.1.3.3 European model of accountability 
Consortium partners in the ERRIN project concluded that there is ‘stronger focus on 
the outcomes of health systems to improve the quality of care and public health - and 
a clear demonstration of the importance of measuring those outcomes for greater 
transparency and accountability for health system performance.’194  They claim that 
this is driven by Europe’s increasing reliance on monitoring and measuring results and 
outcomes, especially when utilising EU funded initiatives.   
 
Following the launch of Health 2020, the policy document contemplates the 
monitoring of progress towards the proposed health targets, as a prelude to hold each 
member state accountable towards these goals.195  Indeed, WHO Europe regularly 
ascertains how many of its members have aligned their national policies to Health 
2020, as well as the proportion of countries that have installed accountability 
mechanisms.  The European Health Report of 2015 calculates that there was an 
increase from 58% in 2010 to 75% in 2013 in the proportion of countries aligning their 
policies with Health 2020.196  WHO is also apt at regularly producing performance 
reports on environmental health on its member states, providing recommendations for 
improvement and increased.197 
 
4.8 National and international perspectives 
Many of the documents reviewed provide an account of the experiences of different 
countries, as well as inter-regional and international collaborations on HSPA.  This 
theme discusses the role that national and international organisations have in 
promoting HSPA and delineates several good practice cases at national and 
international level. 
 
4.8.1  Promoting performance assessment 
Not all countries automatically promote the use of performance assessment and 
associated methods and tools.  This very much depends on the maturity of the health 
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system in question and the experience in using performance assessment for service 
improvement and policy making. 
 
4.8.1.1 Promoting performance assessment across Europe 
The European Union has many means at its disposal to monitor and facilitate 
performance assessment.  Whilst some would argue that these instruments intrude 
upon the national competencies of member states, they do keep health systems in 
check, especially in matters of fiscal sustainability and efficiency, as well ensuring 
equitable access to quality health care across the board.  The current EU Commissioner 
for Health’s mandate specifically includes the development and consolidation of 
HSPA across the EU.198   
 
Several declarations of Councils of Ministers have emphasised the need to strengthen 
health systems through better performance management and monitoring.  This 
invariably led to various initiatives to promote HSPA in numerous member states and 
has also led to the creation of an EU Unit dedicated wholly to the promotion of HSPA 
in the EU.199   
 
Furthermore in 2012, CION set up an important multi-sectoral and independent expert 
panel to provide advice on effective ways of investing in health.200 Country Specific 
Recommendations is another EU mechanism that mandates CION to obtain and 
analyse performance-related data generated at local level through member states.  This 
encourages cross border exchange of performance related data.201  There is also 
significant collaboration amongst European countries towards HTA processes through 
the EUnetHTA initiative.202 
 
On the other hand, whilst the EU can boast of several performance indicator models, 
these may create confusion and duplication of effort, which is why the Euro Observer 
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laments that Europe still lacks a ‘comprehensive health information infrastructure and 
well-established governance mechanisms on the EU-level.’203  In response to this state 
of affairs, CION has been actively considering the creation of a European research 
infrastructure consortium (ERIC) on health information, although this has not yet 
gained the desired momentum.   
 
The European Regional Office of WHO has also been a major proponent of HSPA 
over the past two decades, wherein WHO considers the improvement of the 
performance of health systems as one of its key priorities.  This bourgeoned following 
the 2008 economic crisis where health systems were suddenly propelled into the 
limelight, with calls for greater efficiency, sustainability and resilience, which in turn 
led to the Tallinn Charter in 2008, citing HSPA as the main instrument to implement 
the Charter.204   
 
4.8.1.2 Role of national organisations 
National organisations, from the public, private and voluntary sectors, have a key role 
of developing and promoting performance assessment.  This section outlines this role 
and the type of organisations involved. 
 
4.8.1.2.1 England 
England provides a rich, if not eye-opening, illustration of how several national 
organisations have been created, dissolved, re-packaged and re-shaped in line with the 
political exigencies of the government of the day.  The more stable, tried and tested 
agencies, such as the Cochrane Library and the National Institute for Health and Care 
Excellence (NICE) contrast sharply with several other organisations which have 
transformed over time, such as the National Service Frameworks, NHS Evidence, the 
National Patient Safety Agency, the NHS Institute for Innovation and Improvement, 
the Academic Health Sciences Centres and the Biomedical Research Centres and 
Units amongst others.  These were all established with the primary aim to promote the 
translation of research knowledge into clinical practice and policy.205  The latest 
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addition to the UK’s arsenal of research-based policy organisations is the National 
Institute for Health Research.206   
 
4.8.1.2.2 Organisations in EU member states 
Small EU countries usually have one or perhaps two key organisations involved in the 
collection and dissemination of performance data.  Belgium boasts of the KCE, which 
is an independent scientific institute established by law with a ‘mandate to support 
health and health services policy and decision making in the Belgian health-care and 
health insurance systems’ and responsibility for Belgium’s HSPA.207  Its success is 
largely attributed to the political commitment of the federal Government in sustaining 
this organisation, whilst maintaining a certain distance guaranteeing its autonomy.208  
The Dutch National Institute for Public Health and the Environment (RIVM) is 
particularly active in performance measurement, participating in several 
benchmarking and comparative exercises which then invariably feeds into the 
performance assessment of the Dutch health care system.209 
 
The Nordic countries are leaders in the establishment of national organisations 
responsible for providing unbiased evidence-based advice on policies to national 
governments and legislative bodies.  The NOKC has already been mentioned in a 
previous section, as an organisation that has been successful in providing the evidence 
base for policy makers in Norway.210  Norway’s neighbour has a similar structure in 
the form of the National Institute for Health and Welfare in Finland, which is 
responsible to brief parliament on issues of national import,211 whilst the Danish 
National Board of Social Services also has the mandate to inform policy based on 
evidence and to act as a ‘clearing house’ of the available research.212 
 
On the southern flank, the Spanish Society of Public Health and Health Administration 
(SESPAS) presents a unique, if not unusual type of organisation.  Set up in Spain in 
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1985, it brings together a collective of scientific societies in the realm of public health 
and advocates for evidence-based public health interventions.  Its diverse and large 
membership provides a breadth and depth of expertise to tackle contentious but 
important issues at regional and national level in Spain.213  France also created a 
national agency responsible for accreditation and assessment termed the Agence 
nationale d’accréditation et d’évaluation en santé.214 
 
4.8.1.2.3 Other models 
Across the Atlantic, the Commonwealth Fund has been at the forefront in promoting 
a culture of performance assessment and has long advocated, albeit unsuccessfully, 
for a nation-wide HSPA framework in the United States for many years.  Nonetheless, 
it is the author of several important leading publications, including the development 
of a National Scorecard on U.S. Health System Performance.215  The lack of a national 
HSPA in the United States is syndromic of many other nations based on a federal 
system.  Other notable examples are Italy, Spain, Germany and Australia whilst a 
singular exception is Belgium.  Still, whilst many of Italy’s regions have advanced 
performance mechanisms, key national agencies in Italy such as the Agenzia 
Nazionale per i Servizi Sanitari Regionali (National Agency for Regional Health 
Services – AGENAS) facilitate data sharing and support performance-related 
initiatives.  However, these national organisations, although many times possessing a 
legislative and central mandate, rarely impose unitary standards or models across the 
regions but rather ‘define a more consistent regional approach to the performance 
management of health systems.’216  This is akin to the EU approach of subsidiarity. 
 
4.8.1.2.4 How these organisations function 
National research organisations work best as autonomous entities although most are 
publicly funded.  Legislation or policies usually guarantee their independence, but this 
requires a mature socio-political context, which is not always present, even in EU 
member states.  Many of these agencies are mandated by and are accountable to 
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legislative bodies (usually national or regional parliaments) and thus are in a better 
position to maintain their impartiality and objectivity.217  
 
The best performing organisations, such as the KCE, have a multidisciplinary and 
scientific skill mix, drawing from various socio-scientific disciplines and experts.  The 
KCE has a legislative mandate to act as an ‘interface between health systems 
information and health policy.’218  Another successful type of organisation is one that 
is embedded within a civil service structure, such as the Personal Social Services 
Research Unit in England.  Since this is linked to three separate universities, it is 
viewed as being impartial and has gained the trust of civil servants who usually have 
direct access to policy makers. In so doing, it has secured funding from the Department 
of Health’s Policy Research Programme in England and has provided policy advice 
based on research and evidence for the past four decades.219 
 
The best examples of research organisations that have impacted policy decisions at 
national and international level are those that are not only involved in ‘traditional 
academic research’ such as many universities, but those research organisations which 
have made ‘influencing the policy process’ their fundamental mission.  Notable 
examples are the Kings Fund and the Nuffield Trust.  Their modus operandi is based 
upon creating an environment of mutual trust between researchers and policy 
makers.220 
 
A private organisation involved in performance monitoring and assessment is the 
Health Consumer Powerhouse, an analytical information provider based in Sweden 
(Health Power House, 2015).  Whilst its focus is mainly on measuring aspects of 
consumer empowerment and patients’ rights, its methodology and indeed source of 
funding have been the subject of considerable controversy across many European 
member states.221 
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4.8.1.3 Role of international and regional organisations and networks 
The work of international organisations in comparative and collaborative performance 
assessment contributed immensely to our collective understanding of policy 
development and generating more resilient health systems.  A key publication by 
Smith et al. confirms the role of international organisations when they contend that: 
 
… international organizations play a key role in holding policy-makers to 
account, by using international data to draw comparisons between similar 
countries and offering the public and the media the ability to scrutinise 
them. International comparisons can also prompt countries to develop a 
national strategy, or framework, to improve performance in a systematic 
way. 222 
 
The OECD is playing an increasingly important and influential role in health care, 
especially ever since health care became an important economic commodity.  OECD 
has been at the forefront of facilitating cross-country policy learning through the 
collation, analysis and dissemination of performance data and evidence.  This is 
confirmed in a position paper by OECD itself in 2013 wherein it stated that ‘the OECD 
can contribute to assuring that national health information infrastructures become 
better capable of supporting multi-country monitoring and multi-country research.’223  
Whilst OECD does not promote the use of league tables, it does regularly produce 
cross country comparative studies with the aim of distilling coherent policies and 
identifying ‘potential complementarities among reforms, where co-ordinated pursuit 
of multiple mutually reinforcing reforms may increase the benefits generated by each 
member state.’224  OECD’s comparative work is considered pioneering in that, for the 
first time, it managed to harness and realise the power of comparative health care 
system performance data in the pursuit of ‘identifying the strengths and weaknesses of 
each country’s health care system and the policies with the aim to improve its 
efficiency and effectiveness.’225 
 
One of the first major collaborations driven by the European Office of WHO was the 
development of the Health for All indicators at the turn of the millennium.  The HFA 
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framework has been indispensable at providing analytical and comparative data for 
policy making and, in many ways, was the precursor for HSPA at an international 
level.  The HFA is now considered one of the three main indicator international 
databases, together with ECHI and OECD’s HCQI framework.226  A recent important 
development is the bid to move towards an integrated common indicator dataset, by 
combining WHO’s HFA with the EU’s ECHI model and OECD’s Quality Care 
indicator database.  This is increasingly becoming more relevant in today’s globalised 
environment, especially since these frameworks provide similar health data on the 
same countries.  This is also important for standardisation, comparability and fostering 
cooperation at European and international level.227 
 
The Performance Assessment Tool for Quality Improvement in Hospitals (PATH) is 
another network to support hospitals in collecting data on their performance and 
improve quality of care through comparative data analysis,228 whilst one of the most 
successful ‘investor’ collaborations is the European Observatory on Health Systems 
and Policies (EOHSP).  This initiative allowed for the production of a plethora of 
evidence-based publications and findings, besides policy statements and papers that 
have directed health policy for many countries.  One of its five pillars of its work plan 
for 2009-2013 was performance assessment and it has contributed to the debate very 
rigorously over the past few years.229 
 
4.8.2 Good practice examples 
Many researchers have noted and commented on the corollary between the advances 
made in evidence-based medicine and those achieved in evidence-based management 
(Heneghan, et al., 2017).  Whilst evidence-based medicine is now an integral part of 
safe and quality clinical practice, the same cannot be said of management, especially 
in utilising performance assessment data to take the correct management and policy 
decisions.  This is corroborated by Rechel and McKee (2014) who believe that whilst 
evidence-based policy making has been in place for decades, its implementation was 
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still lacking.230  This is perhaps the reason why the document analysis uncovered many 
statements attesting to the importance of evidence-based policy-making but few 
concrete examples of how this concept has actually been implemented.  Nonetheless, 
the purpose of this theme is to provide an overview of good practice examples in the 
field of HSPA, performance assessment and policy development.  It looks at 
organisations that are considered exemplars in this field and also at notable examples 
of their work.   
 
4.8.2.1 Case studies of linking evidence with policy change 
Tello and Baez-Camargo (2015) have outlined that there are at least 32 countries in 
the WHO European Region with national repositories or frameworks of data and 
health system performance information.  These contain a wide variety of indicators, 
from 26 in Austria to more than 1000 in Finland, highlighting the lack of homogeneity 
in this field.231 
 
One of the best examples of applying evidence into practice whilst having significant 
public health impact at population level was the strategy adopted by Switzerland to 
reduce iodine deﬁciency and hence, goitre through iodisation of salt. Whilst this led to 
the elimination of goitre, it was also emulated by many other countries to eliminate 
iodine deficiency in Europe and elsewhere.232   
 
A very good example of a ‘research-policy partnership’ originates from Malaysia, 
where researchers and policy makers in the Department of Road Safety piloted a few 
road traffic safety initiatives, measuring their success or otherwise as they progressed, 
allowing allocation of resources and funding in those areas which were deemed 
lacking.233   
 
Another good practice example originates from Mumbai, India, where a few research 
and advocacy efforts translated into legislative reforms aimed at improving the quality 
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of care in private health care institutions.234  Also, the Ontario province in Canada 
provides one of the prime and first examples of how a HSPA is incorporated into the 
policy cycle, through a regular budgeting and planning process.235   
 
Responsibility for health care in Italy is devolved to the regions.  The Tuscan Region 
developed the Performance Evaluation Programme with the aim of measuring health 
care performance and quality of care through almost 300 indicators spread over six 
dimensions, resulting in significant improvements in population health and quality of 
life.236  This project was later shared with another 13 regions in Italy.   
 
A similar programme is run by Israeli Maccabi Healthcare Services, a HMO, where it 
introduced an innovative ICT system called Health Value Added to improve care 
through target setting, monitoring and reporting of 30 indicators in six clinical 
dimensions, with the aim of improving performance and reducing inequities amongst 
its population.237 
 
4.8.2.2 Examples in the use of HSPA when determining policy agenda 
The previous section contained a variety of case studies showing a link between 
research and the generation of evidence and policy making. However, many of the 
examples cited were not related directly to HSPA but to various other research 
activities which generate evidence from performance data.  Whilst this is 
commendable and extremely important, it shows that HSPA, in its purest form, is still 
not widely used as a basis for policy development. For this reason, the analysis also 
looked for specific examples of how HSPAs informed policy. This sub-theme would 
highlight these examples. 
 
Portugal’s HSPA is a prime example on how it was designed to inform Portugal’s 
National Health Plan.  Policy questions, which focused on the performance of 
Portugal’s health system in relation to its strategic goals, were drawn up as part of the 
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initial HSPA process, leading to policy recommendations which were based on the 
evidence generated through its HSPA.238  As we have seen, the Dutch have produced 
four editions of their Health Care Report with the aim of contributing to strategic 
policy-making.  A Dutch Minister for Health viewed this report as ‘a solid empirical 
foundation for the policy of the Ministry of Health.’239,240  The Dutch experience is one 
of the few that has emerged attesting to the concrete link between the HSPA process 
and policy development.  The Italian Minister of Health, in his 2014 report on the 
performance of the Italian health system, clearly advocated for the development of 
performance matrices in order to inform policy and strategy,241 whilst OECD noted 
that several Italian regions, such as Calabria, Campania, Molise and Piemonte, have 
used performance data to inform local policy making.242 
 
In its performance assessment reviews of several Euro region countries, such as 
Portugal, Estonia, Georgia and Turkey, WHO states that ‘HSPA has been used 
successfully by health authorities to inform policy decisions; align stakeholders and 
build dialogue towards a common goal; and increase transparency and 
accountability.’243  In Georgia’s HSPA, stewardship was an important dimension in 
order to measure how well the ‘government uses evidence and health system 
performance information in its strategic planning and resource allocation 
processes.’244  During WHO’s assessment of Turkey’s performance, the Minister for 
Health also intimated that measurement and monitoring of performance was 
mandatory for decision taking and to improve accountability and efficiency.245  This 
is an important statement, seeing that it is essential to engage politicians in the policy 
cycle.  However, WHO’s enthusiasm is yet to be corroborated at the local level given 
that there are, as yet, few documented case studies at the local level to substantiate 
their claims.246 
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4.9 Communication 
Communicating the evidence and communicating to the public are important aspects 
to consider when linking evidence to policy making.  This theme explores the 
importance and relevance of how the evidence derived from performance assessment 
should be and is communicated to stakeholders, especially the public and policy 
makers.  Given the diverse needs of these two audiences, it is a challenge to 
communicate the same information in the appropriate manner, in very different ways.   
 
4.9.1  Communicating the evidence 
Communicating the evidence and results ensuing from HSPAs is not an easy task.  
Many researchers report that communicating their results is challenging if it goes 
beyond the usual route of publications in peer reviewed journals.  Several national 
experts depict a ‘poorly developed capacity for communicating effectively research 
results to policy makers.’247 
 
The Bridge Project was aware of the difficulties encountered in communicating the 
evidence.  They term the methods employed as ‘information-packaging mechanisms,’ 
in use by knowledge-brokering organisations in an attempt to surpass the traditional 
scientific formats of communication and develop communication avenues that are 
easier to understand by policy-makers and other stakeholders.248 
 
4.9.1.1 How to communicate 
Various methods have been devised for policy makers and other recipients to fully 
understand the meaning and implications behind HSPA data.  These include visual 
representations of comparative data, warning signals in the form of synoptic tables, 
colour codes and traffic lights and visual and descriptive maps to show differences in 
health outcomes across population groups, geographic areas or over time.  These are 
particularly apt in showing the policy timeline, especially to showcase those policies 
that have worked in contrast with those that have not.249  Policies briefs are an 
important tool in analysing a policy problem and communicating solutions, such as 
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the praxis to produce policy briefs by the EOHSP, usually in collaboration with the 
respective national health authorities.250  Policy makers find that purposefully written 
policy papers are more affiliated to their needs.  However, these reports must be 
backed by full scientific rigour to ensure ‘legitimacy to the executive summary.’  The 
thoroughness and robustness of the research process must be upheld and demonstrated, 
if it is to stand the test of reproach and debate, as most controversial policy documents 
tend to generate.251 
 
4.9.1.2 What and to whom to communicate 
Performance systems provide a wide description of data for a variety of reasons.  Some 
systems provide information on one aspect of performance, such as waiting times.  
Others delve into more complex indicators dealing with clinical and experiential 
aspects of care.  These different types of performance data render understanding and 
disseminating the information a challenging prospect which requires the correct means 
and channels of communication.252   
 
Some elements of a HSPA are more relevant to policy makers, others to clinical 
professional groups, or to patient groups and yet others to the general public.  
Depending upon the audience, components of the HSPA are communicated in a 
manner that is pertinent to the audience being targeted.   
 
This is a well-known practice in marketing, termed market segmentation and audience 
channelling,253 although communicating to policy makers is particularly demanding 
since the evidence needs to be pieced together from a diverse array of sources.254 
 
4.9.1.3 Alignment 
As discussed previously, there is evidence to indicate that ‘researchers and policy-
makers operate in two different worlds with researchers often not understanding 
policy maker needs and policy makers often not able to readily find and use many 
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sources of health systems information.’255  Whereas earlier efforts were directed at 
communicating evidence that had already been produced and that had been on the 
agenda of academics and researchers, rather than that of policy makers, more recent 
wisdom advocates more of an ‘alignment’ strategy.   
 
The purpose of generating evidence is driven by the need to inform policy makers and 
to improve service provision.  It should not be driven solely by the research or 
academia agenda.  Hence, unless these two realities converge, the evidence produced 
by researchers may not be relevant to policy makers and in turn, their requirements 
would not be met.  Lavis et al. (2013) continues to explain that alignment is a two-
way communication process, where ‘health system policy-makers, stakeholders and 
knowledge brokers (including researchers) can learn a great deal from one another 
by working together.’256  This is the methodology of choice for leading policy 
organisations, such as the King’s Fund and the EOHSP. 
 
4.9.2 The media and evidence-based policy 
The media plays an influencing role in the policy developmental process and cannot 
be discounted as a factor that impacts the policy cycle. 
 
4.9.2.1 The role of the media 
The media plays a hugely significant role in shaping policy.  Its influence could be 
harnessed to advance the policy agenda.  Many research organisations deploy media 
tools to communicate the findings of their research, such as the Belgian’s KCE, which 
publishes its research reports and hence propounds a public platform for its activities.  
Similarly, many HSPA reports, once published, are invariably launched at press 
conferences which have the dual function of publicising the results of the HSPA 
process, as well as garnering public and media support for its main messages or 
recommendations.257Italy places substantial effort in converting health data generated 
through its national and regional health information systems into usable information 
for the public, its professionals and policy makers.  The use of interactive maps and 
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dartboards targets the public, whilst more complex information targeting professionals 
is disseminated through a series of events and regional workshops.258 
 
The media is known to be unpredictable, following their own agenda, especially in 
dealing with controversial policies or performance data which uncovers information 
that was previously unknown.  Nonetheless, the media has the potential to bring an 
issue to the fore and this is invariably used by various stakeholders to guide, or rather 
steer policy in a certain direction.  Media outlets that ‘shock can also have a major 
impact by bringing the scale and nature of an otherwise hidden problem to public 
attention.’259  The challenge, of course, lies in sifting the ‘noise’ from the evidence in 
these circumstances and not allow controversy or sensationalism to usurp the reasoned 
interpretation provided by scientific evidence.   
 
Gollust, as cited in Bayer & Thompson (2015) 260, contends that providing information 
is not enough for policy change.  For the evidence to ‘influence public opinion and 
policy, communication will need to reflect important societal values that resonate with 
large audiences.’  In other words, even though there is an abundance of evidence, 
unless the issue impacts the wider society or is viewed as an important matter by the 
public, policy makers will not act upon the availability of evidence alone.  This is 
where the media plays a pivotal role, in garnering facets of the available evidence and 
transmitting this to the public for policy makers to take notice. 
 
4.9.2.2 Public accountability and transparency 
The media plays an important role in the policy process, often at the stage of setting 
the agenda261.  Modern communication strategies allow citizens and the general public 
to hold their politicians to account by being able to measure the performance of the 
health system and determine whether its performance is improving or regressing.262  
In this regard, the media often exposes discrepancies in the policy making process or 
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highlights inept policies or policies that have not worked as expected.  This sometimes 
sets them on a collision course with policy makers.   
 
Evidence produced by performance assessment systems allows for the objective, 
impartial arbitration between media pundits and politicians.  However, the media is 
also capable of translated what is essentially complex performance information to a 
language that is understandable and digestible to policy makers and by the public.263 
 
4.10 Further work 
The document analysis uncovered gaps in evidence and makes a case for further 
research.  Many authors argue that: 
 
… health policy and management, although admittedly different from 
clinical practice in signiﬁcant ways, are lagging behind clinical practice in 
addressing the problems of ‘overuse, underuse and misuse’ of evidence 
related to management practice and that this has a signiﬁcant impact on the 
quality of care and patient outcomes.264 
 
It is important to address this discrepancy since policy and managerial decisions have 
as much, if not more, of an impact upon patients and the public in general as do clinical 
decisions.   
 
Health Systems Research (Europe) clearly outlines what needs to be done to place 
Europe at the top of the health systems research agenda.  In its 2013 policy brief 
addressed to various European stakeholders it declared that what is needed is: 
  
... a broader research chain from research lab to real-life implementation 
... to use Europe as a natural laboratory for health services and systems 
research ... to move from centres of excellence to a sector of excellence ... 
to synchronize national and European research agendas ... to better monitor 
the societal impact of health services research ... better training in 
transferring knowledge in order to realise more evidence informed policies 
... capacity building in countries with less HSR potential265  
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4.11 Conclusion 
Today, there are many advocates for HSPA.  Most view HSPA as an effective means 
to develop evidence-based policies, improve quality of care and strengthen health 
system governance.  As such, all major international agencies and organisations 
strongly believe that each member state should develop a HSPA framework to inform 
policies, improve care as well as increase transparency and accountability.266  The 
establishment of HSPA as a ‘solid tradition in the Member States and at European 
level’ is an important goal to achieve in the near future.267  This is the ultimate legacy 
of HSPA. 
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CHAPTER 5 
PHASE II: DEVELOPING A NATIONAL HSPA 
FRAMEWORK (MALTA) 
 
 
 
“Knowing is not enough; we must apply.  Willing is not enough;  
we must do.” 
Johann Wolfgang von Goethe 
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CHAPTER 5 
PHASE II: 
DEVELOPING A NATIONAL HSPA FRAMEWORK (MALTA) 
 
 
 
5.1 Background 
To meet the many challenges facing the health system in Malta, including an ageing 
population, the growing burden of non-communicable diseases and environmental 
changes, the Ministry for Health in Malta initiated the development of a National 
Health System Strategy (NHSS) for 2014-2020 (Parliamentary Secretariat for Health, 
Malta, 2014).  The strategy is based on a life-course approach and builds on existing 
thematic policies and plans that have been developed in recent years. 
 
The next stage of the process was to develop a national Health System Performance 
Assessment (HSPA) Framework.  The HSPA was necessary to devise an effective and 
sustainable monitoring and review system during the implementation of the NHSS.  
The purpose of developing and implementing a Maltese HSPA was to bring Malta in 
line with many other European states in creating suitable systems to measure and 
assess the performance of its health system. 
 
A National Expert Working Group (NEWG) (Appendix 4) was set up to spearhead the 
development of the HSPA Framework for Malta.  Given the author’s interest and 
expertise on the subject, the author was nominated to form part of this group and in so 
doing, he coordinated and anchored all facets of its work.  As part of the author’s 
original contribution on this group, the author carried out his primary research for this 
phase of the thesis.   
 
This chapter outlines, in detail, the process undertaken for the creation of Malta’s first 
HSPA framework, including the methodology used and the results stemming from this 
exercise. 
  
 164 
5.2 Objectives of Phase II  
The objectives of this phase of the research study were threefold: 
 
1. To develop a national health system performance assessment 
framework for Malta. 
 
2. To develop a set of key national performance indicators for the Maltese 
health system. 
 
3. To produce and present the results of Malta’s first performance 
assessment of its health system. 
 
As explained before, the direct and original contribution of the author in this research 
project is recorded in this chapter as part of a wider exercise carried out by the Ministry 
for Health towards the development of Malta’s first ever HSPA Framework.  Hence, 
it was important to also outline the objectives for the drafting of the HSPA Framework 
for Malta, since this Government report emanated directly from the research findings 
for the development of this thesis and for which the author was the main contributor 
and editor of this report.   
 
The Government of Malta resolved that the main aim for Malta’s first HSPA was for 
it to serve as an adjuvant to Malta’s NHSS in terms of monitoring the implementation 
of this strategy and the attainment of the targets outlined in the NHSS.  The HSPA 
should serve as a tool to enhance and consolidate transparency and accountability in 
the decision-making process and ensure timely and effective delivery of care to 
Malta’s population.  Moreover, the development of a HSPA formed part of the 
monitoring framework for Malta’s bilateral meetings with the European Commission 
on the Partnership Agreement 2014-2020 for the access of structural funds.   
 
5.3 Methodological & developmental process of HSPA Framework 
The process and procedures undertaken by the NEWG and, for this thesis, the personal 
contribution of the author, are documented and reflected upon in the next section.  This 
section will outline in detail the methods used for each step of the process and will 
also present the results for each stage.  The outputs or results of one stage served as 
the inputs for the next stage, given that an iterative step-wise approach was adopted, 
until a final report with results was produced. 
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5.3.1  Methodological approach and study design 
The author reflected upon the various methodological approaches that could be used 
for this type of project.  This reflection was primarily informed by the methods used 
by previous authors in similar projects, as outlined in the literature review.   
 
5.3.1.1 Method approach 
In the main, a mixed methods approach was adopted for the development of HSPA 
frameworks internationally (Tashakkori & Creswell, 2007).  This is logical since these 
types of research projects require a multifaceted approach with multiple inputs and 
outputs, utilising a myriad of stakeholders as key participants in the research process.  
The information gleaned from these projects is both qualitative and quantitative in 
nature and therefore both methods were required to solicit the required response and 
obtain the required data and information to develop a meaningful and robust HSPA 
framework. 
 
‘Mixed methods’ is not simply the ad hoc combination of qualitative and quantitative 
methods.  It is the planned mixing of methods at a pre-determined stage of the research 
and hence, this methodology is incorporated into the research design from the start 
(Kroll & Neri, 2009).  Therefore, mixed methods research collects both qualitative and 
quantitative data in one study and integrates these data at some stage or at different 
stages of the research process.  In fact, a distinction needs to be made between mixed 
methods (using both quantitative and qualitative approaches) and multi-method 
research (using more than one method from the same tradition). 
 
Prior to commencing the data collection process, Creswell (2009, pp. 206-210) puts 
forward several questions to consider to inform the design of a mixed methods study.  
These include the sequence of data collection, the relative priority given to the 
qualitative and quantitative elements of data collection and analysis, the point of 
integrating both these methods and the elucidation of an overall theoretical perspective 
which should be used to guide the study. 
 
The author, together with the NEWG, considered the above aspects at design stage 
and indeed, followed a logical sequence as subscribed by the proponents of this 
methodology.  The first phase of the study, in fact, was qualitative in nature, followed 
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by a predominantly quantitative phase and ending with a predominantly qualitative 
input.  Since one phase fed into the other, priority setting was not strictly required, 
however the development of the HSPA model itself took considerable time since this 
laid the basis for the rest of the results to follow.  A flawed framework, at an early 
stage would have derailed the whole process.  Integration of qualitative with 
quantitative data occurred at each step of the process, where the results of the 
qualitative study fed into the quantitative part of the study and vice versa.   
 
It is important to highlight, at this juncture, the political nature of this process.  This 
has been amply highlighted in the literature and from the document analysis.  Whilst 
the methodology followed a rigorous scientific approach, the NEWG was in constant 
contact with the Ministry, which regularly ‘reviewed’ progress and also, towards the 
end, ‘suggested’ changes to the indicator set to better reflect the political realities at 
the time.  Whilst these changes were minimal, they are discussed later in this chapter. 
 
5.3.1.2 Study design and data analysis 
The next decision that needed to be taken was to choose the most appropriate study 
design and data analysis.  The mixed method approach can incorporate a number of 
study designs. A few of these were considered and discussed for the purpose of this 
research.   
 
The separate or ‘parallel’ Mixed Methods Analysis was first considered.  This is where 
qualitative and quantitative data sets are analysed separately and conclusions, or 
‘meta-inferences’ are made that incorporate both data sets.  This was discarded since 
data sets were produced in synch and were inter-related with one another.   
 
The author then considered whether the ‘convergent’ mixed method design would be 
appropriate where the results from one tradition (quantitative or qualitative) explains 
or confirms the results from the other tradition.  However, this was not the case for 
this project and confirmation of the results (in the form of triangulation) was not part 
of the research design and hence was not required.  Another type of analysis that was 
discussed was the Meta Matrix (or Joint Display) analysis.  Again, this process did not 
match the project requirements and was also rejected.  
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The method design that best fitted with the aspirations of this project was the Mixed 
Method Multiphase (or Multistage) Design.  The rationale for subscribing to this 
design was that it was ‘developmental’ in nature, where the results of analysis using 
one method, shapes subsequent methods or steps in the research process.  This design 
combines concurrent and/or sequential data collection over multiple phases of a 
programme of research or study.  It utilises sequential analysis using an Exploratory 
(not explanatory) Mixed Methods Design (Andrew & Halcomb, 2009, pp. 31-40), as 
is shown in Figure 5.1.  Furthermore, data analysis is carried out sequentially such that 
the second strand (qualitative or quantitative) emerges and builds on the previous 
strand (i.e. the second strand is not standalone and depends on and is informed by the 
first strand).  This is defined by Greene as ‘the importation of mid-stream results from 
the analysis of one data type into the analysis of a different data type’ (Greene, 2007, 
p. 148). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Sequential analysis using a multiphase mixed methods design 
 
5.3.1.3 Challenges/benefits of adopting a mixed methods approach 
Tashakkori and Teddlie (2010) imparted a few cautionary notes for those undertaking 
mixed methods research.  Whilst the qualitative and quantitative analysis need to be 
conducted within their own paradigms, the datasets however need to ‘merge’ before 
the final analysis.  The second strand needs to build on the first in a meaningful way, 
in line with the research question (Fetters, Curry & Creswell (2013).   
1. Initial qualitative 
analysis 
2. Measurement 
development 
3. Analysis 
incorporating both 
datasets 
QUALITATIVE QUANTITATIVE QUALITATIVE 
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Also, caution needs to be taken with sampling (size and who is selected) across the 
different strands to ensure validity and to decide from the start whether to adopt a 
concurrent and/or sequential sampling methodology at the various phases of the study.  
Care also needs to be exercised when choosing and interpreting the results that would 
be followed up by the second and subsequent strands since spurious results at any 
stage can vitiate the whole study.  These caveats were upheld as much as possible.   
 
The main advantage of this study approach is that it provides researchers with the 
opportunity to creatively rethink the research design and think outside the box.  In fact, 
although the approach of this research project is based upon a mixed method 
development design, some creative steps were needed to circumvent the difficulties 
and impracticalities of carrying out this type of project.  This allowed for the potential 
to generate new insights and levels of analysis, bringing together researchers from 
different backgrounds and different specialisms, allowing them to think together on a 
given research problem (Bryman, 2008). 
 
5.4 Overview of steps 
The methodology selected for this process consisted of several iterative and successive 
steps over a span of 12 months, starting in December 2013.  The methodology outlined 
above was also approved by the Ministry Management Board of the Ministry for 
Health in early December 2013 and was discussed and endorsed during the PhD 
upgrade panel session for the author on 14th May 2014.  The ‘traditions’ used 
(qualitative or quantitative) at each step are outlined in italics.  The final step was the 
production of Malta’s first health system performance assessment report. 
 
The process consisted of the following steps as shown in Box 5.1: 
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Box 5.1: Methodological process for development of Malta’s HSPA 
 
 
1. Setting up the National Expert Working Group (NEWG). 
 
2. Analysing current international health system performance frameworks 
(literature review) and testing them for their appropriateness in the Maltese 
health care setting – Qualitative. 
2a. Examination of performance frameworks from OECD, WHO, ECHI, 
Commonwealth Fund (USA), Canada, Australia, various EU member states. 
2b. Comparative analysis of domains/dimensions and indicators contained in 
each framework. 
 
3. Developing a draft framework for Malta (Roberts, et al., 2008) that would 
clearly distinguish drivers (e.g. funding mechanisms), intermediate goals 
(e.g. quality of services) and goals of the health system (e.g. health 
outcomes) – Qualitative. 
 
4. Extracting, filtering and mapping of indicators to the draft framework - 
qualitative with element of quantitative. 
4a. Extracting of indicators from national vertical strategies. 
4b. Filtering and cleaning of initial list of indicators to produce candidate 
indicators. 
 
5. Short-listing of indicators - quantitative with element of qualitative. 
 
6. Identification of gaps in the list of indicators and mapping of areas were no 
data is available - quantitative with element of qualitative. 
 
7. Review and finalisation of framework model after identification and 
mapping of final list of indicators - qualitative with element of quantitative. 
 
8. Data collection and analysis - production of first iteration of results. 
8a. Giving a weight to each indicator using two reviewers for each indicator 
working independently – qualitative. 
8b. Assigning owner and data collection and analysis of HSPA list of indicators, 
with display of results for each indicator – quantitative. 
8c.  Scoring each indicator in terms of time trend and comparison with 
international benchmarks – quantitative with element of qualitative. 
8d.     Scoring of each dimension – quantitative. 
 
9. Production of results. 
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5.5 Results  
The methods and ensuing results are presented contemporaneously over the rest of the 
chapter. 
 
5.5.1  Step 1: Setting up of the National Expert Working Group 
A National Expert Working Group (NEWG) was set up to oversee the development 
of the HSPA Framework.  This group was chaired by the then a/Chief Medical Officer 
and consisted of national health policy experts and public health consultants, 
numbering eight in all, including the Chair, senior management, public and health 
policy expertise, European policy expertise, expertise in epidemiology and statistics 
as well as administrative and ICT support.  A list of the members is provided in 
Appendix 4.  The author formed part of this group and carried out most of the scientific 
and technical work and research on behalf of the NEWG.  This served as the author’s 
original research contribution for this thesis.   
 
Whilst the methodology and results described in this chapter pertain to the whole 
HSPA developmental process, in practice, this methodology and the ensuing results 
were devised, developed, guided and written up by the author, again as part of his 
membership on the NEWG.  The NEWG served as a scientific and technical forum to 
discuss, debate, reach consensus and verify or scrutinise the process.  This was 
essential, since such a methodological process cannot and indeed, should not be 
carried out by a sole researcher working on his or her own.  As we have seen from the 
literature review and document analysis, this was the case for the development of 
HSPAs in most jurisdictions (Perić, Hofmarcher-Holzhacker & Simon (2017). 
 
The first task was to establish the methodology to be adopted (as described above), 
including the sequence and content of the work processes required throughout this 
task.  A timeline with key intervention points was established, spanning around 6 to 8 
months, from December 2013 to September 2014.  Areas of action were agreed 
amongst members of the group and the wider network of collaborators was also agreed 
upon.  The next step was defining the terms of reference of the NEWG, including the 
objectives, procedures to be followed and deliverables at the end of this task.  The 
objectives and deliverables are outlined hereunder.  
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The main objectives of the NEWG were: 
 
1. To develop a set of national indicators for the Maltese Health Systems 
Strategy. 
 
2. To develop a national Health Performance Assessment Framework. 
 
3. To draft Malta’s first HSPA report. 
 
Furthermore, this process was also expected to instigate and sustain a process of 
policy dialogue regarding performance assessment of the health system as a whole 
and in specific areas of the health system.  This formed part of the policy cycle that 
was to be developed as part of the implementation of the NHSS.  
 
To ensure external scrutiny by an experienced third party, the Ministry for Health 
commissioned a WHO expert to assist the NEWG in the development of the 
framework and to act as an external assessor of the process and its deliverables.  This 
expert was invited to attend the first meetings of the NEWG in mid-December 2013.   
 
5.5.2 Step 2: Analysing current international HSPA frameworks  
  and testing them for the Maltese health care setting. 
The first task of the OWG was to review the experience of other countries in devising 
HSPA frameworks and ascertain whether any of these are appropriate for Malta’s 
needs and requirements. 
 
5.5.2.1 Step 2a: Examination of international HSPA frameworks  
The first task that was carried out was to identify and examine the various performance 
assessment frameworks in place internationally, especially the more established ones 
and those replicated by several different countries.   
 
The purpose of this task was to review the frameworks that were already in place with 
a view of determining which framework or aspects of particular frameworks would be 
applicable to the Maltese context.  This then informed the next stage, where a draft 
framework for Malta was developed.   
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The author’s role at this stage consisted of carrying out a literature review and 
document analysis as detailed in Chapters 2 and 4 and providing the NEWG with the 
relevant findings.  Each framework was scrutinised for congruence to the local 
context, for its conceptual outline and for its content, in particular its domains or 
dimensions.  After an extensive review of the literature, the author, together with the 
NEWG, considered several frameworks that may be pertinent for Malta.  These 
included frameworks pertaining to OECD, WHO, the Commonwealth Fund in the 
United States, the Ontario model of Canada, the framework used in some states in 
Australia, and those used in some EU member states including Estonia, Portugal and 
the Netherlands.   
 
The NEWG also reviewed the European Core Health Indicators project, which 
although not a framework in itself, was deemed relevant due to its collection of the 
most commonly used indicators in the European Union.  An illustrative depiction of a 
few of the frameworks examined is provided in Appendix 5. 
 
5.5.2.2 Step 2b: Comparative analysis of dimensions & indicators  
  in each framework 
The same literature search identified the domains or dimensions present within each 
framework described above.  The analysis consisted of counting the occurrences of 
each dimension within each framework, as well as comparing these dimensions across 
various frameworks, looking for commonalities, divergences and reasons for 
inclusion.   
 
As explained in the literature review, these dimensions provide the building blocks of 
each framework, upon which the indicators would be mapped.  Those dimensions most 
relevant to the Maltese health system were discussed in detail and chosen for inclusion 
into the draft framework for Malta.  The indicators contained within each dimension 
were also noted.  Table 5.1 was compiled by the author to show the various 
domains/dimensions for several frameworks.  This was used by the NEWG for this 
stage of the project.
  
1
7
3
 
Table 5.1 Domains/dimensions of international HSPA Frameworks 
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Table 5.1 Domains/dimensions of international HSPA Frameworks (cont.) 
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Table 5.1 Domains/dimensions of international HSPA Frameworks (cont.) 
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5.5.3  Step 3: Developing and testing a draft framework for Malta 
This stage involved the development and testing of a draft framework for Malta linked 
to a theoretical archetypal health system model that would clearly distinguish drivers, 
intermediate goals, and goals of the health system.  A general discussion ensued on 
the conceptual framework to be adopted for Malta’s HSPA, based upon the literature 
findings previously described.  Frameworks were classified into various conceptual 
themes, including goal-driven frameworks (based on the WHO model), the UK-based 
balance scorecard system, quality-based frameworks as adopted by OECD and the 
Netherlands, results-based logic model taken up by Canada and China and the 
Donabedian Model, adopted by many EU countries, such as Portugal and Estonia.  
Through an iterative process of consensus discussion, the NEWG agreed that the 
Donabedian framework would be most suited for Malta, since we already classify 
many of our activities according to the input-process-output model.  However, the 
NEWG felt that rather than using traditional nomenclature, we would use terms which 
would be better understood by the general public.  Hence, the draft model that was 
drawn up comprised of three phases – drivers, intermediate goals and ‘final’ goals.   
 
The next phase involved an in-depth discussion on the appropriate dimensions in terms 
of their applicability to Malta’s health care system and local context.  The method 
chosen for this exercise was a modified Delphi technique where members of the 
NEWG each scrutinised the dimensions described above, and each came forward with 
their top six (6) dimensions.  These were then compared, and, through an iterative 
process of inclusion and exclusion, the most appropriate dimensions were chosen, with 
the understanding that these could change following testing and external scrutiny.  
Through this process, many of the dimensions portrayed in existing international 
frameworks were individually discussed and included/excluded for Malta.  An initial 
draft list of dimensions was compiled which were then sorted into the three main areas 
described above, i.e. drivers, intermediate goals and ‘final’ goals.  Furthermore, to 
ensure full clarity and understanding of the meanings attributed to each dimension, the 
author compiled a detailed compendium of definitions for each dimension.  These 
definitions are important for comparability and consistency.  The full list of 
dimensions, as drawn up at this stage of the process, together with their definitions, is 
contained in Appendix 6. 
 177 
The last part of this stage involved the establishment of a draft Malta HSPA framework 
incorporating the selected dimensions, as depicted in Figure 5.2. 
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Figure 5.2: First interation of Malta HSPA Framework  
  (showing initial list of dimensions). 
 
The next stage required the NEWG to test the draft HSPA Framework.  This was 
achieved during a national conference for the launch of Malta’s National Health 
System Strategy held on the 21st February 2014.  A bespoke workshop was organised 
within this conference with the participation of 20 persons, composed, in the main, of 
senior civil servants, senior managers and senior clinicians.  The framework was 
presented and discussed in detail and the author took note of the suggestions that were 
made.  In general, the framework was understood and accepted as appropriate to 
Malta’s current health system needs and circumstances.  Apart from the discussion on 
the HSPA framework, there was also a dialogue on the type and nature of indicators 
that could/should be included in the model.  Whilst this did not affect or alter the 
framework itself, the general discussion was useful since it set the scene for the next 
stage of the process, i.e. the generation of the indicators.  The detailed feedback 
received from this workshop can be viewed in Appendix 7.  
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5.5.4 Step 4: Extracting, filtering, mapping indicators 
   to draft framework 
The most challenging part of the process was to populate the framework with the 
appropriate indicators.  This involved a multi-stepped approach of extracting 
indicators from Malta’s health strategies, cleaning and filtering the initial list and 
mapping these against the draft framework. 
 
5.5.4.1 Step 4a: Extracting of indicators from national vertical strategies 
The next major step required the identification of the performance indicators for the 
Malta HSPA.  The NEWG had two main options to consider, both of which were 
feasible and methodologically sound.  The first option involved drawing from 
internationally-based indicators and applying these indicators to the local context.  The 
main advantage of this option was the identification of indicators which are tried and 
tested and which are externally comparable.  The main disadvantage is that a few of 
the chosen indicators may not be collated in Malta and may not necessarily be 
applicable or relevant to our local needs.  The second option was to ‘home grow’ our 
own indicators, driven mostly by our local policies and needs.  This was also deemed 
possible due to the availability of local indicators, collected routinely through the 
implementation of the various national health strategies that were launched in Malta 
over the last few years.  The main advantage of choosing this option was that we would 
identify indicators that are relevant to the Maltese health system and that these 
indicators should already be routinely collected.  The main disadvantage is one of 
comparability and benchmarking with external health systems.   
 
Upon the suggestion of the author, with the confirmation of the external advisor, the 
NEWG opted to go for the latter option, in identifying locally-generated indicators.  
This task was made more feasible since Malta, had, to date, produced a significant 
number of national strategies linked to specific public health challenges, such as, 
amongst others, cancer, non-communicable diseases and obesity.  Most of these 
strategies already had a set of indicators that were being used to monitor the 
implementation of these plans.  Hence, the first task was to delineate all the vertical 
national health strategies that had been produced to date (mid-2014) or those that were 
currently being developed (at the time).  Seventeen (17) national health strategies or 
policies were identified (Appendix 8).   
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An extensive exercise was then carried out where each strategy or policy was 
scrutinised in detail by at least two members of the NEWG to ‘extract’ the appropriate 
indicators related to each strategy.  In all, 335 indicators were initially extracted from 
16 strategies.  Since the strategy on communicable diseases was still being developed 
at the time, the indicators (n=15) linked to this strategy were added later in the day.   
 
This initial list of indicators (n=350) were then mapped onto the first draft Malta 
HSPA framework, by linking each indicator with a primary dimension or domain.  The 
resultant map gave an indication of those dimensions which were heavily populated 
as against those with few indicators attached to them.  This can be seen in Figure 5.3. 
 
 
 
 
 
Figure 5.3 Initial mapping of the original 350 indicators to domains 
 
As can be seen from the model above, those dimensions which were matched with 
most indicators (>30) were Stewardship (n=30), Public Health Services (n=44), Equity 
and Access (n=50), Quality and Effectiveness (n=76), Health Status (n=33) and 
Determinants of Health and Risk Factors (n=41).  Fiscal related dimensions pertaining 
to Financing (n=3), Sustainability (n=2), Efficiency (n=9) and Social Protection (n=8) 
scored low, as did Inequalities (n=1) and Consumer Satisfaction (n=1).   
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Although not directly pertinent to the ultimate task at hand, this mapping exercise was 
important when it came to reconfigure the model at a later stage.  Also, towards the 
end of the process, it served as the groundwork when it came to include additional and 
specific financial, as well as social protection indicators which were not part of the 
original 350 indicators. 
 
5.5.4.2 Step 4b: Filtering and cleaning of initial list of indicators  
  to produce candidate indicators 
Given that some of national strategies were interrelated (for example, the Cancer Plan 
with the Non-Communicable Disease Strategy), the NEWG noted that a good number 
of indicators were duplicated or had similar meanings.  Hence, the list was ‘cleaned 
and filtered’ several times for duplication, clarification of definitions and relevance.  
From an initial total number of 350 indicators, these were filtered down first to 269 
indicators (less 81) and then to 250 (less 100) after several iterations of internal 
discussions, comparisons and consensus agreement.  These are known as the 
‘candidate’ indicators, details of which are presented in Appendix 9.   
 
5.5.5  Step 5: Short-listing of indicators 
Based upon the experience of other countries in developing their HSPA framework 
and as highlighted in the literature review, the NEWG agreed that the number of 
performance indicators needed to be reduced to a more manageable number, down 
from the ‘filtered’ list of 250 (candidate) indicators to around 60-70 indicators.  This 
number was deemed reasonable to cover all the main areas of activity within the 
Maltese health system, whilst retaining a practical and feasible set of indicators to 
measure on a regular basis.  A methodology subscribed by the RAND Corporation and 
later assumed by OECD and replicated in many other instances was selected to achieve 
this reduction (Nolte, 2010).  The method consisted of scoring each candidate indicator 
according to a set of criteria established by OECD and other organisations using a 
method similar to that established by RAND in their work on classifying patient safety 
and quality indicators (Farley, et al., 2008).  A different weight was assigned to each 
criterion, depending on its importance, relevance and feasibility for Malta’s specific 
needs.  The criteria and sub-criteria and their definitions are provided in Appendix 10.  
Based upon these criteria, in agreement with the NEWG, the author created and 
adapted an algorithm to be followed for this purpose, as illustrated below  
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Figure 5.4 Scoring algorithm to produce shortlisted indicators 
Source:  Adopted by author from Farley et al., (2008).
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The first set of criteria was based on ‘importance’, and was given 40% of the total 
marks, sub-divided into three sub-criteria, namely ‘Impact of disease or risk on health 
and health expenditure’ (15%), ‘Policy importance’ (10%) and ‘Susceptibility to being 
influenced by the health care system’ (15%), as indicated in the diagram above.  If an 
indicator did not achieve 20% or more on this first set of criteria, it failed to pass onto 
the next round of scoring, which consisted of another two sets of criteria, namely: 
 
- Feasibility (30%) 
Availability of local indicators – 10% 
Availability of internationally-comparable data across countries – 10% 
Cost or burden of measurement – 10% 
 
- Scientific soundness (30%) 
Validity – 10% 
Reliability – 10% 
Explicitness of the evidence base – 10% 
 
The pass mark was an overall 50%.  Each indicator was initially scored by two internal 
reviewers (NEWG members) working independently.  Each score from both reviewers 
was then compared and either averaged out if scores were less than 20% apart or a 
consensus score was assigned if individual scores were more than 20% apart.  Scores 
were expressed as a % mark.  The table below shows the number of indicators resulting 
from each stage of the process up to this point.   
 
In summary, the first ‘extraction’ of indicators from the 17 national strategies resulted 
in 350 indicators (Step 4a).  These were then filtered, cleaned and reviewed for 
relevance and duplication, reducing the number first to 269 and then to 250 indicators 
(Step 4b).  The 250 ‘candidate’ indicators were then subjected to the scoring process 
as described above and the results (Step 5) are shown in Table 5.2.  Of the 250 
indicators, 82 failed to pass the initial 20% mark linked to the first set of criteria.  
Another 36 failed to obtain the overall pass mark of 50%.  52 indicators obtained 
between 50-59%, 41 indicators obtained between 60-69% and 39 indicators obtained 
more than 70%.  The full list of candidate indicators and their marks are provided in 
Appendix 9 (Internal scoring of candidate indicators, n = 250).  
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Table 5.2:  Extraction, filtering and internal scoring of indicators 
 
 
Step 4a 
Extraction 
of 
indicators 
Step 4b 
Filtering, cleaning 
& reviewing for 
relevance & 
duplication 
Step 5 
Internal Scoring using modified OECD 
algorithm 
National Strategy    <20% 
20 to 
50% 
50 to 
59% 
60 to 
69% 
>70% Total 
Primary Care 25 13 12 2 2 2 2 4 12 
Accessibility & 
Efficiency 
19 18 16 1 3 4 5 3 16 
National Cancer 
Plan 
15 14 12 4  1 2 5 12 
Child Poverty 20 19 18 7 1 5 3 2 18 
National Dementia 
Strategy 
26 9 8 2 3 3   8 
National Diabetes 
Strategy 
45 42 42 6 12 16 6 2 42 
Eating Disorders 13 3 3 2 1    3 
National 
Environmental 
Health Action Plan 
9 6 6 4 1  1  6 
Health Vision 2000 17 13 10  2  3 5 10 
Mental Health 20 18 18 6 1 5 3 3 18 
National Non-
Communicable 
Disease Strategy 
36 33 33 14 6 8 4 1 33 
Health Weight for 
Life Strategy 
(Obesity) 
13 4 3 1  1 1  3 
Occupational 
Health and Safety 
21 15 15 11  1 2 1 15 
Perinatal Indices 24 21 21 9   2 10 21 
Sexual Health 
Strategy 
16 11 10 7 1 1 1  10 
TB Plan 16 15 8 5  1 1 1 8 
Communicable 
Disease Strategy 
15 15 15 1 3 4 5 2 15 
Grand Totals 350 269 250 82 36 52 41 39 250 
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The next stage required external validation of those indicators which passed.  
Following a high-level sensitivity analysis, the NEWG decided to take the 60% mark 
as a cut off point for external scoring and validation.  This resulted in 80 (41+39) 
indicators obtaining 60% or more of the marks.  These were subjected to further 
external scoring and scrutiny.  Three separate and independent professional groupings 
external to the NEWG were asked to score the shortlisted indicators.   
 
The first group consisted of 10 professionals considered as experts in performance and 
quality management in Malta.  These professionals were asked to score the 80 
indicators according to the same detailed set of criteria and algorithm as used by the 
NEWG.  A 100% response rate was obtained from this group.  The second group of 
external reviewers hailed from academia, consisting of academics and researchers 
from the Faculties of Medicine and Health Sciences at the University of Malta (n=539; 
response rate of 3.9%.)268  The third group comprised senior clinical leaders and 
managers within the Maltese public health service (n=130; response rate of 68 (52%)).   
 
Both of these latter two groups were asked, through a covering letter/e-mail, to respond 
to an on-line survey devised by the author.  The survey consisted of a shortened 
version of the previously used criteria containing the same three main (not sub) criteria 
set out previously.  A sample of the survey is shown in Appendix 11.  Unlike the % 
scores for the internal scoring process, these scores were expressed on a Likert scale 
from 1 to 7.   
 
The NEWG considered whether to involve lay external stakeholders at this point in 
time, such as patient groups or NGOs.  After obtaining the views of the Ministry for 
Health, it was decided not to engage with lay stakeholders for the scoring and 
weighting of the individual indicators but to consult with them after the draft results 
of this process are published.  This may not have been the viewpoint of the NEWG, 
given that a wider representation and ownership of the process was deemed 
advantageous.   
 
                                                 
268  Note: NEWG could not verify that all the academics received the on-line survey since this was 
transmitted through third parties.  Hence the response rate may not be accurate and reflect the true 
situation. 
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The scores obtained from the three external groups of reviewers were then compiled 
and analysed, the results of which are also shown in Appendix 9 (External Scoring 
Results).  The mean score that each group obtained for all 80 indicators was calculated 
and taken as the pass mark for each group separately.  Following this, the NEWG 
carried out its last review and consensus discussion on the final list of indicators, based 
primarily upon the scores obtained.  Those indicators that scored above the mean for 
all three groups totalled 39.  These were analysed in detail again and reviewed for 
associations and similarities, after which 28 indicators were selected.   
 
A similar process was followed for those indicators which obtained marks greater than 
the mean in two of the three groups.  These initially numbered 13 and were reduced 
to 5 after further group review and assessment.  An exception to this was the indicator 
pertaining to ‘Prevalence of Cerebral Policy,’ which although did not exceed the pass 
mark, the NEWG felt that it was important to include as a measure of quality of 
perinatal services.  At this juncture, 34 indicators (28+5+1) were shortlisted. 
 
5.5.6 Step 6:  Identification of gaps in the list of indicators and 
  mapping of areas where no data is available 
In the final stage, this final list of 34 indicators was mapped to the framework.  The 
dimensions which were not populated up to this stage were noted.  As intimated 
earlier, the NEWG also had a mandate to insert indicators that are relevant to Malta’s 
European and politico-fiscal priorities at the time.  Hence, the NEWG also reviewed 
other relevant documents and policies that were in place within the European Union, 
given that Malta’s HSPA primarily needed to meet EU requirements to qualify for EU 
funding and to ensure convergence with EU mandated requirements.   
 
To this end, the indicators advanced by the Directorate-General for Economic and 
Financial Affairs (DG ECFIN) and the Social Protection Committee (SPC) - Joint 
Assessment Framework (JAF) of the European Commission were considered in detail 
and another 10 financial indicators were added to meet DG ECFIN requirements, 
whilst another 10 JAF indicators were also incorporated to provide a socio-economic 
context to the Maltese HSPA (the fact that these numbers match is coincidental).   
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The NEWG also added an additional indicator to populate the dimension of efficiency 
since there weren’t enough indicators to assess this dimension suitably.  This was 
Indicator No. 60, measuring the ‘rate of hip surgery fracture initiated within two 
calendar days after admission.’  This indicator was original in the list of candidate 
indicators but only obtained 51% of the marks when scored internally by the NEWG 
and hence, was not considered further at that point.   
 
Finally, two indicators linked to health information and/or e-health were also added, 
since these did not feature at any stage of the process.  These were Indicator No. 61 – 
‘Proportion of population that accesses own health data on-line’ and Indicator No. 62 
– ‘Rate per capita of prescriptions transaction on-line’.  These latest additions were 
not on the original list of indicators that were extracted from the vertical strategies at 
the start of this process.   
 
Hence, the total number of indicators reached was 34+10+10+3=57.  An algorithm 
showing the extraction, filtering, scoring and selection of these 57 indicators is shown 
in Figure 5.5.   
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Figure 5.5: Algorithm to extract, filter, score and select shortlist of indicators  
Extraction of indicators from 
16 national strategies. 
Add communicable disease 
strategy indicators n=15. 
350 indicators 
Filtering, cleaning & 
duplicates. 
Internal scoring by NEWG. 
269 indicators 
250 ‘candidate’ 
indicators 
80 indicators > 60% 
pass mark 
335 indicators 
39 indicators scored 
above mean in all 
three groups. 
13 indicators scored 
above mean in two 
groups. 
1 indicator did not 
pass from any group 
but was still 
considered. 
Further 
filtering for 
associations, 
similarities 
and duplicates. 
28 indicators 
External scoring by experts, academics, 
senior practitioners and management. 
5 indicators 1 indicator 
34 shortlisted indicators 
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Figure 5.5 Algorithm to extract, filter, score and select final list of indicators (cont.) 
 
5.5.7 Step 7:  Review and testing of HSPA framework model after  
  identification and mapping of final list of indicators 
Through an iterative process of allocation, review and discussion, the initial HSPA 
framework was modified to include those dimensions which were relevant for Malta 
and was populated with the final list of 57 indicators.   
 
The result of this process is shown below in Figure 5.6. 
 
Addition of 10  
DG ECFIN 
indicators  
Addition of 1 
efficiency indicator 
Addition of 2  
e-health indicators 
Addition of 10 SPC 
(JAF) indicators  
Final list of 57 indicators 
34 shortlisted indicators 
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Figure 5.6: Mapping of final list of indicators onto revised HSPA Framework  
 
As explained earlier in this chapter, Malta’s HSPA was closely associated with Malta’s 
NHSS.  A further exercise was carried out where the HSPA dimensions were mapped 
alongside the three strategic objectives of the NHSS.  This was important to ensure 
congruence and consistency between the NHSS and the HSPA.  The results of this 
exercise are shown in Table 5.3.  This mapping was carried out by the NEWG through 
internal discussion and consensus building. 
 
Table 5.3 Linking the HSPA dimensions with strategic objectives of NHSS 
 
HSPA DIMENSIONS NHSS OBJECTIVES 
HSPA DRIVERS NHSS 
STEWARDSHIP 
NHSS OBJECTIVE 4 generally refers to sustainable 
policies, governance, whole-of government/society 
approaches. 
 
GOVERNANCE 
RESOURCES 
FINANCING 
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Table 5.3 Linking the HSPA dimensions with strategic objectives of NHSS (cont.) 
 
HSPA INTERMEDIATE 
GOALS 
NHSS 
ACCESS 
NHSS OBJECTIVE 2 generally refers to:  
Access, availability, timeliness and efficiency 
 
NHSS OBJECTIVE 3 generally refers to:  
Quality 
 
SERVICES 
RESPONSIVENESS 
EFFICIENCY 
QUALITY 
 
HSPA GOALS HSPA CONTEXT NHSS 
HEALTH STATUS 
SOCIO-
DEMOGRAPHICS 
NHSS OBJECTIVE 1 
Generally refers to: 
 
Responding to demographic 
changes/ health promotion and 
prevention. 
 
EMPOWERMENT 
DETERMINANTS  
OF HEALTH 
 
 
The 57 indicators were then mapped again using the above templates, resulting in the 
following configuration shown in Table 5.4. 
 
Table 5.4 Mapping of final list of indicators to NHSS and HSPA 
 
NHS STRATEGIC DIRECTIONS 
SD1A SD1B SD2A SD3A SD3B SD4A SD4B 
ENPOWERNMENT SERVICES GOVERNANCE 
19 20 18 
MALTA HSPA FRAMEWORK 
HSPA GOALS 
AND CONTEXT 
HSPA INTERMEDIATE GOALS HSPA DRIVERS 
16+3 25 13 
19 25 13 
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Consequent to this analysis and mapping, the HSPA model was amended to 
incorporate the three main strategic objectives of the NHSS, linked to the dimensions 
of the HSPA.  Again, this last process involved consensus building and agreement on 
the final iteration for the framework.   
 
The NHSS strategic objectives did not feature at the initial stages of the methodology 
after a conscious decision was taken not to confuse the fledging HSPA framework 
with the then recently launched NHSS.  However, both the author and the NEWG 
were aware that the NHSS model needed to be incorporated into the HSPA framework 
at some point of the process and that full convergence needed to occur at the end.  This 
process produced the final HSPA model for Malta, as shown in Figure 5.7. 
 
 
Figure 5.7 Final Malta HSPA Framework 
 
A summary showing the mapping of the final list of indicators to the dimensions is 
shown below.  Some of the 57 ‘main’ indicators were additionally expanded into sub-
indicators creating a full list of 69 indicators.  For instance, the indicator ‘Standardised 
Cancer Incidence Rates’ was further divided into incidence rates for colorectal, lung, 
breast, cervical and prostate cancer as can be seen in Table 5.5.  
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Table 5.5 Mapping of final list of main and sub-indicators with dimensions 
 
 Dimension 
Total 
Main indicators 
Total 
Main and 
sub-indicators 
Drivers Stewardship 6 6 
 Resources 4 5 
 Financing 3 5 
    
Intermediate goals Efficiency 4 4 
 Access 6 7 
 Responsiveness 5 5 
 Quality 10 12 
    
Goals Health Status 11 17 
 
Determinants of 
health 
5 5 
    
Socio-demographic  3 3 
Total  57 69 
 
5.5.8 Step 8: Data collection and analysis:  
  Production of first iteration of results 
This step consisted of the collection and analysis of data pertaining to the final set of 
indicators.  An outline of the data collection and analysis is being presented here.  The 
full report can be viewed at Grech et al. (2015). 
 
5.5.8.1 Step 8a: Data collection and analysis 
Each indicator was assigned an ‘owner’ or responsible person, who was usually the 
senior service manager responsible for the area under which the indicator fell.  These 
persons were asked to collect the requisite data for each indicator, using 2012 as the 
base year or later years if the data was available.  Definitions for each indicator were 
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developed as part of the data collection and analysis procedure.  The owners were also 
given the opportunity to provide qualitative comments where appropriate or necessary.   
 
A final list of indicators, together with their ‘owners,’ can be seen at Appendix 12269.  
A definition for each indicator was drawn up and these are shown in Appendix 13.  
Each indicator was assessed in terms of its performance in two ways; first in 
comparison with international benchmarks and second how it fared over time.  Hence, 
the data was compared to international benchmarks from data pertaining to the EU 28 
average, the EU15 average, WHO Euro Region average and/or OECD data, wherever 
applicable and available.  Time trend analysis was also documented for each indicator.  
The data of each indicator was consequently collected, collated, scrutinised and 
converted into graphs, figures and tables as appropriate.  Indicators were grouped into 
their dimensions and the results for each dimension were reviewed and commented 
upon.  Missing or incomplete data was also noted. 
 
Subsequent to the process explained above, a scoring and weighting system was 
formulated to classify each indicator in terms of performance (score) and importance 
(weight).  With regards to performance, each indicator was scored by four independent 
assessors for its performance in terms of ‘trend over time’ and ‘international 
comparison.’  Points were allotted using these criteria from 0 to 2.  For each indicator, 
the sum of each category was then added to derive the overall performance 
‘Assessment’ score, ranging from Very Poor (0), Poor (1), Satisfactory (2), Good (3) 
and Very Good (4).  The median score for ‘Trend Over Time,’ ‘International 
Comparison’ and ‘Assessment’ from the four independent assessors was then 
calculated for each indicator.  The results from all the indicators of each dimension 
were then examined together.   
 
Table 5.6 provides a representation of the scoring system used for each indicator.  It 
was also decided to introduce a traffic-light colour coded system to aid 
comprehension, given that the report was to be disseminated widely to a diverse 
audience.  Points are indicated in brackets.  
                                                 
269  Note: The reference numbers of the final list of performance indicators are not sequential since 
some indicators were removed during the selection process. 
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Table 5.6 Scoring system for each indicator 
 
Indicator 
reference 
number 
Indicator 
Trend over 
time 
International 
comparison 
 Assessment Score Weight 
     
Very Good 
(4) 
4  
  
Improving 
(2) 
Malta fares 
better (2) 
 Good (3) 3  
  Stable (1) 
Malta fares 
the same (1) 
 
Satisfactory 
(2) 
2  
  
Deteriorating 
(0) 
Malta fares 
worse (0) 
 Poor (1) 1  
     
Very Poor 
(0) 
0  
  
More data / 
research is 
needed 
More data / 
research is 
needed 
 
More data / 
research is 
needed 
  
 
With regards to importance (weight), the Expert Group considered the fact that not all 
indicators carried the same weight in terms of policy importance and relevance in the 
local context.  Hence, to have a more realistic representation of these indicators in 
relation to the dimensions they represent, weights were assigned to each indicator 
independently by 6 local assessors and 2 foreign advisors who weighted each indicator 
from one (1) to three (3), with 1 being the least important and 3 being the most 
important.  The median score of these eight assessors was then calculated for every 
indicator.   
 
Once the ‘Assessment’ scores and ‘Weighted’ scores for each indicator were 
computed and agreed, the overall score for each dimension was extracted using the 
sum of the scores and weights of each indicator within each dimension.  A 
classification was produced for each dimension.  The classification was similar to that 
for each indicator, ranging from Very Poor to Very Good as shown in Table 5.7.  The 
range of points allocated to each tier was equally distributed from 0 to 4 (4 divided by 
5 = 0.8).  The range of points allotted across the classification can also be seen in the 
table below. 
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Table 5.7  Overall scoring schedule and classification for each dimension 
 
Dimension Undetermined 
Very 
Poor 
Poor Fair Good 
Very 
Good 
Range Nil 0 to 0.8 0.81 to 1.6 1.61 to 2.4 2.41 to 3.2 3.21 to 4 
 
 
5.5.8.2 Step 8b: Presentation of results 
  Overall assessment of the Maltese health system 
The results showing an overall assessment of the Maltese health system are 
represented in Table 5.8, whilst the detailed scores for each indicator and dimension 
can be seen in Appendix 14.  The table shows the overall assessment for each 
dimension, as well as the assessment for each indicator.  A reference number, which 
was the same as the number assigned to each indicator, was allocated.   
 
None of the dimensions were classified at the extreme ends, namely either as Very 
Good or Very Poor.  Three dimensions (Efficiency, Resources and Determinants of 
Health) were classified as Poor, whilst four dimensions (Financing, Quality, Access 
and Health Status) have been classified as Fair.  One dimension (Responsiveness) 
scored above average.   
 
It was not possible to classify the dimension for Stewardship due to lack of data.  
Socio-demographic factors, which provide a context within which the Maltese Health 
System must function and operate, has not been scored for the purposes of this exercise 
but the task to improve certain aspects of the health system would be more challenging 
due to an unfavourable environment and the absence of enablers. 
 
  
1
9
6
 
Table 5.8:  Overall assessment of the Maltese health system for the base year 2012 
 
Dimension 
Overall 
Assessment 
 Performance Indicators 
Health Status Fair  46 3 5 27 21 37 17 31a 31b 7a 7b 9 6a 6b 6c 6d 6e 
Determinants 
of Health 
Poor  22 33 51 52 53 
Efficiency Poor  15 40 60 62 
Access Fair  47 13 14 23a 23b 30 43 
Responsiveness Good  2 16 32 26 61 
Quality Fair  18 1 25 12 11 19 50 38 28a 28b 28c 4 
Stewardship Undetermined  8 34 39 45 44 48 
Resources Poor  10 20 24 41a 41b 
Financing Fair  49 35a 35b 36a 36b 36c 
Socio-
Demographics 
Not Scored  55 57 58 
Source: Reproduced from (Grech, et al., 2015). 
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5.6 Conclusion 
The purpose of this exercise was to portray, in as accurate and scientifically robust 
manner as possible, the performance of the Maltese health system.  The above results 
have shown that the Maltese health system is performing well in many areas, but there 
is room for improvement in certain dimensions.  The complete results of this exercise 
were published in the first HSPA report for Malta, where the author was the main 
editor and drafter of the report.  The full results can be seen in the publication ‘Report 
on the Performance of the Maltese Health System’ (Grech, et al., 2015). 
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CHAPTER 6 
POLICY CYCLE: THE RELATIONSHIP BETWEEN 
HSPA FRAMEWORKS AND POLICY DEVELOPMENT 
 
 
 
“When performance is measured, performance improves. When 
performance is measured and reported back, the rate of improvement 
accelerates." 
Thomas S. Monson 
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CHAPTER 6 
POLICY CYCLE: THE RELATIONSHIP BETWEEN HSPA 
FRAMEWORKS AND POLICY DEVELOPMENT 
 
 
 
6.1 Preamble 
In his foreword for the volume ‘Performance Measurement for Health System 
Improvement’ (Smith, et al., 2009a, p. ix), the Deputy Regional Director of WHO 
states that ‘the provision of relevant, accurate and timely performance information is 
essential for assuring and improving the performance of health systems.’  This 
statement shows that whilst performance improvement is very much on the agenda of 
senior health policy makers, the impact of performance assessment on health policy 
development seems to play second fiddle.  This observation epitomises the focus of 
this chapter, which aims to explore the impact that HSPA frameworks have upon the 
development of policy and the shaping of reforms within the health system these 
frameworks are measuring. 
 
This is known as the policy cycle, wherein HSPA ‘informs’ policy and assists policy 
makers in setting priorities and in taking key system-wide decisions.  These policy 
developments, in turn, shape the content and structure of performance frameworks and 
determine which performance indicators are included and excluded in line with 
changing priorities.  Hence, a continuous cycle is created which links performance 
assessment frameworks with policy development.  
 
This chapter continues to explore this phenomenon through the author’s participation 
on the HSPA Expert Committee of the European Commission.  This experience saw 
the author visit many capitals in Europe and other locations over a period of three 
years, actively participating in the formulation of methodologies and strategies on 
HSPA frameworks. 
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6.2 Objectives of Phase III 
The objectives of this part of the study are: 
 
1. To investigate whether there is a relationship between the 
introduction and implementation of national health system 
performance assessment frameworks and national policy making 
and reform. 
 
2. To evaluate to what extent evidence has a bearing upon the 
development and adoption of policies and to understand which 
factors (other than evidence and performance data) impact and 
inform policy and decision making. 
 
6.3 Method 
Following the extraction of results from the documentary analysis, further in-depth 
research was needed to confirm or refute the findings from the document analysis.  
Whilst the analysis of documents presented a rich source of information, a deeper 
understanding of the complexity of the interaction between policy making and 
performance assessment was required which could not be pursued solely from the 
review of documents.  Furthermore, country-specific evidence was also required to 
complete the picture, since most policy is generated at country or local level.  
 
The initial plan for this stage of the research project was to organise key informant 
interviews with experts around Europe involved in HSPA and policy making, possibly 
followed by a focus group or modified Delphi Technique meeting/s.  However, due to 
the professional role of the researcher and his involvement in the development of 
Malta’s HSPA report, work-related events superseded these research plans and 
allowed the author to pursue an intense participatory observation study over a three-
year period, transporting him across Europe and giving him an opportunity to interact 
with renowned experts in the various fields of performance assessment, HSPA and 
public health policy.   
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This journey began in May 2014 when, together with other experts, the researcher was 
invited to participate in a peer review meeting of the Belgian HSPA in Brussels.  It 
was a time when HSPA as a concept and methodology for assessing performance, 
started to gain ground and visibility in Europe, not only within the European Union 
but also in WHO (Europe) and OECD.  This prominence led to a decision by the EU 
Working Party on Public Health at Senior Level, in its meeting on the 15 July 2014, 
to create an Expert Group on Health System Performance Assessment (EG).270  The 
rationale for this development is clearly outlined in the proceedings of this meeting of 
the Working Party, wherein it states… 
 
…that Member States and the Commission were invited to improve the 
coordination on health systems performance assessment (HSPA) at EU 
level by streamlining the debate on the theoretical HSPA framework, 
identifying useful methodologies and tools to support policy makers in 
taking decisions, and defining criteria for selecting priority areas for 
HSPA at EU level and improving the availability and quality of relevant 
data and information.   
 
This was further spelt out in the terms of reference for the EG. 
 
1. Provide participating Member States with a forum for exchange of 
experiences on the use of HSPA at national level. 
2. Support national policy-makers by identifying tools and 
methodologies for developing HSPA. 
3. Define criteria and procedures for selecting priority areas for HSPA 
at national and EU level. 
4. Intensify EU cooperation with international organisations, in 
particular the OECD and the WHO. 
 
These objectives, particularly the first two, resonated clearly with the objectives and 
research questions of this latter stage of the author’s research.  Due to the author’s 
interest and expertise on HSPA at the time, he was nominated by the Government of 
Malta as Malta’s representative on the Expert Group (EG) (Appendix 15), together 
                                                 
270  Council of the European Union.  Outcome of Proceedings.  HSPA - Terms of reference for an 
expert group. Brussels, 9 September 2014. 
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with representatives from each EU Member State, in addition to OECD, WHO and the 
European Observatory on Health Policy and Systems.  Hence, the membership 
consisted of national and international experts in the field of HSPA, performance 
assessment and public health policy. 
 
These developments and the author’s membership of the HSPA Expert Group allowed 
him to pursue alternative avenues of research methodologies, which, at the end, proved 
much richer and fulfilling. 
 
6.3.1  HSPA Expert Group Meetings 
The EG met four times a year, apart from other contacts through teleconferencing or 
other expert meetings.  The first meeting was held on the 10th November 2014 and up 
to the end of 2016, eight meetings were held in: 
 
• Brussels 10 November, 2014 
• Stockholm   6 February, 2015 
• Brussels   5 May, 2015 
• Berlin   9 October, 2015 
• Brussels   4 December, 2015 
• Rome   7 April, 2016 
• Brussels 23 September, 2016 
• Vienna 14 December, 2016 
 
As a full member of the EG, the author actively participated in the meetings and helped 
shape the agenda and proceedings of the group.  He was also actively involved in the 
production of the first report produced by the EG entitled ‘So What? Strategies across 
Europe to assess quality of care’ (Expert Group on Health Systems Performance 
Assessment, 2016) and in numerous other presentations and policy papers.  The 
members of the EG were informed and hence, were aware of the author’s research 
interests and his reading for his PhD.  They were also aware that the material used and 
generated during all these meetings could be sourced as information for the purposes 
of this research.  Nonetheless, all proceedings and minutes of these meetings were 
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already available in the public domain and can be sourced from the European 
Commission website and other sources.271 
 
The main source of information from these meetings were the author’s own field notes, 
official proceedings or minutes of the meetings and the various presentations, 
documents and papers presented in the course of these meetings or distributed to 
members of the expert group.  Whilst, as mentioned above, most of this documentation 
is already available in the public domain, the researcher also sought the explicit 
consent of the various authors of the presentations or documents through formal 
written e-mails.  All but one author (representing a major international health 
organisation) consented for this material to be used for the purpose of this PhD.  The 
list of respondents authoring use of this material can be seen in Appendix 16. 
 
The full list of documentation derived from the author’s participation in the EG can 
be found in Section C of the Bibliography and consists of field notes, meeting minutes, 
meeting presentations, policy papers, proceedings of official national and regional 
bodies, survey results, articles and other publications (n = 115).  As was the case for 
the document analysis, these documents are referred to as footnotes in the subsequent 
sections.  Similarly, as for the document analysis, all this material was documented 
onto a document analysis worksheet, coded, numbered and inserted into the NVIVO11 
database for analysis.   
 
6.3.2  Peer review meetings  
Besides the EG meetings, as part of its role to facilitate the ‘experiences on how to 
present results from Health Systems Performance Assessment,’272 members of the EG 
were also invited to attend and actively participate in national peer review meetings.  
The first one was hosted by the Belgian authorities over two days on 19th and 20th 
May, 2014.   
 
The Italian and Slovenian Health Ministries also held similar meetings in Rome and 
Ljubljana on 8th April 2016 and over two days on 28th and 29th September, 2016 
                                                 
271  https://ec.europa.eu/health/systems_performance_assessment/policy/expert_group_en.  
 Accessed 16/12/17. 
272 161 DG sante - Minutes – 1st meeting of EG on HSPA, 10 November 2014. Brussels; pg. 1. 
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respectively.  The author was invited to participate in these meetings.  Documentation 
derived from the peer review meetings was also used as material for this phase of the 
research.  The documents utilised during the peer review meetings can also be found 
in Section C of the Bibliography. 
 
6.3.3  Policy focus groups 
Also, as part of the methodology adopted by the EG, two policy focus groups were 
also organised.  The use of focus groups was considered suitable for the elucidation of 
qualitative information which would otherwise be difficult to observe or deals with 
information that is sensitive.  Focus groups are also ideal in determining perspectives 
and exploring experiences from experts in a short time span and to provide a better 
understanding of the complexities involved in using international health systems 
performance indicator comparisons to inform policy making.  Country-specific 
information was also derived.273 
 
The first focus group centred on the policy implications of the performance assessment 
and measurement of quality of care and the second focus group dealt with the 
performance assessment of integrated care.  These two themes were initially chosen 
by the EG as proxies or priority areas for comparisons among EU countries and for 
the elucidation of methods and tools for performance assessment.  The first focus 
group was held in Brussels on 3rd November 2015 and the second also in Brussels on 
22nd September, 2016.  Participation in these focus groups was by invitation to EU 
Member states and experts from the EG, CION, WHO and OECD.  25 persons 
participated in the first focus group, originating from 13 countries (DK, EE, EL, ES, 
FI, FR, HR, IT, LU, MT, PT, SE, NO), WHO, OECD, and CION.  25 experts 
participated in the second focus group, stemming from 19 countries (BE, CZ, EL, ES, 
FI, FR, HR, HU, IE, IT, LV, MT, NO, NL, RO, SE, SI, SK, UK), WHO, OECD and 
CION.   
 
Chatham House rules were adopted for the proceedings of both focus groups (Chatham 
House. The Royal Institute of International Affairs, 2015).  Whilst this may seem to 
                                                 
273 224 EOHSP. Policy focus group on cardiovascular diseases and diabetes. Policy Focus Group.  
 April 2015. 
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diminish the richness of the proceedings, this was necessary to ensure anonymity and 
allow participants to express themselves freely without encumbrance.  This was 
considered essential given that the participants relayed sensitive information and 
knowledge on their countries’ and governments’ experiences.  The European 
Observatory on Health Systems and Policy facilitated both gatherings.  Together with 
the Observatory experts, the author co-facilitated the first meeting, whilst acting as 
rapporteur for the second focus group.   
 
Although the author took audio recordings during both meetings, due to Chatham 
House rules, these recordings were not transcribed verbatim.  This was also not felt 
necessary since detailed notes were taken during the meetings, together with reports 
on the outcome of each focus group.  Furthermore, background reports were produced 
for both focus groups, whilst the integrated care meeting was preceded by a survey to 
member states.  These results were also made available for the focus group for further 
analysis.  Nonetheless, the recordings did serve as a reference to obtain further clarity 
on an issue which was not clear or to extract specific details on a subject that was 
discussed during these sessions.  The documentation related to the focus groups was 
also used for the author’s analysis and can be found in Section C of the Bibliography. 
 
6.3.4  Ethical considerations 
Due to the nature of the interaction between researcher and participant, participatory 
action research presents particular ethical challenges.  The lack of ‘distance’ creates a 
unique situation which needs to be continuously appraised.  Moreover, the continuous 
dialogue within the participatory milieu mandates careful consideration about how the 
data is collected, documented, assigned, coded and interpreted.  This was dealt with in 
two ways.  For material and data referring to an event, case study, experience or policy 
development, the researcher asked the explicit permission of the author for the use of 
that information.  This was required mainly for textual material such as presentations, 
slides, policy papers, articles and other official or informal documents.  
Communication in this regard was invariably dealt with through e-mail 
correspondence.  Appendix 16 provides a list of the e-mails sent and received with a 
positive reply from participants and experts of the HSPA Expert Group and other 
authors.  These emails have been retained.   
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For more sensitive data, anonymity was the chosen technique, where it was ascertained 
that this data or any results derived thereof could not be assigned to a particular author 
or organisation.  However, when citing country or regional experiences, the country 
or region involved was cited for correctness’ sake.  These considerations were 
important since participatory research is always in danger of being used by very 
different parties for purposes that contradict its original intentions (Dentith, Measor & 
O’Mailey, (2012), where the media or other interested parties could use the 
information or results generated to cause sensation or for other vested interests.  Whilst 
the author has little to no control over this, the aim of the measures taken above was 
to safeguard the participants’ identity and/or their disclosures throughout this stage of 
the research project.   
 
Ethical approval for this thesis was obtained from the University of Warwick 
Biomedical and Scientific Research Ethics Committee on 3rd April 2017.  This is 
presented in Appendix 17. 
 
6.4 Final thematic analysis model 
This section describes the results derived from the participatory action stage of the 
research process.  The results from the researcher’s active participation in the various 
meetings, fora and focus groups as part of his membership on the EG will be presented 
together.  As explained in the overview of the Methods section, an inductive thematic 
analytical approach was also adopted for the analysis of the data generated in this 
phase, continuing to build on the model developed from the document analysis.   
 
As a start, the same coding sequences were used, expanding upon the main categories, 
themes and sub-themes derived from the document analysis and continuing to build 
on the same argumentation.  However, new themes were also generated due to a shift 
in emphasis onto country experiences and the data generated specifically from the two 
focus groups.  Hence, a modified final model was drawn up to reflect these new 
arguments.  The revised final model showing the full thematic analysis of both the 
document analysis and the participatory research analysis is presented in Figure 6.1.   
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Figure 6.1: Final Thematic Analysis Model 
 
6.5 Phase III: The Policy Cycle – Results and Discussion 
Given the qualitative nature of this part of the research, the subsequent sections present 
both the results and engage into a discussion of the results contemporaneously in the 
subsequent sections.  Whilst the discussion deals with the results of this chapter, a 
more general discussion covering the whole study follows in the next chapter. 
 
6.6 Development of HSPA Frameworks 
Initially, much emphasis was placed upon the methodological aspects of developing 
and implementing HSPA frameworks since one of the EG’s terms of reference was to 
develop and provide advice on methods that could be adopted and assimilated by 
member states, especially those countries that had not yet developed their own national 
HSPA model.   
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6.6.1  Methods 
As with the document analysis, the elaboration and elucidation of the correct 
methodology was important as a basis on which to construct robust HSPA 
frameworks. 
 
6.6.1.1 Definitions 
Part of the participatory research phase dealt with the performance assessment of 
Quality of Care (QoC) and Integrated Care (IC), as proxies for the performance 
assessment of wider health systems.  It is, therefore, poignant to explain these terms 
in the understanding of the EG.  The overall aim of IC is to improve service outcomes 
through initiatives that bring together services, professionals, organisations and 
sectors leading to better coordination and integration of care.274  Whilst numerous 
definitions have been ventured for QoC, the EG utilised the definitions adopted by 
OECD as part of its Health Care Quality Indicators project, which in turn, was based 
on the concepts developed by the US Institute of Medicine where it defines quality 
care using the three dimensions of effectiveness, safety, and responsiveness.275   
 
6.6.1.2 Methodology 
This section covers the various components of the methods used to ensure the proper 
development of HSPA. 
 
6.6.1.2.1 The use of composite indicators 
Composite indicators create a single score or index from a set of seemingly unrelated 
performance indicators which can be used to compare (and sometimes rank) the 
relative performance of hospitals or health systems.276   
 
The peer review meeting in Brussels acknowledged the usefulness of using composite 
indicators, as a means to reduce the overall number of indicators in a HSPA model.  
Participants also noted their use in assessing progress over time on complex health 
issues and to communicate these results more easily.277  
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Although the use of composite indicators remains a controversial and challenging 
issue, several countries and jurisdictions make ample use of them.  The French Health 
Ministry employs composite indicators in their scheme for Financial Incentives for 
Quality Improvement (IFAQ).  Each health care institution is given an ‘IFAQ’ score 
which is calculated as the weighted sum of each component of composite indicators.278  
This was confirmed during the quality focus group where the French participant stated 
that they try to avoid using single indicators, due to the complex nature of health 
care,279 and reiterated that France uses ‘multiple sources to draw conclusions and 
develop policy.’280  The quality sub-group also acknowledged that the use of composite 
indicators is a widely accepted method for comparative performance assessment and 
in most cases, careful reflection was imbued into the process to ensure a robust 
methodology.  This involved the use of risk-adjustment techniques to account for 
variations in age, sex and comorbidity.  Stratification and subgroup analysis is also 
carried out.281   
 
6.6.1.2.2 Use of routinely collected data for comparative performance assessment 
A systematic approach is required to collect and analyse large amounts of data in the 
form of performance indicators.  Routine data collection is one way to achieve this 
and there are numerous examples of how routinely collected data is used for 
comparative performance assessment.   
 
The EuroHope project developed an interesting methodology to measure variations in 
health outcomes through the use of administrative data from Finland, Hungary, Italy, 
the Netherlands, Norway, Sweden and Scotland, where a common list of indicators 
was developed for comparison and benchmarking purposes.282  This initiative showed 
how routinely collected data such as that collected in registers can be used for 
comparative performance assessment techniques, especially since internationally 
agreed registers have the added benefit of using standardised coding, such as 
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ICD10.283  The publication by Cylus, Papanicolas and Smith (2016) showed how 
registers can be used to measure and improve upon clinical and operational efficiency.   
 
Adoption of this methodology by member states is gaining ground.  Germany utilises 
this approach in their national data-based quality assurance programme, where they 
are utilising over 3.2 million records from 1,557 hospitals nationwide each year to 
generate over 400 indicators in thirty clinical areas.284  Austria also routinely uses its 
Diagnostic Related Groups (DRG) databases, as part of their A-IQI system across the 
country, using 228 indicators.285,286  The Norwegian National Quality Indicator 
System also uses data from existing registries.287 
 
The EG reiterated the usefulness of data derived from administrative and quality 
databases, such as national registries, social insurance databases and hospital archives.  
It was noted that several advantages are associated with this approach, including 
reduced costs, better comparability, completeness of data and reliability.288  The EG, 
on the other hand, also observed certain disadvantages, such as outdated data due to 
the time required for validation of international data, rendering the data ineffectual for 
decision making.289 
 
6.6.1.2.3 Selecting the right indicators 
As outlined in the document analysis and in Malta’s HSPA, the selection of the correct 
indicators to populate a HSPA model is a complex and intricate exercise.  As a first 
step, on a technical level, many jurisdictions adopt scientific criteria for selecting the 
most appropriate indicators, such as Malta’s adoption of OECD’s criteria.290  The IC 
focus group discussed the possible criteria for selecting indicators and identified the 
same desirable attributes of scientific validity, reliability and sensitivity (to change) as 
key considerations.   
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Pringle, Wilson and Grol (2002) produced an exhaustive set of attributes to guide 
indicator selection, including indicators that are effective, objective, available, 
contextual, attributable, comparable, repeatable, feasible, acceptable and are policy 
relevant.  On the other hand, the IC focus group also acknowledged the difficulty in 
matching all indicators to these attributes and argued that the most important aspect is 
that of choosing indicators which actually measure change, in that they could ascribe 
a cause and effect event to the actions or decisions for improvement or change.291   
 
The EG also had occasion to discuss the most appropriate number of indicators that 
should populate a HSPA model.  As attested by the literature and also the document 
analysis, some countries opt for a smaller set of indicators for greater manageability.  
Some models have a set of core indicators and a wider set of auxiliary indicators.  Most 
agree that quality should not be compromised by quantity and that ‘quantity is not 
necessarily an advantage.’292 
 
6.6.1.3 Process in the development of HSPAs & actors involved 
One of the first premises brought up in the first HSPA EG meeting was the realisation 
that HSPA is not only about collecting data but goes beyond.  It is a key tool to improve 
the quality of care, innovate services and address policy issues.293   
 
6.6.1.3.1 HSPA as an evolving process 
The evolution of a HSPA model at national or regional level was well documented in 
the document analysis.  During EG meetings, OECD presented a different perspective, 
outlining the historical or temporal evolution of performance assessment, starting from 
its Health Care Quality Indicators project in 2002, to developing bespoke models, 
amongst others, on primary care prevention, cancer (2007), patient safety indicators 
(2011) and mental health (2013).  This picture shows the almost erratic but 
developmental nature of HSPA, given that, by OECD’s own omission, the trajectory 
in developing performance assessments indicators and models was not mapped out 
initially in 2002.294 
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The development of the more recent performance frameworks in England was 
discussed in the EG.  It deliberated on the reasoning behind the usefulness of creating 
three separate performance frameworks but also the drawbacks of keeping the 
performance assessment of service provision, public health and social care separate.  
The common thread between these was promoting excellence and equality through 
ensuring accountability and transparency in the process.295 
 
As time progressed, the expert group members co-participated in the development of 
several national HSPAs including that of Austria, where the first building blocks were 
put in place in 2014.296  This was followed through in the sixth EG and peer review 
meetings in Rome and Slovenia respectively two years later with the launch of 
Austria’s HSPA.297,298  The Belgian peer review meeting discussed progression in the 
development of the Portuguese HSPA.  It was launched in 2010 following a two-year 
collaborative effort between the WHO Europe and Portugal.299  The peer review 
meeting in Slovenia also highlighted Slovenia’s progress in developing its HSPA and 
its link with institutional reforms, as part of its National Healthcare Plan for 2016-
2025.300  In 2016, they started the process to develop their first HSPA at national level, 
taking over fifteen years to mature and find acceptance amongst stakeholders.301   
 
The development of indicators measuring the performance of integrated care 
initiatives also showed a phased iterative approach, where the IC focus group 
acknowledged that new and revised indicators have been developed akin to the 
progress achieved in understanding and implementing integrated care services.  It was 
further observed that, to date, few countries have yet published a set of indicators 
measuring the performance of integrated health systems.302  This was confirmed from 
the results of a survey carried out in preparation of the IC focus group where ‘most 
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countries reported that they do not have, at present, a systematic approach in place 
that is explicitly designed to assess and evaluate the development of coordination and 
integration of care.’303 
 
6.6.1.3.2 Political and clinical ownership 
Whilst the document analysis placed an emphasis upon political ownership and the 
importance of integrating policy making into the HSPA process, the EG also viewed 
interaction with clinicians as an important aspect of reporting and assimilation of 
findings.  It noted that the reporting of results improved over time as the emphasis on 
quality has increased, leading to an increase in interest from clinicians, with the 
consequent increase in trust, greater acceptance, not only in the HSPA process, but 
more importantly, also in the data generated.304  This collaborative effort was a 
common phenomenon amongst representatives of the various jurisdictions within the 
EG, as attested by the Dutch, Belgian, Swedish and other members.   
 
6.6.1.4 HSPA models 
Participation in the various fora allowed for a wide and rich discussion on the various 
HSPA models in play.  This sub-theme will build on the evidence generated from the 
document analysis on the models, dimensions and indicator sets in use. 
 
6.6.1.4.1 Models 
The model developed by the Commission on a High-Performance Health Systems 
(Commonwealth Fund, USA) in 2006 was used in the first EG meeting as a model of 
good practice to discuss the building blocks of a robust HSPA framework.  This was 
also compared to the OECD and WHO models, which, together with the 
Commonwealth framework, served as precursor models for the development of many 
HSPA models at national level.  Although the expressions and nomenclature varied, 
the basic concepts of these models were comparable, as were the dimensions contained 
within each model.305,306  Oddly enough, the EU models have not shared the same fate, 
perhaps because these were developed much later in the natural history of HSPA, 
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although today the ECHI project is used as a basis by all member states and also by 
the OECD in its Health at a Glance report.307   
 
One of the first findings by the EG was that although many HSPA models were similar 
in content, their objectives differed widely.  Armenia’s and Estonia’s HSPA focused 
upon improving stewardship, accountability, and transparency, whilst the Dutch 
HSPA’s overall purpose was to inform strategic decision-making at Ministry level.308  
Belgium also wished to promote transparency and accountability but was also driven 
by international comparative performance assessment to improve services over time.   
 
England’s focus was performance management of its public health care sector.  
Kyrgyzstan used its HSPA to monitor progress and measure the impact of international 
sponsored programmes on its health sector.  Portugal also viewed its HSPA as a tool 
for greater accountability but due to its link to Portugal’s national health plan, it was 
also formulated to direct its health policy agenda.  The newly developing Slovenian 
HSPA’s main objective is quality driven, for the ‘development of quality improvement 
strategies and action at the national and provider level’309.  Hence, as one can surmise, 
whilst the basic concept of a HSPA remains constant, the reasons for its development 
and implementation varies widely from country to country, certainly in line with their 
respective national priorities.310 
 
Towards 2016, due to the focus on integrated care at the time, the EG and focus group 
explored various integrated care models.  One of the main difficulties in developing 
performance assessment models to measure integrated care is the complex nature of 
this relatively new phenomenon.  WHO had proposed a model to assess integrated 
care consisting of six domains, including system-level measures of community well-
being and population health.311 
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6.6.1.4.2 Dimensions  
A mapping process of dimensions used in various countries and jurisdictions was 
carried out by the author, as part of his role on Malta’s Working Group.  This was 
shown in Table 5.1. 
 
This exercise has shown that health systems adopt those dimensions that are relevant 
and suited to them, in line with their socio-demographic, cultural, epidemiological and 
political nuances.  However, there are a few dimensions that are steadily represented 
across most HSPAs.  These are consistent with the fundamental facets of most health 
systems, representing their most basic and common values.  These dimensions include 
access (to universal health care), equity, quality, efficiency, responsiveness (patient 
centeredness), effectiveness, resource generation and allocation and (financial, social, 
insurance) risk protection.  
 
6.6.1.5 Conditions for using performance assessment for policy making 
EG members relayed their practical experiences in what they felt was required for the 
successful implementation of HSPA.  One of the key success factors is fostering a 
mind-set of mutual trust between all stakeholders.  This is important not only to ensure 
cooperation but also to gain acceptance by professionals, public officials and 
researchers.   
 
HSPA is a relatively new discipline, compared to other scientific techniques and so 
gaining trust and ownership is key to its nascent success.  On the other hand, HSPA is 
not the panacea of performance assessment and so, expectations need to be managed 
by focusing on the quality imperative, on guidelines, evidence based medicine, equity 
and improvement of work practices and policy making.312 
 
6.6.2  Legal, organisational and technological issues 
This next section discusses the wider non-health aspects that impact HSPA. 
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6.6.2.1 Information technological tools: 
 For assessing evidence and for performance measurement 
The author had occasion to collect information on the various tools and techniques 
currently in use for performance measurement.  These are considered the foundations 
or building blocks of any performance assessment system, without which HSPA 
would not be possible.  OECD is also of the same opinion, stating that ‘information 
systems are the bedrock of performance management which enable comparative 
health system assessment as well as evaluate the impact of policies at both the national 
and international levels.’313  Most of these tools are understandably related to 
information systems and information technology. 
 
6.6.2.1.1 The use of registers 
Performance assessment registers or national quality registers, covering many 
conditions and illnesses, are common place in more advanced health systems.  The use 
of these registers was brought up in several country presentations, such as those 
pertaining to Sweden, Slovenia and Germany.314,315  Due to the comprehensive and 
standardised nature of these datasets, they have been termed as quality registers in 
some jurisdictions, since the information contained thereof is used for performance 
assessment measurement and quality improvement.   
 
The QoC policy focus group discussed the advantages of registers.316  It was agreed 
that they are comprehensive, collecting data for the whole population, without the need 
for sampling.  They make use of unique personal or patient identifiers which allow for 
the collection of anonymised patient data collection.  Moreover, the data is not 
collected for specific research purposes, so data protection and data restriction issues 
do not usually apply.  Neither is patient consent required.  Another major benefit is 
that registries present an easy and standardised method for data collection, which in 
turn facilitates international comparative methods.  These characteristics give 
registries an advantage over other research tools and as such, are used extensively for 
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assessment and planning purposes.317  Many cross-national projects, such as ECHO 
and OECD’s HCQI take advantage of these characteristics by using routinely collected 
and standardised administrative data from participating countries for international and 
regional comparative analysis318,319.  Many countries, such as Sweden, Austria and 
Slovenia use nationwide outcome quality registries to contribute to quality assurance 
and improvement320,321, whilst other countries, such as Finland, uses register-based 
data to compare with OECD and other international databases322 and also to link 
administrative data with specific clinical databases.323 
 
6.6.2.1.2 Health ICT 
‘A hospital without a good ICT system cannot have a high quality of care.’324  This 
declaration from the French representative on the EG sums up the importance of 
information technology.  Of course, it is not the technology per se that renders it 
indispensable, but the information it generates, which information is required for 
performance and quality assessment.  The QoC sub-group also reiterated this point, 
exemplifying that ‘a well-functioning health information system is essential to 
measure quality of care systematically across hospitals, regions, health professionals, 
and health care unit.’325  The possibility of integrating data sources and databases is 
becoming a reality and many health authorities have reported that this relatively new 
technique is proving to be very beneficial in analysing complex pieces of data, which 
is particularly pertinent since this allows HSPA to operate as a ‘platform for 
generating evidence.’326  These developments have been corroborated by the 
experiences in the EG where many participants and invited experts have highlighted 
the role technology plays in generating the required data and information for proper 
performance and quality assessment.327   
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6.6.2.1.3 Technological difficulties 
‘A lot of data is collected in national health systems but it is not fully exploited because 
often authorities do not have capacity or plan to analyse and use it.’328  These 
difficulties were observed by the EG and were based on several factors, including 
difficulties in data collection and standardisation problems, availability and 
comparability of data and time lags amongst several other limitations.329,330  The EG 
also encountered difficulties when sharing data of a policy or clinical nature.  This was 
further corroborated by OECD which also expressed similar difficulties when 
compiling their performance reports.331  
 
Another complication, faced by many EU and OECD countries, is that measurement 
of indices, such as quality of care, varies not only across countries but also within 
countries.  The reasons for such variations are difficult to explain and are not down to 
different health systems.332   
 
Understanding such variability requires a concerted effort to not only improve overall 
standards but to also minimise variability in quality and other dimensions of care.333  
The quality policy group also identified difficulties in relation to variability and lack 
of standardisation in the coding of clinical conditions and in definitions for certain 
indicators such as readmission rates.334 
 
6.6.2.2 Legal basis for performance assessment and evidence-based 
 policy making 
The legal implications and ramifications of performance assessment were raised in the 
very first EG meeting, where references were made to the Shipman Inquiry and the 
Mid Staffordshire Inquiry.  These events had repercussions across the UK and beyond, 
and spurred on the call for installing adequate performance and quality assessment 
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systems within health care.335  The quality sub-group also reviewed the various legal 
instruments in place across the EU and how the HSPA process is integrated into the 
legal framework of various countries.  Whereas in some countries, quality and 
performance monitoring is mandatory (France), others developed HSPAs as part of 
national or regional governance arrangements, such as in the development of their 
national health policies (Portugal, Sweden, Finland).   
 
The quality sub-group further states that ‘in several Member States HSPA activities 
are not developed to comply with legal requirements, but rather to introduce 
voluntarily elements of accountability or of better governance of the health systems or 
sectors of it.’336 
 
Many of the participating countries explained their legal frameworks on performance 
assessment.  In 2014, Italy carried out amendments to their legislation on standards 
and quality of care to incorporate performance assessment into law.337  The French 
also have a legal framework for hospitals to share performance data338 and Germany 
have legislated to share performance and quality data.339,340   
 
In England, the Health and Social Care Act 2012 paved the way for the NHS Outcomes 
Framework.341  Some jurisdictions have contractual arrangements in place rather than 
legislative.  Austria has established a contract between stakeholders for the 
measurement of health system outcomes.342 
 
6.7 Relationship between performance assessment and policy  
 development 
The EG considered this subject on many occasions, given that understanding this 
relationship was one of the main mandates of the EG. 
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6.7.1  Linking HSPA with policy development 
The EG Group was commissioned by CION and the terms of reference for this group 
were explained in the Methodology section.  However, as is sometimes the case, there 
were other underlying ‘unofficial’ reasons for creating this group.   
 
This was raised in the EG’s first meeting in 2014, where there was an admission that 
the EU, or more precisely the Employment, Social Policy, Health and Consumer 
Affairs Council (EPSCO), does not use HSPA as a tool for policy making.  However, 
the Council of Health Ministers acknowledged the importance of knowledge transfer 
in specific policy areas and consequently, tasked the EG with the responsibility to fill 
this gap through the generation of new methods, tools and practices to embed HSPA 
into the European policy cycle.343   
 
6.7.1.1 Evidence in favour or against link between performance assessment 
and policy making 
Certain long-standing evidence-based policies are starting to have an impact.  Anti-
smoking policies, such as smoking in public places and plain packaging are registering 
some success in stemming the increase in smoking prevalence.  Similar but less 
spectacular policies on obesity and salt intake have also been partly successful.   
 
The Expert Group, however, noted that it usually takes considerable time and much 
effort for evidence to trickle into policy making and an even longer time for these 
policies to have a beneficial impact upon the population.344 
 
The Belgian and Dutch HSPA each reported instances where policy had been adjusted 
following the publication of the findings in their respective performance reports.  
These examples were outlined in several of the meetings held and provided substance 
for discussion and debate.345   
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The Quality sub-group has also documented recent experiences where national 
governments are already taking action in some areas requiring attention346, noting that: 
 
… a common challenge in linking HSPA reporting to policy action lies 
in how to set targets and standards and in the timeliness of the data and 
its reporting … However, policy making is a complex activity, which has 
to be based on several variables and parameters and not limited to the 
analysis of performance data.347 
 
6.7.1.2 Use of HSPA frameworks to inform policy 
The Swedish responses to the survey carried out prior to the peer review meeting in 
Brussels in 2014 showed that their performance reports are being ‘used both in 
decision-making and (policy) development within the county councils, and also to 
serve as base to decide on national policy initiatives.’348  This was later confirmed in 
the second EG meeting in 2015, where the Swedish representative explained that their 
HSPA experience has, on the whole, increased accountability and transparency.  
Regional comparisons within Sweden have also contributed to improvements in 
care.349 
 
For the Dutch, feedback into the policy cycle is now well developed where regular 
meetings are held at Ministry level to review aspects of the HSPA report and devise 
policy options.350  The Belgians have also reported similar outcomes from their HSPA 
experience, where specific concrete recommendations for policy makers are drawn up 
in each iteration of their HSPA report.351   
 
Using the analysis from its previous HSPA reports in 2013, the Belgian National 
Conference of Health Ministers defined several policy priorities, including reducing 
suicide rates, tackling obesity and improving cancer screening programmes, amongst 
other interventions.352 
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The policy focus group on quality reviewed several good practice examples.  The 
OECD representative outlined how its data and quality reports are increasingly being 
used to initiate reform in its member states.  This is logical since OECD data very 
often ‘positions’ countries in relation to their peers and highlights areas which require 
change or improvement.  For this purpose, OECD is known to draw on multiple data 
sources to inform its conclusions.353 
 
6.7.1.3 Policy cycle, process and tools 
From the first encounter in the peer review meeting in 2014, the author realised the 
difficulties in inserting the HSPA into the policy cycle.  Many countries, such as 
Austria and Portugal, commented that their ‘current HSPA framework has to be 
embedded more deeply in the policy making process in order to allow for the setting 
of health targets based on the analysis provided by HSPA.’354   
 
On the other hand, Portugal did comment that the HSPA provided a ‘critical evidence 
base necessary to develop the 2011-2015 National Health Plan of Portugal’355 and the 
Slovenian State Secretary for Health did emphasise that the newly conceived 
Slovenian HSPA needs to be integrated into the policy process.356 However, in 
contrast with the above, countries with longer experience in the HSPA journey often 
report a loss of interest by policy makers and other stakeholders.  As a result, the 
frequency of HSPA reporting was reduced to every three or four years.   
 
On a more positive note, the policy cycle has also been described as a ‘virtuous circle,’ 
where data is shared with the public, professionals and policy makers and this in turn 
generates interest and motivates stakeholders to change their practice or policies.357,358  
For instance, the Germans use a structured dialogue or peer review process to re-adjust 
direction if quality indicators of service providers are outside normal range.  This is 
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part of the policy cycle feedback loop aimed towards the improvement of services and 
raising standards of care.359,360,361 
 
A very interesting presentation and discussion formed part of the EG’s seventh 
meeting, where a former Minister in Spain shared his experience in linking 
performance assessment with policy making.  He explained that the key for success is 
to ‘engage all stakeholders in the whole cycle of policy making and implementation.’  
He further commented that ‘the preparation of good technical documents is not 
enough; it is vital to engage politicians and to avoid creating a dichotomy between 
politicians and technicians.’  He continued to state that this cannot be achieved solely 
using a scientific approach, but rather by being pragmatic and flexible.362   
 
These ‘revelations’ were refreshing for those present since it presented the views from 
a political point of view and provided insight into how the HSPA project can be 
integrated into policy development.  However, from the survey gathered on the 
experiences of various countries on quality assessment, the quality sub-group noted 
that many countries reported a ‘common challenge in linking HSPA reporting to policy 
action lies in how to set targets and standards and in the timeliness of the data and its 
reporting.’363  This leads to a certain reluctance on the part of governments to 
‘institutionalise’ HSPA into their policy making bodies and mechanisms.  This is a 
dilemma currently faced by some countries, such as Norway364 and Portugal365 and 
only time will tell whether HSPA truly becomes a sustainable and long-term 
proposition. 
 
6.7.1.4 Use of measures and targets to reach policy objectives 
The time for targets is upon us.  Targets have become an important part of the arsenal 
at the disposal of performance assessment and have developed into an intricate 
discipline over time.   
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England has long used targets for performance monitoring.  However, with time, many 
have become sceptical on their long-term benefit.  As aptly put, in describing the NHS 
Outcomes Framework, a participant at the fourth EG meeting described this period as 
a time of ‘targets and terror’ whilst postulated the possibility that this framework may 
‘hit the target but miss the point.’366  The EG emphasised that target setting is a means 
to improve care and services and not a means to an end.  Using targets for ranking 
purposes is another ‘no-go area.’  Whilst using targets as a means of ranking health 
care providers or health systems is common, there was consensus amongst EG 
members that targets should not be used for ranking purposes.367 
 
Target setting again proved to be a controversial subject for the EG.  The use of targets 
to incentivise improvement and gain efficiencies was mentioned on several occasions 
in the course of the participatory research phase.  Some authors showed favour and 
advocated for the introduction of targets as an integral part of any HSPA process.  
Others were more cautious and whilst performance indicators could be used for target 
setting, they felt that this should be separate from the actual HSPA process.  Various 
experiences were shared in the EG.  The Tuscan region in Italy paved the way for other 
regions to set the targets for their own providers, basing their targets on the available 
evidence.368  In Belgium, targets are used to set a ‘road map’ for planning purposes, 
as part of setting priorities for the different provinces within Belgium.369  The Swedes 
and French reported marked improvements in outcomes following the introduction of 
targets, even though these were non-statutory.370 
 
The QoC sub-group acknowledged the difficulty in utilising targets.  Its report admits 
that ‘the definition of targets and benchmarks is often problematic and implies degrees 
of subjective assessments.’371  This subjectivity is difficult to overcome, especially if 
targets are used as a monitoring tool rather than for improvement and reform.  This 
was the experience in the UK where recent debate was dominated by ‘the use of broad 
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health system rankings’ and that ‘comparison between the four countries of the UK 
appears to have become primarily a political issue, rather than a tool for mutual 
learning.’372 
 
6.7.2  Comparative policy making  
The literature and document analysis has already demonstrated the validity and 
effectiveness of comparative performance assessment methodologies.  It is one of the 
most powerful tools available to inform or ‘move’ policy into the right direction.  
Policy makers are particularly sensitive towards comparative assessment which show 
up discrepancies in the standard or quality of the health service that falls under their 
responsibility.  It plays on the sensibilities of human nature, that of striving to be better 
than your neighbour or competitor and performance assessment tools have now 
provided the means to carry out such comparisons in a scientific and robust manner.  
Larger countries not only have the opportunity for international comparisons but also 
undergo comparative exercises across regions.  For the above reasons, comparative 
performance assessment was often under discussion in the EG. 
 
6.7.2.1 International and regional cooperation to inform policy 
EuroHope is a multicentre research project involving research institutions from 
Finland, Italy, Hungary, Norway, Scotland and Sweden.  The aim of the project was 
to use individual, local and disease level data to develop methods for performance 
evaluation and monitoring across jurisdictions and to put forward recommendations 
for the inclusion of new or revised indicators into the European Community Health 
Indicators initiative.  The research explored methodological challenges, such as 
definition of episodes, case-mix adjustment and the elimination of selection bias.  
Whilst the datasets continue to be used for comparative purposes, the methodological 
framework that was developed ‘provides a solid starting point for further elaborating 
an international performance assessment toolkit.’373 
 
BridgeHealth was another collaborative effort, focusing upon improving health 
information in Europe by overcoming the major challenges posed by the diversity and 
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fragmentation of health information structures across Europe.  Its mandate was to 
strengthen information capture at regional level to minimise variations, leading to 
policy actions on better allocation of resources and setting more robust targets for 
improvement and reform.374 
 
Another interesting cooperative network was created between the German speaking 
regions of central Europe involving Austria, Germany and Switzerland.  The A-IQI 
network is a collaborative effort looking at performance indicators across various 
domains for benchmarking purposes with the aim of improving care across the 
participating hospitals and other health care institutions.375 
 
6.7.2.2 International / regional comparisons of performance to inform policy 
As we have seen from the document analysis, comparative performance assessment is 
one of the most powerful tools available to improve service and forge policy. 
 
6.7.2.2.1 Ranking 
Ranking was a frequent topic of the EG’s conversations.  Although there was a 
consensus that ranking, in itself, is not desirable, there was, nonetheless, a realisation 
that most comparative data, charts and figures could be used for ranking purposes.   
 
The visual impact of showing comparative data should not be underestimated and 
although researchers may not give ranking too much importance, the same cannot be 
said for policy makers who immediately latch on the ‘positional status’ of their health 
system as compared to others.  Whilst this cannot be avoided, it should be tackled 
carefully with a judicious use of the available data to provide explanations.376   
 
This was discussed in detail during the seventh EG meeting, where participants 
commented that whilst we may have control over national data sets, international 
comparisons are difficult to control and manage and so the data generated needs to be 
as transparent as possible, linked to robust scientific methods. 
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6.7.2.2.2 Regional comparisons 
Italy has a comprehensive system for health systems performance at regional level.  
Health care is devolved to the regions where each region is responsible to assess its 
own performance.  Over 13 regions now compare around 300 indicators covering 
several domains.377  The Ministry of Health provides oversight to allow inter-regional 
comparisons of performance to be carried out using various benchmarks and a 
‘Dartboard’ graphic provides a clear status of the performance of each indicator for 
each region.378 
 
Sweden also has a similar regional performance system, based on the work of their 
county councils.  Regional comparisons using 189 indicators from 50 different data 
sources are compiled into an annual report, the first produced in 2006.379  These 
regional comparisons allow public authorities, patients and the public to ‘obtain 
accurate and complete information about healthcare quality and efficiency,’ thus 
improving accountability.380  The EG also noted that regional comparisons allow for 
the implementation of ‘peer review mechanisms,’ to stimulate open discussion and 
feedback into the policy cycle.381 
 
6.7.2.2.3 Variability  
OECD noted that within-country variations are as great as intercountry or regional 
variations.382  The ECHO project has also uncovered unexpected variation across 
several performance indicators and has proposed several measures to mitigate against 
these variations.  As ECHO describes it, this includes constructing a ‘homogeneous 
knowledge infrastructure’, whilst developing ‘comparable indicators across different 
languages.’383   
 
Whilst the study of observed variations is important to understand the ‘causality of 
these variations using aggregated data,’384 a key challenge for managers and policy 
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makers is not only to improve overall performance but also reduce the variation in 
performance.385   
 
The quality focus group highlighted several instances where participants reported 
large variability in performance between regions such as in Italy, Denmark, Finland 
and Portugal.386  Moreover, the quality sub-group concluded that: 
 
… the degree of variation in adherence within and across countries 
present important policy challenges.  It suggests a need to identify the 
reasons why systematic variation exists and develop a better 
understanding of the factors that could help lift performance among 
providers and institutions that deliver poor quality care.387 
 
6.7.2.3 Challenges in comparative policy making 
Whilst comparative methods of performance assessment are an invaluable asset, its 
translation into comparative policy making is fraught with difficulties which the EG 
acknowledged and discussed at length. 
 
6.7.2.3.1 Challenges of comparative assessment methodologies 
Several difficulties have already been highlighted in comparative measurement.  The 
members of the EG shared their perspectives on these challenges.  One of the first 
issues raised by some participants was defining the boundary of measurement.  
Different countries have different definitions for their health system.   
 
In some instances, it only refers to direct health care services, such as the NHS 
Outcomes Framework.  In others, the health system also incorporates public health 
and health promotion such as in Portugal.  Other systems also include social care 
within the same definition (Sweden).  It is important to define the ‘boundaries’ of the 
health system, to compare like with like388.   
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Participants in the quality policy group also highlighted the difficulties that arise in 
interpreting cross country comparative data on specific indicators or set of indicators, 
where many stated that ‘it is often difficult for practitioners and policy makers to 
interpret what a country positioning means in terms of performance and what policy 
action needs to be taken in order to improve performance.’389 
 
6.7.2.3.2 Challenges related to size and maturity 
The author had the opportunity to interact frequently with other experts from countries 
facing the same challenges as Malta, primarily due to their size.  ‘Notes were 
compared’ with countries, such as Slovenia, Estonia, Austria, Cyprus, Greece and 
Croatia.  The author also had the opportunity to present and discuss these challenges 
during various meetings and conferences. 
 
Developmental challenges refer to the difficulties encountered in creating a HSPA 
model de novo without having prior experience.  For this reason, many jurisdictions, 
such as Malta, Estonia and Portugal approached external organisations, such as WHO 
for assistance and guidance.  The lack of a local model also requires the adoption or 
adaptation of foreign frameworks, including choosing context appropriate dimensions.  
The identification of suitable indicators is also challenging due to the quandary 
between extracting indicators from local sources versus internationally drawn 
indicators.  Belgium was faced with this particular dilemma in its first HSPA iteration.  
Local ‘political’ influences also need to be contended with in a small community or 
region, sometimes overriding more objective scientific criteria.   
 
Implementation difficulties usually related to the lack of comprehensive information 
systems leading to gaps in data collection.  HSPA requires a robust, mature ICT 
infrastructure to be able to collect and analyse the required data in a routine manner.  
Greece presently faces this difficulty as policy makers are currently more focused on 
fiscal indicators rather than health outcome indicators.390  Finland also acknowledged 
that data capture is problematic.391  There are also cultural barriers that need to be 
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overcome, especially in trying to inculcate an ethos of accountability and transparency 
such as was the case in Austria and Slovenia.  Analytical and interpretative resources 
and expertise are sometimes lacking and may need to be outsourced.  Once the data is 
analysed, smaller populations could present additional difficulties related to size in 
terms of small denominators, leading to large time trend variations, as experienced by 
Malta and Cyprus.  Also, results can potentially be traced to source, and so 
confidentiality and data protection issues are more accentuated in smaller states.   
 
Another challenge is internal comparability or the lack thereof.  Small countries cannot 
compare data findings internally and need to revert to external comparators.392  This 
is not without its own inherent limitations and the quality sub-group understood this 
limitation when expressing that ‘some countries report challenges also when data 
were not immediately comparable with international sources.  The issue of 
comparability with international sources was more serious in small countries, which 
cannot define internally comparable benchmarks.’393 
 
There are also policy challenges due to the inherent proximity between practitioners, 
researchers and policy makers.  This could raise issues of objectivity and independence 
from interference or undue influence.394 
 
6.7.2.3.3 Overcoming the challenges 
Intercountry and regional comparisons are a powerful means to direct policy and 
improve care delivery.  However, this approach comes with a warning.  The 
interpretation of this data must take into consideration the contextual, political, socio-
economic and cultural factors, which ultimately impinge upon the performance of the 
health system.395   
 
The conclusions reached by the EG show a clear realisation that ‘international and 
within country comparisons can be fraught with difficulties and loopholes.’  However, 
                                                 
392 241 Questionnaire Response – Malta. Peer Review on HSPA, Belgium 2014; pg. 6. 
393 217 Expert Group on HSPA. Strategies across Europe to assess quality of care. Mar. 2016. Pg. 35. 
394 228 Grech K. The challenges of developing and implementing a HSPA Framework - A small 
state perspective. Sept. 2016. 
395 256 Federico P.  HSPA EU Expert Group.  Conclusions and recommendations.  
 HSPA quality seminar. Ljubljana. Sept. 2016. 
 231 
the EG also expressed optimism that ‘performance information derived from 
international comparisons can provide the basis for further scrutiny and a deeper 
comprehension of what policies are required to improve the status quo.’396 
 
6.7.3  The political process 
We have seen how the political process is shaped by numerous factors.  This was 
discussed at length during the proceedings of the EG, given that one of the main 
objectives of the EG was to understand more the impact that performance assessment 
has on policy making. 
 
6.7.3.1 The political prerogative 
Whilst policy making is the purview of politicians, evidence through the assimilation 
of performance data is increasingly influencing the political process.  This theme 
discusses this matter in more detail. 
 
6.7.3.1.1 The third revolution in health care 
The advent of performance measurement in health care was described as the ‘third 
revolution in health care’ by Relman (1988).  One may think that this so-called 
revolution came about due to technological advances in the ability of measuring 
complex processes in health care, but this is not the case.   
 
Although the early stages of performance assessment in health care could be traced to 
the turn of the new millennium with the publication of the World Health Report by 
WHO, it really gained momentum following the 2008 financial crisis.  This event 
changed the face of many sectors besides the financial and banking sector.  The health 
sector was not spared.  Rising public expectations, a call for more cost-effective 
treatments, sustaining a health system with ever increasing costs and the need for more 
transparency and accountability, amongst other levers, all contributed to the rise of 
performance assessment and HSPA during the past decade.397  As one can surmise, 
these factors were driven by political and/or economic considerations, and were 
discussed at length in the EG’s fourth meeting.398 
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The relationship between evidence and policy making is a tenuous one.  It requires 
careful nurturing, a mutual understanding and time to mature.  A former minister from 
Spain gave his viewpoint at the seventh EG meeting, where he advocated greater 
engagement with policy makers and commented that merely ‘elevating’ technical 
documents to policy makers does not work and continues to perpetuate the 'us and 
them' mentality, rather than overcome the ‘dichotomy between politicians and 
technicians.’  However, the EG acknowledged that this is an arduous challenge, 
especially when consensus is required across political parties and doctrines.  Indeed, 
this former politician concluded that this is ‘not science but a very messy process,’399 
in the sense that a pragmatic, flexible approach should be adopted, rather than the 
exclusive application of rigorous scientific methods.400 
 
6.7.3.1.2 Reaching political consensus at European level 
From the very first EG meeting, it was declared that a common EU HSPA framework 
would probably be difficult to achieve,401 and indeed there is, as yet, no universally 
accepted HSPA framework at European level.  This realisation conditioned all the 
discussions and conclusions reached throughout the tenure of the EG.  Apart from 
being politically undesirable, the EG also acknowledged that there are serious 
technical difficulties in formulating a common international HSPA model, including 
language barriers and a lack of a balanced set of indicators.402  Hence, at that stage of 
the HSPA journey, there was a commitment to share experiences for mutual 
improvement and to discuss and collaborate on methodologies and development of 
common indicators, as well as improving data availability and comparability.  This 
falls short of a common HSPA approach and it is not yet clear whether this will 
materialise with time.   
 
6.7.3.2 Reforms 
The Expert Group had several presentations on reforms.  This served as an eye opener 
after realising that HSPA became an enduring feature of any reform carried out over 
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the past decade.  Many countries and regions incorporated HSPA into their reform 
process, especially when developing a national plan or strategy which required 
monitoring and regular assessment.  In recognition of the strategic importance of the 
reform agenda, the EU has set up a specific unit (Structural Reform Support Service) 
to support structural reforms in member states.  This unit has participated in some of 
the EG’s deliberations since performance assessment is increasingly being linked to 
reforms and political change.403 
 
The Austrian Health Care Reform of 2013 had, as one of its four key areas of focus, 
‘Health Care Outcomes.’404  The inclusion of performance assessment was mandated 
through the incorporation of ‘outcome measurement into a health governance 
process.’405  Other countries have also linked HSPA with their internal reforms.  
Sweden and Portugal employed national and regional performance assessment data to 
direct their reforms at primary care level.  Estonia was also in the process of instituting 
quality reforms utilising quality indicators as proxies.  Some countries, such as 
Norway use OECD performance data to activate reforms in specific areas, using 
OECD’s HCQI project to compare Norway’s status with its peers.406   
 
6.8 Improving health care delivery through performance 
 monitoring  
 
Several of our hosps have been good enough to send me their statistics this 
year. Among these, St. Bartholomew has unquestionably the best. (Though I 
think he might do still more in improving his Statistical Forms). And Guy, 
who used to be the best, is now unquestionably the worst.407   
 
This is a quotation taken from Florence Nightingale’s notes to James Paget on hospital 
statistics, circa 1861/62.  It encapsulates the importance of performance assessment 
and measurement and its role in improving services.   
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6.8.1  Performance assessment as a tool for service improvement 
There is enough evidence to suggest that quality indicators are used primarily to assess 
and improve health care performance and that the main driver behind national HSPAs 
is performance improvement.408 
 
6.8.1.1 Use of HSPA frameworks for service improvement 
Participants in the first EG meeting agreed that performance assessment is only a 
means to an end, that of service improvement (and secondarily, policy making).409  
This notion was reinforced in the second and third meetings where a performance 
evaluation system has been touted to drive improvement in Italy410 and where in 
France it was viewed as an opportunity to improve standards.411   
 
In the fourth EG meeting, we heard how in Germany ‘more than 3.2 million records 
from more than 1,500 hospitals are collected every year,’ as part of its performance 
assessment system to assure and improve standards of care in hospitals.412  The peer 
review meeting in Slovenia disclosed the thinking behind Slovenia’s nascent HSPA, 
where one of its objectives was to ‘provide an objective reference for the development 
of quality improvement strategies and action at the national and provider level.’413 
 
6.8.1.2 Accountability 
The EG agreed that one of the main aims of HSPA is to improve accountability and 
transparency in the delivery of health care.414  This is the primary objective for the 
NHS Outcomes Framework, where it ‘provides an accountability mechanism between 
the Secretary of State for Health and the NHS Commissioning Board.’415  One the 
main aims of the Belgium’s HSPA is also ‘to provide a transparent and accountable 
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view of the (Belgian) health system performance.’416  Malta’s HSPA is also based on 
monitoring and evaluating the performance of the Maltese health system.417 
 
In those countries with a private/public mix of service provision, creating an equitable 
transparent method of monitoring of standards is important.  HSPA provides this 
framework as it does not distinguish, or rather, does not discriminate between service 
providers.  Italy and France have understood this clearly in the enforcement of 
standards in private and state hospitals alike.418  From presentations held in the peer 
review meeting hosted in Slovenia, it became apparent that the Slovenian authorities 
were struggling with the accountability relationships between the indicators developed 
as part of the HSPA process and the services the HSPA is meant to monitor.419  They 
admitted that further internal discussions and clarifications were required and the peer 
review meeting assisted in providing some clarity.  This is a common dilemma that 
many jurisdictions face when devising their HSPA for the first time as only experience 
provides clarity over time. 
 
6.8.2  The performance assessment of quality of care 
The EG chose quality of care as a main theme for its deliberations in the first year 
because it was viewed as an important measure of performance and also a key 
dimension that is measured by all health care providers.  A Quality Sub-group was 
formed to consider this aspect specifically over 2015.  The author formed part of this 
sub-group.  The Quality Sub-group met outside the main meeting and organised 
several teleconferences.  It also organised a policy focus group on quality of care and 
co-organised a peer review meeting on quality of care in Ljubljana.420 
 
6.8.2.1 Conceptual framework 
OECD views ‘quality of health care services in the overall context of health system 
performance, population health and health system development’ and consists of 
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effectiveness, safety and person centeredness.421  Given that OECD reports 
extensively on quality as part of its HCQI project, its publications were used as 
reference points for the EG and the Quality sub-group to generate the required debate 
and deliberations on this subject.422  Their report on cardiovascular disease and 
diabetes served as a backdrop for the quality focus group (Organisation for Economic 
Co-operation and Development, 2015).   
 
OECD reports that the implementation and maintenance of quality in health care 
organisations depend upon the extent and type of resources that are invested into the 
system, including financial expenditure.  However, the ‘gains are not automatic and 
depends on how resources are allocated and managed.’  This is perhaps why some 
countries, such as Denmark, Luxembourg, Netherlands and Norway regularly 
outperform others in quality of care and other areas.   
 
This seems to suggest that ‘certain health system characteristics may have a bearing 
on performance, but this analysis is (as yet) exploratory.’423  Nonetheless quality of 
care in most developed countries is improving where many ‘governments have 
introduced substantive reforms and invested significant resources to improve the 
quality of care provided to patients.’424 
 
6.8.2.2 Quality of care indicators 
Different models subscribe to several varieties of quality indicators.  These are derived 
from various clinical and managerial disciplines, such as population-based factors 
(potential years of life lost from all causes), acute care (fatality/mortality rates, time to 
surgery post hip fracture, re-admission rates) and primary and community care 
(potentially avoidable hospital admission rates for chronic conditions, prescribing 
rates for antibiotics, annual incidence rate of diabetic patients with complications) 
amongst other areas.  ‘The inclusion of quality indicators is an important development 
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in the evolution of hospital performance analysis.’425  However, in apparent 
contradiction with the above statement, a significant but separate conclusion of the 
quality sub-group was that ‘quality indicators do not measure quality (per se) but can 
only indicate that a system may be delivering high or poor quality.  This implies that 
indicators have to be read within a broad context – a key principle of HSPA – and no 
indicator should be read alone.’426  This statement is in keeping with the general 
approach towards HSPA, that of considering the holistic picture rather than focusing 
on single indicators on their own, where quality indicators are but part of a ‘basket’ of 
indicators to measure performance.427 
 
6.8.2.3 Policy focus group on quality 
The findings from this focus group have already been reported under several other 
themes.  This section will explain aspects of the meeting which are bespoke to this 
theme.  ‘The policy focus group (sought) to take these analytical debates a step further 
to help countries understand the range of reasons that might explain their particular 
positioning on a given indicator.’  The purpose of the focus group was to examine the 
possible reasons for variability of quality care and propose policy actions to address 
the issues raised.428  Comparative performance assessment demonstrated significant 
variations between countries, which creates difficulties for practitioners and policy 
makers to interpret comparative data in terms of performance.  The policy focus group 
concluded that in order to derive accurate and convincing conclusions from 
comparative data on quality, detailed contextual information is required on the health 
systems being assessed.  This level of granularity is necessary to inform policy 
development in the countries concerned. 
 
The policy focus group concluded that it is not always possible to explain the 
variations using available evidence, such as was shown in a study of geographical 
variations of avoidable hospitalisations in Switzerland.429   
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This study concluded that:  
 
… after taking into account many known factors, including health 
expenditure, supply of primary care physicians, specialists, hospital 
beds, pharmacies, as well as for income, education, unemployment and 
after adjusting for co-morbidities, geographical variations in 
hospitalisation rate remained substantial but unexplained by supply or 
demand (Eggli, et al., 2014). 
 
6.8.3  The performance assessment of integrated care 
Integrated care (IC) has gained considerable importance over the past few years as a 
new approach for organising clinical services and initial evidence has shown that 
‘integrated care has a benefit on the quality of patient care and improved health or 
patient satisfaction outcomes.’430  The EG focused on how to measure the effects and 
results of integrated care, given that HSPA models invariably include IC as one of the 
dimensions for measurement.431  Hence, this was discussed during the course of the 
last three meetings of the EG and during a peer review meeting held in Rome in 2016.  
It was also the topic of discussion at a policy focus group organised to discuss the 
performance assessment of IC.   
 
The ultimate objective of the EG was to ‘contribute to the establishment of a 
framework and a methodology for assessing the performance of integrated care 
systems, and in so doing, provide a basis for policy makers who are planning to 
introduce integrated care systems into their health system.’432   
 
These discussions and analysis resulted in the publication of a report by the EG entitled 
‘BLOCKS - Tools and methodologies to assess integrated care in Europe’ where it 
concluded that measuring the performance of integrated care systems is a complex 
process reflecting the multiple tiers of service delivery (Expert Group on Health 
Systems Performance Assessment, 2017). 
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6.8.3.1 Types and levels of integration 
For a relatively new concept, there are several types of models of IC to choose from.  
Whilst it is not the purpose of this section to delve into a detailed description of IC, 
some basic understanding of this new approach is needed, to understand how to 
measure its effects.  IC originated as an alternative to existing care delivery models in 
the hope of better addressing the needs of today’s generation of patients.   
 
Current models of care do not meet the complex needs of patients due to the chronicity 
of many illnesses, the ageing phenomenon and financial and resource constraints.  A 
need was felt to overcome this fragmentation of services.433  A presentation by the 
European Regional and Local Health Authorities (EUREGHA) project to the EG 
clearly outlined the various models of IC at play.  Integration occurs at local, regional, 
national, cross-country or international level.  Integration can also occur vertically and 
horizontally between clinical services, professionals, organisations, systems and 
population-based interventions.434  Many frameworks have now been developed to 
reflect the key elements of how to successfully assimilate IC into the existing models 
of care, although these do not necessarily measure the success of otherwise of this new 
approach of care.435 
 
6.8.3.2 Policy focus group on integrated care 
The policy focus group discussed at length how IC should be incorporated into the 
HSPA process.  Some believed current HSPA models already contain indicators that 
directly or indirectly measure IC and hence, it is not necessary to develop new 
indicators specifically to measure IC.  Others argued that HSPA does not refer 
explicitly to integration of care and so requires bespoke indicators to measure this new 
aspect of care.  However, all participants at least agreed that since IC is a care process 
which requires structural changes and novel resources, any HSPA needs to contain 
both process and structure indicators to successfully measure the effects of IC apart 
from the usual outcome measures.   
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The focus group also stated that it is important to identify the mechanisms between 
these indicators, i.e. the connection between structure, process and outcomes, given 
that integration indeed measures the impact of this connectedness.436  The focus group 
continued to reflect on the possible frameworks for the assessment of IC.  This 
includes measuring integration at patient, hospital, primary care and community levels 
or even integration between the different geographical areas and regions.  
Alternatively, the success of IC could be measured between social and health care.  
Although there was a debate on which model would work best, there was consensus 
that ‘any model has to be general and flexible, to be adaptable to different national 
(or local) contexts, with different goals and value.’437 
 
Prior to the policy focus group, a survey was distributed to elicit responses from 
participating countries.  Twenty (20) member states responded to the survey.  Despite 
large variation in health systems design, countries participating in the survey reported 
a number of similar dimensions and challenges related to IC.  These include the 
challenge to coordinate care in a more structured manner.  However, many 
respondents reported that they are still in the process of developing formal assessment 
mechanisms for IC.  This is not surprising given that this approach is still relatively 
new for many.  Examples of uses of measurement tools included an outcomes 
framework linked to the reforms in Austria and administrative and quality registries, 
such as cancer registries in Luxembourg.  The survey also disclosed some legal 
instruments that have been introduced to assess integrated care, such as the Care 
Provision Strengthening Act in Germany.438 
 
6.8.3.3 Measuring the effects (benefits) of integrated care 
Much of the discussion and debate that ensued in the EG and during the peer review 
and focus group meetings revolved around the perceived or measured benefits or 
outcomes of IC.  One of the main traits of IC is related to patient information and the 
concept that information (should) travel with the patient.  This is one of the 
cornerstones of care at an EU level, where much effort and resources are being devoted 
for the seamless integration of patient information across Europe and beyond. 
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An important part of the work the EG considered was the identification of a core set 
of indicators for measuring the performance of IC.  The discussion paper produced in 
preparation of the policy focus group outlined the main criteria needed to identify the 
most appropriate indicators, particularly to ensure that ‘the evidence shows that taking 
a particular action leads to some desired outcome.’  These criteria include the usual 
parameters of objectivity, availability, contextual relevance, attributability, timeliness, 
interpretability, comparability, feasibility, relevance to policy action, as well as 
others.439 
 
6.8.3.4 Models of policy change incorporating integrated care 
The author had the opportunity to examine examples of good practice which favoured 
policy changes consequent to the introduction of integrated care into their service 
delivery model.  The Catalan region in Spain has been at the forefront of delivering 
innovative methods of care using electronic integrated care models.  They have 
developed a regional strategy on the introduction of e-models of care using electronic 
means of care for patients such as health and social care intervention plans, pharmacy 
prescriptions and how to merge social and health care practices into a shared care plan 
for its community as part of an e-platform for managing health and social care process 
in Catalonia.440  
 
Following the Christie Commission report in 2011, Scotland has embarked on 
reviewing its models of care and consequently introduced new legislation to develop 
new integrated care structures and processes.  This has led to changes in the allocation 
of resources, the creation of new structures and processes and the reorientation of 
social and health care services.  In fact, thirty two new health and social care 
‘partnerships’ were created to jointly deliver care in the community, social care and 
primary care.441  Interestingly, bylaws of the main act were also passed outlining a 
whole array of targets, measures and indicators to measure integrated care.442  As far 
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as can be ascertained, this is one of the very few instances where the specifics of 
performance assessment have been incorporated into law.443 
 
The peer review meeting in Rome highlighted the best practices for the assessment of 
Integrated Care Pathways (ICP).  This programme has its roots in the Lombardy region 
and was extended to the other regions of Italy for the creation of a national evaluation 
system of ICP.  This has been incorporated into Italy’s national HSPA framework and 
includes a ‘comparative evaluation of health care organisation models both for 
chronic and acute diseases and identification of better health care models in terms of 
effectiveness, cost-efficacy, economic sustainability.’444  Whilst this was considered a 
significant development in Italy, its impact upon policy formulation at regional or 
national level is not yet clear and requires further elucidation, even though OECD also 
advocates a deeper assessment of the performance along the entire pathway of 
preventive and care management programmes.445 
 
6.9 National and international perspectives 
One of the most rewarding aspects of the author’s experience on the EG was his 
interaction with national and international HSPA experts who provided their unique 
and inestimable perspective on the intricacies of performance assessment generally 
and HSPA in particular. 
 
6.9.1  Promoting performance assessment 
As with every new endeavour, HSPA requires support and nurturing and whilst it has 
found a home in certain jurisdictions and organisations, its acceptance and 
incorporation into the performance assessment paradigm has not been universal. 
 
6.9.1.1 Promoting performance assessment across Europe 
The creation of the HSPA Expert Group by CION and the interest HSPA has generated 
at various levels within the EU are already testimony of the support and attention this 
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subject is generating at EU level.  The document analysis has amply demonstrated that 
both national authorities and international organisations have boarded the HSPA 
bandwagon and are developing systems, committing resources and lending political 
support towards performance assessment.  Whether this is just a fad, a passing trend, 
is yet to be determined, but from the author’s experience over the past three years, it 
would seem that it is here to stay.  This is also corroborated by the mandate given to 
the EU Health Commissioner Andruikaitis where he was asked to ‘develop expertise 
on performance assessments of health systems, drawing lessons from recent 
experience, and from EU-funded research projects to build up country-specific and 
cross-country knowledge which can inform policies at national and European 
level.’446 
 
From the author’s initial participation in the peer review meeting in Brussels in 2014, 
an official from CION explained that HSPA was already increasing in relevance and 
the need for an assessment framework was felt in the context of the European 
Semester, due to the focus on the sustainability of public finances and the efficiency 
of public spending after the 2008 crisis.447  This same meeting clearly outlined the 
position of the EU on HSPA wherein it was stated that: 
 
… although there is no claimed plan or drive to create an EU wide 
common HSPA framework the focus is to increase Member States’ 
impetus in this respect and ensure a certain level of consistency and 
standardisation so as to facilitate greater comparability.448 
 
The first EG meeting served as an eye opener into the EU’s interest in this subject.  
There were, and still are, no less than 5 separate EU Directorates with an intensive 
interest in performance assessment, namely DG SANCO (later SANTE), DG ECFIN, 
DG Employment, DG Research and Eurostat.449  Between these there were even more 
resources and tools dedicated to performance measurement and indicators, such as the 
System of Health Accounts, the Expert Group on Health Information, the Economic 
Policy Committee, the European Commission Statistics on Income and Living 
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Conditions (SILC), the Classification of the Functions of Government (COFOG), the 
European Health Interview Survey (EHIS), the European System of Integrated Social 
Protection statistics (ESSPROS), the European Health Information System, Heidi, 
ECHI, Reflection Process of Health Systems, Subgroup 5 on Effective, Accessible and 
Resilient Health Systems, Social Protection Committee, JAF (Joint Assessment 
Framework), EuroReach and ECHO, to mention but a few.450   
 
Many consider this not only as overkill, but a dire waste and duplication of resources, 
expertise and energy.  Whilst there are attempts at sharing information between these 
different initiatives, many, including this author, view this situation with bewilderment 
and wonder why these resources cannot be streamlined.   
 
This perspective was again reflected by the author during the sixth Expert Group 
where, during a presentation of the Bridge project, participants questioned why so 
many different frameworks were conceived, given that they are very similar to each 
other, having also analogous dimensions and indicators.451  On the positive side, this 
certainly confirms the interest and support at EU level towards performance 
assessment as reaffirmed by the EU Council’s agenda to ensure effective, accessible 
and resilient health systems.452  DG Sante’s particular focus on HSPA was later 
confirmed following the creation of a specific new Unit responsible only for HSPA.453 
 
6.9.1.2 Role of national organisations 
Many speakers and experts invited to the expert group and peer review meetings 
presented the perspective and experience of the organisation they represented.  In 
2014, in the survey conducted prior to the peer review meeting in Brussels, the German 
response stated that there was no federal or ‘nationwide approach to perform a regular 
Health System Performance Assessment in German.’  However, the Robert Koch 
Institute was tasked with ‘supporting and strengthening the process of a systematic 
monitoring concerning the health status of the population, the underlying health 
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determinants and the utilisation of specific health care services.’454  In a new 
development, presumably in cognisance of the previous admission of not having 
national oversight on performance assessment, the Institute for Quality Assurance and 
Transparency in Health Care (IQTIG) was established in Germany in 2015, with the 
responsibility of examining the quality of care in inpatient and outpatient care to 
improve care to patients through regulation.455  According to the Director of this new 
institution, its creation is testimony of Germany’s commitment towards performance 
assessment as a means to improve services.456 
 
In Sweden, similar to the German experience, due to the regional basis of the health 
system, the Swedish National Board of Health and Welfare and the Swedish 
Association of Local Authorities and Regions jointly conduct performance assessment 
reviews based on the data collected at county and local level.457   
 
Whilst Denmark does not have a national HSPA framework, certain components of its 
health system have a monitoring and assessment function, such as the Danish General 
Practice Quality unit (Dak-E) which provides a ‘performance measurement system 
aimed at monitoring and improving the quality of Danish General Practice.’458 
 
6.9.1.3 Role of international and regional organisations and networks 
The document analysis raised numerous references of EU and international 
organisations involved in performance assessment and HSPA.  Nolte noted that 
organisations such as OECD, WHO and the Commonwealth Fund carried out ‘macro 
level’ performance assessments.459   
 
The OECD was an active and regular participant in the EG’s deliberations.  It provided 
numerous examples, evidence and case studies of the diffusion of performance 
assessment in OECD’s member states and beyond.  Its publications on Health Policies 
Studies and the reports from OECD’s HCQI projects provide invaluable information 
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and insight into the performance of various health systems and how these compare 
with each other.460  Over the years, the OECD has collaborated more intensely with 
CION and WHO in the production of the Health at a Glance Europe reports, where 
there was increasingly greater convergence between the indicators assimilated by the 
OECD’s quality project, Eurostat and WHO’s expenditure and non-expenditure health 
care statistics.461   
 
6.9.2  Good practice examples 
As with evidence-based medicine, good practice examples and models provide a solid 
basis for the acceptance and implementation of HSPA across the board.  This section 
provides an overview of such examples and models. 
 
6.9.2.1 Case studies linking evidence with policy change 
This sub-theme did not score highly since a new main theme, covering specific country 
experiences, has been added following the analysis of the participatory research stage 
of this thesis. 
 
Most case studies of good practice examples emanate from collaboration at regional 
or international level.  The ECHO team presented the project details at the third EG 
meeting in Brussels.  The main messages coming through were how routinely 
collected data from hospitals, patient data, registries and surveys could be used for 
generating evidence on performance improvements.  It also delved into the 
methodological difficulties in creating a homogenous knowledge infrastructure 
amongst participating hospitals and institutions and how to adjust for risk and 
population heterogeneity.462   
 
The maturity model for integrated care is another prime example of a developing 
integrated care tool and sharing experiences in the Puglia region in Italy.  A 
comprehensive model was devised for devising, implementing and assessing 
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integrated care programmes in this region.  It has since been taken up as a good 
practice model for other regions in Italy.463 
 
6.9.2.2 Statements on use of HSPA to determine policy agenda 
The Health Secretary of State in Sweden, in opening the second EG, emphasised the 
importance of performance measurement in informing policy to improve the health 
system.464  This, in itself, was not surprising given that Sweden was one of the first 
countries to adopt HSPA as a tool for performance assessment.  In its fourth meeting, 
one speaker, in trying to emphasise the importance of performance assessment, 
quipped that one should get a ‘gorilla to advocate for the need and usefulness of an 
outcomes framework.’465 
 
6.9.3  Country experiences 
One of the themes generated by the participatory research component of the thesis 
revolved around experiences from individual countries.  As part of the author’s 
participation on the expert group, he encountered national HSPA experts and policy 
makers from these countries and obtained invaluable insight into their experience and 
opinions.  This is important since one of the key objectives of the research was to 
obtain the viewpoints and feedback from countries which have introduced HSPA and 
their experience in linking this with policy making.   
 
All 28-member states plus Norway and Switzerland participated in the proceedings of 
the Expert Group.  These countries are at varying levels or stages of development in 
HSPA and some have gained more experience and are more mature into the process 
than some others, but a commonality is that all are striving, in one way of another, to 
integrate HSPA into their health systems.   
 
As a prelude to this section, the following table (Table 6.1) is an outline of the status 
of these countries at the time of writing (late 2017). 
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Table 6.1: State of HSPA development of various countries 
 
Countries State of HSPA development 
Bulgaria 
Denmark 
Czech Republic 
Exploring possibilities for developing a national 
HSPA. 
Cyprus 
Improve their performance assessment systems but 
no national HSPA. 
Italy 
Germany 
Spain 
Federal approach towards performance assessment 
– several regional HSPAs with central oversight. 
France 
Poland 
Links performance assessment to commissioning, 
fiscal and quality incentives. 
Austria 
Slovenia 
Latvia 
In the process of developing national HSPA 
frameworks. 
Belgium 
UK 
The Netherlands 
Sweden 
Mature HSPA processes. 
Malta 
Estonia 
Portugal 
Turkey 
Hungary 
Recently developed HSPA frameworks linked to 
national reform process. 
 
This section will only describe the HSPA models present in those countries which 
have not been extensively covered under other themes and sub-themes.  Hence, the 
English, Italian, Dutch and Belgian systems will not be covered here as they have been 
amply mentioned under various other themes.  The Maltese HSPA was also amply 
covered in the second part of this study. 
 
6.9.3.1 Austria 
The HSPA process began in 2010, where the Austrian Ministry of Health 
commissioned the Austrian Health Institute to compile a report on the performance of 
the Austrian health system.466  Subsequently, reforms in 2013,467 based on improving 
quality and access of health care, provided the context for their first national HSPA.   
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This synergy is common where HSPA either precedes or follows reforms, such as was 
the case in Portugal and Malta.  In this case, the objective of the HSPA would be to 
monitor the progress of these reforms and in turn, the results of the assessment would 
supposedly encourage reforms to happen in the right direction.468   
 
The proponents of Austria’s HSPA have decried that it should be outcomes-based and 
serve as a ‘tool to prioritize problematic fields in health care where further 
investigation seems to be necessary and bringing stakeholders in the position of 
informed decision making.’  It would certainly not be used as a name, blame and shame 
mechanism and would follow on international good practice examples, such as those 
of Belgium and the UK.469   
 
These are common principles that are applicable to other HSPAs.  However, the 
Austrian expert participating in the peer review meeting in Slovenia disclosed that the 
implementation of the HSPA was stalled due to external factors.470  Nonetheless, 
despite this setback, Austria has implemented several initiatives such as the Austrian 
Inpatient Quality Indicators programme and the introduction of several quality 
registers.471 
 
6.9.3.2 Bulgaria 
Bulgaria describes a rather rigid situation in terms of instituting reforms, changes in 
legislation and new fiscal mechanisms.  Moreover, there are certain limitations in the 
ICT infrastructure.  Nonetheless, they are studying the feasibility of developing a 
national HSPA framework.472 
 
6.9.3.3 Croatia  
Croatia launched its National Health Care Strategy to cover 2012-2020, based upon a 
‘health in all policies,’ ‘whole-of-government’ and ‘whole-of-society’ approach, 
aimed at improving health care indicators and quality of health care.  Several sets of 
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indicators have been developed, however there is no move, as yet, towards a national 
HSPA.473 
 
6.9.3.4 Cyprus 
The lack of a public NHS mitigates against the development of an integrated 
performance assessment system.  Furthermore, the lack of a robust ICT system in the 
public health care sector at national and regional level and the vertical division 
between public and private health care sector also present certain difficulties as does 
a management system in the public sector which is perceived to be very rigid.474 
 
6.9.3.5 France 
France has a national performance monitoring system linked to the measurement of 
quality of care, fiscal incentives to improve quality of care and the disbursement and 
allocation of funding to service providers.  The performance system awards the ‘best 
in class’ or those institutions which show significant improvement.  It is not, however, 
punitive, as it is believed that this would decrease the reporting of adverse events.475   
 
The French system ranks over two hundred private and public hospitals using an 
elaborate performance system and publishes the results every year.  This ranking 
primarily serves as an incentive for these providers to perform better since they are 
particularly sensitive to preserving a good reputation, which reputation is affected by 
the public disclosure of these results.476 
 
6.9.3.6 Germany 
Germany’s response to the survey preceding the peer review meeting in Brussels 
stated that ‘Germany does not apply a systematic HSPA approach … Instead, 
Germany follows a pluralistic approach with various activities to monitor and report 
on health trends and health system performance’ of the status of the population’s 
health, its determinants and its health care services.’477   
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Service provision is monitored through a similar quality assessment system as in 
France wherein regular benchmarking reports are produced and sent to each hospital 
for comparable purposes.  A structured dialogue or peer review then ensues with each 
hospital to identify areas for improvement in those areas that are outside the tolerable 
range.  This outcome data is published and was introduced consequent to the 
implementation of the DRG system in Germany.478  Although, unlike France, 
Germany is governed through a federalist approach, a centralised Federal Joint 
Committee controls the flow of information and supervises the performance 
assessment process, tasking a recently established Institute for Quality Assurance and 
Transparency in Health Care for this work.479   
 
6.9.3.7 Greece 
Following the 2008 recession, Greek authorities focused primarily upon developing 
financial, efficiency, productivity and economic indicators, in tune with the situation 
at the time.  This eclipsed the possibility of adopting other health related indicators, 
although there have been developments as of late in generating indicators more akin 
to the health sector.480 
 
6.9.3.8 Hungary 
During the proceedings of the EG, Hungary was in the course of developing its HSPA.  
A directive was passed in 2013 and WHO was engaged to support the process.481  
During one of the expert meetings, the Hungarian expert outlined the methodology 
and plans for their first HSPA.  At the time, they were discussing how to 
institutionalise HSPA into their organisational agenda whilst creating a policy 
dialogue with relevant internal stakeholders, although no other ministries or NGOs 
were involved.  They were also exploring the possibility of integrating the HSPA into 
their legal framework which would decree that a report would be produced every two 
years.  Their first HSPA was produced in late 2017, containing 90 indicators.482   
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6.9.3.9 Norway 
National quality indicators are produced by the Norwegian National Quality Indicator 
System (NQIS) which was established in 2012 and is based on OECD’s HCQI 
project.483  By 2015 over 97 national quality indicators were developed, covering 
somatic health, mental health, infections and primary care services.  The main 
objective of this system is to provide performance related information to patients and 
users ‘to safeguard their legal interests.’484 
 
6.9.3.10 Slovenia 
The first attempt at performance measurement was a national project on quality 
indicators in 1999.  Surprisingly, it was not the Ministry that took the lead but the 
Slovenian Medical Chamber.  This then led to the introduction of health care quality 
indicators in 2010 by a multi-sectoral working group.  More recently, Slovenia 
launched its National Healthcare Plan for 2016-2025.  This plan incorporates the 
development of HSPA as one of its priorities.485   
 
A current set consists of 72 indicators from several dimensions, such as quality (safety, 
patient centeredness, effectiveness and efficiency) and patient-oriented indicators, 
such as patient safety.  However, there is a recognition that, since these indicators 
originated extraneous to a HSPA framework, the current model is weak and not robust 
enough to partner the national health plan.486  In fact, in 2017, the author was engaged, 
as an external expert, to support and guide the Slovenian Government in the 
development of their first HSPA. 
 
6.9.3.11 Sweden 
Sweden has a long history of HSPA.  Its main thrust is the production of yearly 
thematic reports.487  These reports feature aspects of the whole Swedish health care 
system, for instance reporting on the quality and efficiency of the system, care of 
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stroke, diabetes etc.488  In the EG meeting in Sweden, the State Secretary commented 
on the possible relationship between the long years of producing performance reports 
and policy making in Sweden.  She was of the opinion that the practice of producing 
quality and performance reports led, over the years, to improved equity, patient 
centeredness and efficiency.  The latter aspect was of particular relevance at a policy 
level due to rising costs in Sweden.  However, she also admitted that one of the main 
benefits of the HSPA process was the inculcation of the concept of transparency into 
the Swedish health care system.489 
 
6.9.3.12 Latvia 
Latvia has a long history of data collection and analysis.  However, the presence of 
multiple stakeholders has limited their ability to agree on a national performance 
framework.  Nonetheless, in 2017, together with the Scoula Superiore di Sant’Anna 
(Pisa), the author was also engaged to assist in the development of their national HSPA 
over in the next few years. 
 
6.10 Communication 
The EG considered the best approaches and tools to communicate both HSPA as a 
concept and also the results emanating from HSPA methodology.  This was considered 
an essential element of the HSPA process. 
 
6.10.1 Communicating the evidence 
A key element of the latter stages of the HSPA process is interpreting and then 
communicating the results to policy makers, management and even the public if 
necessary. 
 
6.10.1.1 Expert group considerations 
From the first EG meeting, the need for improved communications was discussed as 
well as the possibility of having a repository of HSPAs of different EU member states 
that could serve as case studies of excellence and foci of knowledge transfer to policy 
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level.490  Various methods of visual reporting systems were discussed, such as 
Dartboard graphics,491 where it was agreed that HSPA results should be published 
regularly, wherever possible.492  However, issues of data protection and sensitivities 
around the public disclosure of political sensitive data presents difficulties and 
challenges in communicating HSPA results and in obtaining the required permission 
from participating countries and organisations.  The EG weighed these considerations 
with the need to ensure transparency and accountability towards the public,493 
although it was noted that some countries are reluctant to publish the results of the 
analysis of the performance of their health systems and hospitals.494   
 
A part of the seventh EG meeting was specifically dedicated to the subject of 
communication.  The members discussed in detail how HSPA results should be 
communicated, whilst understanding the need ‘to combine the simplicity of 
communication with the complexity of the analyses’ as a derivative of the HSPA 
process.  The use of the media, social media, publications, websites, seminars and 
meetings were discussed, amongst other means.  The two-way communication process 
that between researchers and policy makers, was reiterated again as an essential 
communication tactic.495   
 
Both the Quality Sub-group and the review meeting in Slovenia also concluded that 
the method/s chosen for communicating HSPA results ultimately depends upon the 
initial goals of the HSPA.  Hence, the communication strategy would be adjusted to 
the target group receiving the information,496 including service providers, funders, 
patients, policy makers, government and the general public.497  Scientific data and 
findings are aimed for scientists and professionals, whilst quality assessments and 
comparative data is usually communicated to policy makers.498   
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Given the importance of this subject, the EG (with the contribution of the author) 
produced a Policy Paper entitled ‘HSPA – Reporting and Communicating; Practical 
Guide for Policy Makers,499 dealing with communicating HSPA. 
 
6.10.1.1.1 Country experiences 
Many countries recounted their own experience in disclosing HSPA findings to the 
public.  The Swedish authorities publish regular reports on regional comparisons and 
produce guidelines based on performance assessment findings.  There are various 
reasons for instituting a formal public reporting system.  It is primarily aimed at 
encouraging service improvements, certainly to improve transparency and stimulate 
public debate whilst allowing policy makers to interact with the public.500  Italy has 
devised an innovative means of visually depicting the results of their regional 
performance evaluation system, using target diagrams and dartboard graphics to 
showcase the achievements but also the gaps in performance and quality of care.501   
 
The IQTIG in Germany is a firm believer of public disclosure and insists on 
publication of results through its website.502  Furthermore, all German hospitals are 
now required by law to publish quality reports every two years, outlining the results 
from the national quality assurance programme.503  Romania has tried to use the media 
as leverage to garner greater commitment from policy makers, through the increased 
involvement of the public.  Hungary has also placed transparency and objectivity as 
important considerations for its first HSPA.504   
 
Experiences from various countries show that there is a cyclical synergistic effect 
between the publication of performance indicators and the improvement of quality of 
care.  This ‘positive impact is mainly determined by the effect of public reporting that 
… generates significant effects on changes in efficiency and quality of care of health 
services.’505 
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6.10.2 The media and evidence-based policy 
The media was not high on the agenda on the EG or in any of the peer review and 
focus group meetings.  The few references on the use of the media were mostly 
regarding the use of modern communication techniques such as the internet and social 
media.  Many national and regional authorities, such as the A-IQI National Steering 
Committee in Austria506 and Portugal’s Health Commission use the internet for 
communicating with the public.  These are usually presented as web-based tools which 
the public can navigate to obtain information on the results produced by the HSPA 
process.507,508   
 
The issue of how the media can impact policy was raised in the peer review meeting 
in Slovenia, where it was explained how a newspaper report in Slovenia disclosed the 
ranking of hospitals on MRSA infection rates.  Although this information was already 
available on the ministry’s website, it was only after the newspaper report was 
published did it create an outcry and a public reaction.  This example showed the 
power of the media in influencing the public’s perception, and by collusion, the policy 
maker’s opinion.509   
 
Indeed the media could be considered as a stimulus for policy change.  As postulated 
by Kingdon, a window of opportunity may be created by the media, where the media 
may sway the public, which in turn places pressure upon policy makers to effect 
change. 
 
6.11 Further work 
The work of the EG is still on-going.  As it tackled the performance assessment of 
quality of care and integrated care in its first two years, other important themes were 
discussed for which the author is still contributing.  These included the performance 
assessment of primary care, efficiency and resilience.   
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6.11.1 Recommendations 
The EG reached several conclusions along its path.  Whilst it is not the purpose of this 
analysis to list these in any great detail, this next section will outline the more salient 
points that have been concluded.510 
 
• Whilst HSPA provides a high-level balanced overview on the 
performance of a health system, more detailed analysis is always 
required to assess the performance of its component parts.  HSPA 
reports should provide a global evaluation rather than be used for 
the comprehensive monitoring of programmes. 
 
• The dimensions pertaining to a HSPA model, such as quality, 
access, equity, sustainability and efficiency, should reflect the 
values that the health system wishes to pursue. 
 
• HSPA should assess the whole health system, including acute, and 
also chronic and mental care, hospital (residential) care, primary and 
community care, public health and health promotion and also health 
in all policies. 
 
• The set of indicators should be comprehensive and elaborated 
enough to assess the system as a whole.  
 
• A HSPA report should generate concrete recommendations which 
should be translated into action(s). 
 
• An adequate governance structure for the development, analysis and 
implementation of HSPA needs to be in place.511 
 
• Many aspects of HSPA model require further development, such as: 
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o Development of more elaborate dimensions. 
o Better more robust methods to improve data collection. 
o Expound upon suitable indicators for under-developed areas 
such as primary care, mental care, chronic care, end of life 
care, integrated care. 
o Link indicators to concrete themes.512 
o Improve international comparative assessment methods and 
benchmarking. 
o Draw on multiple sources to draw conclusions and develop 
policy. 
 
Finally, there was a suggestion, that following on the work of the HSPA Expert Group, 
an EU-HSPA network could be created, to continue this valuable work and possibly 
as a prelude to an EU wide HSPA model in the future. 
 
6.12 Conclusion 
This chapter presented the author’s research and work as part of his participation on 
the EG.  It continued to explore the themes generated through the document analysis 
and generated new themes by providing a unique, qualitative perspective on HSPA 
and its implementation across Europe and beyond.   
 
The next chapter presents a general high level discussion incorporating the main 
highlights of the thesis and rounding up the main arguments and findings of the three 
phases of this study. 
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CHAPTER 7 
GENERAL DISCUSSION 
 
 
 
“Facts are stubborn things, but statistics are pliable.” 
Mark Twain 
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CHAPTER 7 
GENERAL DISCUSSION 
 
 
 
7.1 Introduction 
Given the qualitative methodology adopted for the greater part of this study, the 
discussion points covering the results of Chapters 4 and 6 (Phase I and III of study) 
have already been expounded in these chapters.  This chapter, on the other hand, serves 
to augment the discussion that has already taken place whilst reflecting upon the 
original research questions of the study as our point of reference. 
 
In the first instance, an appreciation of what HSPA, as a relatively new discipline, has 
achieved to date would be volunteered, as well as offering some predictions of what’s 
in store in the future.  The first research question is then discussed.  This concerns the 
methodological development of Malta’s first HSPA, enquiring as to the most 
appropriate method for developing a health system performance assessment model for 
a small state like Malta as well as the results of this process.  The second research 
question delved into the relationship between HSPA and policy development.  This 
phenomenon is further elaborated upon and a model capturing the findings of this 
second part of the study is proposed to provide a deeper understanding of this complex 
field of study.  A commentary on the methods adopted for this study followed by a 
discussion on the gaps in the evidence that have been addressed by this research 
continues.  A critique of the study in terms of the techniques employed to assure a 
quality approach concludes this chapter. 
 
7.2 The advent and endurance of HSPA 
Performance assessment has a long-standing tradition in many sectors, including 
health (Veillard, et al., 2005).  Whilst several performance tools have been developed 
and are available at an organisational or institutional level, the need to measure the 
performance of health systems at national (and regional) level arose following the 
global 2008 financial crisis.  HSPA grew out of the necessity to organise performance 
 261 
assessment better and to provide information on the performance of the components 
of a health system.  It is important to distinguish performance assessment methods at 
organisational level, (say hospitals, primary care centres etc) as against HSPA as a 
method of assessment at health system (usually national or regional) level.  Whilst the 
underlying model for both hospital performance and HSPA could be traced back to 
the health determinants model (Arah et al. (2006), hospital performance measurement 
models subscribe to theoretical frameworks based on the narrower definition of 
clinical care as it is linked to the health needs of the population that the hospital serves.  
Indeed, Veillard and colleagues, in the PATH project, proposed a hospital framework 
consisting of 6 clinical dimensions, including clinical effectiveness, efficiency, staff 
orientation, responsiveness governance, patient safety and patient centredness 
(Veillard, et al., 2005).   
 
Sicotte and collaborators from Canada proposed using Parsons' social system action 
theory as a theoretical framework to explain health care organisational performance, 
based on Parson’s four fundamental functions to ensure an organisation’s resilience – 
adaptation, goal attainment, integration and latency (Sicotte, et al., 1998).  On the other 
hand, health system performance assessment encompasses the wider definition of 
health and its determinants, where it subscribes to a broader, societal or public health 
viewpoint.  Moreover, given that HSPA is a more recent phenomenon, other models 
such as the Logic Framework Model (Canadian Institute for Health Information, 
2013), WHO’s Results Based model (World Health Organisation, 2010) and OECD’s 
Quality Framework (Arah, et al., 2006) have been proposed and used as a basis for 
HSPA development. 
 
Since HSPA is a relatively recent addition to the performance assessment toolkit, the 
author feels that it has not yet passed the test of time and its longevity is still debatable.  
However, most proponents believe that it is, up to now, the best method to assess 
performance at national or regional level and that given time, it would be incorporated 
within the legal and organisational framework of a country.  Others are not so 
optimistic (Giedrojć, 2016). 
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7.2.1  The end of the beginning or the beginning of the end? 
2018 marks the tenth anniversary of the Tallinn Charter (World Health Organisation, 
Regional Office for Europe, 2008).  It is acknowledged that, whilst the ‘birth’ of 
performance assessment is attributed to the launch of WHO’s World Health Report in 
2000, the Tallinn Charter is certainly credited with its ‘baptism.’  HSPA has therefore 
had the good part of a decade to develop and mature.   
 
This study has provided a detailed overview of the development and utilisation of 
HSPA across the European region over the past few years.  Although its usefulness 
has been well established through numerus case studies and good practice examples 
(Carinci, et al., 2015); (El Turabi, et al., 2011); (Chalmers, et al., 2017), and in spite 
of the author’s emersion into the HSPA paradigm locally and in Europe for over four 
years, the author feels that it is still uncertain whether HSPA would develop into a 
permanent feature on the performance landscape.   
 
Unlike other more mature technology assessment tools such as HTA513, only a few 
countries have incorporated HSPA into their legal framework (Van Den Berg, et al., 
2014), thus relying on the voluntary uptake of this relatively new mechanism into their 
governance system.514  Local, national and EU legal instruments need to be enacted to 
add permanence and significance to HSPA.  If not, then its short but active life may 
expire before it could have a lasting effect on health systems. 
 
7.2.2  Value added or a nice to have? 
HSPA ‘competes’ amongst a plethora of other performance measuring tools and data 
collecting systems.  The author has commented, on several occasions, on the numerous 
performance methods in place at national, European and international level.  These 
include WHO’s HFA database (World Health Organization, 2012) and OECD’s HCQI 
project (Rotar, et al., 2016).  CION also has several data collection and comparative 
systems in place, including ECHI, DG ECFIN’s indicator set, JAFH (SPC), Eurostat, 
the System of Health Accounts, the Economic Policy Committee, SILC, EHIS, the 
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European system of integrated social protection statistics (ESSPROS), Heidi, 
Euroreach and ECHO, to mention but a few.515,516   
 
Policy makers and funders have therefore asked what added value does HSPA provide, 
or in other words, does HSPA provide a viewpoint which is different or unique to the 
other assessment methodologies?  The EG pondered this matter many a time and in its 
meeting on 18th September 2017517, concluded that what distinguishes HSPA from 
other methods is its ability to provide an umbrella assessment or helicopter view of 
how a health system performs.  Whilst many view this positively (Giedrojć, 2016), 
others argue that this reflects a superficial viewpoint, with little or no value added to 
the performance paradigm (Hyder, 2002); (Tashobya, et al., 2014).  They argue that 
whilst it may be ideally placed to identify the gaps in performance and set direction 
for policy makers, due to its overarching nature and irregularity, it is not geared 
towards constant monitoring of the performance of the component parts of a health 
system or service and hence loses its significance and relevance.  Perhaps the fact that 
this debate should occur in the first place is a reflection of its limitations, but until a 
better more acceptable alternative comes along, it is primed to improve in terms of the 
methods employed and its results. 
 
7.2.3  The European project 
HSPA is primarily a European brainchild, if one were to put aside the efforts of the 
US, Canada and Australia.  However, ownership at European level has been meagre 
at best, disjointed at most.  Whilst the response towards HSPA by individual member 
states has been enthusiastic and CION has invested considerable time and effort in 
devising methodologies for the development and implementation of HSPA across the 
EU, harmonisation and standardisation of this relatively novel approach is lacking, 
where Perić, Hofmarcher-Holzhacker and Simon (2017, p. 1) found that ‘the EU HSPA 
landscape is complex with seemingly few streamlining activities.’  There has been 
much debate within EU circles, including that of the EG, on whether there should be 
greater integration of HSPA into the European project.  This conundrum was already 
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apparent at the author’s first peer review meeting in 2014 where the EU claimed, at 
the time, that: 
 
… although there is no claimed plan or drive to create an EU wide 
common HSPA framework the focus is to increase Member States’ 
impetus in this respect and ensure a certain level of consistency and 
standardisation so as to facilitate greater comparability.518 
 
The author can verify that, from his participation in various HSPA fora, this has been 
partially achieved, but more needs to be done.  Of course, in Europe, WHO and OECD 
have also been very active on this front, through practical means of supporting member 
states to develop their own HSPA model (World Health Organisation, 2010), as well 
as facilitate cross national and international comparative assessment processes 
(Organisation for Economic Cooperation and Development, 2017). 
 
The author believes that once more European countries adopt this methodology, it 
would probably gain sufficient momentum and achieve sufficient critical mass to 
ensure its long-term presence on the performance landscape. 
 
7.3 The first research question - the methods behind the  
 development of HSPA and the Malta model 
The first research question dealt with the methodological development of HSPA, both 
in terms of finding the most appropriate method and model for Malta, but also in terms 
of how this method can be applied to similar member states in terms of size and 
maturity.  Indeed, one of the two main objectives of this thesis was to discuss the 
various methodologies employed to develop HSPA frameworks.  As with all valid 
tools, a robust and scientifically driven methodology is essential to ensure the 
durability and relevance of HSPA. 
 
Facets of the various methods retained in the creation of numerous HSPA models and 
frameworks have been discussed widely, first as part of the initial literature search 
(Kelley, Arispe & Holmes (2006); (Carinci, et al., 2015); (Prinja, et al., 2017) but more 
importantly as part of the authors original research into the topic.   
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The document analysis uncovered several instances and examples of model 
construction519,520,521, although the author also noted that only few of these processes 
were actually documented in the scientific literature522,523.  In fact, the little 
information available on the details of the methods used in developing HSPA models 
was gleaned from the grey literature, which confirmed the usefulness of carrying out 
a document analysis at the start of the research process (Grech & Spurgeon, 2018).   
 
7.3.1  The Malta model 
The method for arriving at the Malta model was never used before.  There was no 
precursor or precedent.  Together with the NEWG, the author had searched for 
potential methods that would conform to Malta’s particular needs, that of a small 
island nation with a bespoke, mature, yet complete health system with constraints.  
Various methods were studied (Tashakkori & Creswell, 2007), (Perić, et al., 2017) but 
none fitted into our needs.  Hence, the author opted to develop a new method with the 
backing and comfort of the NEWG.  The process was well described in Chapter 5 and 
the steps taken are illustrated in Appendix 2b.   
 
WHO had drawn up a set of criteria for the development of HSPA by its member states 
(World Health Organization, 2012).  This includes focusing upon health systems as a 
whole, the utilisation of outcome measures as much as possible, incorporation into the 
performance management and policy making process of the country, and that each 
country should develop its own HSPA, although it should still be comparable with 
other countries and health systems.  The NEWG reviewed these criteria and whilst it 
agreed with the whole system approach, it felt that the model should include all three 
types of indicators as ascribed by Donabedian (input, process and output indicators) 
(Donabedian, 1980a).  Indeed, the moulding of a theoretical model on which to build 
Malta’s HSPA was an important first step, although not everyone could understand 
why choosing an archetype was an important consideration and laid the basis to map 
the indicators onto the model.  WHO felt that each country should develop its own 
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HSPA model through a bespoke developmental methodology (World Health 
Organisation, 2010).  Whilst this is understandable in terms of inserting HSPA into 
the local cultural and socio-political context of the health system it is measuring, the 
downside of this suggestion is the lack of a standardised empirically tested method, 
leading to serious difficulties for comparing methods and results.  One of the key 
objectives of the first phase of this research was indeed to develop a method that would 
be documented in detail and tested, with the possibility of replication in other health 
systems.  This was achieved, also to the extent that considerable interest was generated 
by other nations in their quest to develop their own HSPA.   
 
One of the innovative steps undertaken in this method was to ‘extract’ indicators from 
existing national or regional strategies.  There are advantages and drawbacks of using 
locally derived indicators and these have been clearly discussed in Chapter 5.  
However, as far as the author could ascertain, the ‘mining’ of indicators from strategies 
or policies that already exist was never attempted before and represents a robust yet 
achievable method for those HSPA proponents who decide to utilise local indicators 
rather than internationally derived ones.  The condition for this is that such national or 
similar strategies or policies need to be available and accessible (Expert Group on 
Health Systems Performance Assessment, 2017).  However, if done properly, this 
process lends credence and relevance to the indicators chosen to populate the HSPA 
model since these would already be considered meaningful for their health system. 
 
A formula based on the RAND criteria was developed to score and hence shortlist 
indicators (Farley, et al., 2008).  This algorithm was developed de novo by the author 
as a means to simplify the process of scoring and shortlisting indicators.  The raters 
found the scoring method easy to follow and comprehend and was applied fairly 
smoothly.  Definitions for each criterion was produced to ensure a standardised 
approach and the iterative steps allowed for scoring large numbers of indicators.  This 
method was repeated by Slovene colleagues where over 1500 indicators were scored 
and shortlisted using this algorithm (Poldrugovac, et al., 2018). 
 
Another matter considered by the NEWG was whether to score or rate the domains.  
Whilst the core function of any HSPA model is to demonstrate how a health system is 
performing, primarily through its organisation and manifestation of its indicators 
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(Arah, et al., 2003), the NEWG also discussed the usefulness and benefit of also 
showing how the domains performed in their own right.  The purpose of this was to 
help Maltese policy makers focus on specific aspects (or domains) of the health 
system, in the hope that such targeted action would spur change, reform and 
improvement.  The difficulty of this step in the HSPA development process was how 
to establish a scoring metrics that is simple to implement and understand yet retains 
accuracy and validity.  Similar metrics were studied such as those adopted by Belgium 
and Italy (Vrijens, et al., 2016), (Nuti, et al., 2013).   
 
A scoring system was devised that would score and weight each indicator whilst also 
provided an overall score for the domain.  This allowed an immediate visual 
representation of the performance of the Maltese health system through a traffic light 
system which was highly appreciated and also accepted by policy makers and the 
public (Grech, 2015).  The downside of this approach was the risk of oversimplifying 
what is essentially a complex story and hence misrepresent the real message that 
HSPA is purported to convey. 
 
7.3.2  The Malta experience 
The objectives of the second phase of this dissertation have been reached through the 
development of Malta’s first HSPA and national set of key national performance 
indicators as well as producing the results of Malta’s first performance assessment of 
its health system.  Malta was not one of the earlier adopters of HSPA, but this allowed 
us to assume certain best practices whilst adapting them to our needs.   
 
Malta’s first HSPA was developed following the creation of Malta’s National Health 
System Strategy (NHSS) as a means to monitor its implementation.  This was the first 
ever opportunity to introduce a tool to assess our health system performance and to 
enhance and consolidate transparency and accountability in the decision-making 
process in Malta.  It was intended to instil drive within local stakeholders to strive to 
improve the performance of the Maltese health system.   
 
The jury is still out on whether these objectives have been reached as the author feels 
that, whilst it was a very useful national exercise, the real value of HSPA is yet to be 
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grasped and owned locally.  This is not surprising since other countries also reported 
similar initial reactions to their HSPA.524,525 
 
It was felt that the results of the HSPA faithfully reflected the performance of Malta’s 
health system at the time.  In truth, the results did not come as a surprise since they 
mirrored what we, as health service leaders, already knew or suspected.  If this were 
not the case, then either we were working in the dark for many years or the 
methodology adopted for our HSPA was not appropriate for Malta.   
 
None of the dimensions were classified at the extreme ends of the spectrum (Very 
Good or Very Poor).  Three dimensions (Determinants of Health, Efficiency and 
Resources) were classified as ‘Poor’, whilst four dimensions (Financing, Quality, 
Access and Health Status) were deemed to be ‘Fair.’  One dimension (Responsiveness) 
scored above average.   
 
Predictably, ‘Determinants of Health’ indicators had a poor outlook due to the 
proportion of overweight and obese people, the relatively low physical exercise rates 
and also binge drinking which was found to be relatively high and is getting worse.  
As we already knew, ‘Efficiency’ was also not our forte (Azzopardi Muscat, et al., 
2017).   
 
Whilst average length of stay was doing well, low day case surgery rates, coupled with 
high bed occupancy rates and low surgical throughput still places increasing demand 
upon acute in-patient services and ‘slows’ the whole health service down, Malta being 
a small country depends upon its one main acute general hospital.  However, on a 
positive note, these bottlenecks have since started to be addressed.  The lack of 
resources remains one of the main challenges for the health service in Malta.  Bed 
capacity and the lack of adequate human resources in critical areas of the service 
remains a persistent structural challenge which needs to be tackled in the long term.   
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It was not possible to classify the dimension for Stewardship due to lack of data.  This 
presented the working group with a dilemma.  Whilst we understood the critical 
importance of the dimension reflecting stewardship, and hence leadership, proper 
allocation of resources, proper governance etc, we had no indicators to show for it.  
There were those who preferred to omit this dimension rather than concede that we 
did not have indicators to measure this.  On the other hand, others (including the author 
of this study) felt that it should be included precisely to show that this is fundamental 
and that we should develop the indicators to measure it.  This was more relevant given 
the prevailing political situation in Malta, where the government of the day was being 
pilloried for lack of proper governance, alleged corrupt practices and lowering of 
standards in the public service.526,527 
 
Three years have elapsed since the HSPA report was first launched.  Government and 
other stakeholders did take heed of some elements of this report.  Examples are the 
drawing up of national policies on diabetes and rare diseases, legislating to favour 
physical education and healthy balanced diets for a healthy lifestyle528 and tackling 
specific indicators which performed poorly such as ‘Incidence rate of TB, and multi 
drug resistant notification rate,’ ‘Standardised Breast Cancer Incidence Rates,’ and 
‘Hip fracture surgery initiated within 2 calendar days after admission to Mater Dei 
Hospital.’  It is this author’s view that more still needs to be done to imbue 
performance assessment into the decision-making process.  Perhaps, the second 
iteration of Malta’s HSPA, which is due in 2018, would make inroads into inculcating 
a new ethos on performance assessment.   
 
7.3.3  A shared HSPA methodology and model? 
It became apparent that, whilst different jurisdictions and countries employ diverse 
methods in developing their HSPA model, these methods still share a common basis.  
The exchange of modelling methods and data has created a collective understanding 
of HSPA, allowing for harmonisation of definitions, domains and indicators across 
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health systems.  Whilst this was facilitated by the HSPA EG, a common HSPA 
methodology was not pursued.   
 
Of more relevance was the EG’s reticence to create a common European HSPA model.  
This was not due to a lack of enthusiasm or capability but because it lacked the 
mandate, in line with the EU’s Treaties which declare that Health falls under the 
responsibility of individual member states.  However, this conflicts with the 
instructions given to EU Health Commissioner Andruikaitis to ‘develop expertise on 
performance assessments of health systems …’529  Hence, a common European wide 
HSPA model is not on the cards any time soon.  However, on the positive side, the 
EU, WHO and OECD are slowly converging onto a common European standard 
dataset through the production of the Health at a Glance report.530  This, after the 
realisation that these three international organisations request very similar 
performance information from their member states and rather than produce three 
separate data sets, a common performance assessment framework would be more 
valuable and effective. 
 
7.3.4  Policy vs science 
This research considered, in detail, the dynamics between creating a HSPA model 
which is scientifically robust but which, contemporaneously, retains political 
relevance.  The methods adopted have passed the test of time and several techniques 
now exist to test models for reliability and validity (Carinci, et al., 2015).  However, 
experience from member states has shown that scientific robustness is not enough.  
HSPA frameworks align themselves to the policy imperatives of the health system 
they are supposed to assess and as such, need to reflect the priorities set out by policy 
makers and politicians.531  This sometimes blurs the demarcation between scientific 
rigour and political exigencies.  If the two concur, then this wouldn’t present any 
difficulties but sometimes these two realities are at odds, which creates a strain 
between the researcher/scientist and the policy maker.   
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The distance between the technical and political aspects of the HSPA process usually 
determines the outcome of this tug of war.  The greater the distance, the less influence 
the policy maker exerts.  This creates a palpable dilemma for exponents of HSPA, one 
where a balance between scientific robustness and policy ‘closeness’ needs to be 
carefully maintained.   
More mature systems seem to handle this predicament better,532,533,534 whilst for those 
less experienced at HSPA, as was the case for Malta, this impacted upon the final set 
of indicators in the model.535  Indeed, the Malta HSPA process was significantly 
influenced by domestic and foreign policy considerations in the selection of its final 
set of indicators. 
 
7.4 The second research question - the policy conundrum 
This research sought to understand the relationship that HSPA has with policy 
development, with the aim of steering policy based on evidence rather than conjecture 
or other extraneous factors.  This was the basis for the second research question and 
shall be discussed hereunder. 
 
7.4.1  Understanding the policy (political) process in health 
Up to the turn of the millennium, health policies were primarily the domain of the 
health sector.  This statement seems superfluous.  However, the 2008 financial crisis 
changed the face of many sectors including health and, due to the advent of greater 
transparency and accountability, an increased emphasis on efficiency and value added 
and the need to sustain health systems with ever increasing costs, health policy was 
suddenly catapulted into mainstream politics (de Leeuw, Clavier & Breton (2014).  
This also inevitably led to the rise of performance assessment and HSPA over the past 
decade.536 
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The literature and document analysis presented many policy models (Warner & 
Bjarkman, 2011).  The Kingdon’s multi-stream or non-linear policy framework seeks 
alignment between the problem, potential policy solutions and the political will or 
commitment to effect change (Cairney & Jones, 2016).  This creates a ‘window of 
opportunity’ that ‘shakes’ policy into action.537,538  However, most models have 
difficulty in capturing the complexity that is policy making, where innumerable non-
evidentiary factors are involved.  This non-linear connection confounds the policy 
process, removing rationality from the equation.539  This mitigates against an 
evidence-based or performance-driven policy making process since these are based 
upon rational scientific reasoning, which is why the evidence generated through the 
performance assessment process is ‘often contested, and viewed differently by different 
actors at different stages in policy development.’540   
 
We have seen, in fact, that evidence-based policy utilises more of an ‘incremental, 
contingency or contextual approach,’ with evidence in a supplementing role rather 
than taking the lead.541  This is also the view of Cairney and Oliver (2017) in their 
recent discussion of evidence-based medicine versus evidence-policy making. 
 
It is important to understand and indeed wise to accept the above as a given.  Although 
the author occupied several senior national and international management and policy 
roles (and thus should have understood the political intricacies of health policy 
making), throughout this study he still struggled with the realisation that evidence in 
the form of performance assessment was not the prime (or only) mover in devising 
policy on the national or international stage. 
 
7.4.2 The policy cycle 
This leads to a discussion on the policy cycle, i.e. the relationship between evidence 
and policy making.  We have already seen that this is a tenuous link which requires 
careful consideration and time to mature.  A more pragmatic and realistic approach 
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needs to be taken to consolidate this relationship, where political priorities are aligned, 
as much as possible, with the scientific needs of the researcher, rather than relying 
solely upon the application of rigorous scientific methods.542 
 
Several examples of the application of the policy cycle have been cited, from the Dutch 
HSPA process (Van Den Berg, et al., 2014) to the Canadian model of policy making 
(Canadian Institute for Health Information, 2013).  Some countries, such as Portugal 
and Slovenia, commented how HSPA has been instrumental in providing an evidence 
base for their respective national health and reform plans.543,544  Also, the Expert 
Group acknowledged how HSPA and health reforms were intricately linked, with 
many jurisdictions incorporated HSPA into their reform process.  However, 
experience from other countries, such as Austria and Malta have shown that HSPA 
needs to be ‘embedded more deeply in the policy making process.’545  Many countries 
reported a ‘common challenge in linking HSPA reporting to policy action’546 and note 
a reluctance on the part of governments to ‘institutionalise’ HSPA into their policy 
making bodies and mechanisms.547,548  Hence, in summary, a mixed picture is drawn, 
where there have been instances where HSPA was incorporated into the policy cycle 
but it is still not extensively utilised to gauge whether HSPA will become a sustainable 
and long-term proposition. 
 
7.4.3  Good practice examples and country experiences 
As part of the process in collecting evidence on the link between HSPA and policy 
making, good practice examples and country experiences were sought from the 
literature and the document analysis.  This was augmented by the evidence collected 
from the EG’s work.  The author noted that there were numerous references on how 
HSPA could and should affect policy.  This theme was ever present in many of the 
discussions in the EG and in the various meetings the author organised or participated 
in.   
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Indeed, informing policy through HSPA was a common objective of most HSPA 
reports.  Examples from the Bridge and ECHO projects showed that knowledge 
brokering was an effective way of ensuring evidence links to policy making549 and 
routinely collected data is a minefield for generating evidence on performance 
improvements.550 
 
Several years of experience in developing their HSPA served the Belgian KCE and 
the Dutch HSPA well in consolidated HSPA as their nations’ foremost mechanism for 
national health policy making.551  Italy’s devolved yet coordinated response to 
performance assessment is a flag bearer to how performance assessment results should 
be communicated.  Their Performance Evaluation Programme resulting in significant 
improvements in population health and quality of life.552  Sweden also had the 
opportunity to develop a sophisticated performance assessment system over time and 
routinely produces regional and national policy reports based on the evidence 
gathered553.  As with some other countries, due to extraneous factors, the Austrian 
HSPA process has been put on hold (unofficially).554  Nonetheless, Austria has in place 
a well-developed performance system shared with Germany and Switzerland on 
measuring inpatient quality indicators for service improvement.555  During the 
author’s involvement on the EG, Hungary was in the course of developing its HSPA.  
This was completed in 2017 covering the period 2013-2015, following a legal directive 
that was passed in 2013.556   
 
Despite these good practice examples and country experiences, the concrete, practical 
and real-life application of HSPA in policy making still seems to be wanting.  This is 
in contrast with evidence-based medical practice which is now considered an integral 
part of safe and quality clinical practice.   
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Rechel and McKee (2014) were of the same opinion, admitting that implementation 
of HSPA driven policies are still lacking.557  The reasons for this are varied and have 
been covered extensively.  This author believes that, as is the case for most methods 
and treatments, more time is required to generate a portfolio of case studies 
demonstrating the impact that HSPA has on policy development and reform.   
 
7.4.4  Comparative performance assessment 
Comparative performance assessment is worth a special mention as part of this 
discussion due to its significant impact as ‘one of the most powerful drivers of health 
systems improvement by inﬂuencing policy-makers.’558  This method is viewed as the 
foremost and most effective tool in directing policy and influencing policy makers as 
regional, national and international comparisons of HSPA generated data are now 
considered key to policy development (Carinci, et al., 2015).   
 
Efficient data collection and analytical techniques and extensive communication 
networks have facilitated, if not spurred, international and regional comparative 
assessment methodologies, such as those applied by the ECHO, ERAnet and 
EUnetHTA projects.559,560  CION, WHO and OECD have joined ranks in advocating 
for data harmonisation and sharing as enablers of comparative performance 
assessment561 and are now actively considering consolidating their respective datasets 
to create a seamless and shared compendium of performance evidence.   
 
These techniques are, however, mired in difficulties and technical, technological, 
bureaucratic, political and cultural challenges need to be overcome to truly offer a 
platform for sharing evidence across the data landscape.  Moreover, comparative 
assessment methods are viewed both favourably and ominously by politicians, 
depending on which side of the fence they are sitting on.   
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Policy makers express disdain, even publicly, if the data shows negative results or 
regression in those areas under their responsibility.  On the other hand, promising 
outcomes are the politicians’ best friends.  Researchers need to be wary of this 
‘schizophrenic’ reaction to the evidence they are gathering.  Contextual factors should 
also be kept in mind before conclusions are reached using the comparative approach.  
As already intimated, potential hidden political agendas can distort the available 
evidence562 and results can be interpreted in a manner which is not accurate or 
reflective of the true situation.563  This to avoid what is termed as ‘policy abuses of 
comparative measures.’564   
 
7.5 A new model for informing policy through HSPA 
One of the strengths of HSPA is its predilection to utilise models to communicate its 
results.  Models of policy development are also important to understand the 
complexity of policy making.  In this last section, the author proposes a new model to 
garner a greater understanding of how HSPA impacts policy, based upon the findings 
of this research and the experiences of the author whilst pursuing these studies. 
 
7.5.1  Models to date 
This research has presented and discussed numerous models, particularly those 
pertaining to HSPA.  The creation of a HSPA model or framework invariably precedes 
any HSPA process as most countries and health systems have developed a model to 
reflect the main facets of their performance assessment system.  Although these 
models do not add to the scientific process, they are a pictorial representation of what 
the health system stands for and show which dimensions or domains are considered 
important for that health system.  The models depicted during this research pertained 
mainly to the HSPA of a country or region including those of Malta, Belgium, 
Netherlands, Portugal, Estonia, Turkey, England, Ontario (Canada), Australia, China, 
Georgia, Slovenia, Denmark, France and Sweden.   
 
Other models pertaining to international or national organisations were also discussed, 
such as those of the Institute of Medicine (USA), the Commonwealth Fund, OECD 
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HCQI, WHO, ECHI, SPC-JAFH and Canadian Institute for Health Information.  
Whilst each model has its peculiarities, they all follow a similar structure in depicting 
their dimensions and relationships with the external and internal environment.  Indeed, 
we have seen that most of these models have a theoretical basis to underpin the way 
the health system functions.  Most models use the Donabedian framework of input, 
process and outputs (used by Malta, Estonia, Portugal, Georgia).  This nomenclature 
is easy to adopt and reflects how many health systems are structured.  Other theoretical 
underpinnings include the Logic Framework (used by Canada and China), the 
Balanced Score Card (England), the HCQI Quality Model (OECD and Netherlands) 
and Goal Driven (WHO).   
 
Interestingly, the author came across very few models which illustrates the 
relationship between HSPA and policy development.  The only model which was 
formulated specifically to illustrate the input from performance assessment into the 
policy making process was the Ontario Model (Veillard, et al., 2010).  This showed 
how health system performance indicators are incorporated into financial modelling 
and accountability agreements which are then fed back into the strategic planning 
process. 
 
7.5.2  Proposing a new model 
Due to the dearth of models available to represent the main topic of this study, i.e. the 
relationship between HSPA and policy formulation, the author felt that it would be 
appropriate to suggest a new model to encompass the main findings of this research in 
a visual manner.  This model highlights the so called ‘tug-of-war’ between the 
evidentiary path to policy development through HSPA and other non-evidentiary 
extraneous factors that influence the policy agenda.  It acknowledges the multi-faceted 
approach to policy making whilst realising the significant role that HSPA plays in this 
process.  The ultimate objectives remain improved health status and better health 
outcomes. 
 
The dimensions on the left (in red) represent the building blocks of the HSPA.  The 
model places a direct link between each dimension and the policy area it exerts 
influence over.  Quality, the Care Environment, Access and Efficiency indicators 
mostly impact service provision and inform decisions around allocation, distribution 
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and management of resources in health services.  Risk protection and Equity provide 
information on level of health care coverage, uncovers gaps in equity of access and 
determinants mechanisms for health care funding.  Resource generation and 
allocation, stewardship (leadership, governance) and sustainability issues provide 
evidence and information on the budgeting process, investment planning and share of 
budgetary allocation within the health system.  Effectiveness indicators measure the 
outcomes of treatments and direct care services.  Finally, patient centred indicators 
dealing with responsiveness, appropriateness of care and safety are linked to the whole 
raft of patient initiatives such as patient pathways, clinical protocols and patient rights 
and obligations. 
 
On the other hand, there is a recognition that external not evidentiary factors also have 
an impact upon policy making.  These range from the public’s perspectives and 
expectations, to patient pressures, socio-economic and financial factors, political 
exigencies and international variables.  The policy process is also considered where 
various policy making models are outlined, reflecting the many channels available to 
formulate and implement policy.   
 
The ultimate goals and objectives are clearly delineated as the product of this model 
(Figure 7.1), where better health care outcomes, enhancing health status and 
improving health care services remain at the forefront of any performance-policy 
model.   
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Figure 7.1 HSPA - Policy Development Model 
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7.6 An innovative approach to research 
This thesis sought to elicit evidence on the role performance assessment, and HSPA 
in particular, has on policy development and reform.  This initially involved the 
analysis of over 150 documents.  As rich as this exercise was, further in-depth 
exploration was required to gain a deeper understanding of this complex subject.  
Initially, the traditional route of organising key informant interviews and a focus group 
or modified Delphi Technique meeting/s was to be pursued.  However, the author’s 
involvement on Malta’s HSPA serendipitously led him to the centre of the European 
Union’s focus on HSPA, which, at the time, was viewed by the European Commission 
with fervour and zest as the ‘new kid on the block.’  This permitted the author to 
continue to pursue an intense and very rewarding, yet unique participatory observation 
study over a three-year period, taking him to many capitals of Europe and networking 
with prominent experts in the field. 
 
The ethnographic nature of this method ranged from participant observation to 
participatory action.  The author’s membership on Malta’s HSPA Working Group and 
in the EU HSPA Expert Group corresponds with a participatory research 
methodology.  However, this did not follow the traditional participant observatory 
route as suggested by Gold (1958) (based on the level of concealment of the researcher 
from the participants).  Whilst the author was a complete participant in these groups 
(full participation), his research was also known to the other members of the groups 
(no concealment).  Alternative viewpoints to this methodology were sought DeWalt 
& DeWalt (2011, pp. 4-5); Spradley (1980, pp. 58-62); Adler and Adler (1987, p. 39); 
Potvin, Bisset and Walz (2013, pp. 433-441).  However, these were unsatisfactory as 
they were considered rather arbitrary and out of synch with the author’s actual 
experience.   
 
The author could not find similar methodological instances to mirror this research 
experience although as Whyte (1979) observes, the collaborative nature of 
participatory research is the most salient feature of this method as it nurtures a level 
of trust and cooperation between researcher and participant and more importantly 
gains access to the richness and fullness of information that the participatory process 
provides.  This level of trust was also essential to complete the transition from 
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participant observation to participatory action research, which then allowed the author 
to steer Malta’s HSPA working group as well as shape the evolution of HSPA at a 
European level.  Wadsworth (1998, p. 1) describes this as ‘an expression of ‘new 
paradigm science’ that differs significantly from old paradigm or positivist science.’   
 
7.7 The evidence base 
This research has added to the evidence base on performance assessment, particularly 
in relation to policy development.  It has shown how policy makers can and indeed 
should be utilising performance data as evidence to take policy decisions.  It has shown 
the methods available, the challenges and the caveats that one needs to be aware of 
when linking performance and HSPA with policy making.  This research has also 
highlighted which methods and approaches work and which require further 
elaboration. 
 
7.7.1  Gaps in evidence 
The unavailability of information for decision makers leads to insufficient use of 
knowledge for measuring and enhancing health system performance.  The Alliance for 
Health Policy and Systems Research of the WHO believe that the concept of 
‘insufficient use’ is two-dimensional.  On the one hand, sufficient information is not 
available to be able to take informed decisions.  Secondly, even when information is 
available, policy makers do not know how to use it or do not use this information to 
their advantage.  Both these scenarios present difficulties in an ever-changing health 
care scenario.565   
 
For this reason, WHO, at an early stage, cognisant of these challenges, drew up a report 
on ‘Investing in Health Research and Development’, which paved the way for an 
increased investment in health systems research on performance assessment.566 
 
7.7.2  Further research 
As far back as 2001, WHO’s Executive Board had already recognised the need and 
importance of evidence-based research.  It suggested the development of a ‘multi-year 
                                                 
565 93 Alliance for Health Policy and Systems Research, Geneva.  Strengthening health systems. 
2004. Pg. viii. 
566 55 – WHO (Europe).  Health systems strengthening in the context of Health 2020.  2015. 
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plan for further research and development of the framework and its relevant indicators 
to assess the effectiveness and efficiency of health system.’567  Since then research and 
studies on evidence-based management or policy-making have become more 
mainstream.  Kyratsis Y. et al. (2014) claim that ‘the discourse espousing the 
principles of evidence-based management and the idea of using research evidence to 
support managerial decisions also emerged in mainstream management and 
organisation studies literature.’568 
 
Public health and policy research is not as well developed and not equally funded as 
other health sciences although the European Observatory on Health Systems and 
Policy believes that ‘excellence in public health research will strengthen the role of 
public health in Europe and support (further) funding.’  However, it also calls for 
public health research to be more systematically driven and to be based on more cost-
effective research goals.569   
 
Fortunately, there are many EU funded research projects such as SPHERE570 and 
STEPS,571 which, although providing ‘insights into the state of public health research 
in EU member states,’ Europe still lags behind the United States where ‘far more 
systematic research’ is undertaken.572  This is perhaps because research at EU level is 
not yet well coordinated as the Working Party on Public Health at Senior Level admits 
by stating that ‘the Commission could facilitate the setting up and the continuity of a 
research infrastructure to support the harmonisation of data collection, the 
development of indicators, methodologies for analysis and methodologies for 
recommendations.’573  
                                                 
567 52 WHO Executive Board.  Health Systems Performance Assessment. 2001. Pg. 3. 
568 127 Kyratsis Y. et al.  Making sense of evidence in management decisions. Health Serv Deliv 
Res 2014. Pg. 1. 
569 8 Euro Observer Volume 21, No. 1, 2015. Reducing inequalities in health and health care. Pg. 26. 
570  www.ucl.ac.uk/public- health/sphere.  [Accessed 3 July, 2016]. 
571  www.steps- ph.eu [Accessed 3 July, 2016] 
572 125 Rechel, B., McKee M. (Eds).  Facets of Public Health in Europe. EOHSP. 2014. Pgs. 289, 318. 
573 4 Working Party on Public Health at Senior Level - Report by sub-group 5:  
 Health investments. 2013. Pg. 27. 
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7.8 A critique of the study 
Given the qualitative approach adopted for most of the study, certain challenges 
peculiar to to qualitative studies were encountered.  This section discusses these 
challenges and the techniques adopted to assure the quality of the study. 
 
7.8.1  Attributability 
The major challenge or limitation of HSPA is one of attributing causality, in the form 
of performance measurement, to the development of policy, given that policy 
formulation takes many forms and is determined by a myriad of internal (to the 
organisation/system) and external factors such as the economy, values inherent to the 
population and other environmental and political influences.  Hence, the relationship 
between performance and policy, even after considering political and economic issues, 
may remain open to external and other influences and confounders, due to the more 
‘political’ and managerial issues commonly encountered in service delivery.   
 
As is widely evidenced, many other non-health factors have had and continue to have 
a direct or indirect influence upon policy setting.  Furthermore, environmental, socio-
economic and other factors are known to have an impact upon the health status of the 
population (Novice, 1999).  Indeed, much research is currently being carried out on 
the social determinants of health (Wilkinson & Marmot, 2003).   
 
Researchers have partially dealt with this challenge by generating performance 
indicators which are considered a direct consequence of the health system and not of 
other non-health systems, such as that of avoidable or amenable mortality (Nolte & 
McKee, 2008).  However, confounding remains a challenge that needs to be 
acknowledged, if not overcome.  This is the reason why this research did not only look 
for evidence of a direct and indirect causal link between health system performance 
assessment frameworks and policy development and change but also at other factors 
that influence policy.  This was possible since the nature of the study permitted a 
deeper analysis of the factors impacting upon the pace and extent of policy 
development and reforms, both health related and non-health variables.   
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7.8.2  Confirmability 
Confirmability relates to ensuring an objective interpretation of the findings, rather 
than being subject to the researcher’s whims and preferences (Lincoln & Guba, 1985).  
Whilst a certain element of personal intrusion into the interpretative process cannot be 
avoided, the author sought to confirm and support his findings through discussion with 
the other members of the NEWG and the HSPA EG.  The uptake of a document 
analysis worksheet for each report or document that was reviewed also ensured a 
standardised and methodological approach to the analysis.  When discussing the 
findings, the author also sought to present rival and contrasting viewpoints, as a means 
to remain as close as possible to the varying interpretations of the participants 
(Silverman, 2013). 
 
7.8.3  Replicability 
This refers to the dependable nature of the study in terms of repeatability (Bowling, 
2014).  It presupposes that if the study were repeated by another researcher using the 
same context and same participants, similar conclusions would be reached.  This was 
kept in mind when outlining the detail of the methods used, both as part of the 
development of Malta’s HSPA and also in his participation of the HSPA EG.  This 
detail would allow other researchers to follow suit and adopt the same methodology. 
 
7.8.4  Credibility 
This relates to the trustworthiness of the research process and is also linked to 
dependability.  The author’s research as part of the NEWG was embedded into a 
collective, where issues were discussed, and consensus was reached on the methods 
to be adopted.  This is congruent with similar studies were the development of a HSPA 
model requires multi-user and multi-expert input (Perić, Hofmarcher-Holzhacker & 
Simon (2017).  Also, the multiple methods utilised as part of the participatory 
observation phase ensured an element of triangulation and verification.  The notes and 
data collected by the researcher in this phase was complemented by focus groups and 
peer review meetings, which continued to discuss and debate the issues at hand.  
Moreover, the immersion of the author into a group of individuals who were the de 
facto experts of HSPA in Europe for over 3 years certainly lended credibility to the 
research experience  
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7.8.5  Transferability 
Transferability refers to the applicability and relevance of this research and its findings 
to other settings, other populations, locations and time frames  (Miles & Huberman, 
1994).   Throughout the text, the author sought to explain the contextual and social 
relationships of the key players involved as well as the political milieu that most 
proponents faced when integrating HSPA into their policy cycle.  This provided 
sufficient detail to understand how and if various aspects of this study can be 
transferable to other settings and situations.   
 
Certainly, the reality of the small state or the small health system of a region within a 
larger country can be associated with this study (Grech & Lai, 2014).  Indeed, other 
small states such as Slovenia and Latvia have sought to replicate parts, if not all, of 
the methodology adopted for Malta’s HSPA. 
 
The findings derived from the author’s participation in the EU HSPA Expert Group 
pertain to the European arena and are certainly applicable to most countries in the 
European region.  Indeed, the research findings may also be transferable to other geo-
political blocks or regions, similar in constitution and political status to Europe. 
 
7.9 Conclusion 
This chapter provided an overview of the salient points that have emerged in the course 
of this research journey, culminating with a proposal of a new model to understand 
how HSPA and other factors influence and direct policy.   
 
The next chapter draws some final conclusions and suggests a number of 
recommendations for the future.  
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CHAPTER 8 
CONCLUSION AND RECOMMENDATIONS 
 
 
 
"You can fool all the people some of the time, and some of the people 
all the time, but you cannot fool all the people all the time."  
Abraham Lincoln 
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CHAPTER 8  
CONCLUSION AND RECOMMENDATIONS 
 
 
 
8.1 Introduction 
This final chapter rounds up the main salient points that have arisen throughout this 
research and puts forward recommendations for further research and for policy 
development. 
 
8.1.1  HSPA: Its current and future position 
HSPA has been with us for around 15 years.  During this time, both the scientific 
community and health service leaders have come to appreciate and use the results 
emanating from HSPA to primarily improve services but also to inform policy.  They 
have also learnt how to apply HSPA in many settings and contexts (Kelley, Arispe & 
Holmes (2006).  We have seen that a conceptual model is important for HSPA to 
outline the boundaries of the heath system and delineate its various components as 
well as select the most appropriate indicators.   
 
It was also important to understand the limitations of HSPA, especially in view of 
attributability or causality, as well as limitations in comparability (Mainz, et al., 2004).  
HSPA is not the be all and end all of performance assessment but should be viewed as 
one of the main tools available today to assess the performance of health systems.  
Recognising its ‘fit’ into the performance assessment landscape is important to 
position HSPA correctly.   
 
Today, there are many advocates for HSPA.  Most view HSPA as an effective means 
to develop evidence-based policies, improve quality of care, and strengthen health 
system governance.  It has the support of all the major international agencies and 
organisations which believe that each health system should have a HSPA framework 
to inform policies, improve care as well as increase transparency and accountability.574   
                                                 
574 139 ERRIN 15.  Enhancing Value in European Health Systems - The Role of Outcomes 
Measurement.  2016. Pg. 33. 
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The EU views HSPA as a ‘solid tradition in the Member States and at European 
level.’575  In truth only time will tell if this tradition is upheld and strengthened or 
whether HSPA would be superseded by newer more innovative measurement 
methodologies.  In this author’s view, HSPA is already a permanent feature in health 
and it can only improve and become more attuned to the needs of the health systems 
it is supporting. 
 
8.1.2  Policy making: Adopting a wider definition 
The greatest quandary faced by the author in this study was why evidence-based 
solutions to problems are not implemented in practice.  There is no easy answer to 
this.  We have seen that policy making is a dynamic, shifting and sometimes 
unpredictable process, involving a myriad of actors with different priorities and 
agendas.576  We have also deduced that policy is influenced by many factors, not all 
of which are grounded in evidence.  This thesis held the premise, certainly initially, 
that evidence is only obtained through robust scientifically proven methods, including 
data and information obtained through HSPAs.   
 
On hindsight and after this journey of discovery, it is now evident that this could be 
considered as a ‘narrow’ definition of evidence.  If a wider interpretation of evidence 
is considered, it can be argued that many other factors, which are not necessarily 
grounded in scientific fact, also contribute towards providing the required evidence to 
take the correct policy decisions.  We have recognised this as a paradigm shift from 
‘evidence-based public health,’ to ‘evidence-informed public health,’ one which 
‘acknowledges more explicitly the multitude of factors that influence public health 
decisions.577  The author feels that this consideration is fundamental to understand the 
role that HSPAs (and other evidence gathering methods) have in future policy making.  
Moreover, understanding the ‘decision-making processes and factors that influence 
the process can increase the potential for inserting research information into the 
process.’578 
                                                 
575 4 Working Party on Public Health at Senior Level - Report by sub-group 5:  
 Health investments. 2013. Pg. 24. 
576 14 Leppo, K., et al. Health in All Policies. 2013. Pg. 5. 
577 125 Rechel, B., McKee M. (Eds).  Facets of Public Health in Europe.  EOHSP. 2014. Pg. 303. 
578 93 Alliance for Health Policy and Systems Research, Geneva.  Strengthening health systems.  
2004. Pg. 51. 
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Once the above is recognised and accepted, then HSPA can and already has been 
considered as one of the more important and relevant methods to inform policies and 
plan reforms.  This research has shown that it is difficult to directly attribute HSPA to 
specific policies and reforms but this is not to say that this relationship does not exist, 
only that measuring its impact is difficult.  This is because researchers look towards 
the traditional scientifically robust methods to seek out an association but this study 
and the chosen methodology has clearly shown that other creative approaches could 
be used to evaluate and trace the relationship between HSPA and policy development.  
 
8.2 Limitations of method and analytical approach 
The benefits and richness of the research methodology, in particular the mixed 
methods approach and the participatory observatory experience undertaken have 
already been highlighted under the respective methods sections and so shall not be 
repeated here.  As with all research, limitations and challenges have been encountered.  
Many of these have already been covered under the respective chapter.  Those 
highlighted in the next sections refer to overall considerations. 
 
8.2.1  Phase I: Document analysis 
As with most qualitative research, because samples are usually (though not always) 
small and non-probabilistic, the ability to claim a representative sample is often 
diminished, and statistical generalization is impossible, although this was not the aim.  
However, this was partly mitigated by extending the number of documents that were 
reviewed to a substantial amount (n=159) until no new information was generated, 
reaching saturation of the data analysed.   
 
One of the more common pitfalls in document analysis is that subtle or less-than-
obvious data may be missed or overlooked.  This was mitigated by sticking to a 
standardised process for analysis and by creating a document analysis worksheet for 
each document.  Another inevitable limitation was the use of only the English 
language for sourcing the documents.  Whilst this is not usually a problem when 
searching for research literature, some official policy and legal documents in European 
countries are not in English and so have been automatically excluded from the study.  
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Translation techniques could have been employed but this was not feasible for a single 
researcher with time limitations. 
 
Another well-documented shortcoming is the risk of low retrievability, wherein it is 
sometimes not possible to retrieve all relevant documentation due to access 
restrictions.  However, this is now less of a problem with the advent of the internet, 
especially since most documents, even official and policy documents, are in the public 
domain or can be accessed due to freedom of information provisions (Yin, 1994, pp. 
32-33).  Documents are not produced for research purposes but for a myriad of other 
reasons.  They are created independently of the research agenda.  This inevitably leads 
to a mismatch between the sufficiency of detail required from a document and the 
research question under examination.   
 
One other limitation linked to a single researcher working on his/her own, as is the 
case for this study, is biased selectivity, wherein certain types of documents are 
included or excluded from the analysis, depending upon the perspective of the 
researcher.  This is overcome by procuring as many documents as possible from as 
varied a source as possible.   
 
8.2.2  Phase II: Development of Malta’s HSPA 
The main limitation, in terms of scientific ‘purity,’ was the influence that the policy 
makers had on the latter stage of the process in the development of Malta’s HSPA.  
Whilst this was not obvious and was actually expected as part of the methodology, it 
did impact the selection of the final set of indicators, some of which were not chosen 
on the basis of the adopted scientific method but were inserted to meet the contextual 
and political exigencies at the time.  Nonetheless, the development of the model, its 
dimensions and the selection of most of the indicators, as well as the data collecting 
and analytical process were all methodologically sound. 
 
8.2.3  Phase III: Participatory research 
The obvious possible limitation was one of observer bias.  However, since the author 
was one of the first members of the HSPA Expert Group, his presence and contribution 
was (and still is) appreciated by all and the rapport generated was such that it did not 
impede, in any way, frank and candid discussions. 
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8.3 Recommendations for action by researchers and policy makers 
There are several recommendations for action directed at both researchers and policy 
makers, on their own as well as together.579  It is important for all those involved to 
view ‘performance management as a collective exercise that influences policy and 
leads to continuous quality improvement, rather than as a technical problem that 
involves few stakeholders and leads to few policy relevant outputs.’580 
 
The HSPA process is quite unique in that it requires the close interface of researchers 
with policy makers.  Whilst traditional research is positioned at a distance from its 
audience, for HSPA to be effective, there needs to be a close interplay between those 
who develop HSPA and those who act on it.  This collaboration is key for HSPA and 
determines the difference between those HSPAs that have been successful and those 
that have not had an impact on health system improvement and policy change. 
 
Mutual action by both researchers and policy makers contemporaneously is therefore 
advocated, not only to foster greater cooperation but to also create relationships based 
on mutual trust and understanding.  This is the basis for generating evidence from 
HSPAs.  This can be achieved through the implementation of health policy networks 
or observatories that promote the joint efforts of researchers and policy makers.  The 
European Observatory of Health Systems and Policies is a prime example of such a 
collaborative effort.  The benefits emanating from its work are numerous as the 
Observatory has participated and indeed was implicated in many reforms and policy 
changes. 
 
Moreover, knowledge brokering methods need to be enhanced to foster a greater 
‘awareness about concepts and tools among policy-makers, stakeholders and 
researchers.’581  This is achieved through supporting the strategic process for 
evidence-based policy making,582 and increasing the availability of data, health 
information, performance indicators and relevant evidence.583  Researchers and policy 
                                                 
579 10 Garrido, MV, et al. Health Technology Assessment and Health Policy Making in Europe. 
2008. Pg. 150-151. 
580 84 OECD.  OECD Reviews of Health Care Quality-Italy 2014-Raising Standards.  2014. Pg. 182. 
581 102 Lavis, JN., et al. Bridging the worlds of research & policy in European health systems. 
EOHSP. 2014. Pg. 9. 
582 149 WHO (Europe).  Investment for Health Appraisal in Malta.  2001. Pg. 17. 
583 49 SNIPH. Ten years of Swedish public health policy. 2013. Pg. 22. 
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makers also need to work more closely together to create efficient health information 
systems for the collection and use of performance and outcomes data.  ‘The 
development of health information infrastructures should therefore be a key objective 
of national governments in the development of HSPA frameworks.’584  This is also 
achieved through the uptake of national registries and other administrative databases 
for measuring quality of care and the use of electronic health records to generate the 
required detailed clinical information to populate a health information system.585 
 
On the part of researchers, whilst their work is essential for the development of HSPA 
and for extracting the evidence derived from their implementation, it is important that 
they seek to generate evidence that is cost-effective, of policy relevance and that it 
creates value for money.  The aim of such research is very different to that derived 
from academic research.  Data analysis and results from HSPA feed directly into the 
improvement and change management cycle and so the evidence needs to be relevant 
for managers and policy makers.  To this effect, HSPA findings need to be translated 
into meaningful conclusions, where the results are communicated in a succinct but 
factual manner.586  Again due to the unique nature of HSPA as a tool for provided 
evidence in the form of data and performance indicators, it is important for researchers 
to retain a modicum of impartiality and autonomy, combined with a great deal of 
objectivity. 
 
On the other hand, policy makers are at the receiving end of the evidence resulting 
from the HSPA process.  They have the enviable responsibility of incorporating HSPA 
into the policy agenda and need to ensure an open transparent setting to allow HSPA 
to fully realise its potential.  Policy makers need to inculcate and encourage a culture 
of inquiry, change and openness, whilst acquiring the required skills and training to 
understand and assimilate the research findings and evidence.  They need review the 
available evidence regularly, constantly question the findings and enquire into the 
methods used by researchers.  In so doing they also need to improve access and 
augment interaction with researchers.  As the Belgian HSPA concluded in their third 
                                                 
584 139 ERRIN 15.  Enhancing Value in European Health Systems - The Role of Outcomes 
Measurement.  2016. Pg. 35. 
585 78 OECD.  Improving Value in Health Care – Measuring Quality. 2010. Pg. 11. 
586 70 WHO (Europe).  Environment and health performance review – Poland. 2009. Pg. xvii. 
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iteration - ‘policymakers should (therefore) define health system objectives that are 
measurable, set deadlines by which these objectives should be attained, and appoint 
accountable organisations. Quantified targets should be proposed along with specific 
objectives.’587 
 
8.4 Policy recommendations 
A number of recommendations are also advocated for the adoption of policy changes 
that would serve to promulgate HSPA at a national and regional level.   
 
The absence of legislation and other legal instruments was apparent in performance 
assessment, especially linked to the implementation of HSPA.  As with many other 
methods, legislation is required, both at EU level and nationally to anchor HSPA into 
the policy cycle and ensure its permanence and relevance for policy makers.  This is 
usually followed by the presence of an adequate governance structure for the 
development, analysis and implementation of HSPA588.  Countries which have 
successfully implemented HSPA have adopted a robust and legally binding 
organisational framework to manage the HSPA process. 
 
Following on the work of the HSPA Expert Group, the author believes that an EU-
HSPA network should be created, to continue this valuable work and possibly serve 
as a prelude to an EU-wide HSPA model in the future.  The purpose for this 
recommendation is not to straight jacket member states into adopting a common HSPA 
framework but to facilitate comparative performance assessment methodologies and 
to enhance mutually learning and growth. 
 
Investment in EU, national and local data collection and analytical tools is essential to 
generate the information and evidence required to sustain any performance assessment 
system, including HSPA.  There have been several attempts at developing common 
definitions and data collecting mechanisms, some of which have been successful in 
generating the required evidence for policy making (Carinci, et al., 2015); 
                                                 
587 158 KCE.  Performance of the Belgian Health System Report 2015.  2015. Pg. 64. 
588 250 Meeus P. HSPA Belgium And so what.  Peer Review meeting.  Brussels. May 2014. 
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(Braithwaite, et al., 2017).  However political and financial commitment is required at 
the highest level to sustain this movement. 
 
8.5 Recommendations for further research 
Several additional gaps in research have been identified.  These merit further work.   
 
Whilst HSPA provides a high-level balanced overview on the performance of a health 
system, more detailed analysis is always required to assess the performance of its 
component parts.  Whilst HSPA reports provide a global evaluation, methods should 
be developed for the comprehensive monitoring, preferably in a timely fashion, of 
programmes embedded within the HSPA model. 
 
As we have seen, the methodological process for the development and implementation 
of HSPAs merits further attention, especially in the development of more elaborate 
domains such as those linked to integrated care, the identification of more suitable 
indicators for under-developed areas such as primary care, mental care, chronic care, 
end of life care and integrated care, the linkage of indicators to concrete themes and 
services.589 and the elucidation of other tools and multiple sources to draw conclusions 
and develop policy. 
 
Comparative performance assessment is one of the most powerful assessment tools 
available.  However, this is fraught with difficulties and challenges and improvements 
in international comparative assessment methods and benchmarking through 
standardisation of processes, definitions and data collecting systems is solicited. 
 
During the course of this research, the author witnessed several attempts of member 
states to start on the HSPA journey.  However, some countries fail to get beyond the 
planning stage due to their lack of preparedness and the lack of political commitment.  
A tool to ascertain whether a health system is prepared for the introduction and 
implementation of a health system performance assessment framework would be 
extremely useful for those countries that have yet to embark on this process.  This 
                                                 
589 222 Grech K. Karanikolos M. Nolte E. Quality Policy Focus Group Meeting notes.  Brussels.  
 3 Nov. 2015, pg. 4. 
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‘maturity model’ would indicate the gaps and challenges that a health system would 
face before introducing HSPA and allow them to address these gaps before beginning 
this journey. 
 
The HSPA-Policy Making Model suggested at the end of Chapter 7 requires testing 
and tweaking.  Although a theoretical framework, testing of this model would confirm 
its validity or otherwise and further research is required to test this model on the field. 
 
8.6 Conclusion 
This thesis has been an enduring experience and exciting journey.  It tackled an 
innovative and exciting topic which has increased in relevance and importance over 
the past few years.  A performance assessment framework is no longer optional or a 
‘nice to have.’  It is now recognised as an essential component of any health system 
or health service.  It provides information on the status of the health system with the 
aim of improving or changing direction to improve.  As one of the main performance 
assessment methods, HSPA has developed almost exponentially, even during the 
course of this research and is now acknowledged as one of the more robust and policy 
relevant performance tools in health care. 
 
Malta, as many other smaller countries, is in transition.  Whilst its health system is 
well developed and comprehensive, as part of its national strategy, it required a 
performance assessment framework to inculcate a culture of improvement and quality 
care.  The production of Malta’s first HSPA served this purpose and led to tangible 
improvements in a number of important areas of its health system.  In recognition of 
this accomplishment and of methodology adopted for Malta’s first HSPA, the author 
has now been tasked to coordinate the production of the second iteration of Malta’s 
HSPA as well as the development of Latvia’s and Slovenia’s first HSPA frameworks.  
Appendix 18 presents a list of publications and projects related to this research.   
 
The second objective of the thesis was to understand the impact HSPA has on policy.  
This was inevitable, given the author’s background and experience in managing health 
policy at a national and European level.  The author wished to explore whether 
evidence-based policy making (through the use of HSPA frameworks) has come of 
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age, similarly to evidence-based medical care.  The logical consequence of health 
system performance assessment was that it would direct or at least influence policy 
development in a positive constructive manner.   
 
This study has shown that whilst HSPA and other evidence-generating tools influence 
policy, policy development is a complex, multifaceted process.  HSPA needs to be 
incorporated into a myriad of other variables.  Researchers need to understand how to 
shift the focus more on the available evidence and policy makers need to separate the 
evidence from other factors to generate meaningful policy options.  Nonetheless, 
HSPA is becoming more relevant and mainstream and is being sought out increasingly 
more by the political class. 
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Appendix 1 
Domains/dimensions of international HSPA Frameworks 
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Acceptability   X        X 
Accessibility X  X X X X X X X X X 
Appropriateness X  X X       X 
Care 
environment 
and capability 
X       X    
Competence and 
capability 
  X X   X X   X 
Continuity   X X   X X   X 
Effectiveness, 
improving 
health and 
clinical focus 
X X X X X X X X X X X 
Expenditure  
and cost 
        X X  
Efficiency X  X X X X X X X X X 
Equity  X X X X X X X X  X 
Governance X       X    
Patient-
centredness, 
patient focus 
and 
responsiveness 
X X  X X X  X X X  
Safety  X X X X   X X X X 
Sustainability    X (X)     X  
Timeliness  X   X   X     
Source: Arah, O. et al., 2006. A conceptual framework for the OECD Health Care Quality 
Indicators Project. International Journal for Quality in Health Care, 
September.pp. 5-13 
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Appendix 2a 
Phase I: Methodology – Document Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Document analysis 
of performance and 
policy oriented 
reports and 
literature. 
Document Analysis 
Report using An 
Inductive Thematic 
Analysis approach. 
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Appendix 2b 
Phase II Methodology: Development of Malta’s National Health 
System Performance Assessment Framework 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
Review of literature, policy 
documentation & international 
frameworks. 
Analytical discussion amongst 
expert core group and testing for fit 
into Malta scenario. 
Development of draft 
model & framework, 
including domains. 
Extraction of indicators from 
national vertical strategies. 
Mapping of indicators onto the 
draft framework and the 
identification of gaps in domains. 
Cleaning and filtering of 
indicators (for duplication and 
clarity in definitions) – to produce 
candidate indicators. 
Scoring of candidate indicators 
using a criteria matrix and 
algorithm adapted from OECD. 
Sensitivity analysis of scores. 
Mapping of shortlisted indicators 
onto the framework and 
identification of gaps. 
Testing model for reliability and 
validity. 
External validation using Likert 
scale on-line survey. 
Setting definitions of indicators 
and benchmarks. 
Creation of draft set of 
national performance 
indicators. 
Testing and 
implementation of 
new framework. 
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Appendix 2c 
Phase III Methodology – The Policy Cycle 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Participatory action 
research in EU Expert 
Group on HSPA. 
Participatory 
Research 
Analysis. 
Peer Review Meetings. 
Analysis of 
meetings’ 
outcomes. 
Analysis of policy 
groups’ findings. Policy Focus Groups. 
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Appendix 3a 
Data Analysis Worksheet – Example 1 
 
TITLE  3 - Seychell M, Hackbart B. The EU health strategy – investing in health. Public Health 
Reviews. 2013;35 
 
DATE 2013     TYPE Article 
 
AUTHOR/ EDITOR Seychell M, Hackbart B  ORGANISATION/SOURCE DG 
Sante, EU  
 
BIAS OF AUTHOR/ BACKGROUND 
As Deputy DG, Seychell has an interest in promoting the EU agenda and specifically the 
health agenda in relation to EU 2020. 
 
KEY WORDS  
Public policy, public health, health systems, sustainability, European Union 
 
INTENDED AUDIENCE  
Policy makers, academics 
 
WHY WAS DOCUMENT WRITTEN?  
As an explanation or summative attempt to the main document on the Social Investment Package 
(SIP) including a document dedicated to ”Investing in Health 
 
SUMMARY OF DOCUMENT FINDINGS – MAIN CONCLUSIONS 
A healthy population and sustainable health systems are decisive for economic growth. Investing in 
sustainable health systems means that cost-effective spending, structural reforms and sound 
innovation can bring efficiency gains and secure better health outcomes. Investing in people’s health 
also boosts economic growth by enabling individuals to remain active longer and in better health 
 
EVIDENCE OF LINK BETWEEN HSPA & POLICY DEVELOPMENT 
In 2013 the Annual Growth Survey (AGS) recommended monitoring performance of health system 
against the twin aims of providing access to high-quality healthcare and using public resources more 
efficiently. 
 
EU giving importance to assessment of performance to foster growth and sustainability 
OTHER IMPORTANT INFERENCES. 
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Appendix 3b 
Data Analysis Worksheet – Example 2 
 
TITLE 155 – van den Berg, M. et al.  Dutch Health Care Performance Report 2014.   
 
MJ van den Berg, D de Boer, R Gijsen, R Heijink, LCM Limburg, SLN Zwakhals.  Dutch Health 
Care Performance Report 2014.  National Institute for Public Health and the Environment 
(RIVM) 
 
DATE   2014   TYPE Country report 
 
AUTHOR/ EDITOR MJ van den Berg, D de Boer, R Gijsen, R Heijink, LCM Limburg, SLN 
Zwakhals 
 
ORGANISATION/SOURCE  National Institute for Public Health and the Environment 
(RIVM) 
 
BIAS OF AUTHOR/ BACKGROUND 
Experts and researchers on subject.  Responsible for developing HSPA in Netherlands. 
 
KEY WORDS  
 
INTENDED AUDIENCE  
Policy makers, politicians, parliament, academics. 
 
WHY WAS DOCUMENT WRITTEN?  
Fourth iteration of HSPA report of the Netherlands. 
 
SUMMARY OF DOCUMENT FINDINGS – MAIN CONCLUSIONS 
Overview of results of HSPA report.  Policy links and decisions are elaborated upon.  Each 
conclusion has policy implications and decisions. 
 
EVIDENCE OF LINK BETWEEN HSPA & POLICY DEVELOPMENT 
Some examples and good practice of linking policy with hspa results and recommendations. 
 
OTHER IMPORTANT INFERENCES 
Rather meagre in presenting policy inferences, even though this is the fourth HSPA report. 
 
  
 338 
Appendix 4  
List of members of National Expert Working Group (NEWG) 
 
Dr Neville Calleja,  a/Chief Medical Officer - Chair 
Dr Natasha Azzopardi Muscat,  Consultant, Public Health Medicine 
Dr Antoinette Calleja,  Officer in Scale 5 
Dr Miriam Dalmas,  Consultant, Public Health Medicine 
Ms Karen Demicoli,  Director, European Policy & International Affairs 
Dr Sandra Distefano,  Consultant, Public Health Medicine 
Dr Kenneth Grech,  Consultant, Public Health Medicine 
Dr Maya Podesta,  Specialist Trainee, Public Health Medicine 
Dr Taavi Lai,   WHO Advisor to NEWG 
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International HSPA Frameworks 
 
World Health Organization, OECD and Netherlands 
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European Commission  
Social Protection Committee (Joint Assessment Programme) 
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WHO Sustainable Development Goals Framework 
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Definitions of dimensions 
 
CATEGORY DIMENSION DEFINITION 
DRIVERS 
(INPUTS) 
Stewardship 
Refers to, leadership, governance, legislation 
& regulation. 
Resources 
(Resource 
Generation) 
Corresponds to the “financial, human, 
physical, technical and informational 
(including evidence and high-quality data) 
resources that are available to the health 
system.”590 
Financing 
The method and means of financing the 
health system. 
Health Care 
Services 
The delivery of care to patients with the aim 
to improve, cure or manage ill health. 
Public Health 
Services 
Public Health is defined as “the art and 
science of preventing disease, prolonging life 
and promoting health through the organized 
efforts of society.591 
 
Public health systems are commonly defined 
as “all public, private, and voluntary entities 
that contribute to the delivery of essential 
public health services within a jurisdiction. 
INTERMEDIATE 
GOALS 
(Equity and) Access 
Access – “[I]s the ease with which health 
services are reached.  Access can by physical, 
financial or psychological, and requires that 
health services are a priori available.”   
 
The notion of access encompasses, “all types 
of delay during the contact between a patient 
and a provider, such as delay for a medical 
appointment, the waiting time in an 
emergency room and delays for surgery after 
admission.”592 
 
  
                                                 
590  Canadian Institute for Health Information. 2013.  A Performance Measurement Framework 
for the Canadian Health System. Canadian Institute for Health Information: Ontario, pg. vii. 
591  Acheson D. Public health in England. The report of the committee of inquiry into the future 
development of the public health function. London, HMSO, 1988 
592  Kelley, E., Hurst, J. 2006.  Health Care Quality Indicators Project Conceptual Framework 
Paper, Paris: OECD, pg. 13. 
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CATEGORY DIMENSION DEFINITION 
INTERMEDIATE 
GOALS (cont.) 
Responsiveness  
(and Choice) 
Responsiveness used synonymously with 
patient-centeredness. “Patient centeredness 
is the degree to which a system actually 
functions by placing the patient/user at the 
centre of its delivery of healthcare and is 
often assessed in terms of patient’s 
experience of their health care.   
 
This experience of care refers to the caring 
(Scott et al., 1995)593, communication (Ong 
et al., 1995594; Roter et al., 1997595), and 
understanding that should characterize the 
clinician-patient relationship.   
 
The emphasis here is on the patient’s report 
of her or his experience with specific aspects 
of care and goes beyond her or his general 
satisfaction or opinion regarding the 
adequacy of care.” 
Efficiency 
The system’s ability of maximising the use of 
available resources. 
Quality  
(and Effectiveness) 
Quality of care is the degree to which health 
services for individuals and populations 
increase the likelihood of desired health 
outcomes and are consistent with current 
professional knowledge.596  
 
 
                                                 
593  Scott, Robert A., Linda H. Aiken, David Mechanic, and Julius Moravcsik. 1995. 
Organizational aspects of caring. Milbank Quarterly 73(1):77-95. IN Kelly, E., Hurst, J. 2006.  Health 
Care Quality Indicators Project Conceptual Framework Paper, Paris: OECD, pg. 13. 
594  Ong, L. M., J. C. de Haes, A. M. Hoos, and F. B. Lammes. 1995. Doctor-patient 
communication: A review of the literature. Social Science and Medicine 40(7):903-918. IN, Kelly, E., 
Hurst, J. 2006.  Health Care Quality Indicators Project Conceptual Framework Paper, Paris: OECD, 
pg. 13. 
595  Roter, Debra L., Moira Stewart, Samuel M. Putnam, Mack Lipkin Jr., William Stiles, and 
Thomas S. Inui. 1997. Communication patterns of primary care physicians. Journal of the American 
Medical Association 277(4):350-356. IN, Kelly, E., Hurst, J. 2006.  Health Care Quality Indicators 
Project Conceptual Framework Paper, Paris: OECD, pg. 13. 
596  Lohr, KN (1990). Institute of Medicine Medicare: A strategy for quality assurance, Volume I. 
Washington, DC, Institute of Medicine, in Legido-Quigley, H., Mckee, M., Nolte, E., Glinos, I.A. 
(2008) “Assuring the Quality of Health Care in the European Union – A case for action”. Observatory 
Studies Series No. 12, European Observatory in Health Systems and Policies, Copenhagen. 
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CATEGORY DIMENSION DEFINITION 
INTERMEDIATE 
GOALS (cont.) 
Sustainability 
Sustainability refers to sustainable 
development which is, “development that 
meets the needs of the present without 
compromising the ability of future 
generations to meet their own needs.”597 
GOALS 
(OUTCOMES) 
Inequalities 
Social or economic disparity between people 
or groups leading to unequal opportunity or 
treatment based on social, ethnic, racial, or 
economic disparity. 
Health Status 
“Health status of individuals and the 
population covers three components: health 
conditions, health function and well-being. 
 
Health conditions reflect the health 
problems and alterations of an individual 
that may lead to distress, interference with 
daily activities or contact with health 
services. They may be a disease (acute or 
chronic), disorder, injury or trauma, or they 
may reflect other health-related states, such 
as pregnancy, aging, stress, a congenital 
anomaly or a genetic predisposition that can 
lead to death. 
 
Health function corresponds to the general 
health status and functions of the population 
and is associated with the consequences of 
diseases, disorders, injuries and other health 
conditions. 
 
Health functions which include the body 
functions/structures (impairments), 
activities (activity limitations), participation 
(restrictions in participation) and life 
expectancy. 
                                                 
597  United Nations General Assembly. 1987. Report of the World Commission on Environment 
and Development: Our Common Future. Transmitted to the General Assembly as an Annex to 
document A/42/427 - Development and International Co-operation: Environment. Retrieved on: 2009-
02-15. IN WIKIPEDIA, Sustainability.   
Available at, http://en.wikipedia.org/wiki/Sustainability#cite_note-7. [accessed 13 January 2014]. 
United Nations General Assembly. March 20, 1987."Report of the World Commission on Environment 
and Development: Our Common Future; Transmitted to the General Assembly as an Annex to 
document A/42/427 - Development and International Co-operation: Environment; Our Common 
Future, Chapter 2: Towards Sustainable Development; Paragraph 1". United Nations General 
Assembly. Retrieved 1 March 2010. IN WIKIPEDIA, Sustainability.   
Available at: http://en.wikipedia.org/wiki/Sustainability#cite_note-7. [accessed 13 January 2014]. 
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CATEGORY DIMENSION DEFINITION 
GOALS 
(OUTCOMES) 
(cont.) 
Health Status (cont.) 
Well-being reflects the level of physical, 
mental and social well-being of individuals 
and of populations as it relates to material 
conditions, quality of life and sustainability 
of well-being over time.”598 
Determinants of 
Health (and Risk 
Factors) 
Determinants of health are: 
 
i. “Those that shape individuals’ and 
families’ socio-economic position, 
such as income and social status, 
education and literacy, and gender 
and ethnicity.”599 
 
ii. Biological factors include genetic 
endowment, aging processes and 
sex-related biology; Material 
circumstances include the 
characteristics of neighbourhoods, 
homes, workplaces and the physical 
environment; Psychosocial 
circumstances include stress, an 
individual’s sense of control and a 
person’s social support networks; 
Behavioural factors include 
smoking, physical exercise and diet 
and nutrition.600 
 
  
                                                 
598  OECD. OECD Health Systems Paper. Paris: 2012. Canadian Institute for Health Information. 
2013.  A Performance Measurement Framework for the Canadian Health System. Ontario: Canadian 
Institute for Health Information, pg. v. 
599  Canadian Institute for Health Information. 2013.  A Performance Measurement Framework 
for the Canadian Health System. Ontario: Canadian Institute for Health Information, pg. 5. 
600  Canadian Institute for Health Information. 2013.  A Performance Measurement Framework 
for the Canadian Health System. Ontario: Canadian Institute for Health Information, pg. v 
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CATEGORY DIMENSION DEFINITION 
GOALS 
(OUTCOMES) 
(cont.) 
Social Protection 
“The public actions taken in response to 
levels of vulnerability, risk and deprivation 
which are deemed socially unacceptable 
within a given polity or society.”601 
 
Social protection thus deals with both the 
absolute deprivation and vulnerabilities of 
the poorest, and also with the need of the 
currently non-poor for security in the face of 
shocks and life-cycle events.  
 
The ‘public’ character of this response may 
be governmental or non-governmental, or 
may involve a combination of institutions 
from both sectors. 
CONTEXT Socio-demographics 
“Relating to, or involving a combination of 
social and demographic factors.”602 
 
  
                                                 
601  Norton A, Conway T, Foster F.  Working Paper 143. Social Protection Concepts and 
Approaches: Implications for Policy and Practice in International Development.  February 2001. 
Overseas Development Institute, London (https://www.odi.org/sites/odi.org.uk/files/odi-
assets/publications-opinion-files/2999.pdf). 
602  Sociodemographic." Merriam-Webster.com. Merriam-Webster, n.d. Web. 12 June 2014. 
<http://www.merriam-webster.com/dictionary/sociodemographic>. 
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Feedback from National Health System Strategy Workshop 
 
Feedback received from NHSS workshop on HSPA 
21st February 2014 
 
Report compiled by Rapporteurs on: 
Workshop 5: HSPA: A TOOL FOR CONTINUOUS IMPROVEMENT 
 
Chair:  Dr Neville Calleja 
Rapporteurs: Dr Kenneth Grech, Dr Maya Podesta 
 
Workshop 5: 
Theme Summary of discussion 
Universal 
coverage and 
social justice 
• More money needs to be channelled to health, which should 
remain free. 
 
• We are living in an emotional society, thus we need to spend 
more money. 
Inclusion & 
scoring of 
performance 
indicators 
• Impact of disease criterion should have been given a higher 
percentage (60-20-20) as this is the most patient-centred. 
 
• Expenditure values should also be considered/ included.  
Inequalities in areas covered by indicators might be evident 
according to health expenditure. 
 
• The availability of indicators is important for benchmarking. 
 
• The introduction of new services must also be considered. 
We cannot measure something that isn’t there, but needs to 
be introduced. 
 
• An indicator/domain to measure our health package may be 
a good idea. 
 
• Health promotion indicators/domain should be given more 
importance. 
 
• Detailed definitions of indicators should be provided as 
metadata for the consultation survey (scoring of indicators). 
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Workshop 5: 
Theme Summary of discussion (cont.) 
Inclusion & 
scoring of 
performance 
indicators (cont.) 
• Socio-economic indicators are needed. These should either 
be included or factored into indicators. Education level and 
housing are important. Those with low educational levels 
and poor housing may not have access to the health care 
system. 
 
• Availability of medical equipment should be included. 
 
• Bed occupancy and efficiency are good indicators: Results 
can then be used to report on whether beds are being used 
in the right way. 
 
• Key clinical indicators as proxy indicators for operational 
performance and use of care pathways, e.g. time for cardiac 
patient to take troponin.  Care pathways should be 
established across the board, in a way that they can be 
measured at ground level, and feed up into the system. 
 
• Indicators should also be chosen relating to specified age-
related issues: how the system is catering for specific groups 
e.g. cataracts extractions for the elderly. 
 
• Community acquired pneumonia is a good indicator of health 
and the health system. 
 
• Robust data collection systems are needed in some cases, 
data input and storage is essential, as is its quality. 
 
• Licensing and accreditation should be kept apart from the 
HSPA process. 
 
• Customer satisfaction needs to be given more importance as 
it is related to the quality of health care. 
 
• Patient safety is difficult to measure, but international 
standards should be adopted. 
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Workshop 5: 
Theme Summary of discussion (cont.) 
Relevance of the 
HSPA 
• The aim is for a system of assessment that is periodic and 
that will provide for an assessment of the outcome of 
investment into the health system. 
 
• The strong focus being placed on a health systems 
performance assessment framework (HSPA) within the NHSS 
is very positive.   
 
• This performance assessment framework should indeed be 
developed locally and not imported, with KPI’s and related 
benchmarks that are wholly applicable to our unique local 
setting.  The HSPA needs to have: 
 
a) Realistic and relevant indicators, and 
b) Adequate reliability and validity checks, to be truly 
effective. 
 
Today’s NHSS consultation is being viewed as indeed working 
towards achieving a vital and excellent HSPA. 
 
• Training will be required and a structured plan for persons 
carrying monitoring and reviewing duties.  Without 
evaluating and recommending changes and acting on these 
changes the way forward will still remain a little unclear. 
The HSPA Policy 
Cycle 
• Health systems, performance measurement, monitoring and 
evaluation to perhaps include: (i) outcomes – that need to be 
monitored as part of national health policy; (ii) exposures – 
exposure to risk of health determinants (iii) health system 
response – strategies screening, policies, services etc. 
 
• Policy feeds to strategy which feeds to HSPA. 
 
• Hence, HSPA needs to have convincing indicators that detect 
changes at ground level that bring the desired 
improvements. 
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Workshop 5: 
Theme Summary of discussion (cont.) 
The logic of 
health systems 
analysis / health 
system 
framework 
• Equity in access and coverage - perhaps one needs to take 
into consideration: (i) access to essential medicines 
especially to the low and low to middle income; (ii) poverty; 
(iii) social determinants; (iv) our guiding values and principles 
as a Maltese society; (v) reducing health inequities;  (vi) 
sustainability; and (vii) environmental factors. 
 
• Legal and regulatory - perhaps one needs to take into 
consideration: (i) environmental factors that affect directly 
or indirectly health such as tobacco, air quality, noise 
pollution; and (ii) legal and regulatory strengthening of 
current legislations to meet emerging trends and their 
effective monitoring and re-enforcement. 
 
• Financial risk protection - perhaps one needs to take into 
consideration the social aspect to this dimension. 
 
• Service provision - perhaps one needs to take into 
consideration two aspects: (i) reducing waiting lists therefore 
the need to establish a maximum standard for waiting for 
specific services in policies and / or strategies; (ii) and the fact 
that private providers are used by poor as well as rich people 
alike (with regards to access and continuum of care). 
• Access, quality, efficiency and effectiveness - one needs to 
highlight safety issues. 
 
• Does demographic / epidemiology incorporate information, 
surveillance, research and development, national 
information systems, reporting, methods, tools standards, 
tracking performance, synthesis, analysis, obligations etc.? 
 
• Resource generation and allocation - to perhaps include 
training and education. 
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Workshop 5: 
Theme Summary of discussion (cont.) 
Other Comments 
• Medicinal products, vaccination, equipment, technologies, 
procurement, options. 
 
• Strengthening public health and primary health care as part 
of strengthening health systems. 
 
• Everyone’s rights and responsibilities towards health, health 
living, health services access / utilisation. 
 
  
 352 
Appendix 8 
List of national vertical strategies and plans in Malta 
 
National Cancer Plan 
National Non-Communicable Diseases Strategy 
Health Vision 2000 
Healthy Weight for Health Life (Obesity) Strategy 
Primary Care Services Plan 
TB Plan 
Access & Efficiency Measures 
Occupational Health and Safety Strategy 
National Sexual Health Policy 
National Dementia Strategy 
National Plan on Eating Disorders 
National Environmental Health Action Plan 
Mental Health Services Plan 
Child poverty & social exclusion 
Perinatal Health Services 
~National Diabetes Strategy (Draft) 
*Communicable Disease Strategy (Draft) 
 
~National Diabetes Strategy was still in draft form at the time of extraction of indicators. 
*Indicators from this strategy were extracted at a later stage of the process 
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Appendix 9 
Candidate indicators with scores 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
1 Birth induction rate 97.5 5.0678 4.7895 5.0943 
2 
Mode of delivery by parity, plurality, presentation, previous 
Caesarian section and gestational age. 
97 5.0000 4.8824 4.8050 
3 
5 year cancer survival rates  
(breast, colorectal, prostate, lung, cervical) 
90 6.2879 5.7143 6.6625 
4 
Response rate to screening programmes  
(eg. breast cancer screening, colorectal, [cervical] screening) 
87.5 6.0000 5.2381 5.5989 
5 
Mortality & premature death rates 
(due to cardiovascular diseases) 
87.5 5.8000 5.9048 6.4042 
6 
Infant mortality rate 
(by gestational age, birth weight and plurality.)  
87.5 5.8710 5.6190 6.0171 
7 All-cause mortality rate 86.5 5.8125 5.9048 6.4313 
8 
Standardised incidence rates of cancer 
(breast, colorectal, prostate, lung, cervical) 
86.5 5.9403 5.7619 6.4754 
9 All-cause premature mortality rate 85.5 6.1231 6.2381 6.6500 
10 Maternal mortality ratio 85.5 5.9833 5.6667 6.2708 
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
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Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
11 Multiple birth rate by number of fetuses. 84 5.1967 5.0000 5.2679 
12 
Perinatal mortality rate 
(by gestational age, birth weight and plurality) 
83 5.9333 5.5714 6.2550 
13 
Fatal accidents at the place of work/fatality rates 
(per economic sector) 
82.5 5.1818 5.4286 5.3474 
14 
Child mortality rate (1-14 years)  
(per 100,000 population) 
82 5.9545 5.8095 6.4058 
15 
Standardised mortality rate of cancers 
(breast, colorectal, prostate, lung, cervical) 
82 5.8636 5.8095 6.3750 
16 Acute hospital bed-occupancy rates by sector 79 6.1045 6.1905 6.2250 
17 
Rate of road traffic fatalities per year 
(per 100,000 population) 
78 4.7879 4.9500 5.0788 
18 
Admission to age and gender appropriate settings/wards in a 
mental health institution 
77 5.2769 5.3810 4.2543 
19 
Mortality rate due to tobacco 
(Smoking related deaths) 
76 5.8806 6.1905 5.7021 
20 
Incidence rate of AIDS  
(per 100,000 population) 
76 5.8769 5.5238 6.1946 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
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Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
21 Ratio of GPs to hospital specialists 75.5 5.1515 4.4762 4.5850 
22 
Annual death rate (per 100,000 population) in patients, who 
have as primary or secondary cause of death, diabetes 
mellitus, adjusted for standard European population. 
75 5.7576 5.4286 5.8257 
23 
Incidence of MRSA Hospital Acquired Infection/1000 
admissions 
75 6.3235 6.2857 6.1500 
24 Percentage of self-referrals to A&E 74 5.6462 5.7619 5.2438 
25 
Waiting times for appointment at out-patient clinics  
(from date of request) 
74 6.0299 5.8571 5.5563 
26 
Pharmaceutical expenditure per capita by disease category 
(eg. oncology, diabetes) 
73 5.6364 5.0476 4.6483 
27 Annual incidence of amputations above the ankle 73 5.2540 5.2381 5.2429 
28 
Hospital average length of stay  
(acute, mental and rehabilitation hospitals) 
73 5.7612 5.7619 5.5875 
29 Distribution of gestational age by vital status and plurality  73 4.9649 4.6316 4.8519 
30 Distribution of maternal age 73 4.8889 4.5714 5.3004 
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
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Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
31 
Percentage of infants fully vaccinated against pertussis, 
diphtherria, tetanus and polio by first birthday, against MMR 
by second birthday. 
72.5 6.0469 5.8000 5.8563 
32 TB multi-drug resistant case notification rate 603 71.5   5.6957 
33 Percentage of new borns weighing 4kg or over 71 5.0968 4.9444 4.4333 
34 
Hospital readmissions rates by category  
(eg. psychiatric, medical) 
71 5.9265 5.6667 5.2925 
35 Distribution of Apgar score at 5 minutes 71 5.3636 4.8235 5.1314 
36 
30-day in-hospital mortality rate for specific clinical 
conditions (eg. MI, stroke). 
70.5 5.6515 5.5238 5.4010 
37 
Number of hospital beds (acute, palliative, rehabilitation, 
long-term care, dementia) per 100,000 population. 
70 6.0448 5.8095 6.0063 
38 Medical specialists per 100,000 population 70 5.4242 5.1429 5.1500 
39 
Distribution of birth weight by vital status, gestational age 
and plurality. 
70 5.0678 4.7368 5.5086 
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7) 
                                                 
603 This indicator was inadvertently not scored by the practitioners and academics and was subsequently combined with Indicator No. 48. 
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Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
40 Prevalence of diabetes mellitus per 1,000. 69.5 5.8438 5.7619 5.4786 
41 
Annual incidence of dialysis and/or transplantation (renal 
replacement therapy) in patients with diabetes. 
69.5 5.5313 5.2857 5.5890 
42 
Annual incidence of Type 1 diabetes in children between 0-
14 years of age at diagnosis (clinical) per 100,000 children. 
69 5.5397 4.7143 5.6648 
43 Prevalence of smoking in males and females >15yrs 69 5.6765 5.6190 5.6217 
44 
Average waiting time for admission to long-term care 
facility. 
68.5 5.7910 5.6190 5.2813 
45 
Availability of diagnostic and therapeutic infrastructure 
(MRI, CT etc.) 
68.5 6.0152 5.7619 6.0063 
46 Annual incidence of stroke in patients with diabetes. 68.5 5.6719 5.3333 5.7771 
47 Rate of accidents at the place of work. 68 5.1061 5.2500 4.9995 
48 TB incidence rate 68 5.6000 5.5238 6.2296 
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7) 
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Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
49 
Ratio of discharges from hospitals to community care to 
discharges to long-term care facilities in the elderly 
population. 
67.5 5.7424 6.0000 5.1500 
50 
Road traffic accidents (all outcomes) by age and means of 
transport. 
67.5 4.9091 4.9048 4.6779 
 MEAN SCORES FOR 3 GROUPS  5.4688 5.2000 5.2679 
51 
Prevalence of adults with diabetes, hypertension, 
hypercholesterolaemia by age and gender. 
67 5.9242 6.2381 6.0008 
52 
Number of persons on waiting list for admission to long-term 
care. 
66.5 5.6716 5.5714 4.4938 
53 
Avoidable hospital admission rate for specific diseases  
(eg. asthma, diabetes, congestive heart failure, COPD) 
66.5 6.0606 5.9524 4.9754 
54 Prevalence of cerebral palsy 66 5.3492 5.1500 5.0938 
55 
Ratio of emergency attendances to Health Centres vs 
Accident & Emergency department. 
65 5.9077 5.2857 4.8313 
56 
Number of persons benefitting from entitlement to free 
medicines. 
65 5.5909 5.1905 4.8750 
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
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Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
57 
Waiting times for out-patient based investigations  
(eg. Angiograms, MRI, ultrasound, CT scan) 
65 5.9403 5.3333 5.6338 
58 
Annual incidence of myocardial infarction in patients with 
diabetes. 
65 5.6557 5.3810 5.4871 
59 
Number of discharges per 1000 population due to stroke, MI 
by gender and age. 
65 5.3906 5.1429 5.3604 
60 Incidence rate of HIV per 100,000 population. 65 5.8769 5.4762 6.0571 
61 Incidence of measles, per 100,000 population. 65 5.4688 5.1000 5.4058 
62 Average waiting time for transfer to rehabiliation facility 64.5 5.7761 5.3333 5.4683 
63 
Oncology waiting times  
(eg. outpatients, surgery, radiotherapy, chemotherapy) 
64.5 6.1343 5.9524 5.5229 
64 
Number of children found to have developmental problems 
and disorders per 100,000 population. 
64.5 5.4308 5.6316 4.7188 
65 
Standardised death rate per 100,000 population for 
bronchitis/emphysema/asthma. 
64.5 5.6563 5.1905 5.7021 
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7) 
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Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
66 
Deaths caused by suicide per 100,000 population  
(by gender and age-group including 15-24 years old.) 
64 5.0308 5.1429 4.8875 
67 
Portion of patients treated with insulin among patients with 
diabetes. 
64 5.1774 4.8571 4.4929 
68 Incidence of Hepatitis B, per 100,000 population. 64 5.7846 5.3810 6.1350 
69 Incidence of legionellosis, per 100,000 population. 64 5.5714 5.0000 5.3392 
70 
Rate of use of anticholinergic antidepressant drugs among 
elderly patients. 
62 5.0000 4.6111 4.1150 
71 Rate of work-related absenteeism 62 5.1940 5.1579 3.9076 
72 
Percentage of all pregnancies following treatment for sub-
fertility.  
62 5.1311 4.6842 4.3829 
73 
Number of vaccine preventable diseases covered by the 
national vaccination programme. 
61.5 5.8281 5.5238 5.4104 
74 Length of treatment for substance-related disorders 61 5.0161 4.6316 4.3050 
75 Case management rate for severe psychiatric disorders 61 5.4286 4.8000 3.9491 
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
  
3
6
1
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
76 Rate of hospital admissions with hip fractures by gender  61 5.0000 5.4286 5.2667 
77 
Percentage overweight and obesity from self-reported BMI 
by age group (over 15yr olds). 
60.5 5.4697 5.8095 5.4075 
78 Teenage pregnancy rate 60.5 5.2656 5.2000 5.4471 
79 
Percentage of health budget allocated to public health incl. 
preventive services. 
60 6.0303 5.4762 5.9000 
80 Incidence of Hepatitis A, per 100,000 population 60 5.5846 4.8095 5.6008 
  
60%  
Pass mark 
   
81 
Proportion of people reporting not having accessed medical 
services due to cost, distance, or waiting times (unmet self-
declared need for medical care) (by age-groups, including 
15-25 year olds). 
58.5    
82 Prevalence of dementia 58.5    
83 
Number of multidisciplinary care teams by category  
(eg. mental health, rehabilitation, oncology). 
58.5    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
  
3
6
2
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
84 Number of visits to GPs per capita 58    
85 Pure alcohol intake in ltrs per capita 58    
86 
Rate of children/schools covered by screening/surveillance 
services. 
58    
87 
Rate of mental hospital discharges requiring follow-up 
appointments within 7 days and within 30 days. 
58    
88 
Percentage of babies breastfed on discharge from hospital 
and at 6 months of age. 
58    
89 
Number of implemented clinical guidelines and care 
pathways by category (eg. MI, TB ). 
58    
90 Incidence of mumps, per 100,000 population. 58    
91 Rate of admissions to palliative care unit. 57.5    
92 Response rate to HPV vaccination programme. 57.5    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7) 
  
  
3
6
3
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
93 
Waiting times for in-patient based investigations 
(eg. angiogram, MRI, ultrasound, CT scan) 
57    
94 
Percentage of young persons aged 15-24 reporting >3 hours 
of physical activity per week. 
57    
95 
Portion of diabetic patients treated with insulin in 
combination with oral anti-diabetic drugs. 
56.5    
96 Portion of diabetic patients also on lipid lowering medication 56    
97 
Percentage of requests for mental health crisis intervention 
team satisfied within x number of hours. 
56    
98 Rate of work-related injury benefit claims 56    
99 Expenditure ratio of primary to secondary/tertiary care  55.5    
100 Waiting time to see specialist in dementia 55.5    
101 Daily consumption of fruit and vegetables 55.5    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
  
3
6
4
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
102 Number of deaths according to place of death 55    
103 
Portion of Type 2 diabetic patients on oral anti-diabetic 
drugs, and distribution of drug types. 
55    
104 
Portion of diabetic patients also on anti hypertensive 
treatment. 
55    
105 
Percentage of patients with most recent HbA1c level >7.5 
and 9.0 (poor control). 
55    
106 
Frequency of moderate and vigorous physical activity in 
adults and children according to age-group. 
55    
107 Rate of current smokers among diabetic patients 54.5    
108 
Percentage of chronic mental health patients receiving a 
holistic review at least once a year. 
54.5    
109 
Percentage of 13 year olds above the 95th weight chart 
centile. 
54.5    
110 
Rate of children who smoke and daily cigarette smokers 
among those aged 15 to 24. 
54    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7) 
  
  
3
6
5
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
111 
Annual incidence of blindness among patients with diabetes 
who are reviewed. 
54    
112 
Incidence of E. Coli infections (VTEC, STEC, EHEC), per 
100,000 population. 
54    
113 Incidence rate of influenza per 100,000 population. 54    
114 
Percentage of diabetic patients with one or more HbA1c tests 
during the last 12 months. 
53    
115 Percentage of diabetic patients with BMI >30 kg/m2 53    
116 
Percentage of diabetic patients ever having had eye laser 
treatment. 
52.5    
117 
Portion of diabetic patients enrolled in structured Disease 
Management Programmes (DMP). 
52    
118 
Prevalence of end-stage renal disease among diabetic 
patients. 
52    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7) 
  
  
3
6
6
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
119 
Alcohol consumption rates and drinking patterns in general 
population by age-group. 
52    
120 
Prevalence of caries (mean number of decayed, missing and 
filled teeth (DMFT) in 5 and 12 year olds. 
52    
121 
Percentage of emergency admissions admitted to MDH 
holding areas. 
51.5    
122 
Percentage of mental health patients receiving in-patient 
treatment vs treatment in the community. 
51.5    
123 
Time allocated to physical activity per week in primary 
schools. 
51.5    
124 
Percentage of young people aged 15 to 24 reporting 
substance use, harmful alcohol consumption and unprotected 
sexual intercourse. 
51    
125 Stage at which dementia medication started. 51    
126 
Percentage of diabetic patients with one or more total 
cholesterol/HDL tests during the last 12 months. 
51    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7) 
 
  
  
3
6
7
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
127 
Percentage of diabetes patients who received a dilated eye 
examination or evaluation of retinal photography by a 
trained caregiver within the last 12 months. 
51    
128 
Percentage of diabetes patients receiving at least one foot 
examination within the last 12 months. 
51    
129 
Prevalence of alcohol use among 15 and 16 year olds during 
the previous 12 months.  
51    
130 
Time between admission and surgical procedure for hip 
fracture. 
51    
131 Incidence of syphilis, per 100,000 population 51    
132 
Percentage of diabetic patients with serum creatinine tested 
in the last 12 months. 
50.5    
133 Waiting times for emergency care  49.5    
134 
Percentage of patients with at least one test for 
microalbuminuria during the measurement year or who had 
evidence of medical attention for existing nephropathy. 
49.5    
135 Number of referrals to specialised multidisciplinary team 49    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
  
3
6
8
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
136 Consumption of sweets (candy and chocolate) (HBSC) 49    
137 
Waiting time for admittance into dementia long term care 
units 
48    
138 
The prevalence of the self-reported and the measured 
hypercholesterolaemia in Maltese adults (HIS) and (EHES 
2010). 
48    
139 Incidence of chlamydia, per 100,000 population. 48    
140 Waiting times at the MDH A&E Department 47.5    
141 
Percentage of patients with diabetes and one or more blood 
pressure measurements within the last 12 months. 
47.5    
142 
Percentage of patients with clinically diagnosed CVD and 
diabetes who are treated with antiplatelet therapy. 
47    
143 
Rates and patterns of alcohol consumption among 13 to 15 
year olds (HBSC). 
47    
144 Age at diagnosis by 10 year age bands (incidence) 46    
145 
Annual admissions to mental hospital and acute psychiatric 
unit. 
46    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
  
3
6
9
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
146 
Percentage of care plans which are adequately followed and 
appropriately documented. 
46    
147 Incidence of campylobacteriosis, per 100,000 population 46    
148 Incidence of salmonellosis, per 100,000 population 46    
149 
Percentage of elderly persons receiving community care. 
(eg Home help, Meals on Wheels, Handyman service etc.) 
45    
150 
Body Mass Index (BMI) in women of reproductive age (20-
40 years). 
45    
151 Number of investigations ordered by private and public GPs 44.5    
152 
Average number of insulin injections per day in insulin 
treated patients. 
44    
153 
Average number of antihypertensive agents used per 
diabetes patient with anti hypertensive treatment. 
44    
154 Rate of persons with dementia admitted to acute hospitals. 43.5    
155 
Percentage of emergency operations being performed during 
the day (as opposed to evenings and nights). 
43    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
  
3
7
0
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
156 Percentage of patients with Total-Chol / HDL-Chol < 4.5 43    
157 
Percentage of patients with most recent blood pressure 
<140/90 mmHg. 
42.5    
158 Rate of contraception usage amongst teenagers. 42.5    
159 
Number of chilldren with asthma - Schedule V; 
Number of young persons aged 15-24 yrs suffering from 
asthma / using asthma medication – EHIS. 
42    
160 Portion of diabetic patients treated with diet only. 42    
161 
Percentage of individuals who drive under the influence of 
alcohol (HIS). 
42    
162 Diabetics with former or current foot ulceration. 41    
163 
Percentage of population reporting bad or very bad health by 
environmental exposure in Malta [EQLS]. 
41    
164 
Ratio of arthritis in Maltese population (HIS) in comparison 
with number of total knee and hip replacements carried out 
by age group (NHIS, DHIR). 
41    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7) 
  
  
3
7
1
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
165 
Percentage of Maltese population reporting having had a 
mental disorder at some point in their life (HIS 2008). 
41    
166 
Percentage of diabetes patients whose smoking status was 
ascertained and documented within the last 12 months. 
40.5    
167 
Number of persons with dementia admitted for rehabilitation 
and discharge to the community. 
35.5    
168 
Percentage of patients with diabetes performing self-
monitoring of blood glucose/urine testing. 
34    
169 Daily consumption of fruit and vegetables. 19    
170 
Number of school/children benefitting from school fruit and 
vegetable scheme. 
19    
171 
Number of GPs trained in the use of cognitive assessment 
tools. 
19    
172 
Percentage of patients with diabetes specific education at 
least once before. 
19    
173 Number of readmissions to institutional care 19    
174 Percentage weight change 19    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
  
3
7
2
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
175 Number of consent forms duly filled and signed 19    
176 
Number of staff members attending training related to their 
line of work. 
19    
177 Mortality rates for persons with psychiatric disorders 19    
178 
Percentage of Maltese 16 year olds abusing addictive 
substances (ESPAD 2007). 
19    
179 
Prevalence of self-reported chronic depression and chronic 
anxiety by gender and age group (HIS 2008).  
19    
180 
Occupational injury and illness rate  
(number of injuries per 100,000 employees) 
19    
181 Distribution of mothers' prepregnancy BMI 19    
182 Percentage of TB patients for whom HIV status is known 19    
183 
Incidence of invasive pneumococcal disease  
(per 100,000 population). 
19    
184 Exposure to indoor tobacco smoke. 18    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
  
3
7
3
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
185 Weight at birth of <2500g - from NOIS. 18    
186 
Young people (aged 15-24) with depressive syndrome / 
mental illness - from EHIS. 
18    
187 
Percentage with microalbuminuria in last 12 months  
(among those who have been tested). 
18    
188 Rate of patients with current alcohol abuse/dependence. 18    
189 
Crude mortality rate (per 100,000) from fatal falls by age 
group, year and gender among Maltese residents (DHIR). 
18    
190 Consumption of coke and soft drinks with sugar (HBSC). 18    
191 
Percentage of children who smoke and their smoking habits 
(ESPAD). 
18    
192 Percentage of school children who smoke (HBSC) 18    
193 Hospitilisation costs due to work related injuries/illnesses. 18    
194 Incidence of severe maternal morbidity. 18    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
  
3
7
4
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
195 
Percentage of TB cases tested by drug sensitivity testing for 
first-line drugs. 
18    
196 
Proportion of 'group practices' / multi-disciplinary teams 
versus solo practices. 
17.5    
197 Percentage of HIV patients for whom TB status is known. 17.5    
198 Number of patients 'linked' to (registered with) a GP. 17    
199 Percentage of pregnant mothers smoking. 17    
200 Exposure to PM10 particles. 17    
201 
Number/rate of children living in a household at risk of 
poverty/severely materially deprived (<60% of national 
median equivlised disposable income) - from SILC. 
17    
202 
Self-reported health status by financial capacity and ability 
to afford home heating in Malta (EQLS). 
17    
203 
Number of women with IGT/diabetes prior to 
commencement of or during pregnancy (NOIS). 
17    
204 
Number of occupational health and safety officers  
(per 100,000 population). 
17    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
  
3
7
5
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
205 Incidence of tears to the perineum.  17    
206 
Frequency of unprotected sexual intercourse in persons 
reporting more than one partner in the past 12 months. 
17    
207 
Incidence of STIs [IDCU registers] 
(syphillis, gonorrohea, chlamydia)  
17    
208 Percentage of new pulmonary TB cases confirmed by culture 17    
209 
Young people not in employment, education or training 
(aged 15-19) - from Eurostat LFS. 
16    
210 
Percentage of the population reporting infrastructural 
housing problems by chronic health conditions (EQLS). 
16    
211 
Percentage of adults exposed to tobacco in public spaces, 
transport and place of work (HIS). 
16    
212 
Percentage of mothers who consume alcohol during 
pregnancy (NOIS). 
16    
213 
Lifetime prevalence of asthma in children aged 6-7 years and 
13-14 years (ISAAC study, 2003). 
16    
214 Lifetime prevalence of asthma as reported by adults (HIS). 16    
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
  
3
7
6
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
215 Fluoride concentration in the water supply (WSC/DEH). 16    
216 
Hospitilisation admissions due to work-related 
injuries/illnesses. 
16    
217 Number of OHS assessments at the place of work. 16    
218 Number of non-compliances per workplace visit. 16    
219 Prevalence of selected congenital anomalies.  16    
220 Fetal and neonatal deaths due to congenital anomalies. 16    
221 Number of self-referrals for screening for TB. 15.5    
222 Waiting times for community mental health clinics. 15    
223 Percentage of pregnant mothers smoking.  15    
224 Number/rate of preventable incidents at the place of work. 15    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7) 
  
  
3
7
7
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
225 
Knowledge and level of awareness relating to sexual health 
(SHQ).  
15    
226 Number of persons using helpline and assisted technologies. 14.5    
227 Age at first sexual intercourse (HBSC). 14.4    
228 Enrollment of professionals and public to myHealth. 14    
229 New Client Index. 14    
230 
Incidence of oral mucosal malignant lesions and tumours 
(Malta Cancer Registry). 
14    
231 
How (by whom, at what age, where, what resources were 
used) is knowledge about a number of issues related to 
sexual behaviour and sexuality obtained? (SHQ) 
14    
232 Maternity statistics: Unintended pregnancies (NOIS) 14    
233 Percentage of women who smoked during pregnancy. 13.5    
234 Number of careworkers specialised in youth care. 13    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
  
3
7
8
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
235 
Crude mortality rate (per 100,000 population) for fatal 
accidental poisonings by age group, year and gender 
(DHIR). 
13    
236 
Annual household consumption expenditure on food and 
non-alcoholic beverages (%). 
(Household Budgetary Survey). 
13    
237 
Frequency of sexual intercourse under the influence of 
alcohol/drugs. 
13    
238 
Percentage of patients who have appointed a responsible 
carer in writing. 
12    
239 Distribution of parity 11.5    
240 
Number of doctors who regularly take care of diabetic 
patients in diabetes clinics in primary or secondary care  
(per 100,000 population). 
11    
241 
Number of diabetes nurses employed  
(per 100,000 population). 
11    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7)  
  
3
7
9
 
Appendix 9 (cont.) 
 
 
Filtered list of ‘candidate’ indicators as extracted from 17 national strategies (n=250), with internal and external scores. 
 
No. Indicator 
~Internal 
score 
*Practitioners' 
scores 
*Academics' 
scores 
*Experts' 
scores 
242 
Number of physicians who offer structured Disease 
Management Programme (DMP) participations to patients 
per 1000 patients with diabetes mellitus. 
11    
243 
Proportion of children cared for (by formal arrangements 
other than the family) as a proportion of all children in the 
same group. 
10.5    
244 
Data on most popular modes of travel in Maltese population 
(National Household Travel Survey, Transport Malta, May 
2010). 
10.5    
245 Distribution of parent's occupational classification.  10    
246 Number of court/judicial cases. 9    
247 Distribution of mother's educational level. 9    
248 Number of administrative fines and total amount. 7    
249 Number and cost of insurance claims. 6    
250 Number of accidents reported vs investigated. 0    
 
Notes: ~ scores expressed as % mark   * scores expressed on Likert Scale (1-7) 
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Criteria and sub-criteria for scoring of indicators 
 
Scoring criteria used to select indicators 
Total marks – 100% 
 
1. IMPORTANCE OF WHAT IS BEING MEASURED 
 
1a. Impact of disease or risk on health and on health expenditure – 15%. 
What is the impact on health and on health expenditure associated with each 
disease, risk or client group?  The measure should address areas in which there 
is a clear gap between the actual and potential levels of health that can be 
influenced by improvements in the quality of care 
1b. Policy importance – 10%.  
Are policy makers and consumers concerned about this disease or risk group 
area? 
1c. Susceptibility to being influenced by the health care system – 15%.  
Can the health care system meaningfully address this disease area or problem? 
The measure should reflect an aspect of health that can be influenced by the 
health care system as it exists or as it is envisioned. That is, policy makers can 
take specific actions (generally at the structural or process level) to improve 
health care in that area and, ultimately, health status. Injuries caused by 
automobile accidents, for example, are the leading cause of death among young 
adults, but most remedies (for example, changing car design or reducing the 
speed limit) lie outside the influence of the health care sector. 
 
2. FEASIBILITY OF OBTAINING INTERNATIONALLY COMPARABLE 
DATA FOR THE MEASURE 
 
2a. Existence of prototype indicator -10%.  
Is the measure in use? A further question is if the measure is in use at the 
national level, or for sub-national population groups. 
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2b. Availability of internationally-comparable data across countries – 10%.  
Can internationally-comparable information needed for the measure be 
collected for sufficient countries in the time frame required? At one extreme, 
a few indicators of the technical quality of health care can already be found for 
most countries in WHO/EU/OECD Health Data. At the other extreme, there 
will be many potential indicators for which few if any countries could provide 
any data in the foreseeable future. In between these extremes, there are likely 
to be some indicators for which data would be readily available at national 
level for a significant group of countries, but with variations in the precise 
definitions of numerators and denominators. There are likely to be other 
indicators for which national data has not yet been assembled (say, from local 
or clinical databases) and which could be put together according to a common 
definition only with considerable effort. 
 
2c. Cost or burden of measuring indicator – 10%.  
How much will it cost to collect the data needed for the measure? 
3. SCIENTIFIC SOUNDNESS OF THE INDICATOR 
 
3a. Validity – 10% - does the measure actually measure what it is intended to 
measure? 
3b. Reliability – 10% - does the measure provide stable results across various 
populations and circumstances? 
3c. Explicitness of the evidence base – 10% is there scientific evidence available to 
support the measure? 
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Online survey  
 
Screen shot of online survey for practitioners and academics to rate shortlisted 
indicators using Google Forms. 
Example of one indicator: ‘All Cause Mortality Rate.’ 
 
Health System Performance Assessment Framework - Malta 
 
* Required 
All-cause mortality rate * 
 1 (Least) 2 3 4 5 6 7 (Most) 
Don't 
Know 
Importance of 
the indicator 
to the 
Maltese 
Health 
System 
        
Availability 
and 
Comparability 
of the 
indicator 
        
Validity and 
Reliability of 
the indicator 
        
 
 
1% completed 
Powered by This content is neither created nor endorsed by Google.  
Report Abuse - Terms of Service - Additional Terms 
Screen reader support enabled. 
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Final list of performance indicators with ‘key owners’ of each 
indicator 
 
Ref. 
no. 
Performance indicator Key owner by department 
1 
Five year cancer survival rates. 
(Breast, colorectal, prostate, lung, cervical). 
Directorate of Health 
Information and Research 
2 
Response rate to screening programmes (e.g. 
breast cancer screening, colorectal, [cervical] 
screening). 
National Cancer  
Screening Service 
3 
Standardised mortality rates (all-cause, cancers, 
cardiovascular disease, diabetes [as primary or 
secondary], smoking related). 
Directorate of Health 
Information and Research 
4 Maternal mortality ratio 
Directorate of Health 
Information and Research 
5 
Standardised premature mortality rates (all-cause, 
cancers, cardiovascular disease, diabetes [as 
primary or secondary], smoking related). 
Directorate of Health 
Information and Research 
6 
Standardised incidence rates of cancer. 
(Breast, colorectal, prostate, lung, cervical). 
Directorate of Health 
Information and Research 
7 
Perinatal and infant mortality rates by gestational 
age, birth weight, and plurality.  
Directorate of Health 
Information and Research 
8 
Fatal accidents at the place of work/fatality rates 
(per economic sector). 
Occupational Health and 
Safety Authority 
9 
Child mortality rate (1-14 years)  
(per 100,000 population). 
Directorate of Health 
Information and Research 
10 Acute hospital bed-occupancy rates by sector. 
Clinical Performance Unit, 
Mater Dei Hospital 
11 Incidence rate of AIDS per 100,000 populations. 
Directorate of Health 
Promotion and Disease 
Prevention 
12 
Incidence of MRSA hospital acquired 
infection/1000 admissions. 
Infection Control Unit,  
Mater Dei Hospital 
13 Percentage of self-referrals to A&E. 
Clinical Performance Unit, 
Mater Dei Hospital 
14 
Waiting times for appointment at Out-patient 
Clinics (from date of request). 
Clinical Performance Unit, 
Mater Dei Hospital 
15 
Hospital average length of stay.  
(Acute, mental and rehabilitation hospitals). 
Directorate of Health 
Information and Research 
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Ref. 
no. 
Performance indicator Key owner by department 
16 
Percentage of infants fully vaccinated against 
pertussis, diphtheria, tetanus and polio by first 
birthday, against MMR by second birthday.  
Department of  
Primary Health Care 
17 
TB incidence and multi-drug resistant case 
notification rates. 
Directorate of  
Health Promotion and 
Disease Prevention 
18 
Hospital readmissions rates by speciality.  
(e.g. psychiatric, medical). 
Clinical Performance Unit, 
Mater Dei Hospital 
19 
30-day in-hospital mortality rate for specific 
clinical conditions (e.g. MI, stroke, hip fracture). 
Clinical Performance Unit, 
Mater Dei Hospital 
20 
Number of hospital beds (acute, palliative, 
rehabilitation, long-term care and dementia) per 
100,000 population. 
Directorate of Health 
Information and Research 
21 
Annual incidence of Type 1 Diabetes in children 
between 0-14 years of age at diagnosis (clinical) 
per 100,000 children. 
Department of Paediatrics, 
Mater Dei Hospital 
22 
Prevalence of smoking in males and females 
>15yrs. 
Directorate of Health 
Information and Research 
23 
Waiting times for admission to public 
rehabilitation facility and to public long-term care 
facility. 
Department for the Elderly 
24 
Availability of diagnostic and therapeutic 
infrastructure (MRI, CT etc.) 
Directorate of Health 
Information and Research 
25 
Complications of diabetes - annual incidence rates 
of stroke, myocardial infarction, dialysis and/or 
renal transplantation in patients with diabetes. 
Directorate of Health 
Information and Research 
26 
Ratio of discharges from public acute hospital to 
community care to discharges to long-term care 
facilities in the elderly population. 
Clinical Performance Unit, 
Mater Dei Hospital 
27 
Prevalence of adults with diabetes, hypertension, 
hypercholesterolemia by age and gender. 
Directorate of Health 
Information and Research 
28 
Avoidable hospital admission rate for specific 
diseases (asthma, diabetes, congestive heart 
failure, COPD). 
Directorate of Health 
Information and Research 
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Ref. 
no. 
Performance indicator Key owner by department 
30 
Waiting times for out-patient based investigations 
(Angiograms, MRI, ultrasound, CT scan), 
interventions (total knee replacement, total hip 
replacement, cataracts, varicose veins, inguinal 
hernias, chemotherapy, radiotherapy). 
Clinical Performance Unit, 
Mater Dei Hospital 
31 
Incidence rate of HIV and Hepatitis B per 100,000 
population. 
Directorate of Health 
Promotion and  
Disease Prevention 
32 
Number of vaccine preventable diseases covered 
by the national vaccination programme. 
Department of  
Primary Health Care 
33 
Percentage overweight and obesity from Self-
reported BMI by age group (over 15 year olds). 
Directorate of Health 
Information and Research 
34 
Percentage of health budget allocated to public 
health, including preventive services. 
Directorate General Finance, 
Ministry of Health 
35 
Health expenditure as a percentage of GDP/per 
capita [pps]. 
National Statistics Office 
36 
General government health expenditure as a 
percentage of total government expenditure and 
percentage of total health expenditure.  
National Statistics Office 
37 
Life expectancy and healthy life expectancy at 
birth and at over 65 years of age. 
National Statistics Office 
38 Amenable mortality/potential years life lost. 
Directorate of Health 
Information and Research 
39 
Public expenditure as a percentage of GDP for 
hospitals, ambulatory services and long term care. 
Directorate General Finance, 
Ministry of Health 
40 
Day case discharges as a percentage of total 
discharges. 
Directorate of Health 
Information and Research 
41 
Numbers and ratios of all practicing doctors, GPs, 
specialists, and  nurses & midwives per 100,000 
inhabitants (GPs, specialists,  nurses, physicians) 
Superintendence of  
Public Health 
43 GP contacts per capita. 
Department of  
Primary Health Care 
44 
Public outpatient pharmaceuticals as a percentage 
of GDP. 
Directorate General Finance, 
Ministry of Health 
45 
Generic share of pharmaceuticals in value/volume 
(public). 
Central Procurement and 
Supplies Unit 
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Ref. 
no. 
Performance indicator Key owner by department 
46 
Self-perceived general health (SILC) - income 
inequalities. 
National Statistics Office 
47 Unmet need (SILC) - income inequalities. National Statistics Office 
48 
Percentage of population covered by public health 
insurance (tax-based, public health insurance and 
income tax, including social security contribution 
schemes). 
National Statistics Office 
49 
Out of pocket health expenditure as a percentage 
of total health expenditure/private health 
expenditure. 
National Statistics Office 
50 Influenza vaccine coverage in 65+.  
Directorate of Health 
Promotion and Disease 
Prevention 
51 
Frequency of population having 6 or more units of 
alcohol on one occasion. 
Directorate of Health 
Information and Research 
52 Fruit and vegetable consumption (EHIS). 
Directorate of Health 
Information and Research 
53 
Percentage reporting >2.5 hours of physical 
activity per week - age/sex. 
Directorate of Health 
Information and Research 
55 
Share of population 65+/80+, old age dependency 
(65+/15-64). 
National Statistics Office 
57 At risk of poverty or social exclusion. National Statistics Office 
58 
Percentage of population 25-64 with low 
educational attainment (ISCED 0-2). 
National Statistics Office 
60 
Hip fracture surgery initiated within 2 calendar 
days after admission to Mater Dei Hospital. 
Clinical Performance Unit, 
Mater Dei Hospital 
61 
Proportion of population that accesses own health 
data online. 
Information Management 
Unit 
62 Rate per capita of prescriptions transacted online. 
Information Management 
Unit 
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INDICATOR 1:  
5-YEAR CANCER SURVIVAL RATE  
 
Definition: 
‘The relative survival rate for cancer that is the proportion of patients who survive at 
least five years after diagnosis, after correction for background mortality.’ 
 
Calculation: 
‘Relative survival rate is calculated as the observed rate of persons diagnosed with 
cancer surviving five years after diagnosis, divided by expected survival rate in the 
general population.’ 
 
____________________________________________________________________ 
 
INDICATOR 2: 
RESPONSE RATE TO SCREENING PROGRAMMES  
Breast Screening  
 
Definition:  
‘Proportion of women (aged 50-69) reporting to have undergone a breast cancer 
screening test within the past two years.’  
 
Calculation:  
‘Percentage of women aged 50-69 reporting to have had a breast examination by X-
ray (i.e. mammography) within the past 2 years, derived from European Health 
Interview survey questions, PA.10 and PA.11: PA.10: Have you ever had a 
mammography, which is an X-ray of one or both of your breasts? Yes / No / Don’t 
know / Refusal; and PA.11: When was the last time you had a mammography (breast 
X-ray)? Within the past 12 months / More than 1 year, but not more than 2 years / 
More than 2 years, but not more than 3 years / Not within the past 3 years / Don’t 
know / Refusal.’ 
 
The ‘preferred data type is from the European Health Interview Survey (EHIS). In the 
future however, when the situation with regard to administrative based data has 
improved the European Community Health Indicators and monitoring project 
(ECHIM) prefers to use those data instead of EHIS. For comparability reasons 
ECHIM would prefer age-standardised data.’  
 
‘Ideally, the recall period used in the definition for this indicator coincides with the 
recall period actually applied in the screening programmes, as in the definition 
applied by the Organisation for Economic Co-operation and Development (OECD). 
As a common methodology needs to be applied in EHIS for all countries, such a 
flexible approach is not possible in EHIS. The recall period used in the definition for 
this indicator therefore represents an average and hence it will not be aligned with 
the programme methodologies for all countries.’ 
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INDICATOR 2 (cont.) 
Cervical screening  
 
Definition: 
‘Proportion of women (aged 20-69) reporting to have undergone a cervical cancer 
screening test within the past three years.’  
 
Calculation: 
‘Percentage of women aged 20-69 reporting to have had a cervical smear test (pap 
smear) within the last 3 years, derived from EHIS questions PA.13 and PA.14. PA.13: 
Have you ever had a cervical smear test? Yes / No; PA.14: When was the last time you 
had a cervical smear test? Within the past 12 months / More than 1 year, but not more 
than 2 years / More than 2 years, but not more than 3 years / Not within the past 3 
years.’  
 
‘The preferred data type for the moment is from EHIS. In the future however, when 
the situation with regard to administrative-based data has improved ECHIM prefers 
to use administrative- based data instead of EHIS. For comparability reasons ECHIM 
would prefer age-standardised data.’  
 
‘Ideally, the recall period used in the definition for this indicator coincides with the 
recall period actually applied in the screening programmes. However, the recall 
periods applied in national cancer screening programmes differ. As a common 
methodology needs to be applied in EHIS for all countries, a flexible approach with 
country specific questions is not possible. The recall period used in the definition for 
this indicator therefore represents an average and hence it will not be aligned with 
the programme methodologies for all countries.’ 
 
Colorectal cancer screening  
 
Definition:  
‘Proportion of persons (aged 50-74) reporting to have undergone a colorectal cancer 
screening test in the past 2 years.’  
 
Calculation:  
‘Percentage of persons (aged 50-74) that have undergone a colorectal cancer 
screening test (faecal occult blood test) in the last 2 years, derived from EHIS 
questions: PA.16 and PA.17. PA.16: Have you ever had a faecal occult blood test? 1. 
Yes / 2. No; PA.17: When was the last time you had a faecal occult blood test? Within 
the past 12 months / More than 1 year, but not more than 2 years / More than 2 years, 
but not more than 3 years / Not within the past 3 years.’  
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INDICATOR 2  
Colorectal cancer screening (cont.) 
 
‘Ideally, the recall period used in the definition for this indicator coincides with the 
recall period actually applied in the screening programmes. However, the recall 
periods applied in national cancer screening programmes differ. As a common 
methodology needs to be applied in EHIS for all countries, a flexible approach with 
country specific questions is not possible.  
 
The recall period used in the definition for this indicator therefore represents an 
average and hence it will not be aligned with the programme methodologies for all 
countries.’  
 
‘Administrative sources based on screening programme data would be preferable over 
(E)HIS based data, as the latter will be influenced by recall and sampling biases. 
Currently however there is no adequate international coverage of programme based 
data. Therefore for the moment EHIS is the best source available for this indicator. In 
the future however, when the situation with regard to programme based data has 
improved, ECHIM prefers to use those data instead of EHIS.’ 
____________________________________________________________________ 
 
INDICATOR 3: 
STANDARDISED MORTALITY RATES  
 
Definition:  
‘Deaths caused by specific diseases or disease groups per 100,000 inhabitants.’  
 
Calculation:  
‘Number of deaths per 100,000 inhabitants (age-standardised rates). The (age-) 
standardised death rate is a weighted average of age-specific mortality rates. The 
weighting factor is the age distribution of a standard reference population. 
Standardisation is carried out through the direct method. The standard reference 
population used is the European standard population as defined by the World Health 
Organisation (WHO). The annual average population available in Eurostat's 
demography database is used to calculate the rates.’ 
 
____________________________________________________________________ 
 
INDICATOR 4:  
MATERNAL MORTALITY RATIO  
 
Definition 1: ‘The maternal mortality ratio is the number of women who die from 
pregnancy-related causes while pregnant or within 42 days of pregnancy termination 
per 100, 000 live births.   
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INDICATOR 4 (cont.)  
 
Calculation:  
‘The data are estimated with a regression model using information on the proportion 
of maternal deaths among non-AIDS deaths in women ages 15-49, fertility, birth 
attendants and gross domestic product.’ 
 
Definition 2: 
‘The maternal mortality ratio is defined as the number of maternal deaths during a 
given time period per 100 000 live births during the same time period. It depicts the 
risk of maternal death relative to the number of live births.’ 
 
____________________________________________________________________ 
 
INDICATOR 5 
STANDARDISED PREMATURE MORTALITY RATES  
 
Definition:  
‘This measure is used to assess the age-standardised rate of premature deaths per 
100,000 population younger than 75 years.’  
 
Calculation: 
‘The numerator is the total number of deaths at age younger than 75 years and the 
denominator is the total mid-year population younger than age 75 years.’  
 
____________________________________________________________________ 
 
INDICATOR 6 
STANDARDISED INCIDENCE RATE OF CANCER  
 
Definition:  
‘Total cancer incidence and incidence of the most important cancers, per 100,000 
population, in a given year.’  
 
Calculation:  
‘Number of patients with newly diagnosed cancer during a given calendar year 
divided by person-years at risk, expressed per 100,000 population. The age 
standardise incidence rate is calculated.’ 
 
CI5plus: Cancer incidence rates are age-standardised to the World Standard 
Population.  
GLOBOCAN 2008: Cancer incidence rates are age-standardised to the World 
Standard Population 1960.  
ECO 2008: Cancer incidence rates are age-standardised to the Standard European 
Population. 
____________________________________________________________________  
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INDICATOR 7 
PERINATAL AND INFANT MORTALITY RATES BY GESTATIONAL AGE, 
BIRTH WEIGHT AND PLURALITY 
 
Perinatal mortality rates  
 
Definition:  
‘The number of early neonatal deaths after live birth plus fetal deaths in a given year 
per 1000 live and stillbirths.’ 
 
Calculation:  
‘The number of fetal deaths and deaths in the early neonatal period (up to 6 completed 
days after birth) after live birth, expressed per 1000 live and stillbirths in the same 
year. For international comparisons, it is recommended by the WHO that elements in 
both the nominator (fetal deaths and early neonatal deaths) and denominator (fetal 
deaths and live births) are restricted to fetuses and infants weighting 1000 grams or 
more.’ 
 
Infant mortality rate  
 
Definition:  
‘The number of deaths of infants (younger than one year of age at death) per 1000 live 
births (based on one year data).’ 
 
Calculation:  
‘Number of deaths under one year of age (aged 0-364 days) in a given year, per 1000 
live births in that year.’ 
 
____________________________________________________________________ 
 
INDICATOR 8:  
FATAL ACCIDENTS AT PLACE OF WORK/FATALITY RATES PER 
ECONOMIC SECTOR  
 
Definition and calculation:  
‘Incidence rates relate the number of accidents to the reference population of persons 
in employment (persons exposed to the risk of accident at work). A fatal accident is 
defined as an accident, which leads to the death of a victim within one year of the 
accident. The incidence rate as defined by the European Statistics on Accidents at 
Work methodology is the number of accidents at work per 100 000 persons in 
employment. From an epidemiological point of view an incidence rate should relate 
the number of accidents to the working hours of the reference population. This 
approach would describe more precisely the relevant exposure as time under risk and 
therefore adjust for differences, e.g. with regard to different working hours or 
differences with regard to part-time employment.’ 
____________________________________________________________________ 
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INDICATOR 9 
CHILD MORTALITY RATE (1-14 YEARS) PER 100 000 POPULATION  
 
Definition: ‘Number of deaths per 1000 live births until 5 years of age or Probability 
of dying before 5 years per 1000 live births.’ 
 
Calculation: ‘Number of deaths age 1-14 years divided by population in that age 
group per 100,000 population.’  
 
____________________________________________________________________ 
 
INDICATOR 10 
ACUTE HOSPITAL BED OCCUPANCY RATES BY SECTOR  
 
Definition and calculation:  
‘The occupancy rate is calculated as the number of beds effectively occupied (bed-
days) for curative care divided by the number of beds available for curative care 
multiplied by 365 days, with the ratio multiplied by 100. Occupancy rate = Total 
number of bed-days during the year / (Number of beds available * 365 days) * 100.’  
 
____________________________________________________________________ 
 
INDICATOR 11: 
INCIDENCE RATE OF AIDS PER 100,000 POPULATION  
 
Definition: ‘Incidence of AIDS cases, in a given calendar year, per 100,000 
population.’  
 
Calculation: ‘The rates are calculated as the number of newly diagnosed cases per 
100,000 population, based on the number of cases reported by national surveillance 
systems to the joint WHO-Euro/ECDC database for AIDS surveillance in The 
European Surveillance System (TESSy). A case of AIDS is defined following the 
European AIDS surveillance case definitions.’ 
 
____________________________________________________________________ 
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INDICATOR 12 
INCIDENCE OF MRSA HOSPITAL ACQUIRED INFECTION PER 1000 
ADMISSIONS  
 
Definition of Hospital Acquired Infection (HAI): 
‘An infection is considered an HAI  if all elements of a CDC/NHSN (Centers for 
Disease Control and Prevention/National Healthcare Safety Networks) site-specific 
infection criterion were first present together on or after the 3rd hospital day (day of 
hospital admission is day 1). For an HAI, an element of the infection criterion may be 
present during the first 2 hospital days as long as it is also present on or after day 3. 
All elements used to meet the infection criterion must occur within a timeframe that 
does not exceed a gap of 1 calendar day between elements.’ 
____________________________________________________________________ 
 
INDICATOR 13 
PERCENTAGE OF SELF-REFERRALS TO THE ACCIDENT AND 
EMERGENCY DEPARTMENT 
 
Definition of Indicator 13: 
Numerator:  
Number of all referrals to the A&E Department where no ticket of referral by a GP or 
a Health Centre Doctor was presented at the A&E Reception on registration. 
 
Denominator:  
All A&E registrations during one year multiplied by 100 to obtain the percentage. 
 
____________________________________________________________________ 
 
INDICATOR 14 
WAITING TIMES FOR APPOINTMENTS AT OUT-PATIENT CLINICS 
FROM DATE OF REQUEST  
 
The time taken between date of request of outpatient appointment until the actual 
appointment date. Data are available for all outpatient clinics. 
____________________________________________________________________ 
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INDICATOR 15 
HOSPITAL AVERAGE LENGTH OF STAY  
 
Definition: 
‘The average length of stay (ALOS) in days in a hospital per discharged in-patient, 
i.e. average duration of a single episode of hospitalization.’  
 
Calculation:  
‘ALOS is computed by dividing the total number of in-patent hospital days, in all 
hospitals, counted from the date of admission to the date of discharge by the total 
number of discharges (including deaths) in all hospitals during a given year.  
 
A hospital day (or bed-day or in-patient day) is a day, during which a person admitted 
as an in-patient, is confined to a bed and stays overnight in a hospital.  
 
Day-cases (patients formally admitted for a medical procedure or surgery in the 
morning and discharged before the evening) are excluded.  
 
Patients admitted with the intention of discharge on the same day, but who 
subsequently stay in hospital overnight, are included.’ 
‘The preferred data type is from registers (administrative data sources, national 
hospital discharge registers). ECHIM does not require disaggregation by sex for this 
indicator, and only by two age groups (0-64 and 65+) to reduce the number of 
operationalisations.’  
 
‘A (hospital) discharge is the formal release of a patient from a hospital after a 
procedure or course of treatment (episode of care). A discharge occurs anytime a 
patient leaves because of finalisation of treatment, signs out against medical advice, 
transfers to another health care institution or because of death.  
 
Transfers to another department within the same institution are excluded. A discharge 
can refer to in-patients or day cases, but day treatment cases (day cases, patients 
admitted for a medical procedure or surgery in the morning and released before the 
evening) should be excluded.’  
 
‘Discharges by diagnosis refer to the principal diagnosis, i.e. the main condition 
diagnosed at the end of the hospitalisation. The main condition is the one primarily 
responsible for the patient's need for treatment or investigation.’  
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INDICATOR 16 
PERCENTAGE OF INFANTS FULLY VACCINATED AGAINST 
PERTUSSIS, DIPHTHERIA, TETANUS AND POLIO BY 1ST BIRTHDAY 
AND AGAINST MMR BY 2ND BIRTHDAY  
 
Definition:  
‘Percentage of infants who have been fully vaccinated against important infectious 
childhood diseases.’  
 
Calculation:  
‘Percentage of infants reaching their 1st birthday in the given calendar year who have 
been fully vaccinated, according to national vaccination schemes, against pertussis, 
diphtheria, tetanus and poliomyelitis, and percentage of infants reaching their 2nd 
birthday in the given calendar year who have been fully vaccinated against measles, 
mumps and rubella.’ 
 
____________________________________________________________________ 
 
INDICATOR 17 
TUBERCULOSIS INCIDENCE AND MULTIDRUG RESISTANT CASES 
NOTIFICATION RATES 
 
Tuberculosis incidence  
 
Definition: 
‘Number of newly diagnosed tuberculosis cases, all forms (ICD-9:010-018; ICD-10: 
A15-A19) during the given calendar year. The definition has been modified in June 
2001 version of Health for All Database. Now, relapses are included in the incidence 
figures (before relapses were excluded).’   
 
Calculation: 
The incidence of a disease per year is calculated as the total number of reported new 
cases of the disease in a specific year divided by the population of the country in 
question in the same year, expressed per 100 000 population. 
 
Notification rate:  
‘The numerator is the number of cases that are notified and the denominator is the 
total number of cases ascertained through use of supplemental data sources.’ 
 
____________________________________________________________________ 
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INDICATOR 18 
HOSPITAL READMISSION RATES BY SPECIALITY  
 
‘The 30‐day readmission rate is defined as: the number of stays with at least one 
subsequent hospital stay within 30 days/the total number of hospital stays between 
January and November. That is, when a patient is discharged from the hospital (the 
index stay), they are followed for 30 days in the data. If any readmission to the same 
or a different hospital occurs during this 30‐day time period, the index stay is counted 
as having a readmission. No more than one readmission is counted within the 30‐day 
period since the outcome measure assessed here is "percentage of admissions with a 
readmission.’ 
 
‘A readmission is a subsequent hospital admission in the same or a different hospital 
within 30 days following an original admission (or index stay).  The discharge date 
for the index stay must occur between January and November to allow a 30‐day 
follow‐up period for all index stays.  This approach captures an index stay with a 
discharge date in November and a readmission in December.’ 
  
____________________________________________________________________ 
 
INDICATOR 19 
30-DAY IN-HOSPITAL MORTALITY RATE FOR SPECIFIC CLINICAL 
CONDITIONS  
 
Definition: 
‘Admission-based AMI and ischemic stroke 30-day in-hospital (same hospital) 
mortality rate. This indicator is defined as the age-sex standardised percentage of 
people aged 45+ who die within 30 days of being admitted to a hospital in a specified 
year with principal diagnosis of: a) acute myocardial infarction (AMI) or b) ischemic 
stroke.’ 
 
Calculation:  
‘Numerator: the number of deaths in the same hospital that occurred within 30 days 
of hospital admission with a principal diagnosis of AMI / ischemic stroke in a specified 
year. Denominator: the number of patients admitted to a hospital with a principal 
diagnosis of AMI / ischemic stroke in a specified year, including same day admissions. 
AMI diagnostic codes: ICD-10: I21, I22; ICD-9: 410. Ischemic stroke diagnostic 
codes: ICD-10: I63-I64; ICD-9: 433, 434, 436. The indicator is age-sex standardised 
according to 2005 OECD population (45+). Therefore 5-year age specific numerators 
and denominators are needed, separate for men and women: 45-49, 50-54…85+.’ 
 
____________________________________________________________________ 
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INDICATOR 20 
NUMBER OF HOSPITAL BEDS  
 
Definition:   
‘Number of hospital beds per 100,000 inhabitants.’  
 
Calculation:  
‘The total number of hospital beds in a given calendar year by 31 December divided 
by the end of year population expressed per 100,000 inhabitants. Total hospital beds 
are all hospital beds which are regularly maintained and staffed and immediately 
available for the care of admitted patients. Both occupied and unoccupied beds in 
general hospitals, mental health and substance abuse hospitals and other specialty 
hospitals are included.’ 
 
____________________________________________________________________ 
 
INDICATOR 21 
ANNUAL INCIDENCE OF TYPE 1 DIABETES IN CHILDREN BETWEEN  
0-14 YEARS OF AGE AT CLINICAL DIAGNOSIS PER 100,000 CHILDREN* 
 
Definition:  
Number of children between 0 – 14 years of age with newly diagnosed Type 1 diabetes 
during a given calendar year.  
 
Calculation:  
The rates are calculated as the number of newly diagnosed cases per 100,000 
population.  
 
(*Note: Definition not yet validated) 
 
____________________________________________________________________ 
 
INDICATOR 22 
PREVALENCE OF SMOKING IN MALES AND FEMALES MORE THAN 15 
YEARS OF AGE  
 
Definition:  
‘Percentage of regular daily smokers in the population, age 15+.’ 
 
Calculation: 
‘This indicator is measured using the standard questionnaire during a health 
interview of a representative sample of the population aged 15 years and above. Many 
countries are carrying out such health interview surveys on a more or less regular 
basis. However, most of the data are collected from multiple sources by the Tobacco 
or Health unit at WHO/EURO.’  
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INDICATOR 23:  
WAITING TIMES FOR ADMISSION TO PUBLIC REHABILITATION 
FACILITY AND TO PUBLIC LONG-TERM CARE FACILITY  
 
Waiting times for admission to public rehabilitation facility: 
‘The denominator is the total number of patients referred for rehabilitation in a year 
under review who are accepted for a period of rehabilitation at RHKG. The numerator 
is the total number of patients actually transferred for rehabilitation at RHKG during 
the year under review.   
 
The median waiting time is from date of referral to date of transfer. 
Exclusion criteria: deceased patients while waiting and discharged patients while 
waiting.’  
 
Waiting times for admission to public long-term care facility: 
‘The denominator is the total number of patients applying for government long term 
care during the year under review. The numerator is the total number of patients 
admitted to government long term care within 18 months from the date of application.  
 
The median waiting time is from date of application of long term care to date of 
admission. 
 
Exclusion criteria: deceased patients while waiting and patients withdrawing their 
application.’   
 
____________________________________________________________________ 
 
INDICATOR 24 
AVAILABILITY OF DIAGNOSTIC / THERAPEUTIC INFRASTRUCTURE  
 
Definition: 
‘1) Number of Computer Tomography scanners (CT units) per 100,000 inhabitants.  
2) Number of Magnetic Resonance Imaging units (MRI units) per 100,000 
inhabitants.’  
 
Calculation:  
‘1) The total number of computer tomography scanners (CT units) in hospitals and 
ambulatory sector registered by 31 December in a given calendar year, per 100,000 
inhabitants (end of year population).  
 
2) The total number of magnetic resonance imaging units (MRI units) in hospitals and 
ambulatory sector by 31 December in a given calendar year, per 100,000 inhabitants 
(end of year population).  
 
The preferred data type is from national administrative sources.’ 
____________________________________________________________________ 
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INDICATOR 25 
COMPLICATIONS OF DIABETES: ANNUAL INCIDENCE RATES OF 
STROKE, MYOCARDIAL INFARCTION, DIALYSIS AND/OR RENAL 
TRANSPLANTATION IN PATIENTS WITH DIABETES* 
 
Annual incidence rate by age category of diabetic patients with stroke: 
‘Number of patients discharged from Mater Dei Hospital in 2013 with a recorded 
primary discharge diagnosis of Stroke (Codes: I63.x and I64.x) on the Electronic Case 
Summary database and who were alive and on the POYC diabetes register in May 
2014, per 100,000 diabetic population.’ 
 
Annual incidence rate by age category of diabetic patients with myocardial 
infarction: 
‘Number of patients discharged from Mater Dei Hospital in 2013 with a recorded 
primary discharge diagnosis of myocardial infarction (Code: I21.x) on the Electronic 
Case Summary database and who were alive and on the POYC diabetes register in 
May 2014, per 100,000 diabetic population.’ 
 
Annual incidence rate by age category of diabetic patients with renal dialysis: 
‘Number of patients admitted to the Renal Unit to start renal replacement therapy in 
2013 and who were alive and on the POYC diabetes register in May 2014, per 100,000 
diabetic population.’ 
 
Annual incidence rate by age category of diabetic patients with renal transplant:  
‘Number of patients with recorded renal transplantation (Code: 55.69) performed at 
Mater Dei Hospital in 2013 and who were alive and on the POYC diabetes register in 
May 2014, per 100,000 diabetic population.’ 
 
(*Note: Definition not yet validated) 
 
____________________________________________________________________ 
 
 
INDICATOR 26 
RATIO OF THE NUMBER OF DISCHARGES OF OLDER PERSONS AGED 
OVER 75 YEARS WHO ARE DISCHARGED FROM PUBLIC ACUTE 
HOSPITAL (MATER DEI HOSPITAL) TO THEIR HOME OF RESIDENCE 
AS COMPARED TO THOSE DISCHARGED TO LONG-TERM FACILITY 
 
Definition:  
Number of patients over 75 years of age who are discharged to their residence as 
compared to the number of patients over 75 years who are discharged to a long term 
residential or nursing facility. 
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INDICATOR 26 (cont.) 
 
Calculation:  
Ratio or percentage of patients over 75 years of age who are discharged to their 
residence as compared to patients over 75 years who are discharged to a long term 
residential or nursing facility. 
 
____________________________________________________________________ 
 
INDICATOR 27 
PREVALENCE OF ADULTS WITH DIABETES, HYPERTENSION, 
HYPERCHOLESTEROLAEMIA BY AGE AND GENDER  
 
Diabetes  
 
Definition:  
‘Number of individuals that have ever been diagnosed with diabetes and that have 
been affected by this condition during the past 12 months. Expressed per 100,000 and 
as percentage of total population.’ 
 
Calculation: 
‘National best estimate of number of individuals that have ever been diagnosed with 
diabetes and that have been affected by this condition during the past 12 months (ICD-
10 codes E10-E14; includes both diabetes mellitus type 1 and type 2 and other 
diabetes mellitus). Age standardisation should be done for men and women separately, 
according to the direct method, using the 1976 WHO European population as 
standard population.’ 
 
Hypertension  
 
Definition: 
‘Proportion of individuals reporting to have been diagnosed with high blood pressure 
which occurred during the past 12 months.’ 
 
Calculation:  
‘Proportion of individuals reporting to have been diagnosed with high blood pressure 
(hypertension) which occurred during the past 12 months, derived from European 
Health Interview Survey (EHIS) questions HS.4/5/6: HS.4: Do you have or have you 
ever had any of the following diseases or conditions? High blood pressure 
(hypertension) (yes / no). If yes: HS.5: Was this disease/condition diagnosed by a 
medical doctor? (yes / no). HS.6: Have you had this disease/condition in the past 12 
months? (yes / no).’  
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INDICATOR 27 (cont.) 
 
Hypercholesterolaemia* 
 
Definition: Proportion of individuals reporting to have been diagnosed with 
hypercholesterolaemia which occurred during the past 12 months.  
 
Calculation: Proportion of individuals reporting to have been diagnosed with 
hypercholesterolaemia which occurred during the past 12 months. 
(*Note: Definition not yet validated) 
 
____________________________________________________________________ 
 
INDICATOR 28 
AVOIDABLE HOSPITAL ADMISSION RATES FOR SPECIFIC DISEASES  
 
Definition and calculation: The avoidable hospital admission rates for asthma and 
Chronic Obstructive Pulmonary Disease ‘are defined as the number of hospital 
discharges of people aged 15 years and over per 100 000 population. The indicator 
for diabetes is based on the sum of three indicators: admissions for short-term and 
long-term complications and for uncontrolled diabetes without complications.’ 
 
____________________________________________________________________ 
 
INDICATOR 30 
WAITING TIMES FOR OUT-PATIENT BASED INVESTIGATIONS AND 
INTERVENTIONS  
 
Waiting times for elective surgeries 
Definition and calculation: ‘Average inpatient waiting time for elective (i.e. non-
urgent) surgeries of Percutaneous Transluminal Coronary Angioplasty (PTCA), hip 
replacement and cataract operation, measured in number of days. Elective surgery is 
defined as when surgery is necessary, but the timing of the procedure can be scheduled 
and the patient can be sent home.’ 
____________________________________________________________________ 
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INDICATOR 31 
INCIDENCE RATE OF HIV AND HEPATITIS B PER 100,000 POPULATION 
 
Incidence rate of HIV  
 
Definition:  
‘Incidence of HIV-infected and in a given calendar year, per 100,000 population.’ 
 
Calculation:  
‘The rates are calculated as the number of newly diagnosed cases per 100,000 
population, based on the number of cases reported by national surveillance systems 
to the joint WHO-Euro/ECDC database for surveillance in The European Surveillance 
System (TESS). A case of HIV infection is defined following the European HIV 
surveillance case definitions.’ 
 
____________________________________________________________________ 
 
INDICATOR 32 
NUMBER OF VACCINE PREVENTABLE DISEASES COVERED BY THE 
NATIONAL VACCINATION PROGRAMME 
 
Definition: 
Number of vaccines on the national vaccination programme that prevent preventable 
diseases. 
 
Calculation; 
Count of types of vaccines. 
 
____________________________________________________________________ 
 
INDICATOR 33 
PERCENTAGE OVERWEIGHT AND OBESITY FROM SELF-REPORTED 
BMI BY AGE-GROUP (OVER 15 YEAR OLDS)  
 
Definition: 
‘Proportion of adult persons (18+) who are obese, i.e. whose body mass index (BMI) 
is ≥ 30 kg/m². 
 
Calculation: 
‘Body mass index (BMI), or Quetelet index, is defined as the individual’s body weight 
(in kilograms) divided by the square of their height (in metres). Weight and height 
derived from European Health Interview Survey (EHIS) questions BMI01: How tall 
are you? (cm), and BMI02: How much do you weight without clothes and shoes? (kg).’ 
 
____________________________________________________________________  
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INDICATOR 34 
PERCENTAGE OF HEALTH BUDGET ALLOCATED TO PUBLIC HEALTH 
INCLUDING PREVENTIVE SERVICES  
 
Definition: 
Percentage of government budget on health that is allocated to public health activities 
as compared to the overall health budget. 
 
Calculation: 
Ratio of government expenditure on public health activities over total government 
health expenditure. 
 
____________________________________________________________________ 
 
INDICATOR 35 
HEALTH EXPENDITURE AS A PERCENTAGE OF GDP AND PER CAPITA  
 
Health expenditure as percentage of GDP  
 
Definition:  
‘Current and total national health expenditure for total, public, and private sectors, 
as percentage of gross domestic product (GDP), and expressed in millions of 
Purchasing Power Standard (PPS).’ 
 
Calculation:  
‘According to System of Health Accounts (SHA) and the related International 
Classification for the Health Accounts (ICHA) current expenditure on health care 
measures/describes financial means/ flows associated with (the consumption of) 
health care goods and services including governance and administration of health 
care system at large. Total expenditures also include investments (capital formation 
of health care providers). The calculation of Purchasing Power Parities (PPP)/PPS 
is based on the prices for a standard basket of goods.’ 
Health expenditure per capita  
‘Total expenditure on health measures the final consumption of health goods and 
services (i.e. current health expenditure) plus capital investment in health care 
infrastructure. This includes spending by both public and private sources on medical 
services and goods, public health and prevention programmes and administration. To 
compare spending levels between countries, per capita health expenditures are 
converted to a common currency (US dollar) and adjusted to take account of the 
different purchasing power of the national currencies, in order to compare spending 
levels.’ 
 
____________________________________________________________________ 
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INDICATOR 36:  
 404 
GENERAL GOVERNMENT HEALTH EXPENDITURE AS A PERCENTAGE 
OF TOTAL GOVERNMENT EXPENDITURE AND PERCENTAGE OF 
TOTAL HEALTH EXPENDITURE 
 
General government health expenditure as a percentage of total government 
expenditure  
General government health expenditure as a percentage of total health 
expenditure  
‘Public health expenditure consists of recurrent and capital spending from 
government (central and local) budgets, external borrowings and grants (including 
donations from international agencies and nongovernmental organizations), and 
social (or compulsory) health insurance funds. Total health expenditure is the sum of 
public and private health expenditure. It covers the provision of health services 
(preventive and curative), family planning activities, nutrition activities, and 
emergency aid designated for health but does not include provision of water and 
sanitation.’ 
 
Public-sector expenditure on health as a percentage of GDP (WHO estimates) 
Public sector (or general government) expenditure on health is the sum of outlays for 
health maintenance, restoration or enhancement paid for in cash or in kind by 
government entities, such as the Ministry of Health, other ministries, parastatal 
organizations, social security agencies, (without double-counting the government 
transfers to social security and to extra-budgetary funds).  Includes transfer payments 
to households to offset medical care costs and extra-budgetary funds to finance health. 
The revenue base of these entities may comprise multiple sources, including external 
funds. Estimates for this indicator were produced by WHO. The estimates are, to the 
greatest extent possible, based on the National Health Accounts classification (see the 
World Health Report 2006 for details). The sources include both nationally reported 
data and estimates from international organisations like IMF, WB, UN and OECD. 
Therefore they may somewhat differ from official national statistics reported by 
countries.  
____________________________________________________________________ 
 
INDICATOR 37 
LIFE EXPECTANCY AND HEALTHY LIFE EXPECTANCY AT BIRTH AND 
OVER 65  
 
Life expectancy  
 
Definition: ‘Life expectancy at a given age represents the average number of years of 
life remaining if a group of persons at that age were to experience the mortality rates 
for a particular year over the course of their remaining life. Life expectancy at birth 
is a summary measure of the age-specific all cause mortality rates in an area in a 
given period.’ 
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INDICATOR 37 
Life expectancy (cont.) 
 
Calculation:  
‘Life expectancies are calculated using (abridged) life tables presenting age specific 
mortality rates. Life expectancy tables are calculated based on death probabilities 
according to Farr's death rate method:  
 
qx = Mx / (Bx + (Mx/2)) 
where: 
 
• Mx = the number of deaths at the age of x to under x+1 years in the 
reported period. 
• Bx = average population aged x to under x+1 in the base period. 
• qx = death probability from age x to x+1. 
 
Farr's method of calculation of abridged life-tables assumes that there is a constant 
mortality within the age intervals and thus the years of life lived by a person dying in 
the interval is (on average) half of the length of the interval.’ 
 
Healthy life years  
 
Definition:  
‘The Healthy Life Years (HLY) indicator (also called disability-free life expectancy) 
measures the number of remaining years that a person of a certain age is still supposed 
to live without disability.’ 
 
Calculation:  
‘The indicator is calculated following the Sullivan method’ Further information can 
be found at  http://www.ehemu.eu/pdf/Sullivan_guide_final_jun2007.pdf’ 
 
____________________________________________________________________ 
 
INDICATOR 38 
POTENTIAL YEARS OF LIFE LOST  
 
Definition:  
‘Potential Years of Life Lost (PYLL) is a summary measure of premature mortality 
which provides an explicit way of weighting deaths occurring at younger ages, which 
are, a priori, preventable.’  
 
Calculation:  
‘The calculation of PYLL involves summing up deaths occurring at each age and 
multiplying this with the number of remaining years to live up to a selected age limit.’ 
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INDICATOR 39 
PUBLIC HEALTH EXPENDITURE AS A PERCENTAGE OF GDP FOR 
HOSPITALS, AMBULATORY SERVICES AND LONG TERM CARE 
 
Public health expenditure consists of recurrent and capital spending from government 
(central and local) budgets, external borrowings and grants (including donations from 
international agencies and nongovernmental organizations), and social (or 
compulsory) health insurance funds. 
 
____________________________________________________________________ 
 
INDICATOR 40 
HOSPITAL DAY-CASES AS PERCENTAGE OF TOTAL PATIENT 
POPULATION (IN-PATIENTS & DAY-CASES) SELECTED DIAGNOSES 
 
Definition:  
‘Hospital day-cases, for specific ICD-10 diagnosis groups, divided by the sum of 
number of inpatient discharges and the number of day-cases for the same diagnosis 
group.’ 
 
Calculation:  
‘The indicator is calculated as the total number of hospital day-cases from all 
hospitals during the given calendar year, divided by the sum of the number of hospital 
in-patient discharges from all hospitals and the number of hospital day-cases from all 
hospitals, for each of the diagnosis groups, during the given calendar year.’ 
 
____________________________________________________________________ 
 
INDICATOR 41 
NUMBER AND RATIOS OF ALL PRACTICING DOCTORS, GPS, 
SPECIALISTS AND NURSES AND MIDWIVES PER 100,000 INHABITANTS  
 
All practicing doctors  
 
Definition:  
‘The total number of practicing physicians (medical doctors) per 100,000 
inhabitants.’ 
 
Calculation:  
‘The total number of practicing physicians (medical doctors) by 31 December of a 
given calendar year, per 100,000 inhabitants (end of year population). Practicing 
physicians provide services directly to patients.’ 
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INDICATOR 41 
 
Practicing nurses  
Definition:  
‘The total number of practising nursing and caring professionals by 31 December of 
a given calendar year, per 100,000 inhabitants (end of year population). Practicing 
nurses provide services directly to patients. Practising nurses include professional 
nurses, associate professional nurses and foreign nurses licensed to practice and 
actively practicing in the country.’ 
 
Calculation:  
‘The total number of practicing nursing and caring professionals by 31 December of 
a given calendar year, per 100,000 inhabitants (end of year population). Practicing 
nursing and caring professionals provide services directly to patients. Nursing and 
caring professionals include midwives, qualified nurses, associate nurses and caring 
personnel (e.g. nursing aids, assistants). A nurse is a person who has completed a 
programme of basic nursing education and is qualified and authorised in his/her 
country to practice nursing in all settings.’ 
 
____________________________________________________________________ 
 
INDICATOR 43 
GP CONTACTS PER CAPITA  
 
Definition:  
‘Mean number of self-reported visits to general practitioner per person per year.’ 
 
Calculation:  
‘Mean number of visits to general practitioner per person per year, derived from EHIS 
questions HC10 and HC11. HC10:  
When was the last time you consulted a GP (general practitioner) or family doctor on 
your own behalf?  
(1) Less than 12 months ago (2) 12 months ago or longer (3) Never)  
 
If HC10 is 1) HC11: During the past four weeks ending yesterday, that is since (date), 
how many times did you consult a GP (general practitioner) or family doctor on your 
own behalf? (number of times).  
 
Total number of contacts reported under HC11 is extrapolated from 4 to 52 weeks, 
and divided by the total number of respondents in the sample.  
 
For comparability reasons ECHIM would prefer age-standardised data.’ 
 
____________________________________________________________________ 
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INDICATOR 44 
PUBLIC OUTPATIENT PHARMACEUTICALS AS PERCENTAGE OF GDP  
 
Definition:  
‘Pharmaceutical expenditure covers spending on prescription medicines and self-
medication, often referred to as over-the-counter products. In some countries, the data 
also include other medical non-durable goods (adding approximately 5% to the 
spending). The expenditure also includes pharmacists’ remuneration when the latter 
is separate from the price of medicines. Pharmaceuticals consumed in hospitals are 
excluded (their inclusion would add another 15% to pharmaceutical spending 
approximately). Final expenditure on pharmaceuticals includes wholesale and retail 
margins and value-added tax’. 
 
____________________________________________________________________ 
 
INDICATOR 45 
GENERIC SHARE OF PHARMACEUTICALS IN VALUE/VOLUME 
(PUBLIC) 
 
Definition and calculation:  
‘A generic is defined as a pharmaceutical product which has the same qualitative and 
quantitative composition in active substances and the same pharmaceutical form as 
the reference product, and whose bioequivalence with the reference product has been 
demonstrated. Generics can be classified in branded generics (generics with a specific 
trade name) and unbranded generics (which use the international non-proprietary 
name and the name of the company).’  
 
Value: 
‘Data are collected as a share expressed in value. Values can for instance be the 
turnover of pharmaceutical companies, the amount paid for pharmaceuticals by third-
party payers, or the amount paid by all payers (third-party and consumers). Market 
value are most often at ex-factory prices, while amounts paid by third-party payers 
(and consumers) are in general at retails prices.’ 
 
Volume: 
‘Data are collected as a share expressed in volume. Volumes can be expressed in 
DDDs or as a number of packages/boxes or standard units.’ 
 
____________________________________________________________________ 
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INDICATOR 46:  
SELF-PERCEIVED HEALTH  
 
Definition:  
‘Proportion of persons who assess their health to be (very) good.’  
 
Calculation:  
‘Proportion of persons who assess their health to be very good or good, based on EU-
SILC question on self-perceived health (‘How is your health in general?’), which 
contains five answering categories; 1) very good, 2) good, 3) fair, 4) bad, 5) very bad. 
Numbers of people assessing their health as either very good or good should be added 
and divided by the total number of people who were interviewed.  
 
For comparability reasons ECHIM would prefer age-standardised data.’ 
 
____________________________________________________________________ 
 
INDICATOR 47:  
UNMET NEED (SILC)  
 
Definition:  
‘The variables refer to the respondent's own assessment of whether he or she needed 
the respective type of examination or treatment, but did not have it and if so what was 
the main reason of not having it.’  
 
Calculation:  
‘The variables on unmet needs for health care targets two broad types of services: 
medical care and dental care. Eurostat currently disseminates the following indicators 
for unmet needs: 
 
• Self-reported unmet needs for medical examination for reasons of 
barriers of access. 
• Self-reported unmet needs for medical examination by reason. 
• Self-reported unmet needs for dental examination by reason. 
 
All indicators are expressed as percentages within (or share of) the population and 
breakdowns are given by: sex, age, labour status, educational attainment level, and 
income quintile group.’ 
 
____________________________________________________________________ 
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INDICATOR 48 
PERCENTAGE OF POPULATION COVERED BY PUBLIC HEALTH 
INSURANCE  
 
Definition:  
‘The proportion of the population covered by health insurance, taking into account 
both public and private insurance schemes.’ 
 
Calculation:  
‘Public (government/social) health insurance coverage is the share of the population 
(%) eligible for a defined set of health care goods and services that are included in 
total public health expenditure. Private health insurance coverage is the share of the 
population (%) based on a head count of individuals covered by at least one private 
health insurance policy (including both individuals covered in their own name and 
dependents).’ 
 
____________________________________________________________________ 
 
INDICATOR 49 
OUT OF POCKET HEALTH EXPENDITURE AS PERCENTAGE OF TOTAL 
HEALTH EXPENDITURE/ PRIVATE HEALTH EXPENDITURE  
 
Definition and calculation:  
‘Out of pocket expenditure is any direct outlay by households, including gratuities and 
in-kind payments, to health practitioners and suppliers of pharmaceutical, therapeutic 
appliances and other goods and service whose primary intent is to contribute to the 
restoration or enhancement of the health status of individuals or population groups. 
It is a part of private expenditure.’ 
 
____________________________________________________________________ 
 
INDICATOR 50 
INFLUENZA VACCINATION COVERAGE IN 65+  
 
Definition:  
‘Proportion of elderly individuals reporting to have received one shot of influenza 
vaccine during the last 12 months.’  
 
Calculation:  
‘Percentage of persons aged 65 and older reporting to have been vaccinated against 
influenza (brand name of vaccine to be verified in each country) during the last 12 
months, derived from EHIS questions PA.1, PA.2 and PA.3. PA.1:  
 
Have you ever been vaccinated against flu? 1. Yes / 2. No; PA.2:  
 
When were you last time vaccinated against flu?  
1. Since the beginning of this year / 2. Last year /3. Before last year;  
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INDICATOR 50 (cont.) 
 
Calculation (cont.)  
 
PA.3: Can I just check, what month was that? Month (01-12).  
 
A recall period of 12 months is used to cover one influenza season.  
For comparability reasons ECHIM would however prefer age-standardised data.’ 
 
____________________________________________________________________ 
 
INDICATOR 51 
FREQUENCY OF POPULATION HAVING 6 OR MORE UNITS OF 
ALCOHOL ON ONE OCCASION  
 
Definition:  
‘Proportion of individuals reporting to have had an average rate of consumption of 
more than 20 grams pure alcohol daily for women and more than 40 grams daily for 
men.’ 
 
Calculation:  
‘Percentage of men/women having over the week on average ≥2 drinks/day (women) 
or ≥3 drinks/day (men), derived from EHIS question AL.2: How many drinks 
containing alcohol do you have each day in a typical week when you are drinking? 
Start with Monday and take one day at a time. Number of drinks of: Beer, Wine, 
Liqueur, Spirits, Other local alcoholic beverage.’   
 
____________________________________________________________________ 
 
INDICATOR 52 
FRUIT AND VEGETABLE CONSUMPTION 
 
Fruit consumption  
Definition:  
‘Proportion of people reporting to eat fruits (excluding juice) at least once a day.’ 
 
Calculation:  
‘Percentage of people reporting to eat fruits (excluding juice) at least once a day, 
derived from EHIS question FV.1.  
How often do you eat fruits (excluding juice)?  
1. Twice or more a day / 2. Once a day / 3. Less than once a day but at least 4 times a 
week / 4. Less than 4 times a week, but at least once a week / 5. Less than once a week 
/ 6. Never (answering categories 1 and 2 should be added for the calculation of this 
indicator).  
 
For comparability reasons ECHIM would prefer age-standardised data.’ 
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INDICATOR 52 (cont.) 
 
Vegetable consumption  
 
Definition:  
‘Proportion of people reporting to eat vegetables (excluding potatoes and juice) at 
least once a day.’  
 
Calculation:  
Percentage of people reporting to eat vegetables (excluding potatoes and juice) at 
least once a day, derived from EHIS question FV.2. How often do you eat vegetables 
or salad (excluding juice and potatoes)? 1. Twice or more a day / 2. Once a day / 3. 
Less than once a day but at least 4 times a week / 4. Less than 4 times a week, but at 
least once a week / 5. Less than once a week / 6. Never (answering categories 1 and 2 
should be added for the calculation of this indicator).  
 
For comparability reasons ECHIM would prefer age-standardised data.’ 
 
____________________________________________________________________ 
 
INDICATOR 53 
PERCENTAGE REPORTING MORE THAN 2.5 HOURS OF PHYSICAL 
ACTIVITY PER WEEK BY AGE AND SEX  
 
Definition:  
‘Proportion of individuals reporting to perform a certain period of time of health 
enhancing physical activity on an average day/at least x times per week.’ 
 
Calculation:  
‘EHIS instrument to measure the proportion of population performing moderate and 
vigorous physical activity (days and/or hours per week), derived from questions 
PE.16: During the past 7 days, a) days and time devoted to vigorous physical 
activities, b) days and time devoted to moderate physical activities, c) days and time 
spent walking. For comparability reasons ECHIM prefers age-standardised data.’  
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INDICATOR 55 
OLD-AGE DEPENDENCY RATIO AND SHARE OF POPULATION 65+/80+  
 
Old age dependency ratio  
Definition and calculation:  
‘The ratio between the total number of elderly persons of an age when they are 
generally economically inactive (aged 65 and over) and the number of persons of 
working age (from 15 to 64). National annual estimates of the population can be based 
on data from the most recent census adjusted by the components of population change 
produced since the last census. The total population may comprise either all usual 
residents of the country (de jure population) or all persons present (de facto 
population) in the country at a given moment in time. Usual residents are those who 
have lived in their place of usual residence for a continuous period of at least 12 
months before the reference date or those who arrived in their place of usual residence 
during the 12 months before the reference date with the intention of staying there for 
at least one year.’ 
 
____________________________________________________________________ 
 
INDICATOR 57: AT RISK OF POVERTY OR SOCIAL EXCLUSION  
 
Definition:  
‘At risk of poverty refers to the share of persons with an income below the poverty 
line. Income inequality is defined by the ratio of total income received by 20% of the 
country’s population with the highest income to that received by 20% of the country’s 
population with the lowest income.’ 
 
Calculation:  
‘Population at risk of poverty: Percentage of persons in the total population with an 
equivalised disposable income below the “national poverty line” (i.e. below 60% of 
the national median equivalised disposable income). Total population is all persons 
living in private household on the national territory. Total disposable income of a 
household is calculated by adding together the personal income received by all of the 
household members, plus income received at household level. Disposable household 
income includes all income from work, private income from investment and property, 
transfers between households and all social transfers received in cash including old-
age pensions. Personal equivalised income is obtained by dividing the total household 
disposable income by the equivalised size of the household, using modified OECD 
scale: 1 for the first person aged 14 or more; 0.5 for any subsequent person aged 14 
or more; and 0.3 for persons aged less than 14. 
 
Income inequality is calculated as the ratio of the sum of equivalised disposable 
income received by the 20% of the country’s population with the highest equivalised 
disposable income (top inter-quintile interval) to that received by the 20% of the 
country’s population with the lowest equivalised disposable income (lowest inter-
quintile interval).’ 
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INDICATOR 58:  
POPULATION BY EDUCATION  
 
Definition: ‘Proportion (%) of population divided up into three classes of educational 
attainment (low, middle and high education). Attainment profiles are based on highest 
completed specified level of education.’ 
 
Calculation: ‘Percentage of total population in the 7 classes of ISCED (International 
Standard Classification of Education 1997), aggregated into three attainment groups 
comprising of: elementary and lower secondary education (ISCED level 0, 1 and 2), 
upper/post secondary (ISCED levels 3 and 4) and tertiary (ISCED levels 5 and 6).’  
 
____________________________________________________________________ 
 
INDICATOR 60 
HIP FRACTURE SURGERY INITIATED WITHIN TWO CALENDAR DAYS 
AFTER ADMISSION TO MATER DEI HOSPITAL 
 
Coverage:  
Patients aged 65 and older (5 year age group) admitted to the main public acute 
hospital in Malta. 
 
Numerator:  
Number of patients as defined in the denominator who were surgically treated within 
2 calendar days after admission.  
 
Denominator:  
Number of patients aged 65 years or older admitted to the hospital with a diagnosis 
of upper femur fracture who were surgically treated in the specified year [Hip fracture 
diagnostic codes: ICD-10 S72.0, S72.1, S72.2 or ICD-9 820]. 
 
Technical notes: 
 - “Within two calendar days” is defined as:  
1. Treated on Day 0 (same day as admission)  
2. Treated on Day 1 (next day)  
3. Treated on Day 2. 
 
 - The following cases need to be included in both numerator and denominator:  
1. Fixation, hip joint.  
2. Application of external fixator device.  
3. Implantation of internal device, hip joint.  
4. Fixation, femur.  
5. Implantation of internal device pelvis. 
6. Closed reduction of fracture with internal fixation.  
7. Open reduction of fracture with internal fixation.  
8. Total hip replacement  
9. Partial hip replacement.  
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INDICATOR 60 (cont.) 
 
Technical notes (cont.): 
 
- The following cases were excluded from both numerator and denominator:  
 
1. Elective cases (admission not recorded as emergency).  
2. Events where hip fracture is coded as post-admission diagnosis on the 
index hospitalisation or the surgery hospitalisation (regardless of the 
admission category).  
3. Records with invalid admission, discharge or procedure date.  
4. Discharged as self-sign-out or did not return from a pass. 
 
____________________________________________________________________ 
 
INDICATOR 61 
PROPORTION OF POPULATION THAT ACCESSES OWN HEALTH DATA 
ON-LINE 
 
Definition:  
Proportion of the population aged 14 and over that has successfully logged into 
online services that provide access to the person’s own health data. 
 
Calculation:  
Number of persons successfully logging into the Government’s patient access portal 
(currently myHealth – www.mygov.mt) at least once during a calendar year, divided 
by the number of Maltese residents aged 14 and over. 
 
____________________________________________________________________ 
 
INDICATOR 62 
RATE PER CAPITA OF PRESCRIPTIONS TRANSACTED ON LINE 
 
Definition:  
Number of prescriptions transacted online (“ePrescriptions”) during a calendar 
year, expressed as a rate per capita of the resident Maltese population. 
 
Calculation:  
Number of completed ePrescription transactions during a calendar year, divided by 
the total number of Maltese residents. 
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SOCIO-ECONOMIC INDICATORS 
No. Indicator 
Trend over 
time 
International 
comparison 
55 
Share of population 65+/80+; old age 
dependency (65+/15-64). 
Stable Malta fares better 
58 
Percentage of population 25-64 with 
low educational attainment. 
Improving Malta fares worse 
57 
Proportion of population at risk of 
poverty or social exclusion. 
Deteriorating Malta fares better 
 
HEALTH STATUS Fair 1.88 
 
No. Indicator 
Trend over 
Time 
International 
comparison 
Assessment Score Weight 
46 
Self-perceived general 
health (SILC) 
according to income. 
Stable 
Malta fares 
better 
Good 3 2 
3 
Standardised mortality 
rates. 
Improving 
Malta fares 
the same 
Good 3 2 
5 
Standardised premature 
mortality rates. 
Improving 
Malta fares 
better 
Very good 4 3 
27 
Prevalence of adults 
with diabetes, 
hypertension, 
hypercholesterolae-mia 
More data / 
research is 
needed 
More 
data/research 
is needed 
More 
data/research 
is needed 
 3 
21 
Annual incidence of 
Type 1 diabetes in 
children. 
Deteriorating 
Malta fares 
the same 
Poor 1 1 
37 
Life expectancy at birth 
and at age 65. 
Stable 
Malta fares 
better 
Good 3 3 
17 
Incidence rate of TB, 
and multi drug resistant 
notification rate. 
Deteriorating 
Malta fares 
the same 
Poor 1 2 
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HEALTH STATUS (cont.) Fair 1.88 
 
No. Indicator 
Trend over 
Time 
International 
comparison 
Assessment Score Weight 
31a 
Notification rate of 
HIV per 100,000 
population. 
Deteriorating 
Malta fares 
worse 
Very poor 0.1 1.5 
31b 
Notification rate of 
Hepatitis B per 100,000 
population. 
More 
data/research 
is needed 
More 
data/research 
is needed 
More 
data/research 
is needed 
 1 
7a Perinatal mortality rate Stable 
Malta fares 
better 
Satisfactory 2 2.5 
7b Infant mortality rate Stable 
Malta fares 
worse 
Very poor 0.1 3 
9 
Child mortality rate  
(1-14 years). 
Improving 
Malta fares 
worse 
Satisfactory 2 3 
6a 
Standardised Cancer 
Incidence Rates – 
Colorectal 
Deteriorating 
Malta fares 
better 
Satisfactory 2 2.5 
6b 
Standardised Cancer 
Incidence Rates –  
Lung 
Deteriorating 
Malta fares 
better 
Satisfactory 2 2.5 
6c 
Standardised Cancer 
Incidence Rates – 
Prostate 
Deteriorating 
Malta fares 
better 
Satisfactory 2 2 
6d 
Standardised Cancer 
Incidence Rates – 
Cervical 
Deteriorating 
Malta fares 
better 
Satisfactory 2 2.5 
6e 
Standardised Cancer 
Incidence Rates – 
Breast 
Deteriorating 
Malta fares 
worse 
Very poor 0.1 3 
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DETERMINANTS OF HEALTH Poor 1.30 
 
No. Indicator 
Trend over 
time 
International 
comparison 
Assessment Score Weight 
22 
Prevalence of smoking 
in males and females in 
over 15 year olds. 
Stable 
Malta fares 
better 
Good 3 3 
33 
Proportion of the 
population who are 
overweight and obese. 
Deteriorating 
Malta fares 
worse 
Very Poor 0.1 3 
51 Rate of binge drinking. Deteriorating 
Malta fares 
worse 
Very Poor 0.1 1.5 
52 
Percentage of the 
resident population in 
Malta aged over 15 
years who report 
consuming fruit and/or 
vegetables daily. 
Deteriorating 
Malta fares 
better 
Satisfactory 2 1.5 
53 
Proportion of the 
population who report 
conducting more than 
2.5 hours of physical 
activity per week. 
Stable 
More data / 
research is 
needed 
Poor 1 2.5 
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EFFICIENCY Poor 1.38 
 
No. Indicator 
Trend over 
time 
International 
comparison 
Assessment Score Weight 
15 
Hospital inpatient 
average length of stay 
Deteriorating 
Malta fares 
better 
Satisfactory 2 3 
40 
Day case discharges as a 
percentage of curative 
care discharges 
Stable 
Malta fares 
worse 
Poor 1 3 
60 
Hip fracture surgery 
initiated within two 
calendar days after 
admission to  
Mater Dei Hospital 
Deteriorating 
Malta fares 
the same 
Poor 1 2 
62 
Rate per capita of 
prescriptions  
transacted online 
More 
data/research 
is needed 
More 
data/research 
is needed 
More 
data/research 
is needed 
 2 
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ACCESS Fair 1.61 
 
No. Indicator 
Trend over 
Time 
International 
comparison 
Assessment Score Weight 
47 
Unmet need by 
income quintile. 
Improving 
Malta fares 
better 
Very good 4 2 
13 Self-referrals to A&E. Poor 
More data / 
research is 
needed 
Very poor 0.1 2 
14 
Waiting times for 
appointment at  
out-patient clinics. 
More data / 
research is 
needed 
More data / 
research is 
needed 
More data / 
research is 
needed 
 3 
23a 
(Median) waiting 
times for admission to 
the public 
rehabilitation facility. 
Stable 
More data / 
research is 
needed 
Good 3 2 
23b 
(Median) waiting 
times for admission to 
the public long-term 
care facility. 
Deteriorating 
More data / 
research is 
needed 
Very poor 0.1 3 
30 
Waiting time for  
out-patient based 
investigations. 
More data / 
research is 
needed 
More data / 
research is 
needed 
More data / 
research is 
needed 
 3 
43 GP contacts per capita. 
More data / 
research is 
needed 
More data / 
research is 
needed 
More data / 
research is 
needed 
 2 
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RESPONSIVENESS Good 2.55 
 
No. Indicator 
Trend over 
time 
International 
comparison 
Assessment Score Weight 
2 
Response rate to 
screening programmes. 
Improving 
Malta fares 
the same 
Good 3 3 
16 
Percentage of infants 
fully vaccinated by first 
and second birthdays. 
Improving 
Malta fares 
better 
Very good 4 2.5 
32 
Number of vaccine 
preventable diseases 
covered by the national 
vaccination programme 
(2012). 
Stable 
Malta fares 
worse 
Satisfactory 2 2 
26 
Ratio of the number of 
discharges of older 
persons aged over 75 
years who are 
discharged from public 
acute hospital (Mater 
Dei Hospital) to their 
home of residence as 
compared to those 
discharged to long-
term facility. 
Deteriorating 
More data / 
research is 
needed 
Poor 1 2.5 
61 
Proportion of 
population that 
accesses own health 
data online. 
Improving 
More data / 
research is 
needed 
More data / 
research is 
needed 
 2 
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QUALITY Fair 1.93 
 
No. Indicator 
Trend Over 
Time 
International 
Comparison 
Assessment Score Weight 
18 
Hospital readmission 
rates within 30 days,  
by specialty. 
More data / 
research is 
needed 
More data / 
research is 
needed 
More data / 
research is 
needed 
 2.5 
1 
Five-year cancer  
survival rates. 
Improving 
Malta fares 
worse 
Satisfactory 2 3 
25 
Complications of 
diabetes - annual 
incidence rate of 
diabetic patients with 
complications. 
More data / 
research is 
needed 
More data / 
research is 
needed 
More data / 
research is 
needed 
 2.5 
12 
Incidence of  
MRSA hospital  
acquired infection. 
Improving 
Malta fares 
worse 
Satisfactory 2 2 
11 
Incidence rate of AIDS 
per 100,000 population 
More data / 
research is 
needed 
Malta fares 
worse 
Poor 1 2 
19 
Thirty (30) day in-
hospital mortality rate 
for specific clinical 
conditions. 
Stable 
Malta fares 
the same 
Satisfactory 2 3 
50 
Influenza vaccine 
coverage in  
over 65 years. 
More 
data/research 
is needed 
More 
data/research 
is needed 
More 
data/research 
is needed 
 2 
38 
Potential years of life 
lost from all causes. 
Stable 
Malta fares 
better 
Good 3 3 
28a 
Potentially avoidable 
hospital admission 
rates (standardised by 
age  
and sex) for asthma. 
Improving 
Malta fares 
worse 
Satisfactory 2 2.5 
28b 
Potentially avoidable 
hospital admission 
rates (standardised by 
age and sex) for CHF. 
Deteriorating 
Malta fares 
worse 
Very poor 0.1 3 
28c 
Potentially avoidable 
hospital admission 
rates (standardised by 
age and sex) for COAD 
Deteriorating 
Malta fares 
the same 
Poor 1 3 
4 
Maternal Mortality 
Ratio 
Improving 
Malta fares 
better 
Very Good 4 3 
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STEWARDSHIP UNDETERMINED 
 
No. Indicator 
Trend over 
Time 
International 
comparison 
Assessment Score Weight 
8 
Fatal accidents  
at the place of  
work / fatality rates 
(per economic sector) 
Improving 
Malta fares 
the same 
Good 3 1.5 
34 
Percentage of health 
budget allocated to 
public health, including 
preventive services. 
More data / 
research is 
needed 
More data / 
research is 
needed 
More data / 
research is 
needed 
 3 
39 
Public expenditure as a 
percentage of GDP  
for hospitals, 
ambulatory services 
and long term care. 
More data / 
research is 
needed 
More data / 
research is 
needed 
More data / 
research is 
needed 
 3 
45 
Generic share of 
pharmaceuticals in 
value/volume  
(public expenditure). 
More data / 
research is 
needed 
More data / 
research is 
needed 
More data / 
research is 
needed 
 2 
44 
Public outpatient 
pharmaceuticals as a 
percentage of GDP. 
More data / 
research is 
needed 
More data / 
research is 
needed 
More data / 
research is 
needed 
 2 
48 
Percentage of 
population covered by 
public health insurance 
(tax-based, public 
health insurance and 
income tax, including 
social security 
contribution schemes). 
More data / 
research is 
needed 
More data / 
research is 
needed 
More data / 
research is 
needed 
 2.5 
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RESOURCES Poor 1.40 
 
No. Indicator 
Trend over 
time 
International 
comparison 
Assessment 
Scor
e 
Weigh
t 
10 
Acute hospital bed 
occupancy rates. 
Stable 
Malta fares 
worse 
Poor 1 3 
20 
Number of hospital 
beds per 100,000 
population. 
Deteriorating 
Malta fares 
worse 
Very poor 0.1 3 
24 
Availability of 
diagnostic/therapeutic 
infrastructure. 
Stable 
Malta fares 
the same 
Satisfactory 2 3 
41a 
Numbers and ratios of 
all practising doctors, 
GPs, specialists per 
100,000 population. 
More data / 
research is 
needed 
Malta fares 
the same 
Satisfactory 2 2.5 
41b 
Numbers and ratios of 
all nurses per 100,000 
population. 
Improving 
Malta fares 
worse 
Satisfactory 2 3 
 
  
 425 
Appendix 14 (cont.) 
 
 
FINANCING Fair 1.66 
 
No. Indicator 
Trend over 
time 
International 
comparison 
Assessment Score Weight 
49 
Out of pocket health 
expenditure as a 
percentage of total 
health expenditure / 
private health 
expenditure. 
Stable 
Malta fares 
worse 
Poor 1 3 
35a 
Total health 
expenditure as a 
percentage of GDP. 
Stable 
Malta fares 
better 
Good 3 2.5 
35b 
Health expenditure as  
a percentage of  
GDP/per capita [pps]. 
More 
data/research 
is needed 
More 
data/research 
is needed 
More 
data/research 
is needed 
 2 
36a 
General government 
health expenditure as a 
percentage of total 
government expenditure. 
Stable 
Malta fares 
better 
Good 3 2.5 
36b 
General government 
health expenditure as a 
percentage of total 
health expenditure for 
2012. 
Deteriorating 
Malta fares 
worse 
Very poor 0.1 2 
36c 
Public-sector 
expenditure on health 
as a percentageof GDP. 
Stable 
Malta fares 
worse 
Poor 1 2.5 
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Dr Kenneth Grech’s nomination on EU HSPA Expert Group 
 
From: Gera Paula at MEAIM 
Sent: 30 October 2014 15:03 
To: Permanent Representative of Malta (EU) at MaltaRep (MEAIM) 
Cc: Calleja Antoinette at MEH-Health Information-Health; Demicoli Karen at 
MEH-DPDEUIA-Health; Mifsud Stephen M at MaltaRep; Gatt Moreau Nadine at 
MEAIM; Grech Kenneth at MDH-Health; Camilleri Darren at MaltaRep; Deputy 
Permanent Representative of Malta (EU) at MaltaRep; Genkhang Rigzin at MaltaRep; 
Pace Lupi Christine at MaltaRep; Head EU Secretariat at MEAIM 
 
Subject:  
Malta’s Nomination to the first expert group meeting on Health Systems Performance 
Assessment to be held on 10 November 2014 
 
Attachments:  
invitation_signed&registered_10-11-2014.pdf; draft agenda_10-11-2014.pdf 
 
Importance: High 
Health and Consumer Affairs Attaché 
 
Subject:  
Malta’s Nomination to the first expert group meeting on Health Systems Performance 
Assessment to be held on 10 November 2014. 
 
Kindly send the following nomination to SANCO-HSPA@ec.europa.eu 
 
“Reference is being made to Malta’s Nomination to the first expert group meeting on 
Health Systems Performance Assessment to be held on 10 November 2014. 
 
Kindly be informed that Malta’s representative is as follows: 
 
Name: Kenneth Grech 
Position: Consultant 
Address: Public Health Medicine 
  Ministry for Energy and Health 
  Mater Dei Hospital, 
  Triq Tal-Qroqq, 
  Msida, Malta 
Tel No: +356 22992462 
Email: kenneth.grech@gov.mt 
 
Paula  
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From: SANCO-HSPA@ec.europa.eu [mailto:SANCO-HSPA@ec.europa.eu] 
Sent: Tuesday, 21 October 2014 16:18 
To: philipp.tillich@bmeia.gv.at; kris.boers@diplobel.fed.be; david.royaux@diplobel.fed.be; 
Zlatimira.dobreva@bg-permrep.eu; tea.kelviser@mvep.hr; lgeorgiou@mphs.moh.gov.cy; 
klambraki@mphs.moh.gov.cy; eva_gottvaldova@mzv.cz; maloro@um.dk; tairi.taht@mfa.ee; 
sari.vuorinen@formin.fi; vincent.houdry@diplomatie.gouv.fr; ges-10-eu@brue.auswaertiges-
amt.de; a.lanaras@rp-grece.be; laszlo.bencze@mfa.gov.hu; eddie.oreilly@dfa.ie; 
sanita@rpue.esteri.it; karina.zalite@mfa.gov.lv; svens.henkuzens@mfa.gov.lv; 
sandra.rumseviciute@eu.mfa.lt; laura.valli@mae.etat.lu; Mifsud Stephen M at MaltaRep; 
Marianne.Vaes@minbuza.nl; lilianna.michalik@msz.gov.pl; ljb@reper-portugal.be; 
stefan.staicu@rpro.eu; alexandra.turkovicova@mzv.sk; gabrijela.korze@gov.si; 
francisco.sevilla@reper.maec.es; thomas.allvin@gov.se; Rebecca.brown@fco.gov.uk; 
E.Nolte@lse.ac.uk; Pascal.meeus@inami.fgov.be; Lieven.deraedt@health.fgov.be; 
friederike.botzenhardt@bmg.bund.de; irene.keinhorst@bmg.bund.de; mbho@sum.dk; 
chm@sum.dk; liis.roovali@sm.ee; secretary.gen@yyka.gov.gr; secretary.gen@moh.gov.gr; 
nmaniadakis@esdy.edu.gr; felix.faucon@sante.gouv.fr; eric.trottmann@sante.gouv.fr; 
dijana.cimera@miz.hr; mihalicza.peter@gyemszi.hu; kristine.klavina@vm.gov.lv; 
Beate.Margrethe.Huseby@helsedir.no; jml@reper-portugal.be 
 
Cc: Nathalie.Chaze@ec.europa.eu; Andrzej.RYS@ec.europa.eu; 
Federico.PAOLI@ec.europa.eu; Dirk.VAN-DEN-STEEN@ec.europa.eu; 
olivia.wigzell@regeringskansliet.se; Ingrid.Schmidt@regeringskansliet.se; jfi@obs.euro.who.int; 
Gaetan.LAFORTUNE@oecd.org 
 
Subject: FOR YOUR ATTENTION: Invitation to the first expert group meeting on 
health systems performance assessment – 10 November 2014. 
 
Dear all, 
See attached an invitation to the first expert group meeting on health systems 
performance assessment that will take place on 10 November 2014 in Brussels.  
We also enclose a draft agenda of the meeting.  
 
I kindly remind those Member States who have not nominated their representative(s) 
to the expert group yet to please do so as soon as possible and not later than Friday 24 
October by notifying the secretariat at SANCO-HSPA@ec.europa.eu. Please specify 
if s/he will attend the meeting on the 10th of November. 
 
Best regards,  
 
On behalf of the HSPA secretariat,  
Katarina Dvorska  
Katarina Dvorska 
Assistant 
European Commission 
Directorate-General for Health and Consumers 
Healthcare systems 
Workforce & Patient Safety & Patients' Rights team B232 08/63B-1049  
Brussels/Belgium+32 229-96329 
katarina.dvorska@ec.europa.eu
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List of email correspondence requesting permission from 
participants and experts of HSPA Expert Group and other meetings 
 
Recipient Subject Received 
Patrizia Theurer 
AW: HSPA Presentation - Rome,  
April 2016 
02/11/2016 
Ralf Jacob RE: Peer Review Presentation 12/10/2016 
Francesca Avolio 
R: HSPA - Integrated Care Presentation - 
Rome, April 2016 
11/10/2016 
Niek Klazinga RE: HSPA - Presentation 06/10/2016 
Giada Li Calzi 
Re: HSPA - Integrated Care Presentation - 
Rome, April 2016 
05/10/2016 
Ellen Nolte 
RE: HSPA Presentation - Rome,  
April 2016 
05/10/2016 
Pascal Meeus 
RE: HSPA Presentation - Rome,  
April 2016 
04/10/2016 
Florian Bachner AW: HPSA Presentation - Rome, April 2016 04/10/2016 
Maria M Hofmarcher-
Holzhacker 
AW: HSPA Presentation - Rome, 2016 04/10/2016 
Thilo Grüning HSPA Presentation - Berlin 24/11/2015 
Michael van den Berg Re: HPSA Presentation - May 2015 24/11/2015 
Ellen Nolte RE: HSPA Presentations 23/11/2015 
Peter Mihalicza RE: HPSA Presentation - February 2015 23/11/2015 
Sabina Nuti R: HPSA Presentation - February 2015 23/11/2015 
Thilo Grüning HSPA Presentation - Berlin 20/11/2015 
Pascal Meeus 
RE: Presentations during Peer Review 
Meeting held in Brussels in May 2014 
20/11/2015 
Peter C Smith 
Re: Presentations during Peer Review 
Meeting held in Brussels in May 2014 
20/11/2015 
Juan Tello RE: HSPA Presentation - Berlin  20/11/2015 
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Recipient Subject Received 
Enrique Bernal-Delgado Re: HPSA Presentation - May 2015 20/11/2015 
Kjell Asplund Re: HSPA Presentation - February 2015 19/11/2015 
CI HSD RE: HSPA Presentation - Berlin  19/11/2015 
Christof Veit AW: HSPA Presentation - Berlin  19/11/2015 
Olivia Wigzell Re: HSPA Presentations 19/11/2015 
Marina Davoli Re: HPSA Presentation - February 2015 19/11/2015 
Keith Derbyshire RE: HSPA Presentation - Berlin 19/11/2015 
Felix Faucon RE: HPSA Presentation - May 2015 19/11/2015 
Mikko Peltola VS: HSPA Presentation - Berlin 19/11/2015 
Elvtegen Henning SV: HPSA Presentation - February 2015 19/11/2015 
Federico Paoli RE: HSPA Presentations 19/11/2015 
Gaetan Lafortune RE: HPSA Presentation - February 2015 19/11/2015 
Niek Kalzinga RE: HSPA Presentation - May 2015 19/11/2015 
Hans Kluge HSPA Presentation - Berlin  19/11/2015 
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Ethical approval from the University of Warwick  
Biomedical and Scientific Research Ethics Committee 
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Appendix 18 
Publications and Projects 
 
 
PUBLICATIONS 
 
Azzopardi-Muscat N., Grech K., Cachia JM., Xuereb D.  Sharing capacities–Malta 
and the United Kingdom. In: Rosenmoller M, McKee M, Baeten R, editors. 
Patient Mobility in the European Union Learning from Experience Copenhagen.  
Publisher: World Health Organisation Copenhagen.  2006.  Pp.119. 
 
Azzopardi-Muscat N., Grech K.  Malta. In: Bernd R, Dubois CA, McKee M, editors. 
The Health Care Workforce in Europe: Learning from Experience.  Chapter 5 
Malta, Publisher: World Health Organisation. 2006.  Pp.59-70 
 
Azzopardi Muscat, N. and Grech, N., 2005. Case-study: Malta. Human resources for 
health in Europe. Copenhagen, European Observatory on Health Systems and 
Policies. 
 
Azzopardi Muscat N., Grech K., Buttigieg S.  Challenges and policy concerns for 
health systems in small European states; The European Journal of Public Health 
24 (Suppl. 2) October 2014 
 
Azzopardi Muscat N., Grech K.  Implementation of the patients’ rights and cross 
border care directive in Malta: A window of opportunity for domestic health 
system reform.  Health Systems and Policy Monitor Network, Berlin, 2014. 
 
Azzopardi-Muscat N., Funk T., Buttigieg SC., Grech K., Brand H.  Policy challenges 
and reforms in small EU member state health systems: a narrative literature 
review.  European Journal of Public Health, Volume 26, Issue 6, 1 December 
2016, Pages 916–922. 
 
Azzopardi-Muscat N., Calleja N., Grech K.  Trends in the performance of the Maltese 
Health System.  Seminar on Resilience.  WHO Collaborating Centre for Health 
Systems and Policies in Small States, Islands and Small State Institute, University 
of Malta.  Tuesday 17th October 2017. 
 
Buttigieg, SC., Azzopardi Muscat, N., Grech, K.  Malta: Reform of the Medical 
Profession and Reversal of Brain Drain in Malta: A Success Story in Braithwaite, 
J., Mannion, R., Matsuyama, J., Shekelle, P., Whittaker, S., Al-Adawi S.  
(Editors).  Health Systems Improvement Across the Globe; Success Stories from 
60 Countries.  CRC Press; 2017. 
 
Azzopardi-Muscat N., Grech K., Buttigieg SC.  Strengthening the primary care sector 
and workforce in Malta: upskilling, diversifying, empowering in Wismar, M., 
Glinos IA., Sagan A. (Eds).  Patients, peers, professionals: Skill-mix innovations 
and developments in primary and chronic care settings.  (In progress). 
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Buttigieg SC., Grech K., Azzopardi-Muscat N.  Malta: The National Cancer Plan: 
Strengthening the System in Braithwaite, J., Mannion, R., Matsuyama, J., 
Shekelle, P., Whittaker, S., Al-Adawi S (Editors).  Health Care Systems: Future 
Predictions for Global Care. Taylor & Francis.  (In progress). 
 
Grech K., 2017. Quality of Care and Innovative Funding. In EIT Health (Eds).  
Assessing Performance and Driving Innovation in Health Systems.  8 December 
2017. Jussieu Campus, Paris. 
 
Grech K., Azzopardi Muscat N., Calleja N.  The performance of the Maltese health 
system: An idiosyncratic story.  European Journal of Public Health Volume 25 
Supplement 3 (2014). 
 
Grech K., Lai T.  The challenges of developing and implementing a Health System 
Performance Assessment Framework in small states – the experience of Malta 
and Estonia.  The European Journal of Public Health 10/2014; 24 (suppl_2). 
 
Grech K., Podesta M., Calleja A., Calleja N.  Performance of the Maltese Health 
System.  Ministry for Energy and Health (Health), Valletta, Malta. 2015. 
 
 
Jakovljevic MM., Camilleri C., Rancic N., Grima S., Jurisevic M., Grech K., Buttigieg S.  
Cold War Legacy in Public and Private Health Spending in Europe.  Frontiers in Public 
Health (Health Economics).  Under Review. 
 
 
 
PROJECTS 
 
Co-Chair and Member of the European Commission Expert Group on Health System 
Performance Assessment (2014- date).  Reports on Performance Assessment of 
Quality of Care; Integrated Care; Primary Health Care; Resilience. 
 
Principal Advisor in EU funded project coordinated by the Strategic Reform Support 
Service (EU Commission) in developing national Health System Performance 
Assessment Frameworks for the Governments of Latvia and Slovenia, 2017-
2019. 
 
Collaborator and co-researcher in multi-national and multi-centred EU funded 
Horizon 2020 project – To Reach, Transforming Innovation in Health Systems.  
 
Member of the WHO Collaborating Centre for Health Systems and Policies in Small 
States, Islands and Small State Institute, University of Malta.  Responsible for tier 
on Performance and Governance of Health Systems. 
 
